{
 "cells": [
  {
   "cell_type": "code",
   "execution_count": 1,
   "id": "78d40c64",
   "metadata": {},
   "outputs": [],
   "source": [
    "import pandas as pd\n",
    "import os\n",
    "\n",
    "import requests\n",
    "import json\n",
    "import numpy as np\n",
    "from time import sleep\n",
    "import re\n",
    "from copy import deepcopy\n",
    "\n",
    "# improt zip-file stuff\n",
    "import unicodedata\n",
    "from zipfile import ZipFile\n",
    "from bs4 import BeautifulSoup as bsp\n",
    "from io import StringIO, BytesIO\n",
    "import json"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 2,
   "id": "a6661026",
   "metadata": {},
   "outputs": [],
   "source": [
    "working_directory = os.getcwd()"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "98daaf99",
   "metadata": {},
   "source": [
    "# Download FDA_DB.zip"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 5,
   "id": "86ae9b42",
   "metadata": {},
   "outputs": [],
   "source": [
    "os.mkdir(os.path.join(working_directory, '0_zip_files'))\n",
    "os.mkdir(os.path.join(working_directory, '1_unzipped_current_files'))"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 7,
   "id": "a2647fcc",
   "metadata": {},
   "outputs": [],
   "source": [
    "url = 'https://www.fda.gov/drugs/drug-approvals-and-databases/drugsfda-data-files'\n",
    "url_req = requests.get(url, headers={'User-Agent':'Custom'})\n",
    "new_str = unicodedata.normalize(\"NFKD\", url_req.text)\n",
    "soup = bsp(new_str, 'html.parser')\n",
    "\n",
    "link = soup.find('div', class_='col-md-8 col-md-push-2')\n",
    "\n",
    "link_fin = 'https://www.fda.gov' + link.ul.li.a['href']\n",
    "sleep(3)\n",
    "r = requests.get(link_fin, stream=True)\n",
    "\n",
    "with open(os.path.join(working_directory, '0_zip_files', f'FDA_database.zip'), 'wb') as f:\n",
    "    f.write(r.content)\n",
    "\n",
    "with ZipFile(os.path.join(working_directory, '0_zip_files', f'FDA_database.zip'), 'r') as zipObj:\n",
    "    zipObj.extractall(os.path.join(working_directory, '1_unzipped_current_files'))"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "ce6508ec",
   "metadata": {},
   "source": [
    "# Prepare extracted files"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 8,
   "id": "99431af2",
   "metadata": {
    "scrolled": true
   },
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "C:\\Users\\user79\\AppData\\Local\\Temp\\ipykernel_4724\\688377870.py:1: FutureWarning: The error_bad_lines argument has been deprecated and will be removed in a future version. Use on_bad_lines in the future.\n",
      "\n",
      "\n",
      "  df_mark_st = pd.read_csv(os.path.join(working_directory, '1_unzipped_current_files/MarketingStatus.txt'), sep='\\t', encoding = \"cp1252\", error_bad_lines=False)\n",
      "C:\\Users\\user79\\AppData\\Local\\Temp\\ipykernel_4724\\688377870.py:2: FutureWarning: The error_bad_lines argument has been deprecated and will be removed in a future version. Use on_bad_lines in the future.\n",
      "\n",
      "\n",
      "  df_product = pd.read_csv(os.path.join(working_directory, '1_unzipped_current_files/Products.txt'), sep='\\t', encoding = \"cp1252\", error_bad_lines=False)\n",
      "Skipping line 35350: expected 8 fields, saw 9\n",
      "Skipping line 35351: expected 8 fields, saw 9\n",
      "Skipping line 35352: expected 8 fields, saw 9\n",
      "Skipping line 43879: expected 8 fields, saw 9\n",
      "Skipping line 43981: expected 8 fields, saw 9\n",
      "Skipping line 43982: expected 8 fields, saw 9\n",
      "Skipping line 43983: expected 8 fields, saw 9\n",
      "Skipping line 43984: expected 8 fields, saw 9\n",
      "Skipping line 43985: expected 8 fields, saw 9\n",
      "Skipping line 44735: expected 8 fields, saw 9\n",
      "Skipping line 44736: expected 8 fields, saw 9\n",
      "Skipping line 44986: expected 8 fields, saw 9\n",
      "\n",
      "C:\\Users\\user79\\AppData\\Local\\Temp\\ipykernel_4724\\688377870.py:3: FutureWarning: The error_bad_lines argument has been deprecated and will be removed in a future version. Use on_bad_lines in the future.\n",
      "\n",
      "\n",
      "  df_types = pd.read_csv(os.path.join(working_directory, '1_unzipped_current_files/Applications.txt'), sep='\\t', encoding = \"cp1252\", error_bad_lines=False)\n"
     ]
    }
   ],
   "source": [
    "df_mark_st = pd.read_csv(os.path.join(working_directory, '1_unzipped_current_files/MarketingStatus.txt'), sep='\\t', encoding = \"cp1252\", error_bad_lines=False)\n",
    "df_product = pd.read_csv(os.path.join(working_directory, '1_unzipped_current_files/Products.txt'), sep='\\t', encoding = \"cp1252\", error_bad_lines=False)\n",
    "df_types = pd.read_csv(os.path.join(working_directory, '1_unzipped_current_files/Applications.txt'), sep='\\t', encoding = \"cp1252\", error_bad_lines=False)\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 9,
   "id": "5f822a65",
   "metadata": {
    "scrolled": true
   },
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>ApplNo</th>\n",
       "      <th>ProductNo</th>\n",
       "      <th>Form</th>\n",
       "      <th>Strength</th>\n",
       "      <th>ReferenceDrug</th>\n",
       "      <th>DrugName</th>\n",
       "      <th>ActiveIngredient</th>\n",
       "      <th>ReferenceStandard</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>4</td>\n",
       "      <td>4</td>\n",
       "      <td>SOLUTION/DROPS;OPHTHALMIC</td>\n",
       "      <td>1%</td>\n",
       "      <td>0</td>\n",
       "      <td>PAREDRINE</td>\n",
       "      <td>HYDROXYAMPHETAMINE HYDROBROMIDE</td>\n",
       "      <td>0.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>159</td>\n",
       "      <td>1</td>\n",
       "      <td>TABLET;ORAL</td>\n",
       "      <td>500MG</td>\n",
       "      <td>0</td>\n",
       "      <td>SULFAPYRIDINE</td>\n",
       "      <td>SULFAPYRIDINE</td>\n",
       "      <td>0.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>552</td>\n",
       "      <td>1</td>\n",
       "      <td>INJECTABLE;INJECTION</td>\n",
       "      <td>20,000 UNITS/ML</td>\n",
       "      <td>0</td>\n",
       "      <td>LIQUAEMIN SODIUM</td>\n",
       "      <td>HEPARIN SODIUM</td>\n",
       "      <td>0.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>552</td>\n",
       "      <td>2</td>\n",
       "      <td>INJECTABLE;INJECTION</td>\n",
       "      <td>40,000 UNITS/ML</td>\n",
       "      <td>0</td>\n",
       "      <td>LIQUAEMIN SODIUM</td>\n",
       "      <td>HEPARIN SODIUM</td>\n",
       "      <td>0.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>552</td>\n",
       "      <td>3</td>\n",
       "      <td>INJECTABLE;INJECTION</td>\n",
       "      <td>5,000 UNITS/ML</td>\n",
       "      <td>0</td>\n",
       "      <td>LIQUAEMIN SODIUM</td>\n",
       "      <td>HEPARIN SODIUM</td>\n",
       "      <td>0.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>...</th>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>45246</th>\n",
       "      <td>761289</td>\n",
       "      <td>1</td>\n",
       "      <td>INJECTABLE;INTRAVENOUS</td>\n",
       "      <td>25MG/1.25ML(20MG/ML)</td>\n",
       "      <td>0</td>\n",
       "      <td>IMJUDO</td>\n",
       "      <td>TREMELIMUMAB-ACTL</td>\n",
       "      <td>0.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>45247</th>\n",
       "      <td>761289</td>\n",
       "      <td>2</td>\n",
       "      <td>INJECTABLE;INTRAVENOUS</td>\n",
       "      <td>300MG/15ML(20MG/ML)</td>\n",
       "      <td>0</td>\n",
       "      <td>IMJUDO</td>\n",
       "      <td>TREMELIMUMAB-ACTL</td>\n",
       "      <td>0.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>45248</th>\n",
       "      <td>761291</td>\n",
       "      <td>1</td>\n",
       "      <td>INJECTABLE;INJECTION</td>\n",
       "      <td>30MG/3ML(10MG/ML)</td>\n",
       "      <td>0</td>\n",
       "      <td>TECVAYLI</td>\n",
       "      <td>TECLISTAMAB-CQYV</td>\n",
       "      <td>0.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>45249</th>\n",
       "      <td>761291</td>\n",
       "      <td>2</td>\n",
       "      <td>INJECTABLE;INJECTION</td>\n",
       "      <td>153MG/1.7ML(90MG/ML)</td>\n",
       "      <td>0</td>\n",
       "      <td>TECVAYLI</td>\n",
       "      <td>TECLISTAMAB-CQYV</td>\n",
       "      <td>0.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>45250</th>\n",
       "      <td>761310</td>\n",
       "      <td>1</td>\n",
       "      <td>INJECTABLE;INJECTION</td>\n",
       "      <td>100mg/20mL single-dose vial</td>\n",
       "      <td>0</td>\n",
       "      <td>ELAHERE</td>\n",
       "      <td>MIRVETUXIMAB SORAVTANSINE-GYNX</td>\n",
       "      <td>0.0</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>45251 rows × 8 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "       ApplNo  ProductNo                       Form  \\\n",
       "0           4          4  SOLUTION/DROPS;OPHTHALMIC   \n",
       "1         159          1                TABLET;ORAL   \n",
       "2         552          1       INJECTABLE;INJECTION   \n",
       "3         552          2       INJECTABLE;INJECTION   \n",
       "4         552          3       INJECTABLE;INJECTION   \n",
       "...       ...        ...                        ...   \n",
       "45246  761289          1     INJECTABLE;INTRAVENOUS   \n",
       "45247  761289          2     INJECTABLE;INTRAVENOUS   \n",
       "45248  761291          1       INJECTABLE;INJECTION   \n",
       "45249  761291          2       INJECTABLE;INJECTION   \n",
       "45250  761310          1       INJECTABLE;INJECTION   \n",
       "\n",
       "                          Strength  ReferenceDrug          DrugName  \\\n",
       "0                               1%              0         PAREDRINE   \n",
       "1                            500MG              0     SULFAPYRIDINE   \n",
       "2                  20,000 UNITS/ML              0  LIQUAEMIN SODIUM   \n",
       "3                  40,000 UNITS/ML              0  LIQUAEMIN SODIUM   \n",
       "4                   5,000 UNITS/ML              0  LIQUAEMIN SODIUM   \n",
       "...                            ...            ...               ...   \n",
       "45246         25MG/1.25ML(20MG/ML)              0            IMJUDO   \n",
       "45247          300MG/15ML(20MG/ML)              0            IMJUDO   \n",
       "45248            30MG/3ML(10MG/ML)              0          TECVAYLI   \n",
       "45249         153MG/1.7ML(90MG/ML)              0          TECVAYLI   \n",
       "45250  100mg/20mL single-dose vial              0           ELAHERE   \n",
       "\n",
       "                      ActiveIngredient  ReferenceStandard  \n",
       "0      HYDROXYAMPHETAMINE HYDROBROMIDE                0.0  \n",
       "1                        SULFAPYRIDINE                0.0  \n",
       "2                       HEPARIN SODIUM                0.0  \n",
       "3                       HEPARIN SODIUM                0.0  \n",
       "4                       HEPARIN SODIUM                0.0  \n",
       "...                                ...                ...  \n",
       "45246              TREMELIMUMAB-ACTL                  0.0  \n",
       "45247              TREMELIMUMAB-ACTL                  0.0  \n",
       "45248                 TECLISTAMAB-CQYV                0.0  \n",
       "45249                 TECLISTAMAB-CQYV                0.0  \n",
       "45250   MIRVETUXIMAB SORAVTANSINE-GYNX                0.0  \n",
       "\n",
       "[45251 rows x 8 columns]"
      ]
     },
     "execution_count": 9,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df_product"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 11,
   "id": "2aa5f2fe",
   "metadata": {},
   "outputs": [],
   "source": [
    "df_mark_st['MarketingStatusID'] = df_mark_st['MarketingStatusID'].replace(3, 'Discontinued').replace(1, 'Prescription').replace(2, 'Over-the-counter').replace(4, 'None (Tentative Approval)')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 57,
   "id": "9a93790e",
   "metadata": {},
   "outputs": [],
   "source": [
    "df_from_FDA = df_product.merge(df_mark_st, how='left').merge(df_types, how='left').drop_duplicates()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 13,
   "id": "3ceaddc0",
   "metadata": {
    "scrolled": true
   },
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>ApplNo</th>\n",
       "      <th>ProductNo</th>\n",
       "      <th>Form</th>\n",
       "      <th>Strength</th>\n",
       "      <th>ReferenceDrug</th>\n",
       "      <th>DrugName</th>\n",
       "      <th>ActiveIngredient</th>\n",
       "      <th>ReferenceStandard</th>\n",
       "      <th>MarketingStatusID</th>\n",
       "      <th>ApplType</th>\n",
       "      <th>ApplPublicNotes</th>\n",
       "      <th>SponsorName</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>4</td>\n",
       "      <td>4</td>\n",
       "      <td>SOLUTION/DROPS;OPHTHALMIC</td>\n",
       "      <td>1%</td>\n",
       "      <td>0</td>\n",
       "      <td>PAREDRINE</td>\n",
       "      <td>HYDROXYAMPHETAMINE HYDROBROMIDE</td>\n",
       "      <td>0.0</td>\n",
       "      <td>Discontinued</td>\n",
       "      <td>NDA</td>\n",
       "      <td>NaN</td>\n",
       "      <td>PHARMICS</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>159</td>\n",
       "      <td>1</td>\n",
       "      <td>TABLET;ORAL</td>\n",
       "      <td>500MG</td>\n",
       "      <td>0</td>\n",
       "      <td>SULFAPYRIDINE</td>\n",
       "      <td>SULFAPYRIDINE</td>\n",
       "      <td>0.0</td>\n",
       "      <td>Discontinued</td>\n",
       "      <td>NDA</td>\n",
       "      <td>NaN</td>\n",
       "      <td>LILLY</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>552</td>\n",
       "      <td>1</td>\n",
       "      <td>INJECTABLE;INJECTION</td>\n",
       "      <td>20,000 UNITS/ML</td>\n",
       "      <td>0</td>\n",
       "      <td>LIQUAEMIN SODIUM</td>\n",
       "      <td>HEPARIN SODIUM</td>\n",
       "      <td>0.0</td>\n",
       "      <td>Discontinued</td>\n",
       "      <td>NDA</td>\n",
       "      <td>NaN</td>\n",
       "      <td>ORGANON USA INC</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>552</td>\n",
       "      <td>2</td>\n",
       "      <td>INJECTABLE;INJECTION</td>\n",
       "      <td>40,000 UNITS/ML</td>\n",
       "      <td>0</td>\n",
       "      <td>LIQUAEMIN SODIUM</td>\n",
       "      <td>HEPARIN SODIUM</td>\n",
       "      <td>0.0</td>\n",
       "      <td>Discontinued</td>\n",
       "      <td>NDA</td>\n",
       "      <td>NaN</td>\n",
       "      <td>ORGANON USA INC</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>552</td>\n",
       "      <td>3</td>\n",
       "      <td>INJECTABLE;INJECTION</td>\n",
       "      <td>5,000 UNITS/ML</td>\n",
       "      <td>0</td>\n",
       "      <td>LIQUAEMIN SODIUM</td>\n",
       "      <td>HEPARIN SODIUM</td>\n",
       "      <td>0.0</td>\n",
       "      <td>Discontinued</td>\n",
       "      <td>NDA</td>\n",
       "      <td>NaN</td>\n",
       "      <td>ORGANON USA INC</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>...</th>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>45246</th>\n",
       "      <td>761289</td>\n",
       "      <td>1</td>\n",
       "      <td>INJECTABLE;INTRAVENOUS</td>\n",
       "      <td>25MG/1.25ML(20MG/ML)</td>\n",
       "      <td>0</td>\n",
       "      <td>IMJUDO</td>\n",
       "      <td>TREMELIMUMAB-ACTL</td>\n",
       "      <td>0.0</td>\n",
       "      <td>Prescription</td>\n",
       "      <td>BLA</td>\n",
       "      <td>NaN</td>\n",
       "      <td>ASTRAZENECA AB</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>45247</th>\n",
       "      <td>761289</td>\n",
       "      <td>2</td>\n",
       "      <td>INJECTABLE;INTRAVENOUS</td>\n",
       "      <td>300MG/15ML(20MG/ML)</td>\n",
       "      <td>0</td>\n",
       "      <td>IMJUDO</td>\n",
       "      <td>TREMELIMUMAB-ACTL</td>\n",
       "      <td>0.0</td>\n",
       "      <td>Prescription</td>\n",
       "      <td>BLA</td>\n",
       "      <td>NaN</td>\n",
       "      <td>ASTRAZENECA AB</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>45248</th>\n",
       "      <td>761291</td>\n",
       "      <td>1</td>\n",
       "      <td>INJECTABLE;INJECTION</td>\n",
       "      <td>30MG/3ML(10MG/ML)</td>\n",
       "      <td>0</td>\n",
       "      <td>TECVAYLI</td>\n",
       "      <td>TECLISTAMAB-CQYV</td>\n",
       "      <td>0.0</td>\n",
       "      <td>Prescription</td>\n",
       "      <td>BLA</td>\n",
       "      <td>NaN</td>\n",
       "      <td>JANSSEN BIOTECH</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>45249</th>\n",
       "      <td>761291</td>\n",
       "      <td>2</td>\n",
       "      <td>INJECTABLE;INJECTION</td>\n",
       "      <td>153MG/1.7ML(90MG/ML)</td>\n",
       "      <td>0</td>\n",
       "      <td>TECVAYLI</td>\n",
       "      <td>TECLISTAMAB-CQYV</td>\n",
       "      <td>0.0</td>\n",
       "      <td>Prescription</td>\n",
       "      <td>BLA</td>\n",
       "      <td>NaN</td>\n",
       "      <td>JANSSEN BIOTECH</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>45250</th>\n",
       "      <td>761310</td>\n",
       "      <td>1</td>\n",
       "      <td>INJECTABLE;INJECTION</td>\n",
       "      <td>100mg/20mL single-dose vial</td>\n",
       "      <td>0</td>\n",
       "      <td>ELAHERE</td>\n",
       "      <td>MIRVETUXIMAB SORAVTANSINE-GYNX</td>\n",
       "      <td>0.0</td>\n",
       "      <td>Prescription</td>\n",
       "      <td>BLA</td>\n",
       "      <td>NaN</td>\n",
       "      <td>IMMUNOGEN INC</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>45251 rows × 12 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "       ApplNo  ProductNo                       Form  \\\n",
       "0           4          4  SOLUTION/DROPS;OPHTHALMIC   \n",
       "1         159          1                TABLET;ORAL   \n",
       "2         552          1       INJECTABLE;INJECTION   \n",
       "3         552          2       INJECTABLE;INJECTION   \n",
       "4         552          3       INJECTABLE;INJECTION   \n",
       "...       ...        ...                        ...   \n",
       "45246  761289          1     INJECTABLE;INTRAVENOUS   \n",
       "45247  761289          2     INJECTABLE;INTRAVENOUS   \n",
       "45248  761291          1       INJECTABLE;INJECTION   \n",
       "45249  761291          2       INJECTABLE;INJECTION   \n",
       "45250  761310          1       INJECTABLE;INJECTION   \n",
       "\n",
       "                          Strength  ReferenceDrug          DrugName  \\\n",
       "0                               1%              0         PAREDRINE   \n",
       "1                            500MG              0     SULFAPYRIDINE   \n",
       "2                  20,000 UNITS/ML              0  LIQUAEMIN SODIUM   \n",
       "3                  40,000 UNITS/ML              0  LIQUAEMIN SODIUM   \n",
       "4                   5,000 UNITS/ML              0  LIQUAEMIN SODIUM   \n",
       "...                            ...            ...               ...   \n",
       "45246         25MG/1.25ML(20MG/ML)              0            IMJUDO   \n",
       "45247          300MG/15ML(20MG/ML)              0            IMJUDO   \n",
       "45248            30MG/3ML(10MG/ML)              0          TECVAYLI   \n",
       "45249         153MG/1.7ML(90MG/ML)              0          TECVAYLI   \n",
       "45250  100mg/20mL single-dose vial              0           ELAHERE   \n",
       "\n",
       "                      ActiveIngredient  ReferenceStandard MarketingStatusID  \\\n",
       "0      HYDROXYAMPHETAMINE HYDROBROMIDE                0.0      Discontinued   \n",
       "1                        SULFAPYRIDINE                0.0      Discontinued   \n",
       "2                       HEPARIN SODIUM                0.0      Discontinued   \n",
       "3                       HEPARIN SODIUM                0.0      Discontinued   \n",
       "4                       HEPARIN SODIUM                0.0      Discontinued   \n",
       "...                                ...                ...               ...   \n",
       "45246              TREMELIMUMAB-ACTL                  0.0      Prescription   \n",
       "45247              TREMELIMUMAB-ACTL                  0.0      Prescription   \n",
       "45248                 TECLISTAMAB-CQYV                0.0      Prescription   \n",
       "45249                 TECLISTAMAB-CQYV                0.0      Prescription   \n",
       "45250   MIRVETUXIMAB SORAVTANSINE-GYNX                0.0      Prescription   \n",
       "\n",
       "      ApplType ApplPublicNotes      SponsorName  \n",
       "0          NDA             NaN         PHARMICS  \n",
       "1          NDA             NaN            LILLY  \n",
       "2          NDA             NaN  ORGANON USA INC  \n",
       "3          NDA             NaN  ORGANON USA INC  \n",
       "4          NDA             NaN  ORGANON USA INC  \n",
       "...        ...             ...              ...  \n",
       "45246      BLA             NaN   ASTRAZENECA AB  \n",
       "45247      BLA             NaN   ASTRAZENECA AB  \n",
       "45248      BLA             NaN  JANSSEN BIOTECH  \n",
       "45249      BLA             NaN  JANSSEN BIOTECH  \n",
       "45250      BLA             NaN    IMMUNOGEN INC  \n",
       "\n",
       "[45251 rows x 12 columns]"
      ]
     },
     "execution_count": 13,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df_from_FDA"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 14,
   "id": "fa73fe5e",
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "C:\\Users\\user79\\AppData\\Local\\Temp\\ipykernel_4724\\347543185.py:2: FutureWarning: The error_bad_lines argument has been deprecated and will be removed in a future version. Use on_bad_lines in the future.\n",
      "\n",
      "\n",
      "  df_appl_docs = pd.read_csv(os.path.join(working_directory, '1_unzipped_current_files/ApplicationDocs.txt'), sep='\\t', encoding = \"cp1252\", error_bad_lines=False)\n"
     ]
    }
   ],
   "source": [
    "# applDocs\n",
    "df_appl_docs = pd.read_csv(os.path.join(working_directory, '1_unzipped_current_files/ApplicationDocs.txt'), sep='\\t', encoding = \"cp1252\", error_bad_lines=False)\n",
    "df_appl_docs_just_labels = df_appl_docs[df_appl_docs['ApplicationDocsTypeID']==2]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 16,
   "id": "b7452a57",
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "C:\\Users\\user79\\AppData\\Local\\Temp\\ipykernel_4724\\2789387.py:1: SettingWithCopyWarning: \n",
      "A value is trying to be set on a copy of a slice from a DataFrame.\n",
      "Try using .loc[row_indexer,col_indexer] = value instead\n",
      "\n",
      "See the caveats in the documentation: https://pandas.pydata.org/pandas-docs/stable/user_guide/indexing.html#returning-a-view-versus-a-copy\n",
      "  df_appl_docs_just_labels['ApplicationDocsDate'] = pd.to_datetime(df_appl_docs_just_labels['ApplicationDocsDate'])\n"
     ]
    }
   ],
   "source": [
    "df_appl_docs_just_labels['ApplicationDocsDate'] = pd.to_datetime(df_appl_docs_just_labels['ApplicationDocsDate'])"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 56,
   "id": "b0f2a468",
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "100%|█████████████████████████████████████████████████████████████████████████████| 4547/4547 [00:10<00:00, 443.51it/s]\n"
     ]
    }
   ],
   "source": [
    "from tqdm import tqdm\n",
    "import warnings\n",
    "with warnings.catch_warnings():\n",
    "    warnings.simplefilter(\"ignore\")\n",
    "    warnings.filterwarnings(\"ignore\")\n",
    "    pd.options.mode.chained_assignment = None\n",
    "\n",
    "    df_appl_docs_latest_marked = pd.DataFrame()\n",
    "    for applNo, df in tqdm(df_appl_docs_just_labels.groupby('ApplNo')):\n",
    "        df_to_add = deepcopy(df)\n",
    "        df_sort = df_to_add.sort_values('ApplicationDocsDate', ascending=False).reset_index(drop=True)\n",
    "        # df_sort.loc[0, 'LatestFDALabel'] = True\n",
    "        df_appl_docs_latest_marked = df_appl_docs_latest_marked.append(df_sort.loc[[0]])"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 59,
   "id": "2fe1424f",
   "metadata": {
    "scrolled": true
   },
   "outputs": [],
   "source": [
    "df_appl_docs_latest_marked_fin = df_appl_docs_latest_marked[['ApplNo', 'ApplicationDocsURL']]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 60,
   "id": "3b7bb50d",
   "metadata": {},
   "outputs": [],
   "source": [
    "df_from_FDA = df_from_FDA.merge(df_appl_docs_latest_marked_fin, how='left')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 40,
   "id": "b2237da2",
   "metadata": {},
   "outputs": [],
   "source": [
    "# df_from_FDA['LatestFDALabel'] = df_from_FDA['LatestFDALabel'].fillna(False)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 74,
   "id": "61e6c17f",
   "metadata": {
    "scrolled": true
   },
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>ApplNo</th>\n",
       "      <th>Form</th>\n",
       "      <th>DrugName</th>\n",
       "      <th>ActiveIngredient</th>\n",
       "      <th>ApplType</th>\n",
       "      <th>SponsorName</th>\n",
       "      <th>ApplicationDocsURL</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>78</th>\n",
       "      <td>4782</td>\n",
       "      <td>TABLET;ORAL</td>\n",
       "      <td>PREMARIN</td>\n",
       "      <td>ESTROGENS, CONJUGATED</td>\n",
       "      <td>NDA</td>\n",
       "      <td>WYETH PHARMS</td>\n",
       "      <td>http://www.accessdata.fda.gov/drugsatfda_docs/...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>92</th>\n",
       "      <td>5213</td>\n",
       "      <td>TABLET;ORAL</td>\n",
       "      <td>HYCODAN</td>\n",
       "      <td>HOMATROPINE METHYLBROMIDE; HYDROCODONE BITARTRATE</td>\n",
       "      <td>NDA</td>\n",
       "      <td>GENUS</td>\n",
       "      <td>http://www.accessdata.fda.gov/drugsatfda_docs/...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>106</th>\n",
       "      <td>5378</td>\n",
       "      <td>TABLET;ORAL</td>\n",
       "      <td>DESOXYN</td>\n",
       "      <td>METHAMPHETAMINE HYDROCHLORIDE</td>\n",
       "      <td>NDA</td>\n",
       "      <td>KEY THERAP</td>\n",
       "      <td>http://www.accessdata.fda.gov/drugsatfda_docs/...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>140</th>\n",
       "      <td>5939</td>\n",
       "      <td>INJECTABLE;INJECTION</td>\n",
       "      <td>BAL</td>\n",
       "      <td>DIMERCAPROL</td>\n",
       "      <td>NDA</td>\n",
       "      <td>AKORN</td>\n",
       "      <td>http://www.accessdata.fda.gov/drugsatfda_docs/...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>151</th>\n",
       "      <td>6035</td>\n",
       "      <td>INJECTABLE;INJECTION</td>\n",
       "      <td>METHERGINE</td>\n",
       "      <td>METHYLERGONOVINE MALEATE</td>\n",
       "      <td>NDA</td>\n",
       "      <td>EDISON THERAPS LLC</td>\n",
       "      <td>http://www.accessdata.fda.gov/drugsatfda_docs/...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>...</th>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>45242</th>\n",
       "      <td>761269</td>\n",
       "      <td>INJECTABLE;INJECTION</td>\n",
       "      <td>LEQEMBI</td>\n",
       "      <td>LECANEMAB-IRMB</td>\n",
       "      <td>BLA</td>\n",
       "      <td>EISAI INC</td>\n",
       "      <td>https://www.accessdata.fda.gov/drugsatfda_docs...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>45244</th>\n",
       "      <td>761270</td>\n",
       "      <td>INJECTABLE;INTRAVENOUS, SUBCUTANEOUS</td>\n",
       "      <td>IMJUDO</td>\n",
       "      <td>TREMELIMUMAB-ACTL</td>\n",
       "      <td>BLA</td>\n",
       "      <td>ASTRAZENECA AB</td>\n",
       "      <td>https://www.accessdata.fda.gov/drugsatfda_docs...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>45246</th>\n",
       "      <td>761289</td>\n",
       "      <td>INJECTABLE;INTRAVENOUS</td>\n",
       "      <td>IMJUDO</td>\n",
       "      <td>TREMELIMUMAB-ACTL</td>\n",
       "      <td>BLA</td>\n",
       "      <td>ASTRAZENECA AB</td>\n",
       "      <td>http://www.accessdata.fda.gov/drugsatfda_docs/...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>45248</th>\n",
       "      <td>761291</td>\n",
       "      <td>INJECTABLE;INJECTION</td>\n",
       "      <td>TECVAYLI</td>\n",
       "      <td>TECLISTAMAB-CQYV</td>\n",
       "      <td>BLA</td>\n",
       "      <td>JANSSEN BIOTECH</td>\n",
       "      <td>http://www.accessdata.fda.gov/drugsatfda_docs/...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>45250</th>\n",
       "      <td>761310</td>\n",
       "      <td>INJECTABLE;INJECTION</td>\n",
       "      <td>ELAHERE</td>\n",
       "      <td>MIRVETUXIMAB SORAVTANSINE-GYNX</td>\n",
       "      <td>BLA</td>\n",
       "      <td>IMMUNOGEN INC</td>\n",
       "      <td>http://www.accessdata.fda.gov/drugsatfda_docs/...</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>3238 rows × 7 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "       ApplNo                                  Form    DrugName  \\\n",
       "78       4782                           TABLET;ORAL    PREMARIN   \n",
       "92       5213                           TABLET;ORAL     HYCODAN   \n",
       "106      5378                           TABLET;ORAL     DESOXYN   \n",
       "140      5939                  INJECTABLE;INJECTION         BAL   \n",
       "151      6035                  INJECTABLE;INJECTION  METHERGINE   \n",
       "...       ...                                   ...         ...   \n",
       "45242  761269                  INJECTABLE;INJECTION     LEQEMBI   \n",
       "45244  761270  INJECTABLE;INTRAVENOUS, SUBCUTANEOUS      IMJUDO   \n",
       "45246  761289                INJECTABLE;INTRAVENOUS      IMJUDO   \n",
       "45248  761291                  INJECTABLE;INJECTION    TECVAYLI   \n",
       "45250  761310                  INJECTABLE;INJECTION     ELAHERE   \n",
       "\n",
       "                                        ActiveIngredient ApplType  \\\n",
       "78                                 ESTROGENS, CONJUGATED      NDA   \n",
       "92     HOMATROPINE METHYLBROMIDE; HYDROCODONE BITARTRATE      NDA   \n",
       "106                        METHAMPHETAMINE HYDROCHLORIDE      NDA   \n",
       "140                                          DIMERCAPROL      NDA   \n",
       "151                             METHYLERGONOVINE MALEATE      NDA   \n",
       "...                                                  ...      ...   \n",
       "45242                                     LECANEMAB-IRMB      BLA   \n",
       "45244                                  TREMELIMUMAB-ACTL      BLA   \n",
       "45246                                TREMELIMUMAB-ACTL        BLA   \n",
       "45248                                   TECLISTAMAB-CQYV      BLA   \n",
       "45250                     MIRVETUXIMAB SORAVTANSINE-GYNX      BLA   \n",
       "\n",
       "              SponsorName                                 ApplicationDocsURL  \n",
       "78           WYETH PHARMS  http://www.accessdata.fda.gov/drugsatfda_docs/...  \n",
       "92                  GENUS  http://www.accessdata.fda.gov/drugsatfda_docs/...  \n",
       "106            KEY THERAP  http://www.accessdata.fda.gov/drugsatfda_docs/...  \n",
       "140                 AKORN  http://www.accessdata.fda.gov/drugsatfda_docs/...  \n",
       "151    EDISON THERAPS LLC  http://www.accessdata.fda.gov/drugsatfda_docs/...  \n",
       "...                   ...                                                ...  \n",
       "45242           EISAI INC  https://www.accessdata.fda.gov/drugsatfda_docs...  \n",
       "45244      ASTRAZENECA AB  https://www.accessdata.fda.gov/drugsatfda_docs...  \n",
       "45246      ASTRAZENECA AB  http://www.accessdata.fda.gov/drugsatfda_docs/...  \n",
       "45248     JANSSEN BIOTECH  http://www.accessdata.fda.gov/drugsatfda_docs/...  \n",
       "45250       IMMUNOGEN INC  http://www.accessdata.fda.gov/drugsatfda_docs/...  \n",
       "\n",
       "[3238 rows x 7 columns]"
      ]
     },
     "execution_count": 74,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df_from_FDA_fin = df_from_FDA[\n",
    "                            (df_from_FDA['MarketingStatusID']!='Discontinued')&\n",
    "                            # (df_from_FDA['ApplType'].isin(['NDA', 'BLA']))&\n",
    "                            (df_from_FDA['ApplicationDocsURL'].notnull())\n",
    "                            ].drop(['ProductNo', 'Strength', 'ReferenceDrug', 'ReferenceStandard', \n",
    "                                    'MarketingStatusID', 'ApplPublicNotes'], axis = 1).drop_duplicates(subset=['ApplNo'])\n",
    "df_from_FDA_fin"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 75,
   "id": "a9b8a400",
   "metadata": {
    "scrolled": true
   },
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>ApplNo</th>\n",
       "      <th>Form</th>\n",
       "      <th>DrugName</th>\n",
       "      <th>ActiveIngredient</th>\n",
       "      <th>ApplType</th>\n",
       "      <th>SponsorName</th>\n",
       "      <th>ApplicationDocsURL</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>29384</th>\n",
       "      <td>103792</td>\n",
       "      <td>VIAL; INTRAVENOUS</td>\n",
       "      <td>HERCEPTIN</td>\n",
       "      <td>TRASTUZUMAB</td>\n",
       "      <td>BLA</td>\n",
       "      <td>GENENTECH</td>\n",
       "      <td>http://www.accessdata.fda.gov/drugsatfda_docs/...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>29482</th>\n",
       "      <td>125427</td>\n",
       "      <td>VIAL; SINGLE-USE</td>\n",
       "      <td>KADCYLA</td>\n",
       "      <td>ADO-TRASTUZUMAB EMTANSINE</td>\n",
       "      <td>BLA</td>\n",
       "      <td>GENENTECH</td>\n",
       "      <td>http://www.accessdata.fda.gov/drugsatfda_docs/...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>45101</th>\n",
       "      <td>761073</td>\n",
       "      <td>VIAL; MULTIDOSE</td>\n",
       "      <td>KANJINTI</td>\n",
       "      <td>TRASTUZUMAB-ANNS</td>\n",
       "      <td>BLA</td>\n",
       "      <td>AMGEN INC</td>\n",
       "      <td>http://www.accessdata.fda.gov/drugsatfda_docs/...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>45103</th>\n",
       "      <td>761074</td>\n",
       "      <td>INJECTABLE;INJECTION</td>\n",
       "      <td>OGIVRI</td>\n",
       "      <td>TRASTUZUMAB-DKST</td>\n",
       "      <td>BLA</td>\n",
       "      <td>MYLAN GMBH</td>\n",
       "      <td>http://www.accessdata.fda.gov/drugsatfda_docs/...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>45114</th>\n",
       "      <td>761081</td>\n",
       "      <td>INJECTABLE;INJECTION</td>\n",
       "      <td>TRAZIMERA</td>\n",
       "      <td>TRASTUZUMAB-QYYP</td>\n",
       "      <td>BLA</td>\n",
       "      <td>PFIZER INC</td>\n",
       "      <td>http://www.accessdata.fda.gov/drugsatfda_docs/...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>45131</th>\n",
       "      <td>761091</td>\n",
       "      <td>INJECTABLE;INJECTION</td>\n",
       "      <td>HERZUMA</td>\n",
       "      <td>TRASTUZUMAB-PKRB</td>\n",
       "      <td>BLA</td>\n",
       "      <td>CELLTRION INC</td>\n",
       "      <td>http://www.accessdata.fda.gov/drugsatfda_docs/...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>45137</th>\n",
       "      <td>761100</td>\n",
       "      <td>POWDER;IV (INFUSION)</td>\n",
       "      <td>ONTRUZANT</td>\n",
       "      <td>TRASTUZUMAB-DTTB</td>\n",
       "      <td>BLA</td>\n",
       "      <td>SAMSUNG BIOEPIS CO LTD</td>\n",
       "      <td>http://www.accessdata.fda.gov/drugsatfda_docs/...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>45145</th>\n",
       "      <td>761106</td>\n",
       "      <td>INJECTABLE;SUBCUTANEOUS</td>\n",
       "      <td>HERCEPTIN HYLECTA</td>\n",
       "      <td>TRASTUZUMAB; HYALURONIDASE-OYSK</td>\n",
       "      <td>BLA</td>\n",
       "      <td>GENENTECH INC</td>\n",
       "      <td>http://www.accessdata.fda.gov/drugsatfda_docs/...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>45173</th>\n",
       "      <td>761139</td>\n",
       "      <td>INJECTABLE;INJECTION</td>\n",
       "      <td>ENHERTU</td>\n",
       "      <td>FAM-TRASTUZUMAB DERUXTECAN-NXKI</td>\n",
       "      <td>BLA</td>\n",
       "      <td>DAIICHI SANKYO</td>\n",
       "      <td>http://www.accessdata.fda.gov/drugsatfda_docs/...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>45192</th>\n",
       "      <td>761170</td>\n",
       "      <td>INJECTABLE;SUBCUTANEOUS</td>\n",
       "      <td>PHESGO</td>\n",
       "      <td>PERTUZUMAB;TRASTUZUMAB;HYALURONIDASE-ZZXF</td>\n",
       "      <td>BLA</td>\n",
       "      <td>GENENTECH INC</td>\n",
       "      <td>https://www.accessdata.fda.gov/drugsatfda_docs...</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "       ApplNo                     Form           DrugName  \\\n",
       "29384  103792        VIAL; INTRAVENOUS          HERCEPTIN   \n",
       "29482  125427         VIAL; SINGLE-USE            KADCYLA   \n",
       "45101  761073          VIAL; MULTIDOSE           KANJINTI   \n",
       "45103  761074     INJECTABLE;INJECTION             OGIVRI   \n",
       "45114  761081     INJECTABLE;INJECTION          TRAZIMERA   \n",
       "45131  761091     INJECTABLE;INJECTION            HERZUMA   \n",
       "45137  761100     POWDER;IV (INFUSION)          ONTRUZANT   \n",
       "45145  761106  INJECTABLE;SUBCUTANEOUS  HERCEPTIN HYLECTA   \n",
       "45173  761139     INJECTABLE;INJECTION            ENHERTU   \n",
       "45192  761170  INJECTABLE;SUBCUTANEOUS             PHESGO   \n",
       "\n",
       "                                ActiveIngredient ApplType  \\\n",
       "29384                                TRASTUZUMAB      BLA   \n",
       "29482                  ADO-TRASTUZUMAB EMTANSINE      BLA   \n",
       "45101                           TRASTUZUMAB-ANNS      BLA   \n",
       "45103                           TRASTUZUMAB-DKST      BLA   \n",
       "45114                           TRASTUZUMAB-QYYP      BLA   \n",
       "45131                           TRASTUZUMAB-PKRB      BLA   \n",
       "45137                           TRASTUZUMAB-DTTB      BLA   \n",
       "45145            TRASTUZUMAB; HYALURONIDASE-OYSK      BLA   \n",
       "45173            FAM-TRASTUZUMAB DERUXTECAN-NXKI      BLA   \n",
       "45192  PERTUZUMAB;TRASTUZUMAB;HYALURONIDASE-ZZXF      BLA   \n",
       "\n",
       "                  SponsorName  \\\n",
       "29384               GENENTECH   \n",
       "29482               GENENTECH   \n",
       "45101               AMGEN INC   \n",
       "45103              MYLAN GMBH   \n",
       "45114              PFIZER INC   \n",
       "45131           CELLTRION INC   \n",
       "45137  SAMSUNG BIOEPIS CO LTD   \n",
       "45145           GENENTECH INC   \n",
       "45173          DAIICHI SANKYO   \n",
       "45192           GENENTECH INC   \n",
       "\n",
       "                                      ApplicationDocsURL  \n",
       "29384  http://www.accessdata.fda.gov/drugsatfda_docs/...  \n",
       "29482  http://www.accessdata.fda.gov/drugsatfda_docs/...  \n",
       "45101  http://www.accessdata.fda.gov/drugsatfda_docs/...  \n",
       "45103  http://www.accessdata.fda.gov/drugsatfda_docs/...  \n",
       "45114  http://www.accessdata.fda.gov/drugsatfda_docs/...  \n",
       "45131  http://www.accessdata.fda.gov/drugsatfda_docs/...  \n",
       "45137  http://www.accessdata.fda.gov/drugsatfda_docs/...  \n",
       "45145  http://www.accessdata.fda.gov/drugsatfda_docs/...  \n",
       "45173  http://www.accessdata.fda.gov/drugsatfda_docs/...  \n",
       "45192  https://www.accessdata.fda.gov/drugsatfda_docs...  "
      ]
     },
     "execution_count": 75,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df_from_FDA_fin[df_from_FDA_fin['ActiveIngredient'].str.contains('TRASTUZUMAB')]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 77,
   "id": "75ee8a9a",
   "metadata": {},
   "outputs": [],
   "source": [
    "df_from_FDA_fin.to_csv(os.path.join(working_directory, 'df_fda_short.csv'), index=False)\n",
    "df_from_FDA.to_csv(os.path.join(working_directory, 'df_fda_full.csv'), index=False)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "d33d7b66",
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": 4,
   "id": "8106c5ce",
   "metadata": {},
   "outputs": [],
   "source": [
    "df_from_FDA_fin = pd.read_csv(os.path.join(working_directory, 'df_fda_short.csv'))"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 7,
   "id": "ce8166f8",
   "metadata": {},
   "outputs": [],
   "source": [
    "df_from_FDA_fin.columns = ['ApplNo', 'Form', 'Drug', 'ActiveIngredient', 'ApplType',\n",
    "                           'Sponsor', 'LatestLabel']"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 20,
   "id": "b4d49e35",
   "metadata": {},
   "outputs": [],
   "source": [
    "df_from_FDA_fin['LinkToFDA'] = df_from_FDA_fin['ApplNo'].apply(lambda x: 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=' + str(x) )\n",
    "df_from_FDA_fin['ApplNo'] = df_from_FDA_fin['ApplNo'].apply(lambda x: str(x))"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 21,
   "id": "b2a51455",
   "metadata": {},
   "outputs": [],
   "source": [
    "drug_fda_dict = {drugName:df.to_dict('records') for drugName, df in df_from_FDA_fin.groupby('Drug')}"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 22,
   "id": "45131596",
   "metadata": {},
   "outputs": [],
   "source": [
    "applno_fda_dict = {drugName:df.to_dict('records')[0] for drugName, df in df_from_FDA_fin.groupby('ApplNo')}"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 23,
   "id": "5d867021",
   "metadata": {
    "scrolled": true
   },
   "outputs": [
    {
     "data": {
      "text/plain": [
       "{'10040': {'ApplNo': '10040',\n",
       "  'Form': 'SOLUTION;URETHRAL',\n",
       "  'Drug': 'CYSTOGRAFIN',\n",
       "  'ActiveIngredient': 'DIATRIZOATE MEGLUMINE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'BRACCO',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/010040s171lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=10040'},\n",
       " '10104': {'ApplNo': '10104',\n",
       "  'Form': 'TABLET;ORAL',\n",
       "  'Drug': 'MEPHYTON',\n",
       "  'ActiveIngredient': 'PHYTONADIONE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'BAUSCH',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/010104s031lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=10104'},\n",
       " '101063': {'ApplNo': '101063',\n",
       "  'Form': 'VIAL',\n",
       "  'Drug': 'ELSPAR',\n",
       "  'ActiveIngredient': 'ASPARAGINASE',\n",
       "  'ApplType': 'BLA',\n",
       "  'Sponsor': 'MERCK',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/101063s5169lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=101063'},\n",
       " '10187': {'ApplNo': '10187',\n",
       "  'Form': 'TABLET;ORAL',\n",
       "  'Drug': 'RITALIN',\n",
       "  'ActiveIngredient': 'METHYLPHENIDATE HYDROCHLORIDE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'NOVARTIS',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/010187s093lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=10187'},\n",
       " '103000': {'ApplNo': '103000',\n",
       "  'Form': 'VIAL; SINGLE-USE',\n",
       "  'Drug': 'BOTOX',\n",
       "  'ActiveIngredient': 'OnabotulinumtoxinA',\n",
       "  'ApplType': 'BLA',\n",
       "  'Sponsor': 'ALLERGAN',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/103000s5322lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=103000'},\n",
       " '103132': {'ApplNo': '103132',\n",
       "  'Form': 'VIAL',\n",
       "  'Drug': 'INTRON A',\n",
       "  'ActiveIngredient': 'INTERFERON ALFA-2B',\n",
       "  'ApplType': 'BLA',\n",
       "  'Sponsor': 'SCHERING',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/103132s5202lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=103132'},\n",
       " '103172': {'ApplNo': '103172',\n",
       "  'Form': 'VIAL; SINGLE-USE',\n",
       "  'Drug': 'ACTIVASE',\n",
       "  'ActiveIngredient': 'ALTEPLASE',\n",
       "  'ApplType': 'BLA',\n",
       "  'Sponsor': 'GENENTECH',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/103172s5268lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=103172'},\n",
       " '103234': {'ApplNo': '103234',\n",
       "  'Form': 'VIAL; SINGLE-USE',\n",
       "  'Drug': 'EPOGEN/PROCRIT',\n",
       "  'ActiveIngredient': 'EPOETIN ALFA',\n",
       "  'ApplType': 'BLA',\n",
       "  'Sponsor': 'AMGEN',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2018/103234s5369lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=103234'},\n",
       " '103293': {'ApplNo': '103293',\n",
       "  'Form': 'VIAL',\n",
       "  'Drug': 'PROLEUKIN',\n",
       "  'ActiveIngredient': 'ALDESLEUKIN',\n",
       "  'ApplType': 'BLA',\n",
       "  'Sponsor': 'CHIRON',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/103293s5130lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=103293'},\n",
       " '103353': {'ApplNo': '103353',\n",
       "  'Form': 'VIAL',\n",
       "  'Drug': 'NEUPOGEN',\n",
       "  'ActiveIngredient': 'FILGRASTIM',\n",
       "  'ApplType': 'BLA',\n",
       "  'Sponsor': 'AMGEN',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/103353s5197lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=103353'},\n",
       " '103362': {'ApplNo': '103362',\n",
       "  'Form': 'VIAL',\n",
       "  'Drug': 'LEUKINE',\n",
       "  'ActiveIngredient': 'SARGRAMOSTIM',\n",
       "  'ApplType': 'BLA',\n",
       "  'Sponsor': 'BERLEX LABS',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/103362s5249lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=103362'},\n",
       " '103411': {'ApplNo': '103411',\n",
       "  'Form': 'VIAL',\n",
       "  'Drug': 'ONCASPAR',\n",
       "  'ActiveIngredient': 'PEGASPARGASE',\n",
       "  'ApplType': 'BLA',\n",
       "  'Sponsor': 'SIGMA TAU',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/103411s5205lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=103411'},\n",
       " '103471': {'ApplNo': '103471',\n",
       "  'Form': 'VIAL; SUBCUTANEOUS',\n",
       "  'Drug': 'BETASERON',\n",
       "  'ActiveIngredient': 'INTERFERON BETA-1B',\n",
       "  'ApplType': 'BLA',\n",
       "  'Sponsor': 'BAYER HEALTHCARE PHARMS',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/103471s5201lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=103471'},\n",
       " '103532': {'ApplNo': '103532',\n",
       "  'Form': 'VIAL',\n",
       "  'Drug': 'PULMOZYME',\n",
       "  'ActiveIngredient': 'DORNASE ALFA',\n",
       "  'ApplType': 'BLA',\n",
       "  'Sponsor': 'GENENTECH',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/103532s5191lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=103532'},\n",
       " '103575': {'ApplNo': '103575',\n",
       "  'Form': 'INJECTABLE; INJECTION',\n",
       "  'Drug': 'REOPRO',\n",
       "  'ActiveIngredient': 'ABCIXIMAB',\n",
       "  'ApplType': 'BLA',\n",
       "  'Sponsor': 'CENTOCOR INC',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/103575s5138lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=103575'},\n",
       " '103608': {'ApplNo': '103608',\n",
       "  'Form': 'VIAL; INTRAVENOUS',\n",
       "  'Drug': 'PROSTASCINT',\n",
       "  'ActiveIngredient': 'CAPROMAB PENDETIDE',\n",
       "  'ApplType': 'BLA',\n",
       "  'Sponsor': 'CYTOGEN',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/103608s5043lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=103608'},\n",
       " '103628': {'ApplNo': '103628',\n",
       "  'Form': 'VIAL',\n",
       "  'Drug': 'AVONEX',\n",
       "  'ActiveIngredient': 'INTERFERON BETA-1A',\n",
       "  'ApplType': 'BLA',\n",
       "  'Sponsor': 'BIOGEN',\n",
       "  'LatestLabel': 'https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/103628s5266lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=103628'},\n",
       " '103691': {'ApplNo': '103691',\n",
       "  'Form': 'GEL; TOPICAL',\n",
       "  'Drug': 'REGRANEX',\n",
       "  'ActiveIngredient': 'BECAPLERMIN',\n",
       "  'ApplType': 'BLA',\n",
       "  'Sponsor': 'SMITH AND NEPHEW',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/103691s5138lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=103691'},\n",
       " '103705': {'ApplNo': '103705',\n",
       "  'Form': 'SOLUTION;INTRAVENOUS',\n",
       "  'Drug': 'RITUXAN',\n",
       "  'ActiveIngredient': 'RITUXIMAB',\n",
       "  'ApplType': 'BLA',\n",
       "  'Sponsor': 'GENENTECH',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/103705s5467lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=103705'},\n",
       " '103764': {'ApplNo': '103764',\n",
       "  'Form': 'VIAL; SINGLE-USE',\n",
       "  'Drug': 'SIMULECT',\n",
       "  'ActiveIngredient': 'BASILIXIMAB',\n",
       "  'ApplType': 'BLA',\n",
       "  'Sponsor': 'NOVARTIS',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/1998/basnov051298lb.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=103764'},\n",
       " '103767': {'ApplNo': '103767',\n",
       "  'Form': 'VIAL',\n",
       "  'Drug': 'ONTAK',\n",
       "  'ActiveIngredient': 'DENILEUKIN DIFTITOX',\n",
       "  'ApplType': 'BLA',\n",
       "  'Sponsor': 'EISAI INC',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/103767s5144lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=103767'},\n",
       " '103770': {'ApplNo': '103770',\n",
       "  'Form': 'VIAL',\n",
       "  'Drug': 'SYNAGIS',\n",
       "  'ActiveIngredient': 'PALIVIZUMAB',\n",
       "  'ApplType': 'BLA',\n",
       "  'Sponsor': 'SWEDISH ORPHAN',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2017/103770s5200lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=103770'},\n",
       " '103772': {'ApplNo': '103772',\n",
       "  'Form': 'VIAL',\n",
       "  'Drug': 'REMICADE',\n",
       "  'ActiveIngredient': 'INFLIXIMAB',\n",
       "  'ApplType': 'BLA',\n",
       "  'Sponsor': 'CENTOCOR INC',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/103772s5401lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=103772'},\n",
       " '103780': {'ApplNo': '103780',\n",
       "  'Form': 'SYRINGE',\n",
       "  'Drug': 'REBIF',\n",
       "  'ActiveIngredient': 'INTERFERON BETA-1A',\n",
       "  'ApplType': 'BLA',\n",
       "  'Sponsor': 'SERONO INC',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/103780s5210lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=103780'},\n",
       " '10379': {'ApplNo': '10379',\n",
       "  'Form': 'TABLET;ORAL',\n",
       "  'Drug': 'CYTOMEL',\n",
       "  'ActiveIngredient': 'LIOTHYRONINE SODIUM',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'KING PHARMS',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2018/010379s054lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=10379'},\n",
       " '103792': {'ApplNo': '103792',\n",
       "  'Form': 'VIAL; INTRAVENOUS',\n",
       "  'Drug': 'HERCEPTIN',\n",
       "  'ActiveIngredient': 'TRASTUZUMAB',\n",
       "  'ApplType': 'BLA',\n",
       "  'Sponsor': 'GENENTECH',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2018/103792s5345lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=103792'},\n",
       " '103795': {'ApplNo': '103795',\n",
       "  'Form': 'VIAL; SUBCUTANEOUS',\n",
       "  'Drug': 'ENBREL',\n",
       "  'ActiveIngredient': 'ETANERCEPT',\n",
       "  'ApplType': 'BLA',\n",
       "  'Sponsor': 'IMMUNEX',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/103795s5591lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=103795'},\n",
       " '103836': {'ApplNo': '103836',\n",
       "  'Form': 'VIAL; SINGLE-USE',\n",
       "  'Drug': 'ACTIMMUNE',\n",
       "  'ActiveIngredient': 'INTERFERON GAMMA-1B',\n",
       "  'ApplType': 'BLA',\n",
       "  'Sponsor': 'VIDARA THERAPEUTICS RESEARCH LTD',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/103836s5182lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=103836'},\n",
       " '103846': {'ApplNo': '103846',\n",
       "  'Form': 'VIAL',\n",
       "  'Drug': 'MYOBLOC',\n",
       "  'ActiveIngredient': 'Botulinum Toxin Type B',\n",
       "  'ApplType': 'BLA',\n",
       "  'Sponsor': 'ELAN PHARM',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/103846s5195lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=103846'},\n",
       " '103909': {'ApplNo': '103909',\n",
       "  'Form': 'VIAL',\n",
       "  'Drug': 'TNKASE',\n",
       "  'ActiveIngredient': 'TENECTEPLASE',\n",
       "  'ApplType': 'BLA',\n",
       "  'Sponsor': 'GENENTECH',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2018/103909s5187lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=103909'},\n",
       " '103946': {'ApplNo': '103946',\n",
       "  'Form': 'VIAL; INTRAVENOUS',\n",
       "  'Drug': 'ELITEK',\n",
       "  'ActiveIngredient': 'RASBURICASE',\n",
       "  'ApplType': 'BLA',\n",
       "  'Sponsor': 'SANOFI SYNTHELABO',\n",
       "  'LatestLabel': 'https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/103946s5103lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=103946'},\n",
       " '103948': {'ApplNo': '103948',\n",
       "  'Form': 'VIAL; INTRAVENOUS',\n",
       "  'Drug': 'CAMPATH',\n",
       "  'ActiveIngredient': 'ALEMTUZUMAB',\n",
       "  'ApplType': 'BLA',\n",
       "  'Sponsor': 'GENZYME',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/103948s5187lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=103948'},\n",
       " '103949': {'ApplNo': '103949',\n",
       "  'Form': 'VIAL',\n",
       "  'Drug': 'PEGINTRON',\n",
       "  'ActiveIngredient': 'PEGINTERFERON ALFA-2B',\n",
       "  'ApplType': 'BLA',\n",
       "  'Sponsor': 'SCHERING',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/103949s5313lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=103949'},\n",
       " '103950': {'ApplNo': '103950',\n",
       "  'Form': 'VIAL; SUBCUTANEOUS',\n",
       "  'Drug': 'KINERET',\n",
       "  'ActiveIngredient': 'ANAKINRA',\n",
       "  'ApplType': 'BLA',\n",
       "  'Sponsor': 'BIOVITRUM AB',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/103950s5189lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=103950'},\n",
       " '103951': {'ApplNo': '103951',\n",
       "  'Form': 'VIAL; INTRAVENOUS',\n",
       "  'Drug': 'ARANESP',\n",
       "  'ActiveIngredient': 'DARBEPOETIN ALFA',\n",
       "  'ApplType': 'BLA',\n",
       "  'Sponsor': 'AMGEN',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/103951s5363lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=103951'},\n",
       " '103964': {'ApplNo': '103964',\n",
       "  'Form': 'VIAL; SUBCUTANEOUS',\n",
       "  'Drug': 'PEGASYS',\n",
       "  'ActiveIngredient': 'PEGINTERFERON ALFA-2A',\n",
       "  'ApplType': 'BLA',\n",
       "  'Sponsor': 'zr pharma&',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/103964s5275lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=103964'},\n",
       " '103976': {'ApplNo': '103976',\n",
       "  'Form': 'VIAL',\n",
       "  'Drug': 'XOLAIR',\n",
       "  'ActiveIngredient': 'OMALIZUMAB',\n",
       "  'ApplType': 'BLA',\n",
       "  'Sponsor': 'GENENTECH',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/103976s5239lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=103976'},\n",
       " '103979': {'ApplNo': '103979',\n",
       "  'Form': 'VIAL; INTRAVENOUS',\n",
       "  'Drug': 'FABRAZYME',\n",
       "  'ActiveIngredient': 'AGALSIDASE BETA',\n",
       "  'ApplType': 'BLA',\n",
       "  'Sponsor': 'GENZYME',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/103979s5309lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=103979'},\n",
       " '10402': {'ApplNo': '10402',\n",
       "  'Form': 'INJECTABLE;INJECTION',\n",
       "  'Drug': 'PREMARIN',\n",
       "  'ActiveIngredient': 'ESTROGENS, CONJUGATED',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'WYETH PHARMS',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2017/010402s068lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=10402'},\n",
       " '10515': {'ApplNo': '10515',\n",
       "  'Form': 'INJECTABLE;INJECTION',\n",
       "  'Drug': 'ISUPREL',\n",
       "  'ActiveIngredient': 'ISOPROTERENOL HYDROCHLORIDE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'BAUSCH',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/010515Orig1s033lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=10515'},\n",
       " '10596': {'ApplNo': '10596',\n",
       "  'Form': 'CAPSULE;ORAL',\n",
       "  'Drug': 'CELONTIN',\n",
       "  'ActiveIngredient': 'METHSUXIMIDE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'PARKE DAVIS',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2010/010596s22lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=10596'},\n",
       " '10669': {'ApplNo': '10669',\n",
       "  'Form': 'TABLET;ORAL',\n",
       "  'Drug': 'LEUKERAN',\n",
       "  'ActiveIngredient': 'CHLORAMBUCIL',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'WOODWARD SPECL',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2011/010669s032lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=10669'},\n",
       " '10721': {'ApplNo': '10721',\n",
       "  'Form': 'TABLET;ORAL',\n",
       "  'Drug': 'ANTIVERT',\n",
       "  'ActiveIngredient': 'MECLIZINE HYDROCHLORIDE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'CASPER PHARMA LLC',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/010721s063lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=10721'},\n",
       " '11153': {'ApplNo': '11153',\n",
       "  'Form': 'TABLET;ORAL',\n",
       "  'Drug': 'MEDROL',\n",
       "  'ActiveIngredient': 'METHYLPREDNISOLONE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'PFIZER',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/011153Orig1s077lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=11153'},\n",
       " '11210': {'ApplNo': '11210',\n",
       "  'Form': 'CAPSULE;ORAL',\n",
       "  'Drug': 'TESSALON',\n",
       "  'ActiveIngredient': 'BENZONATATE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'PFIZER',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2011/011210s053lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=11210'},\n",
       " '11366': {'ApplNo': '11366',\n",
       "  'Form': 'TABLET;ORAL',\n",
       "  'Drug': 'KEVEYIS',\n",
       "  'ActiveIngredient': 'DICHLORPHENAMIDE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'XERIS',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/011366s033lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=11366'},\n",
       " '11459': {'ApplNo': '11459',\n",
       "  'Form': 'CAPSULE;ORAL',\n",
       "  'Drug': 'VISTARIL',\n",
       "  'ActiveIngredient': 'HYDROXYZINE PAMOATE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'PFIZER',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2016/011459s051_011795s028lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=11459'},\n",
       " '11525': {'ApplNo': '11525',\n",
       "  'Form': 'INJECTABLE;INJECTION',\n",
       "  'Drug': 'IC-GREEN',\n",
       "  'ActiveIngredient': 'INDOCYANINE GREEN',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'AKORN',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/011525Orig1s036lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=11525'},\n",
       " '11559': {'ApplNo': '11559',\n",
       "  'Form': 'INJECTABLE;INJECTION',\n",
       "  'Drug': 'BREVITAL SODIUM',\n",
       "  'ActiveIngredient': 'METHOHEXITAL SODIUM',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'PAR STERILE PRODUCTS',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/011559s057lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=11559'},\n",
       " '11665': {'ApplNo': '11665',\n",
       "  'Form': 'TABLET, EXTENDED RELEASE;ORAL',\n",
       "  'Drug': 'MESTINON',\n",
       "  'ActiveIngredient': 'PYRIDOSTIGMINE BROMIDE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'BAUSCH',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2001/15193s18lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=11665'},\n",
       " '11719': {'ApplNo': '11719',\n",
       "  'Form': 'INJECTABLE;INJECTION',\n",
       "  'Drug': 'METHOTREXATE SODIUM',\n",
       "  'ActiveIngredient': 'METHOTREXATE SODIUM',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'HOSPIRA',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/011719Orig1s135lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=11719'},\n",
       " '11757': {'ApplNo': '11757',\n",
       "  'Form': 'INJECTABLE;INJECTION',\n",
       "  'Drug': 'DEPO-MEDROL',\n",
       "  'ActiveIngredient': 'METHYLPREDNISOLONE ACETATE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'PFIZER',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/011757s120lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=11757'},\n",
       " '11790': {'ApplNo': '11790',\n",
       "  'Form': 'SOLUTION;IM-IV',\n",
       "  'Drug': 'ROBAXIN',\n",
       "  'ActiveIngredient': 'METHOCARBAMOL',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'HIKMA',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2004/11790slr046_robaxin_lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=11790'},\n",
       " '11792': {'ApplNo': '11792',\n",
       "  'Form': 'TABLET;ORAL',\n",
       "  'Drug': 'SOMA',\n",
       "  'ActiveIngredient': 'CARISOPRODOL',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'MYLAN SPECIALITY LP',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/011792s050lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=11792'},\n",
       " '11839': {'ApplNo': '11839',\n",
       "  'Form': 'TABLET;ORAL',\n",
       "  'Drug': 'PROVERA',\n",
       "  'ActiveIngredient': 'MEDROXYPROGESTERONE ACETATE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'PFIZER',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/011839s079s080lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=11839'},\n",
       " '11856': {'ApplNo': '11856',\n",
       "  'Form': 'INJECTABLE;INJECTION',\n",
       "  'Drug': 'SOLU-MEDROL',\n",
       "  'ActiveIngredient': 'METHYLPREDNISOLONE SODIUM SUCCINATE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'PHARMACIA AND UPJOHN',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/011856s139lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=11856'},\n",
       " '11870': {'ApplNo': '11870',\n",
       "  'Form': 'SUSPENSION;ORAL',\n",
       "  'Drug': 'DIURIL',\n",
       "  'ActiveIngredient': 'CHLOROTHIAZIDE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'SALIX PHARMS',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2009/011870s040lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=11870'},\n",
       " '11909': {'ApplNo': '11909',\n",
       "  'Form': 'TABLET;ORAL',\n",
       "  'Drug': 'NARDIL',\n",
       "  'ActiveIngredient': 'PHENELZINE SULFATE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'PARKE DAVIS',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2007/011909s038lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=11909'},\n",
       " '11961': {'ApplNo': '11961',\n",
       "  'Form': 'TABLET;ORAL',\n",
       "  'Drug': 'MARPLAN',\n",
       "  'ActiveIngredient': 'ISOCARBOXAZID',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'VALIDUS PHARMS INC',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2018/011961s045lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=11961'},\n",
       " '11963': {'ApplNo': '11963',\n",
       "  'Form': 'FOR SOLUTION;OPHTHALMIC',\n",
       "  'Drug': 'PHOSPHOLINE IODIDE',\n",
       "  'ActiveIngredient': 'ECHOTHIOPHATE IODIDE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'FERA PHARMS LLC',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/011963s052lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=11963'},\n",
       " '12041': {'ApplNo': '12041',\n",
       "  'Form': 'INJECTABLE;INJECTION',\n",
       "  'Drug': 'KENALOG-10',\n",
       "  'ActiveIngredient': 'TRIAMCINOLONE ACETONIDE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'APOTHECON',\n",
       "  'LatestLabel': 'https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/012041s045lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=12041'},\n",
       " '12093': {'ApplNo': '12093',\n",
       "  'Form': 'TABLET;ORAL',\n",
       "  'Drug': 'ISORDIL',\n",
       "  'ActiveIngredient': 'ISOSORBIDE DINITRATE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'BAUSCH',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/012093s052lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=12093'},\n",
       " '12104': {'ApplNo': '12104',\n",
       "  'Form': 'SPRAY;TOPICAL',\n",
       "  'Drug': 'KENALOG',\n",
       "  'ActiveIngredient': 'TRIAMCINOLONE ACETONIDE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'SUN PHARM INDS INC',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2011/012104s032lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=12104'},\n",
       " '12141': {'ApplNo': '12141',\n",
       "  'Form': 'TABLET;ORAL',\n",
       "  'Drug': 'CYTOXAN',\n",
       "  'ActiveIngredient': 'CYCLOPHOSPHAMIDE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'BAXTER HLTHCARE',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/012141s090,012142s112lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=12141'},\n",
       " '12151': {'ApplNo': '12151',\n",
       "  'Form': 'TABLET;ORAL',\n",
       "  'Drug': 'ALDACTONE',\n",
       "  'ActiveIngredient': 'SPIRONOLACTONE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'PFIZER',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/012151s079lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=12151'},\n",
       " '12250': {'ApplNo': '12250',\n",
       "  'Form': 'INJECTABLE;INJECTION',\n",
       "  'Drug': 'CARBOCAINE',\n",
       "  'ActiveIngredient': 'MEPIVACAINE HYDROCHLORIDE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'HOSPIRA',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2018/012250s037lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=12250'},\n",
       " '12342': {'ApplNo': '12342',\n",
       "  'Form': 'TABLET;ORAL',\n",
       "  'Drug': 'PARNATE',\n",
       "  'ActiveIngredient': 'TRANYLCYPROMINE SULFATE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'CONCORDIA',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2018/012342s064lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=12342'},\n",
       " '12380': {'ApplNo': '12380',\n",
       "  'Form': 'CAPSULE;ORAL',\n",
       "  'Drug': 'ZARONTIN',\n",
       "  'ActiveIngredient': 'ETHOSUXIMIDE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'PARKE DAVIS',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/012380s037lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=12380'},\n",
       " '12429': {'ApplNo': '12429',\n",
       "  'Form': 'TABLET;ORAL',\n",
       "  'Drug': 'THIOGUANINE',\n",
       "  'ActiveIngredient': 'THIOGUANINE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'WOODWARD SPECL',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2018/012429s028lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=12429'},\n",
       " '12462': {'ApplNo': '12462',\n",
       "  'Form': 'TABLET;ORAL',\n",
       "  'Drug': 'LOMOTIL',\n",
       "  'ActiveIngredient': 'ATROPINE SULFATE; DIPHENOXYLATE HYDROCHLORIDE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'PFIZER',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2018/012462s048lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=12462'},\n",
       " '125019': {'ApplNo': '125019',\n",
       "  'Form': 'INJECTABLE; INJECTION',\n",
       "  'Drug': 'ZEVALIN',\n",
       "  'ActiveIngredient': 'IBRITUMOMAB TIUXETAN',\n",
       "  'ApplType': 'BLA',\n",
       "  'Sponsor': 'SPECTRUM PHARMS',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2018/125019s227lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=125019'},\n",
       " '125031': {'ApplNo': '125031',\n",
       "  'Form': 'SYRINGE',\n",
       "  'Drug': 'NEULASTA',\n",
       "  'ActiveIngredient': 'PEGFILGRASTIM',\n",
       "  'ApplType': 'BLA',\n",
       "  'Sponsor': 'AMGEN',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/125031s203lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=125031'},\n",
       " '125057': {'ApplNo': '125057',\n",
       "  'Form': 'SYRINGE',\n",
       "  'Drug': 'HUMIRA',\n",
       "  'ActiveIngredient': 'ADALIMUMAB',\n",
       "  'ApplType': 'BLA',\n",
       "  'Sponsor': 'ABBVIE INC',\n",
       "  'LatestLabel': 'https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/125057s417lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=125057'},\n",
       " '125058': {'ApplNo': '125058',\n",
       "  'Form': 'VIAL',\n",
       "  'Drug': 'ALDURAZYME',\n",
       "  'ActiveIngredient': 'LARONIDASE',\n",
       "  'ApplType': 'BLA',\n",
       "  'Sponsor': 'BIOMARIN',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/125058s244lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=125058'},\n",
       " '125084': {'ApplNo': '125084',\n",
       "  'Form': 'VIAL; INTRAVENOUS',\n",
       "  'Drug': 'ERBITUX',\n",
       "  'ActiveIngredient': 'CETUXIMAB',\n",
       "  'ApplType': 'BLA',\n",
       "  'Sponsor': 'IMCLONE',\n",
       "  'LatestLabel': 'https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/125084s279lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=125084'},\n",
       " '125085': {'ApplNo': '125085',\n",
       "  'Form': 'VIAL; INTRAVENOUS',\n",
       "  'Drug': 'AVASTIN',\n",
       "  'ActiveIngredient': 'BEVACIZUMAB',\n",
       "  'ApplType': 'BLA',\n",
       "  'Sponsor': 'GENENTECH',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/125085s340lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=125085'},\n",
       " '125103': {'ApplNo': '125103',\n",
       "  'Form': 'INJECTABLE; INJECTION',\n",
       "  'Drug': 'KEPIVANCE',\n",
       "  'ActiveIngredient': 'PALIFERMIN',\n",
       "  'ApplType': 'BLA',\n",
       "  'Sponsor': 'BIOVITRUM AB',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/125103s176lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=125103'},\n",
       " '125104': {'ApplNo': '125104',\n",
       "  'Form': 'VIAL; SINGLE-USE',\n",
       "  'Drug': 'TYSABRI',\n",
       "  'ActiveIngredient': 'NATALIZUMAB',\n",
       "  'ApplType': 'BLA',\n",
       "  'Sponsor': 'BIOGEN IDEC',\n",
       "  'LatestLabel': 'https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/125104s973s975lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=125104'},\n",
       " '125117': {'ApplNo': '125117',\n",
       "  'Form': 'INJECTABLE; INJECTION',\n",
       "  'Drug': 'NAGLAZYME',\n",
       "  'ActiveIngredient': 'GALSULFASE',\n",
       "  'ApplType': 'BLA',\n",
       "  'Sponsor': 'BIOMARIN',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/125117s129lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=125117'},\n",
       " '125118': {'ApplNo': '125118',\n",
       "  'Form': 'INJECTABLE; IV (INFUSION)',\n",
       "  'Drug': 'ORENCIA',\n",
       "  'ActiveIngredient': 'ABATACEPT',\n",
       "  'ApplType': 'BLA',\n",
       "  'Sponsor': 'BRISTOL MYERS SQUIBB',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/125118s240lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=125118'},\n",
       " '125141': {'ApplNo': '125141',\n",
       "  'Form': 'INJECTABLE; IV (INFUSION)',\n",
       "  'Drug': 'MYOZYME',\n",
       "  'ActiveIngredient': 'ALGLUCOSIDASE ALFA',\n",
       "  'ApplType': 'BLA',\n",
       "  'Sponsor': 'GENZYME',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/125141s223lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=125141'},\n",
       " '125147': {'ApplNo': '125147',\n",
       "  'Form': 'INJECTABLE; IV (INFUSION)',\n",
       "  'Drug': 'VECTIBIX',\n",
       "  'ActiveIngredient': 'PANITUMUMAB',\n",
       "  'ApplType': 'BLA',\n",
       "  'Sponsor': 'AMGEN',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/125147s210lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=125147'},\n",
       " '125151': {'ApplNo': '125151',\n",
       "  'Form': 'INJECTABLE; IV (INFUSION)',\n",
       "  'Drug': 'ELAPRASE',\n",
       "  'ActiveIngredient': 'IDURSULFASE',\n",
       "  'ApplType': 'BLA',\n",
       "  'Sponsor': 'SHIRE',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2018/125151s197lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=125151'},\n",
       " '125156': {'ApplNo': '125156',\n",
       "  'Form': 'INJECTABLE; INJECTION',\n",
       "  'Drug': 'LUCENTIS',\n",
       "  'ActiveIngredient': 'RANIBIZUMAB',\n",
       "  'ApplType': 'BLA',\n",
       "  'Sponsor': 'GENENTECH',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2018/125156s117lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=125156'},\n",
       " '125160': {'ApplNo': '125160',\n",
       "  'Form': 'INJECTABLE; INJECTION',\n",
       "  'Drug': 'CIMZIA',\n",
       "  'ActiveIngredient': 'CERTOLIZUMAB PEGOL',\n",
       "  'ApplType': 'BLA',\n",
       "  'Sponsor': 'UCB INC',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/125160s305lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=125160'},\n",
       " '125164': {'ApplNo': '125164',\n",
       "  'Form': 'SOLUTION; INJECTION',\n",
       "  'Drug': 'MIRCERA',\n",
       "  'ActiveIngredient': 'METHOXY POLYETHYLENE GLYCOL-EPOETIN BETA',\n",
       "  'ApplType': 'BLA',\n",
       "  'Sponsor': 'HOFFMAN-LA ROCHE',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/125164s086lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=125164'},\n",
       " '125166': {'ApplNo': '125166',\n",
       "  'Form': 'INJECTABLE; IV (INFUSION)',\n",
       "  'Drug': 'SOLIRIS',\n",
       "  'ActiveIngredient': 'ECULIZUMAB',\n",
       "  'ApplType': 'BLA',\n",
       "  'Sponsor': 'ALEXION PHARM',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/125166s434lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=125166'},\n",
       " '125249': {'ApplNo': '125249',\n",
       "  'Form': 'VIAL; SINGLE-USE',\n",
       "  'Drug': 'ARCALYST',\n",
       "  'ActiveIngredient': 'RILONACEPT',\n",
       "  'ApplType': 'BLA',\n",
       "  'Sponsor': 'KINIKSA PHARMACEUTICALS (UK), LTD.',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/125249s049lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=125249'},\n",
       " '125261': {'ApplNo': '125261',\n",
       "  'Form': 'INJECTABLE; INJECTION',\n",
       "  'Drug': 'STELARA',\n",
       "  'ActiveIngredient': 'USTEKINUMAB',\n",
       "  'ApplType': 'BLA',\n",
       "  'Sponsor': 'CENTOCOR ORTHO BIOTECH INC',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/125261s161lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=125261'},\n",
       " '125268': {'ApplNo': '125268',\n",
       "  'Form': 'INJECTABLE; SUBCUTANEOUS',\n",
       "  'Drug': 'NPLATE',\n",
       "  'ActiveIngredient': 'ROMIPLOSTIM',\n",
       "  'ApplType': 'BLA',\n",
       "  'Sponsor': 'AMGEN',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/125268s172lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=125268'},\n",
       " '125274': {'ApplNo': '125274',\n",
       "  'Form': 'INJECTABLE; INJECTION',\n",
       "  'Drug': 'DYSPORT',\n",
       "  'ActiveIngredient': 'abobotulinumtoxinA',\n",
       "  'ApplType': 'BLA',\n",
       "  'Sponsor': 'IPSEN BIOPHARM LTD',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2023/125274s123lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=125274'},\n",
       " '125276': {'ApplNo': '125276',\n",
       "  'Form': 'INJECTABLE; INJECTION',\n",
       "  'Drug': 'ACTEMRA',\n",
       "  'ActiveIngredient': 'TOCILIZUMAB',\n",
       "  'ApplType': 'BLA',\n",
       "  'Sponsor': 'GENENTECH',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/125276s138lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=125276'},\n",
       " '125277': {'ApplNo': '125277',\n",
       "  'Form': 'INJECTABLE; INJECTION',\n",
       "  'Drug': 'KALBITOR',\n",
       "  'ActiveIngredient': 'ECALLANTIDE',\n",
       "  'ApplType': 'BLA',\n",
       "  'Sponsor': 'DYAX CORP.',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/125277s081lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=125277'},\n",
       " '125288': {'ApplNo': '125288',\n",
       "  'Form': 'INJECTABLE; INJECTION',\n",
       "  'Drug': 'NULOJIX',\n",
       "  'ActiveIngredient': 'BELATACEPT',\n",
       "  'ApplType': 'BLA',\n",
       "  'Sponsor': 'BRISTOL MYERS SQUIBB',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/125288s101lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=125288'},\n",
       " '125289': {'ApplNo': '125289',\n",
       "  'Form': 'INJECTABLE; INJECTION',\n",
       "  'Drug': 'SIMPONI',\n",
       "  'ActiveIngredient': 'GOLIMUMAB',\n",
       "  'ApplType': 'BLA',\n",
       "  'Sponsor': 'CENTOCOR ORTHO BIOTECH INC',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/125289s146lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=125289'},\n",
       " '125290': {'ApplNo': '125290',\n",
       "  'Form': 'INJECTABLE; SUBCUTANEOUS',\n",
       "  'Drug': 'EXTAVIA',\n",
       "  'ActiveIngredient': 'INTERFERON BETA-1B',\n",
       "  'ApplType': 'BLA',\n",
       "  'Sponsor': 'NOVARTIS PHARMS',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/125290s073lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=125290'},\n",
       " '125291': {'ApplNo': '125291',\n",
       "  'Form': 'POWDER; IV (INFUSION)',\n",
       "  'Drug': 'LUMIZYME',\n",
       "  'ActiveIngredient': 'ALGLUCOSIDASE ALFA',\n",
       "  'ApplType': 'BLA',\n",
       "  'Sponsor': 'GENZYME',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/125291s156s157lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=125291'},\n",
       " '125293': {'ApplNo': '125293',\n",
       "  'Form': 'INJECTABLE; INJECTION',\n",
       "  'Drug': 'KRYSTEXXA',\n",
       "  'ActiveIngredient': 'PEGLOTICASE',\n",
       "  'ApplType': 'BLA',\n",
       "  'Sponsor': 'HORIZON PHARMA',\n",
       "  'LatestLabel': 'https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/125293s104lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=125293'},\n",
       " '125294': {'ApplNo': '125294',\n",
       "  'Form': 'INJECTABLE; INJECTION',\n",
       "  'Drug': 'GRANIX',\n",
       "  'ActiveIngredient': 'TBO-FILGRASTIM',\n",
       "  'ApplType': 'BLA',\n",
       "  'Sponsor': 'SICOR BIOTECH',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/125294s046lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=125294'},\n",
       " '125319': {'ApplNo': '125319',\n",
       "  'Form': 'INJECTABLE; SUBCUTANEOUS',\n",
       "  'Drug': 'ILARIS',\n",
       "  'ActiveIngredient': 'CANAKINUMAB',\n",
       "  'ApplType': 'BLA',\n",
       "  'Sponsor': 'NOVARTIS PHARMS',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/125319s100lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=125319'},\n",
       " '125320': {'ApplNo': '125320',\n",
       "  'Form': 'INJECTABLE; SUBCUTANEOUS',\n",
       "  'Drug': 'PROLIA',\n",
       "  'ActiveIngredient': 'DENOSUMAB',\n",
       "  'ApplType': 'BLA',\n",
       "  'Sponsor': 'AMGEN',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2023/125320s211lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=125320'},\n",
       " '125326': {'ApplNo': '125326',\n",
       "  'Form': 'INJECTABLE; INJECTION',\n",
       "  'Drug': 'ARZERRA',\n",
       "  'ActiveIngredient': 'OFATUMUMAB',\n",
       "  'ApplType': 'BLA',\n",
       "  'Sponsor': 'NOVARTIS',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/125326s075lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=125326'},\n",
       " '125327': {'ApplNo': '125327',\n",
       "  'Form': 'INJECTABLE; INJECTION',\n",
       "  'Drug': 'VORAXAZE',\n",
       "  'ActiveIngredient': 'GLUCARPIDASE',\n",
       "  'ApplType': 'BLA',\n",
       "  'Sponsor': 'BTG INTERNATIONAL INC',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/125327s064lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=125327'},\n",
       " '125338': {'ApplNo': '125338',\n",
       "  'Form': 'SOLUTION; INJECTION',\n",
       "  'Drug': 'XIAFLEX',\n",
       "  'ActiveIngredient': 'COLLAGENASE CLOSTRIDIUM HISTOLYTICUM',\n",
       "  'ApplType': 'BLA',\n",
       "  'Sponsor': 'AUXILIUM PHARMS',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/125338s129lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=125338'},\n",
       " '125349': {'ApplNo': '125349',\n",
       "  'Form': 'INJECTABLE; IV (INFUSION)',\n",
       "  'Drug': 'RAXIBACUMAB',\n",
       "  'ActiveIngredient': 'RAXIBACUMAB',\n",
       "  'ApplType': 'BLA',\n",
       "  'Sponsor': 'HUMAN GENOME SCIENCES INC.',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/125349s026lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=125349'},\n",
       " '125360': {'ApplNo': '125360',\n",
       "  'Form': 'INJECTABLE;INJECTION',\n",
       "  'Drug': 'Xeomin',\n",
       "  'ActiveIngredient': 'incobotulinumtoxinA',\n",
       "  'ApplType': 'BLA',\n",
       "  'Sponsor': 'MERZ PHARMS',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/125360s093lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=125360'},\n",
       " '125370': {'ApplNo': '125370',\n",
       "  'Form': 'INJECTABLE; INJECTION',\n",
       "  'Drug': 'BENLYSTA',\n",
       "  'ActiveIngredient': 'BELIMUMAB',\n",
       "  'ApplType': 'BLA',\n",
       "  'Sponsor': 'HUMAN GENOME SCIENCES INC.',\n",
       "  'LatestLabel': 'https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/125370s073,761043s013lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=125370'},\n",
       " '125377': {'ApplNo': '125377',\n",
       "  'Form': 'INJECTABLE; INJECTION',\n",
       "  'Drug': 'YERVOY',\n",
       "  'ActiveIngredient': 'IPILIMUMAB',\n",
       "  'ApplType': 'BLA',\n",
       "  'Sponsor': 'BRISTOL MYERS SQUIBB',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/125377s130lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=125377'},\n",
       " '125387': {'ApplNo': '125387',\n",
       "  'Form': 'INJECTABLE; INJECTION',\n",
       "  'Drug': 'EYLEA',\n",
       "  'ActiveIngredient': 'AFLIBERCEPT',\n",
       "  'ApplType': 'BLA',\n",
       "  'Sponsor': 'REGENERON PHARMACEUTICALS',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/125387s076lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=125387'},\n",
       " '125388': {'ApplNo': '125388',\n",
       "  'Form': 'INJECTABLE; INJECTION',\n",
       "  'Drug': 'ADCETRIS',\n",
       "  'ActiveIngredient': 'BRENTUXIMAB VEDOTIN',\n",
       "  'ApplType': 'BLA',\n",
       "  'Sponsor': 'SEATTLE GENETICS',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/125388s106lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=125388'},\n",
       " '125390': {'ApplNo': '125390',\n",
       "  'Form': 'INJECTABLE;INJECTION',\n",
       "  'Drug': 'MYALEPT',\n",
       "  'ActiveIngredient': 'METRELEPTIN',\n",
       "  'ApplType': 'BLA',\n",
       "  'Sponsor': 'AEGERION',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/125390s024lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=125390'},\n",
       " '125399': {'ApplNo': '125399',\n",
       "  'Form': 'INJECTABLE; INJECTION',\n",
       "  'Drug': 'ADCETRIS',\n",
       "  'ActiveIngredient': 'BRENTUXIMAB VEDOTIN',\n",
       "  'ApplType': 'BLA',\n",
       "  'Sponsor': 'SEATTLE GENETICS',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2011/125388s000,125399s000lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=125399'},\n",
       " '125409': {'ApplNo': '125409',\n",
       "  'Form': 'VIAL; SINGLE-USE',\n",
       "  'Drug': 'PERJETA',\n",
       "  'ActiveIngredient': 'PERTUZUMAB',\n",
       "  'ApplType': 'BLA',\n",
       "  'Sponsor': 'GENENTECH',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/125409s124lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=125409'},\n",
       " '125418': {'ApplNo': '125418',\n",
       "  'Form': 'INJECTABLE; INJECTION',\n",
       "  'Drug': 'ZALTRAP',\n",
       "  'ActiveIngredient': 'ZIV-AFLIBERCEPT',\n",
       "  'ApplType': 'BLA',\n",
       "  'Sponsor': 'SANOFI AVENTIS US',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/125418s047lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=125418'},\n",
       " '125422': {'ApplNo': '125422',\n",
       "  'Form': 'INJECTABLE; INTRAVITREAL',\n",
       "  'Drug': 'JETREA',\n",
       "  'ActiveIngredient': 'OCRIPLASMIN',\n",
       "  'ApplType': 'BLA',\n",
       "  'Sponsor': 'THROMBOGENICS, INC',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2017/125422s038lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=125422'},\n",
       " '125427': {'ApplNo': '125427',\n",
       "  'Form': 'VIAL; SINGLE-USE',\n",
       "  'Drug': 'KADCYLA',\n",
       "  'ActiveIngredient': 'ADO-TRASTUZUMAB EMTANSINE',\n",
       "  'ApplType': 'BLA',\n",
       "  'Sponsor': 'GENENTECH',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/125427s111lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=125427'},\n",
       " '125433': {'ApplNo': '125433',\n",
       "  'Form': 'INJECTABLE; INJECTION',\n",
       "  'Drug': 'SIMPONI ARIA',\n",
       "  'ActiveIngredient': 'GOLIMUMAB',\n",
       "  'ApplType': 'BLA',\n",
       "  'Sponsor': 'JANSSEN BIOTECH',\n",
       "  'LatestLabel': 'https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/125433s032lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=125433'},\n",
       " '125460': {'ApplNo': '125460',\n",
       "  'Form': 'INJECTABLE;INJECTION',\n",
       "  'Drug': 'VIMIZIM',\n",
       "  'ActiveIngredient': 'ELOSULFASE ALFA',\n",
       "  'ApplType': 'BLA',\n",
       "  'Sponsor': 'BIOMARIN PHARM',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/125460s017lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=125460'},\n",
       " '125469': {'ApplNo': '125469',\n",
       "  'Form': 'INJECTABLE;INJECTION',\n",
       "  'Drug': 'TRULICITY',\n",
       "  'ActiveIngredient': 'DULAGLUTIDE',\n",
       "  'ApplType': 'BLA',\n",
       "  'Sponsor': 'ELI LILLY AND CO',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/125469s051lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=125469'},\n",
       " '125472': {'ApplNo': '125472',\n",
       "  'Form': 'INJECTABLE;INTRAVENOUS, SUBCUTANEOUS',\n",
       "  'Drug': 'ACTEMRA',\n",
       "  'ActiveIngredient': 'TOCILIZUMAB',\n",
       "  'ApplType': 'BLA',\n",
       "  'Sponsor': 'GENENTECH',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/125472s049lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=125472'},\n",
       " '125476': {'ApplNo': '125476',\n",
       "  'Form': 'INJECTABLE;INJECTION',\n",
       "  'Drug': 'ENTYVIO',\n",
       "  'ActiveIngredient': 'VEDOLIZUMAB',\n",
       "  'ApplType': 'BLA',\n",
       "  'Sponsor': 'TAKEDA PHARMS USA',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/125476Orig1s046lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=125476'},\n",
       " '125477': {'ApplNo': '125477',\n",
       "  'Form': 'INJECTABLE;INJECTION',\n",
       "  'Drug': 'CYRAMZA',\n",
       "  'ActiveIngredient': 'RAMUCIRUMAB',\n",
       "  'ApplType': 'BLA',\n",
       "  'Sponsor': 'ELI LILLY AND CO',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/125477s042lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=125477'},\n",
       " '125486': {'ApplNo': '125486',\n",
       "  'Form': 'INJECTABLE;INJECTION',\n",
       "  'Drug': 'GAZYVA',\n",
       "  'ActiveIngredient': 'OBINUTUZUMAB',\n",
       "  'ApplType': 'BLA',\n",
       "  'Sponsor': 'GENENTECH',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/125486s034lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=125486'},\n",
       " '125496': {'ApplNo': '125496',\n",
       "  'Form': 'INJECTABLE;INJECTION',\n",
       "  'Drug': 'SYLVANT',\n",
       "  'ActiveIngredient': 'SILTUXIMAB',\n",
       "  'ApplType': 'BLA',\n",
       "  'Sponsor': 'JANSSEN BIOTECH',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/125496s018lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=125496'},\n",
       " '125499': {'ApplNo': '125499',\n",
       "  'Form': 'INJECTABLE;INJECTION',\n",
       "  'Drug': 'PLEGRIDY',\n",
       "  'ActiveIngredient': 'PEGINTERFERON BETA-1A',\n",
       "  'ApplType': 'BLA',\n",
       "  'Sponsor': 'BIOGEN IDEC INC',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/125499s025lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=125499'},\n",
       " '125504': {'ApplNo': '125504',\n",
       "  'Form': 'INJECTABLE;INJECTION',\n",
       "  'Drug': 'COSENTYX',\n",
       "  'ActiveIngredient': 'SECUKINUMAB',\n",
       "  'ApplType': 'BLA',\n",
       "  'Sponsor': 'NOVARTIS PHARMS CORP',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/125504_S050_S051lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=125504'},\n",
       " '125509': {'ApplNo': '125509',\n",
       "  'Form': 'INJECTABLE;INJECTION',\n",
       "  'Drug': 'ANTHIM',\n",
       "  'ActiveIngredient': 'OBILTOXAXIMAB',\n",
       "  'ApplType': 'BLA',\n",
       "  'Sponsor': 'ELUSYS THERAPEUTICS INC',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/125509s015lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=125509'},\n",
       " '125511': {'ApplNo': '125511',\n",
       "  'Form': 'INJECTABLE;INJECTION',\n",
       "  'Drug': 'NATPARA',\n",
       "  'ActiveIngredient': 'PARATHYROID HORMONE',\n",
       "  'ApplType': 'BLA',\n",
       "  'Sponsor': 'NPS PHARMS INC',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/125511s028lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=125511'},\n",
       " '125513': {'ApplNo': '125513',\n",
       "  'Form': 'SOLUTION;INJECTION',\n",
       "  'Drug': 'STRENSIQ',\n",
       "  'ActiveIngredient': 'ASFOTASE ALFA',\n",
       "  'ApplType': 'BLA',\n",
       "  'Sponsor': 'ALEXION PHARM',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/125513s018lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=125513'},\n",
       " '125514': {'ApplNo': '125514',\n",
       "  'Form': 'SOLUTION;INTRAVENOUS',\n",
       "  'Drug': 'KEYTRUDA',\n",
       "  'ActiveIngredient': 'PEMBROLIZUMAB',\n",
       "  'ApplType': 'BLA',\n",
       "  'Sponsor': 'MERCK SHARP DOHME',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2023/125514s128lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=125514'},\n",
       " '125516': {'ApplNo': '125516',\n",
       "  'Form': 'INJECTABLE;INTRAVENOUS',\n",
       "  'Drug': 'UNITUXIN',\n",
       "  'ActiveIngredient': 'DINUTUXIMAB',\n",
       "  'ApplType': 'BLA',\n",
       "  'Sponsor': 'UNITED THERAP',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/125516s025lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=125516'},\n",
       " '125521': {'ApplNo': '125521',\n",
       "  'Form': 'INJECTABLE;INJECTION',\n",
       "  'Drug': 'TALTZ',\n",
       "  'ActiveIngredient': 'IXEKIZUMAB',\n",
       "  'ApplType': 'BLA',\n",
       "  'Sponsor': 'ELI LILLY AND CO',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/125521s024lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=125521'},\n",
       " '125522': {'ApplNo': '125522',\n",
       "  'Form': 'INJECTABLE;INJECTION',\n",
       "  'Drug': 'REPATHA',\n",
       "  'ActiveIngredient': 'EVOLOCUMAB',\n",
       "  'ApplType': 'BLA',\n",
       "  'Sponsor': 'AMGEN INC',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/125522s033lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=125522'},\n",
       " '125526': {'ApplNo': '125526',\n",
       "  'Form': 'INJECTABLE;SUBCUTANEOUS LYOPHILIZED POWER',\n",
       "  'Drug': 'NUCALA',\n",
       "  'ActiveIngredient': 'MEPOLIZUMAB',\n",
       "  'ApplType': 'BLA',\n",
       "  'Sponsor': 'GLAXOSMITHKLINE LLC',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/761122s008,125526s019lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=125526'},\n",
       " '125527': {'ApplNo': '125527',\n",
       "  'Form': 'INJECTABLE;INJECTION',\n",
       "  'Drug': 'OPDIVO',\n",
       "  'ActiveIngredient': 'NIVOLUMAB',\n",
       "  'ApplType': 'BLA',\n",
       "  'Sponsor': 'BRISTOL MYERS SQUIBB',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/125527s000lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=125527'},\n",
       " '125544': {'ApplNo': '125544',\n",
       "  'Form': 'INJECTABLE;INJECTION',\n",
       "  'Drug': 'INFLECTRA',\n",
       "  'ActiveIngredient': 'INFLIXIMAB-DYYB',\n",
       "  'ApplType': 'BLA',\n",
       "  'Sponsor': 'CELLTRION INC',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/125544s018lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=125544'},\n",
       " '125545': {'ApplNo': '125545',\n",
       "  'Form': 'INJECTABLE;INJECTION',\n",
       "  'Drug': 'RETACRIT',\n",
       "  'ActiveIngredient': 'EPOETIN ALFA-EPBX',\n",
       "  'ApplType': 'BLA',\n",
       "  'Sponsor': 'HOSPIRA INC',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/125545s005lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=125545'},\n",
       " '125547': {'ApplNo': '125547',\n",
       "  'Form': 'INJECTABLE;INTRA-ARTICULAR, INTRAMUSCULAR, INTRAVITREAL',\n",
       "  'Drug': 'PORTRAZZA',\n",
       "  'ActiveIngredient': 'NECITUMUMAB',\n",
       "  'ApplType': 'BLA',\n",
       "  'Sponsor': 'ELI LILLY CO',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/125547s000lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=125547'},\n",
       " '125553': {'ApplNo': '125553',\n",
       "  'Form': 'INJECTABLE;INJECTION',\n",
       "  'Drug': 'ZARXIO',\n",
       "  'ActiveIngredient': 'FILGRASTIM-SNDZ',\n",
       "  'ApplType': 'BLA',\n",
       "  'Sponsor': 'SANDOZ INC',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/125553s023lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=125553'},\n",
       " '125554': {'ApplNo': '125554',\n",
       "  'Form': 'INJECTABLE;INJECTION',\n",
       "  'Drug': 'OPDIVO',\n",
       "  'ActiveIngredient': 'NIVOLUMAB',\n",
       "  'ApplType': 'BLA',\n",
       "  'Sponsor': 'BRISTOL MYERS SQUIBB',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/125554s114lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=125554'},\n",
       " '125557': {'ApplNo': '125557',\n",
       "  'Form': 'INJECTABLE;INJECTION',\n",
       "  'Drug': 'BLINCYTO',\n",
       "  'ActiveIngredient': 'BLINATUMOMAB',\n",
       "  'ApplType': 'BLA',\n",
       "  'Sponsor': 'AMGEN',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/125557s021lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=125557'},\n",
       " '125559': {'ApplNo': '125559',\n",
       "  'Form': 'INJECTABLE;INJECTION',\n",
       "  'Drug': 'PRALUENT',\n",
       "  'ActiveIngredient': 'ALIROCUMAB',\n",
       "  'ApplType': 'BLA',\n",
       "  'Sponsor': 'REGENERON PHARMACEUTICALS',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/125559s029s030lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=125559'},\n",
       " '125561': {'ApplNo': '125561',\n",
       "  'Form': 'INJECTABLE;INJECTION',\n",
       "  'Drug': 'KANUMA',\n",
       "  'ActiveIngredient': 'SEBELIPASE ALFA',\n",
       "  'ApplType': 'BLA',\n",
       "  'Sponsor': 'ALEXION PHARM',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/125561s013lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=125561'},\n",
       " '12616': {'ApplNo': '12616',\n",
       "  'Form': 'TABLET;ORAL',\n",
       "  'Drug': 'ALDACTAZIDE',\n",
       "  'ActiveIngredient': 'HYDROCHLOROTHIAZIDE; SPIRONOLACTONE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'PFIZER',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/012616s083lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=12616'},\n",
       " '12623': {'ApplNo': '12623',\n",
       "  'Form': 'TABLET;ORAL',\n",
       "  'Drug': 'FLAGYL',\n",
       "  'ActiveIngredient': 'METRONIDAZOLE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'PFIZER',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/012623s069lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=12623'},\n",
       " '12750': {'ApplNo': '12750',\n",
       "  'Form': 'CAPSULE;ORAL',\n",
       "  'Drug': 'LIBRAX',\n",
       "  'ActiveIngredient': 'CHLORDIAZEPOXIDE HYDROCHLORIDE; CLIDINIUM BROMIDE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'BAUSCH',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2023/012750s068lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=12750'},\n",
       " '12770': {'ApplNo': '12770',\n",
       "  'Form': 'SOLUTION/DROPS;OTIC',\n",
       "  'Drug': 'VOSOL HC',\n",
       "  'ActiveIngredient': 'ACETIC ACID, GLACIAL; HYDROCORTISONE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'AKORN',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/1997/012770s024lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=12770'},\n",
       " '12787': {'ApplNo': '12787',\n",
       "  'Form': 'CREAM;TOPICAL',\n",
       "  'Drug': 'SYNALAR',\n",
       "  'ActiveIngredient': 'FLUOCINOLONE ACETONIDE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'MEDIMETRIKS PHARMS',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/012787s071lblrev.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=12787'},\n",
       " '12806': {'ApplNo': '12806',\n",
       "  'Form': 'OINTMENT;TOPICAL',\n",
       "  'Drug': 'CORDRAN',\n",
       "  'ActiveIngredient': 'FLURANDRENOLIDE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'ALMIRALL',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/012806s037lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=12806'},\n",
       " '12827': {'ApplNo': '12827',\n",
       "  'Form': 'TABLET;ORAL',\n",
       "  'Drug': 'ROBINUL',\n",
       "  'ActiveIngredient': 'GLYCOPYRROLATE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'CASPER PHARMA LLC',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/012827s059lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=12827'},\n",
       " '12836': {'ApplNo': '12836',\n",
       "  'Form': 'TABLET;ORAL',\n",
       "  'Drug': 'PERSANTINE',\n",
       "  'ActiveIngredient': 'DIPYRIDAMOLE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'BOEHRINGER INGELHEIM',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/012836s061lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=12836'},\n",
       " '12911': {'ApplNo': '12911',\n",
       "  'Form': 'CAPSULE;ORAL',\n",
       "  'Drug': 'METOPIRONE',\n",
       "  'ActiveIngredient': 'METYRAPONE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'HRA PHARMA',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/012911s038lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=12911'},\n",
       " '13025': {'ApplNo': '13025',\n",
       "  'Form': 'SOLUTION;INJECTION',\n",
       "  'Drug': 'THAM',\n",
       "  'ActiveIngredient': 'TROMETHAMINE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'HOSPIRA',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2006/013025s040lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=13025'},\n",
       " '13026': {'ApplNo': '13026',\n",
       "  'Form': 'TABLET;ORAL',\n",
       "  'Drug': 'TRECATOR',\n",
       "  'ActiveIngredient': 'ETHIONAMIDE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'WYETH PHARMS',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2016/013026s029lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=13026'},\n",
       " '13217': {'ApplNo': '13217',\n",
       "  'Form': 'TABLET;ORAL',\n",
       "  'Drug': 'SKELAXIN',\n",
       "  'ActiveIngredient': 'METAXALONE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'KING PHARMS',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2018/013217s057lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=13217'},\n",
       " '13263': {'ApplNo': '13263',\n",
       "  'Form': 'TABLET;ORAL',\n",
       "  'Drug': 'VALIUM',\n",
       "  'ActiveIngredient': 'DIAZEPAM',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'WAYLIS THERAP',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2023/013263s097lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=13263'},\n",
       " '13295': {'ApplNo': '13295',\n",
       "  'Form': 'INJECTABLE;INJECTION',\n",
       "  'Drug': 'CONRAY',\n",
       "  'ActiveIngredient': 'IOTHALAMATE MEGLUMINE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'LIEBEL-FLARSHEIM',\n",
       "  'LatestLabel': 'https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/013295s072lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=13295'},\n",
       " '13422': {'ApplNo': '13422',\n",
       "  'Form': 'SUSPENSION/DROPS;OPHTHALMIC',\n",
       "  'Drug': 'MAXIDEX',\n",
       "  'ActiveIngredient': 'DEXAMETHASONE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'NOVARTIS',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/013422s049lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=13422'},\n",
       " '13684': {'ApplNo': '13684',\n",
       "  'Form': 'INJECTABLE;INJECTION',\n",
       "  'Drug': 'OSMITROL 5% IN WATER',\n",
       "  'ActiveIngredient': 'MANNITOL',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'BAXTER HLTHCARE',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/013684s106lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=13684'},\n",
       " '13790': {'ApplNo': '13790',\n",
       "  'Form': 'LOTION;TOPICAL',\n",
       "  'Drug': 'CORDRAN',\n",
       "  'ActiveIngredient': 'FLURANDRENOLIDE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'ALMIRALL',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2011/013790s021lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=13790'},\n",
       " '14134': {'ApplNo': '14134',\n",
       "  'Form': 'INJECTABLE;INJECTION',\n",
       "  'Drug': 'PROTOPAM CHLORIDE',\n",
       "  'ActiveIngredient': 'PRALIDOXIME CHLORIDE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'BAXTER HLTHCARE CORP',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2010/014134s022lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=14134'},\n",
       " '14399': {'ApplNo': '14399',\n",
       "  'Form': 'TABLET;ORAL',\n",
       "  'Drug': 'NORPRAMIN',\n",
       "  'ActiveIngredient': 'DESIPRAMINE HYDROCHLORIDE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'VALIDUS PHARMS',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2018/014399s071lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=14399'},\n",
       " '14602': {'ApplNo': '14602',\n",
       "  'Form': 'INJECTABLE;INJECTION',\n",
       "  'Drug': 'CELESTONE SOLUSPAN',\n",
       "  'ActiveIngredient': 'BETAMETHASONE ACETATE; BETAMETHASONE SODIUM PHOSPHATE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'ORGANON',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/014602Orig1s065lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=14602'},\n",
       " '14879': {'ApplNo': '14879',\n",
       "  'Form': 'INJECTABLE;INJECTION',\n",
       "  'Drug': 'DOPRAM',\n",
       "  'ActiveIngredient': 'DOXAPRAM HYDROCHLORIDE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'HIKMA',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2005/14879s044lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=14879'},\n",
       " '14901': {'ApplNo': '14901',\n",
       "  'Form': 'INJECTABLE;INJECTION',\n",
       "  'Drug': 'KENALOG-40',\n",
       "  'ActiveIngredient': 'TRIAMCINOLONE ACETONIDE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'APOTHECON',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/014901Orig1s047lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=14901'},\n",
       " '15034': {'ApplNo': '15034',\n",
       "  'Form': 'CAPSULE;ORAL',\n",
       "  'Drug': 'PONSTEL',\n",
       "  'ActiveIngredient': 'MEFENAMIC ACID',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'AVION PHARMS',\n",
       "  'LatestLabel': 'https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/015034s045lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=15034'},\n",
       " '15193': {'ApplNo': '15193',\n",
       "  'Form': 'SYRUP;ORAL',\n",
       "  'Drug': 'MESTINON',\n",
       "  'ActiveIngredient': 'PYRIDOSTIGMINE BROMIDE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'BAUSCH',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2001/15193s18lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=15193'},\n",
       " '15197': {'ApplNo': '15197',\n",
       "  'Form': 'TABLET;ORAL',\n",
       "  'Drug': 'AMICAR',\n",
       "  'ActiveIngredient': 'AMINOCAPROIC ACID',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'AKORN',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2008/015197s043,015230s035lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=15197'},\n",
       " '15230': {'ApplNo': '15230',\n",
       "  'Form': 'SOLUTION;ORAL',\n",
       "  'Drug': 'AMICAR',\n",
       "  'ActiveIngredient': 'AMINOCAPROIC ACID',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'AKORN',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2009/015230s037lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=15230'},\n",
       " '15296': {'ApplNo': '15296',\n",
       "  'Form': 'SOLUTION;TOPICAL',\n",
       "  'Drug': 'SYNALAR',\n",
       "  'ActiveIngredient': 'FLUOCINOLONE ACETONIDE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'MEDIMETRIKS PHARMS',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/015296s064lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=15296'},\n",
       " '16084': {'ApplNo': '16084',\n",
       "  'Form': 'TABLET;ORAL',\n",
       "  'Drug': 'ZYLOPRIM',\n",
       "  'ActiveIngredient': 'ALLOPURINOL',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'CASPER PHARMA LLC',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/016084Orig1s049lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=16084'},\n",
       " '16092': {'ApplNo': '16092',\n",
       "  'Form': 'TABLET;ORAL',\n",
       "  'Drug': 'EDECRIN',\n",
       "  'ActiveIngredient': 'ETHACRYNIC ACID',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'BAUSCH',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2005/16092s042,16093s044lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=16092'},\n",
       " '16093': {'ApplNo': '16093',\n",
       "  'Form': 'INJECTABLE;INJECTION',\n",
       "  'Drug': 'EDECRIN',\n",
       "  'ActiveIngredient': 'ETHACRYNATE SODIUM',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'BAUSCH',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2005/16092s042,16093s044lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=16093'},\n",
       " '16151': {'ApplNo': '16151',\n",
       "  'Form': 'TABLET;ORAL',\n",
       "  'Drug': 'UREX',\n",
       "  'ActiveIngredient': 'METHENAMINE HIPPURATE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'ALVOGEN',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2008/016151s025lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=16151'},\n",
       " '16199': {'ApplNo': '16199',\n",
       "  'Form': 'ENEMA;RECTAL',\n",
       "  'Drug': 'CORTENEMA',\n",
       "  'ActiveIngredient': 'HYDROCORTISONE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'ANI PHARMS',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2008/016199s035lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=16199'},\n",
       " '16267': {'ApplNo': '16267',\n",
       "  'Form': 'INJECTABLE;INJECTION',\n",
       "  'Drug': 'DESFERAL',\n",
       "  'ActiveIngredient': 'DEFEROXAMINE MESYLATE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'NOVARTIS',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/016267s062lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=16267'},\n",
       " '16269': {'ApplNo': '16269',\n",
       "  'Form': 'INJECTABLE;INJECTION',\n",
       "  'Drug': 'MANNITOL 25%',\n",
       "  'ActiveIngredient': 'MANNITOL',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'HOSPIRA',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/016269s056lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=16269'},\n",
       " '16273': {'ApplNo': '16273',\n",
       "  'Form': 'TABLET;ORAL',\n",
       "  'Drug': 'LASIX',\n",
       "  'ActiveIngredient': 'FUROSEMIDE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'VALIDUS PHARMS',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2018/016273s069lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=16273'},\n",
       " '16295': {'ApplNo': '16295',\n",
       "  'Form': 'CAPSULE;ORAL',\n",
       "  'Drug': 'HYDREA',\n",
       "  'ActiveIngredient': 'HYDROXYUREA',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'CHEPLAPHARM',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/016295Orig1s055lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=16295'},\n",
       " '16320': {'ApplNo': '16320',\n",
       "  'Form': 'TABLET;ORAL',\n",
       "  'Drug': 'MYAMBUTOL',\n",
       "  'ActiveIngredient': 'ETHAMBUTOL HYDROCHLORIDE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'STI PHARMA LLC',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/016320s066lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=16320'},\n",
       " '16324': {'ApplNo': '16324',\n",
       "  'Form': 'TABLET;ORAL',\n",
       "  'Drug': 'IMURAN',\n",
       "  'ActiveIngredient': 'AZATHIOPRINE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'SEBELA IRELAND LTD',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2018/016324s039lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=16324'},\n",
       " '16366': {'ApplNo': '16366',\n",
       "  'Form': 'INJECTABLE;INJECTION',\n",
       "  'Drug': 'SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER',\n",
       "  'ActiveIngredient': 'SODIUM CHLORIDE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'ICU MEDICAL INC',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2017/016366s214lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=16366'},\n",
       " '16367': {'ApplNo': '16367',\n",
       "  'Form': 'INJECTABLE;INJECTION',\n",
       "  'Drug': 'DEXTROSE 5% IN PLASTIC CONTAINER',\n",
       "  'ActiveIngredient': 'DEXTROSE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'ICU MEDICAL INC',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2006/016367s182lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=16367'},\n",
       " '16608': {'ApplNo': '16608',\n",
       "  'Form': 'TABLET;ORAL',\n",
       "  'Drug': 'TEGRETOL',\n",
       "  'ActiveIngredient': 'CARBAMAZEPINE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'NOVARTIS',\n",
       "  'LatestLabel': 'https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/016608s115_018281_s058_018927s055_020234_s047.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=16608'},\n",
       " '16619': {'ApplNo': '16619',\n",
       "  'Form': 'INJECTABLE;INJECTION',\n",
       "  'Drug': 'SUBLIMAZE PRESERVATIVE FREE',\n",
       "  'ActiveIngredient': 'FENTANYL CITRATE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'AKORN',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/016619Orig1s052lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=16619'},\n",
       " '16620': {'ApplNo': '16620',\n",
       "  'Form': 'CAPSULE;ORAL',\n",
       "  'Drug': 'MACRODANTIN',\n",
       "  'ActiveIngredient': 'NITROFURANTOIN, MACROCRYSTALLINE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'ALMATICA',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/016620Orig1s076lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=16620'},\n",
       " '16673': {'ApplNo': '16673',\n",
       "  'Form': 'INJECTABLE;INJECTION',\n",
       "  'Drug': 'DEXTROSE 5% IN PLASTIC CONTAINER',\n",
       "  'ActiveIngredient': 'DEXTROSE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'BAXTER HLTHCARE',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/016673s149,016694s121lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=16673'},\n",
       " '16677': {'ApplNo': '16677',\n",
       "  'Form': 'INJECTABLE;INJECTION',\n",
       "  'Drug': 'SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER',\n",
       "  'ActiveIngredient': 'SODIUM CHLORIDE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'BAXTER HLTHCARE',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/016677s169,018016s067,020178s021lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=16677'},\n",
       " '16678': {'ApplNo': '16678',\n",
       "  'Form': 'INJECTABLE;INJECTION',\n",
       "  'Drug': 'DEXTROSE 5% IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER',\n",
       "  'ActiveIngredient': 'DEXTROSE; SODIUM CHLORIDE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'BAXTER HLTHCARE',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/016678s007,016683s103,016687s104,016689s107,016697s098lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=16678'},\n",
       " '16679': {'ApplNo': '16679',\n",
       "  'Form': 'INJECTABLE;INJECTION',\n",
       "  'Drug': \"LACTATED RINGER'S AND DEXTROSE 5% IN PLASTIC CONTAINER\",\n",
       "  'ActiveIngredient': 'CALCIUM CHLORIDE; DEXTROSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE; SODIUM LACTATE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'BAXTER HLTHCARE',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/016679s114lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=16679'},\n",
       " '16682': {'ApplNo': '16682',\n",
       "  'Form': 'INJECTABLE;INJECTION',\n",
       "  'Drug': \"LACTATED RINGER'S IN PLASTIC CONTAINER\",\n",
       "  'ActiveIngredient': 'CALCIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM CHLORIDE; SODIUM LACTATE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'BAXTER HLTHCARE',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/016682s117lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=16682'},\n",
       " '16683': {'ApplNo': '16683',\n",
       "  'Form': 'INJECTABLE;INJECTION',\n",
       "  'Drug': 'DEXTROSE 5% IN SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER',\n",
       "  'ActiveIngredient': 'DEXTROSE; SODIUM CHLORIDE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'BAXTER HLTHCARE',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/016678s007,016683s103,016687s104,016689s107,016697s098lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=16683'},\n",
       " '16687': {'ApplNo': '16687',\n",
       "  'Form': 'INJECTABLE;INJECTION',\n",
       "  'Drug': 'DEXTROSE 5% IN SODIUM CHLORIDE 0.33% IN PLASTIC CONTAINER',\n",
       "  'ActiveIngredient': 'DEXTROSE; SODIUM CHLORIDE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'BAXTER HLTHCARE',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/016678s007,016683s103,016687s104,016689s107,016697s098lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=16687'},\n",
       " '16689': {'ApplNo': '16689',\n",
       "  'Form': 'INJECTABLE;INJECTION',\n",
       "  'Drug': 'DEXTROSE 5% IN SODIUM CHLORIDE 0.2% IN PLASTIC CONTAINER',\n",
       "  'ActiveIngredient': 'DEXTROSE; SODIUM CHLORIDE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'BAXTER HLTHCARE',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/016678s007,016683s103,016687s104,016689s107,016697s098lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=16689'},\n",
       " '16693': {'ApplNo': '16693',\n",
       "  'Form': 'INJECTABLE;INJECTION',\n",
       "  'Drug': \"RINGER'S IN PLASTIC CONTAINER\",\n",
       "  'ActiveIngredient': 'CALCIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM CHLORIDE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'BAXTER HLTHCARE',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/016693s101lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=16693'},\n",
       " '16694': {'ApplNo': '16694',\n",
       "  'Form': 'INJECTABLE;INJECTION',\n",
       "  'Drug': 'DEXTROSE 10% IN PLASTIC CONTAINER',\n",
       "  'ActiveIngredient': 'DEXTROSE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'BAXTER HLTHCARE',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/016673s149,016694s121lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=16694'},\n",
       " '16697': {'ApplNo': '16697',\n",
       "  'Form': 'INJECTABLE;INJECTION',\n",
       "  'Drug': 'DEXTROSE 2.5% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER',\n",
       "  'ActiveIngredient': 'DEXTROSE; SODIUM CHLORIDE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'BAXTER HLTHCARE',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/016678s007,016683s103,016687s104,016689s107,016697s098lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=16697'},\n",
       " '16750': {'ApplNo': '16750',\n",
       "  'Form': 'INJECTABLE;INJECTION',\n",
       "  'Drug': 'CORTROSYN',\n",
       "  'ActiveIngredient': 'COSYNTROPIN',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'AMPHASTAR PHARMS INC',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/016750Orig1s032lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=16750'},\n",
       " '16784': {'ApplNo': '16784',\n",
       "  'Form': 'SOLUTION;IRRIGATION',\n",
       "  'Drug': 'GLYCINE 1.5% IN PLASTIC CONTAINER',\n",
       "  'ActiveIngredient': 'GLYCINE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'B BRAUN',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/016784s035lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=16784'},\n",
       " '16812': {'ApplNo': '16812',\n",
       "  'Form': 'INJECTABLE;INJECTION',\n",
       "  'Drug': 'KETALAR',\n",
       "  'ActiveIngredient': 'KETAMINE HYDROCHLORIDE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'PAR STERILE PRODUCTS',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/016812s051lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=16812'},\n",
       " '16831': {'ApplNo': '16831',\n",
       "  'Form': 'SOLUTION;TOPICAL',\n",
       "  'Drug': 'EFUDEX',\n",
       "  'ActiveIngredient': 'FLUOROURACIL',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'BAUSCH',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/016831Orig1s063lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=16831'},\n",
       " '16851': {'ApplNo': '16851',\n",
       "  'Form': 'SUSPENSION/DROPS;OPHTHALMIC',\n",
       "  'Drug': 'FML',\n",
       "  'ActiveIngredient': 'FLUOROMETHOLONE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'ALLERGAN',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/016851s063lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=16851'},\n",
       " '16885': {'ApplNo': '16885',\n",
       "  'Form': 'TABLET;ORAL',\n",
       "  'Drug': 'LYSODREN',\n",
       "  'ActiveIngredient': 'MITOTANE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'HRA PHARMA',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/016885s029lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=16885'},\n",
       " '16909': {'ApplNo': '16909',\n",
       "  'Form': 'OINTMENT;TOPICAL',\n",
       "  'Drug': 'LIDEX',\n",
       "  'ActiveIngredient': 'FLUOCINONIDE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'ALVOGEN',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2016/016909s053lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=16909'},\n",
       " '16931': {'ApplNo': '16931',\n",
       "  'Form': 'INJECTABLE;INJECTION',\n",
       "  'Drug': 'R-GENE 10',\n",
       "  'ActiveIngredient': 'ARGININE HYDROCHLORIDE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'PHARMACIA AND UPJOHN',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2010/016931s031lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=16931'},\n",
       " '16964': {'ApplNo': '16964',\n",
       "  'Form': 'INJECTABLE;INJECTION',\n",
       "  'Drug': 'MARCAINE HYDROCHLORIDE',\n",
       "  'ActiveIngredient': 'BUPIVACAINE HYDROCHLORIDE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'HOSPIRA',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/016964s082lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=16964'},\n",
       " '16968': {'ApplNo': '16968',\n",
       "  'Form': 'SOLUTION;INTRAOCULAR',\n",
       "  'Drug': 'MIOSTAT',\n",
       "  'ActiveIngredient': 'CARBACHOL',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'ALCON',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2016/016968s029lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=16968'},\n",
       " '17001': {'ApplNo': '17001',\n",
       "  'Form': 'CAPSULE;ORAL',\n",
       "  'Drug': 'ANCOBON',\n",
       "  'ActiveIngredient': 'FLUCYTOSINE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'BAUSCH',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/017001Orig1s034lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=17001'},\n",
       " '17011': {'ApplNo': '17011',\n",
       "  'Form': 'SUSPENSION/DROPS;OPHTHALMIC',\n",
       "  'Drug': 'PRED FORTE',\n",
       "  'ActiveIngredient': 'PREDNISOLONE ACETATE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'ALLERGAN',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2018/017011s050lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=17011'},\n",
       " '17016': {'ApplNo': '17016',\n",
       "  'Form': 'INJECTABLE;INJECTION',\n",
       "  'Drug': 'CHORIONIC GONADOTROPIN',\n",
       "  'ActiveIngredient': 'GONADOTROPIN, CHORIONIC',\n",
       "  'ApplType': 'BLA',\n",
       "  'Sponsor': 'FERRING',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2011/017016s156lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=17016'},\n",
       " '17029': {'ApplNo': '17029',\n",
       "  'Form': 'INJECTABLE;INJECTION',\n",
       "  'Drug': 'HEPARIN SODIUM',\n",
       "  'ActiveIngredient': 'HEPARIN SODIUM',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'FRESENIUS KABI USA',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/017029s159lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=17029'},\n",
       " '17037': {'ApplNo': '17037',\n",
       "  'Form': 'INJECTABLE;INJECTION',\n",
       "  'Drug': 'HEPARIN SODIUM',\n",
       "  'ActiveIngredient': 'HEPARIN SODIUM',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'HIKMA',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/017037Orig1s187lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=17037'},\n",
       " '17058': {'ApplNo': '17058',\n",
       "  'Form': 'TABLET, FOR SUSPENSION;ORAL',\n",
       "  'Drug': 'METHADONE HYDROCHLORIDE',\n",
       "  'ActiveIngredient': 'METHADONE HYDROCHLORIDE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'HIKMA',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/017058s027lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=17058'},\n",
       " '17067': {'ApplNo': '17067',\n",
       "  'Form': 'INJECTABLE;INJECTION',\n",
       "  'Drug': 'CHORIONIC GONADOTROPIN',\n",
       "  'ActiveIngredient': 'GONADOTROPIN, CHORIONIC',\n",
       "  'ApplType': 'BLA',\n",
       "  'Sponsor': 'FRESENIUS KABI USA',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2011/017067s057lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=17067'},\n",
       " '17078': {'ApplNo': '17078',\n",
       "  'Form': 'CAPSULE, EXTENDED RELEASE;ORAL',\n",
       "  'Drug': 'DEXEDRINE',\n",
       "  'ActiveIngredient': 'DEXTROAMPHETAMINE SULFATE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'IMPAX LABS INC',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/017078s054lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=17078'},\n",
       " '17100': {'ApplNo': '17100',\n",
       "  'Form': 'SUSPENSION/DROPS;OPHTHALMIC',\n",
       "  'Drug': 'PRED MILD',\n",
       "  'ActiveIngredient': 'PREDNISOLONE ACETATE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'ALLERGAN',\n",
       "  'LatestLabel': 'https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/017100s048lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=17100'},\n",
       " '17105': {'ApplNo': '17105',\n",
       "  'Form': 'TABLET;ORAL',\n",
       "  'Drug': 'TRANXENE',\n",
       "  'ActiveIngredient': 'CLORAZEPATE DIPOTASSIUM',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'KEY THERAP',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2023/017105s085lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=17105'},\n",
       " '17106': {'ApplNo': '17106',\n",
       "  'Form': 'SOLUTION;INTRAMUSCULAR',\n",
       "  'Drug': 'ATROPEN',\n",
       "  'ActiveIngredient': 'ATROPINE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'MMT',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/017106s052lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=17106'},\n",
       " '17116': {'ApplNo': '17116',\n",
       "  'Form': 'CONCENTRATE;ORAL',\n",
       "  'Drug': 'METHADOSE',\n",
       "  'ActiveIngredient': 'METHADONE HYDROCHLORIDE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'SPECGX LLC',\n",
       "  'LatestLabel': 'https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/017116Orig1s043Lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=17116'},\n",
       " '17243': {'ApplNo': '17243',\n",
       "  'Form': 'SOLUTION;INTRAVENOUS',\n",
       "  'Drug': 'ULTRA-TECHNEKOW FM',\n",
       "  'ActiveIngredient': 'TECHNETIUM TC-99M SODIUM PERTECHNETATE GENERATOR',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'CURIUM',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/017243Orig1s046lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=17243'},\n",
       " '17284': {'ApplNo': '17284',\n",
       "  'Form': 'GAS;INHALATION',\n",
       "  'Drug': 'XENON XE 133',\n",
       "  'ActiveIngredient': 'XENON XE-133',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'LANTHEUS MEDCL',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2011/017284s012lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=17284'},\n",
       " '17340': {'ApplNo': '17340',\n",
       "  'Form': 'CREAM;TOPICAL',\n",
       "  'Drug': 'RETIN-A',\n",
       "  'ActiveIngredient': 'TRETINOIN',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'VALEANT PHARMS NORTH',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2002/16921s21s22s25lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=17340'},\n",
       " '17376': {'ApplNo': '17376',\n",
       "  'Form': 'TABLET;ORAL',\n",
       "  'Drug': 'SEPTRA',\n",
       "  'ActiveIngredient': 'SULFAMETHOXAZOLE; TRIMETHOPRIM',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'MONARCH PHARMS',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/017376s062lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=17376'},\n",
       " '17377': {'ApplNo': '17377',\n",
       "  'Form': 'TABLET;ORAL',\n",
       "  'Drug': 'BACTRIM',\n",
       "  'ActiveIngredient': 'SULFAMETHOXAZOLE; TRIMETHOPRIM',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'SUN PHARM INDUSTRIES',\n",
       "  'LatestLabel': 'https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/017377s083lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=17377'},\n",
       " '17378': {'ApplNo': '17378',\n",
       "  'Form': 'INJECTABLE;INJECTION',\n",
       "  'Drug': 'PLASMA-LYTE 148 IN WATER IN PLASTIC CONTAINER',\n",
       "  'ActiveIngredient': 'MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM ACETATE; SODIUM CHLORIDE; SODIUM GLUCONATE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'BAXTER HLTHCARE',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/017378s075lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=17378'},\n",
       " '17381': {'ApplNo': '17381',\n",
       "  'Form': 'CREAM;TOPICAL',\n",
       "  'Drug': 'SILVADENE',\n",
       "  'ActiveIngredient': 'SILVER SULFADIAZINE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'KING PHARMS LLC',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2016/017381s053lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=17381'},\n",
       " '17398': {'ApplNo': '17398',\n",
       "  'Form': 'INJECTABLE;INJECTION',\n",
       "  'Drug': 'REGONOL',\n",
       "  'ActiveIngredient': 'PYRIDOSTIGMINE BROMIDE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'SANDOZ INC',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2004/17398s015lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=17398'},\n",
       " '17422': {'ApplNo': '17422',\n",
       "  'Form': 'INJECTABLE;INJECTION',\n",
       "  'Drug': 'BICNU',\n",
       "  'ActiveIngredient': 'CARMUSTINE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'AVET LIFESCIENCES',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2017/017422s055lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=17422'},\n",
       " '17428': {'ApplNo': '17428',\n",
       "  'Form': 'LIQUID;IRRIGATION',\n",
       "  'Drug': 'STERILE WATER',\n",
       "  'ActiveIngredient': 'STERILE WATER FOR IRRIGATION',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'BAXTER HLTHCARE',\n",
       "  'LatestLabel': 'https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/017428s071_017866s052lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=17428'},\n",
       " '17441': {'ApplNo': '17441',\n",
       "  'Form': 'INJECTABLE;INJECTION',\n",
       "  'Drug': 'INFED',\n",
       "  'ActiveIngredient': 'FERRIC OXYHYDROXIDE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'ALLERGAN',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/017441s179lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=17441'},\n",
       " '17442': {'ApplNo': '17442',\n",
       "  'Form': 'CAPSULE;ORAL',\n",
       "  'Drug': 'MINIPRESS',\n",
       "  'ActiveIngredient': 'PRAZOSIN HYDROCHLORIDE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'PFIZER',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/017442 s043lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=17442'},\n",
       " '17443': {'ApplNo': '17443',\n",
       "  'Form': 'CAPSULE;ORAL',\n",
       "  'Drug': 'DANTRIUM',\n",
       "  'ActiveIngredient': 'DANTROLENE SODIUM',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'PAR STERILE PRODUCTS',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/017443s043s046s048s049lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=17443'},\n",
       " '17450': {'ApplNo': '17450',\n",
       "  'Form': 'CREAM;VAGINAL',\n",
       "  'Drug': 'MONISTAT 7',\n",
       "  'ActiveIngredient': 'MICONAZOLE NITRATE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'MEDTECH PRODUCTS',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/017450Orig1s075,020670Orig1s036,021261Orig1s025,021308Orig1s031lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=17450'},\n",
       " '17453': {'ApplNo': '17453',\n",
       "  'Form': 'SUSPENSION;ORAL',\n",
       "  'Drug': 'PROGLYCEM',\n",
       "  'ActiveIngredient': 'DIAZOXIDE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'TEVA BRANDED PHARM',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/017425s017,017453s023lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=17453'},\n",
       " '17469': {'ApplNo': '17469',\n",
       "  'Form': 'SUSPENSION/DROPS;OPHTHALMIC',\n",
       "  'Drug': 'OMNIPRED',\n",
       "  'ActiveIngredient': 'PREDNISOLONE ACETATE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'NOVARTIS',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/017469Orig1s047lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=17469'},\n",
       " '17478': {'ApplNo': '17478',\n",
       "  'Form': 'INJECTABLE;INJECTION',\n",
       "  'Drug': 'GALLIUM CITRATE GA 67',\n",
       "  'ActiveIngredient': 'GALLIUM CITRATE GA-67',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'LANTHEUS MEDCL',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2018/017478s016lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=17478'},\n",
       " '17484': {'ApplNo': '17484',\n",
       "  'Form': 'INJECTABLE;INJECTION',\n",
       "  'Drug': 'DEXTROSE 5% AND ELECTROLYTE NO. 48 IN PLASTIC CONTAINER',\n",
       "  'ActiveIngredient': 'DEXTROSE; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; POTASSIUM PHOSPHATE, MONOBASIC; SODIUM CHLORIDE; SODIUM LACTATE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'BAXTER HLTHCARE',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/017484s076lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=17484'},\n",
       " '17512': {'ApplNo': '17512',\n",
       "  'Form': 'SOLUTION;INTRAPERITONEAL',\n",
       "  'Drug': 'DIANEAL PD-2 W/ DEXTROSE 1.5% IN PLASTIC CONTAINER',\n",
       "  'ActiveIngredient': 'CALCIUM CHLORIDE; DEXTROSE; MAGNESIUM CHLORIDE; SODIUM CHLORIDE; SODIUM LACTATE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'BAXTER HLTHCARE',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/017512s122,020163s027,020183s026lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=17512'},\n",
       " '17522': {'ApplNo': '17522',\n",
       "  'Form': 'CREAM;TOPICAL',\n",
       "  'Drug': 'RETIN-A',\n",
       "  'ActiveIngredient': 'TRETINOIN',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'VALEANT BERMUDA',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2002/16921s21s22s25lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=17522'},\n",
       " '17530': {'ApplNo': '17530',\n",
       "  'Form': 'INJECTABLE;INJECTION',\n",
       "  'Drug': 'TIGAN',\n",
       "  'ActiveIngredient': 'TRIMETHOBENZAMIDE HYDROCHLORIDE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'PAR STERILE PRODUCTS',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2008/017530s024lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=17530'},\n",
       " '17532': {'ApplNo': '17532',\n",
       "  'Form': 'TABLET;ORAL',\n",
       "  'Drug': 'DIABETA',\n",
       "  'ActiveIngredient': 'GLYBURIDE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'SANOFI AVENTIS US',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2017/017532s038lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=17532'},\n",
       " '17533': {'ApplNo': '17533',\n",
       "  'Form': 'TABLET;ORAL',\n",
       "  'Drug': 'KLONOPIN',\n",
       "  'ActiveIngredient': 'CLONAZEPAM',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'CHEPLAPHARM',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2023/017533s062lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=17533'},\n",
       " '17538': {'ApplNo': '17538',\n",
       "  'Form': 'INJECTABLE;INJECTION',\n",
       "  'Drug': 'TECHNESCAN PYP KIT',\n",
       "  'ActiveIngredient': 'TECHNETIUM TC-99M PYROPHOSPHATE KIT',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'CURIUM',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2017/017538s019lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=17538'},\n",
       " '17555': {'ApplNo': '17555',\n",
       "  'Form': 'TABLET;ORAL',\n",
       "  'Drug': 'SINEMET',\n",
       "  'ActiveIngredient': 'CARBIDOPA; LEVODOPA',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'ORGANON',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/017555s072lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=17555'},\n",
       " '17556': {'ApplNo': '17556',\n",
       "  'Form': 'CREAM;TOPICAL',\n",
       "  'Drug': 'HALOG',\n",
       "  'ActiveIngredient': 'HALCINONIDE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'SUN PHARM INDS INC',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2009/017556s038lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=17556'},\n",
       " '17563': {'ApplNo': '17563',\n",
       "  'Form': 'GRANULE;ORAL',\n",
       "  'Drug': 'FLAVORED COLESTID',\n",
       "  'ActiveIngredient': 'COLESTIPOL HYDROCHLORIDE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'PFIZER',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/017563s023,020222s005lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=17563'},\n",
       " '17579': {'ApplNo': '17579',\n",
       "  'Form': 'GEL;TOPICAL',\n",
       "  'Drug': 'RETIN-A',\n",
       "  'ActiveIngredient': 'TRETINOIN',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'VALEANT INTL',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2002/16921s21s22s25lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=17579'},\n",
       " '17581': {'ApplNo': '17581',\n",
       "  'Form': 'TABLET;ORAL',\n",
       "  'Drug': 'NAPROSYN',\n",
       "  'ActiveIngredient': 'NAPROXEN',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'ATNAHS PHARMA US',\n",
       "  'LatestLabel': 'https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/017581s115,018164s065,020067s064lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=17581'},\n",
       " '17588': {'ApplNo': '17588',\n",
       "  'Form': 'CAPSULE;ORAL',\n",
       "  'Drug': 'GLEOSTINE',\n",
       "  'ActiveIngredient': 'LOMUSTINE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'CORDEN PHARMA',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/017588Orig1s046lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=17588'},\n",
       " '17604': {'ApplNo': '17604',\n",
       "  'Form': 'CAPSULE;ORAL',\n",
       "  'Drug': 'NALFON',\n",
       "  'ActiveIngredient': 'FENOPROFEN CALCIUM',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'XSPIRE PHARMA',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/017604s051lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=17604'},\n",
       " '17607': {'ApplNo': '17607',\n",
       "  'Form': 'INJECTABLE;INJECTION',\n",
       "  'Drug': 'DEXTROSE 5% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER',\n",
       "  'ActiveIngredient': 'DEXTROSE; SODIUM CHLORIDE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'ICU MEDICAL INC',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2006/017607s123lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=17607'},\n",
       " '17624': {'ApplNo': '17624',\n",
       "  'Form': 'LIQUID;INHALATION',\n",
       "  'Drug': 'FORANE',\n",
       "  'ActiveIngredient': 'ISOFLURANE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'BAXTER HLTHCARE',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/017624s042lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=17624'},\n",
       " '17634': {'ApplNo': '17634',\n",
       "  'Form': 'INJECTABLE;INJECTION',\n",
       "  'Drug': 'DEXTROSE 5% AND POTASSIUM CHLORIDE 0.15% IN PLASTIC CONTAINER',\n",
       "  'ActiveIngredient': 'DEXTROSE; POTASSIUM CHLORIDE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'BAXTER HLTHCARE',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/017634s076lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=17634'},\n",
       " '17643': {'ApplNo': '17643',\n",
       "  'Form': 'INJECTABLE;INJECTION',\n",
       "  'Drug': 'INTRALIPID 10%',\n",
       "  'ActiveIngredient': 'SOYBEAN OIL',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'FRESENIUS',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/017643s082lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=17643'},\n",
       " '17648': {'ApplNo': '17648',\n",
       "  'Form': 'INJECTABLE;INJECTION',\n",
       "  'Drug': 'POTASSIUM CHLORIDE 0.15% IN SODIUM CHLORIDE 0.9%',\n",
       "  'ActiveIngredient': 'POTASSIUM CHLORIDE; SODIUM CHLORIDE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'BAXTER HLTHCARE',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/017648s071lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=17648'},\n",
       " '17651': {'ApplNo': '17651',\n",
       "  'Form': 'INJECTABLE;INJECTION',\n",
       "  'Drug': 'HEPARIN SODIUM',\n",
       "  'ActiveIngredient': 'HEPARIN SODIUM',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'FRESENIUS KABI USA',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/017029s156,017651s066lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=17651'},\n",
       " '17681': {'ApplNo': '17681',\n",
       "  'Form': 'TABLET;ORAL',\n",
       "  'Drug': 'HIPREX',\n",
       "  'ActiveIngredient': 'METHENAMINE HIPPURATE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'VALIDUS PHARMS',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/017681Orig1s019lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=17681'},\n",
       " '17692': {'ApplNo': '17692',\n",
       "  'Form': 'INJECTABLE;INJECTION',\n",
       "  'Drug': 'PREGNYL',\n",
       "  'ActiveIngredient': 'GONADOTROPIN, CHORIONIC',\n",
       "  'ApplType': 'BLA',\n",
       "  'Sponsor': 'ORGANON USA INC',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2007/017692s018lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=17692'},\n",
       " '17697': {'ApplNo': '17697',\n",
       "  'Form': 'INJECTABLE;INJECTION',\n",
       "  'Drug': 'KINEVAC',\n",
       "  'ActiveIngredient': 'SINCALIDE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'BRACCO',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2018/017697s033lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=17697'},\n",
       " '17744': {'ApplNo': '17744',\n",
       "  'Form': 'TABLET;ORAL',\n",
       "  'Drug': 'MOTOFEN',\n",
       "  'ActiveIngredient': 'ATROPINE SULFATE; DIFENOXIN HYDROCHLORIDE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'SEBELA IRELAND LTD',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2017/017744s026lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=17744'},\n",
       " '17765': {'ApplNo': '17765',\n",
       "  'Form': 'CREAM;TOPICAL',\n",
       "  'Drug': 'CLODERM',\n",
       "  'ActiveIngredient': 'CLOCORTOLONE PIVALATE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'EPI HLTH',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2003/17765scp024_cloderm_lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=17765'},\n",
       " '17768': {'ApplNo': '17768',\n",
       "  'Form': 'SOLUTION;TOPICAL',\n",
       "  'Drug': 'HIBICLENS',\n",
       "  'ActiveIngredient': 'CHLORHEXIDINE GLUCONATE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'MOLNLYCKE HLTH',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/017768Orig1s056lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=17768'},\n",
       " '17771': {'ApplNo': '17771',\n",
       "  'Form': 'SOLUTION;INTRAVENOUS',\n",
       "  'Drug': 'TECHNELITE',\n",
       "  'ActiveIngredient': 'TECHNETIUM TC-99M SODIUM PERTECHNETATE GENERATOR',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'LANTHEUS MEDCL',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/017771Orig1s044lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=17771'},\n",
       " '17794': {'ApplNo': '17794',\n",
       "  'Form': 'TABLET;ORAL',\n",
       "  'Drug': 'ATIVAN',\n",
       "  'ActiveIngredient': 'LORAZEPAM',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'BAUSCH',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2023/017794s049lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=17794'},\n",
       " '17806': {'ApplNo': '17806',\n",
       "  'Form': 'INJECTABLE;INJECTION',\n",
       "  'Drug': 'THALLOUS CHLORIDE TL 201',\n",
       "  'ActiveIngredient': 'THALLOUS CHLORIDE TL-201',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'LANTHEUS MEDCL',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2011/017806s025lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=17806'},\n",
       " '17808': {'ApplNo': '17808',\n",
       "  'Form': 'INJECTABLE;INJECTION',\n",
       "  'Drug': 'MIACALCIN',\n",
       "  'ActiveIngredient': 'CALCITONIN SALMON',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'MYLAN IRELAND LTD',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2017/017808s037lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=17808'},\n",
       " '17812': {'ApplNo': '17812',\n",
       "  'Form': 'CAPSULE;ORAL',\n",
       "  'Drug': 'LITHIUM CARBONATE',\n",
       "  'ActiveIngredient': 'LITHIUM CARBONATE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'HIKMA',\n",
       "  'LatestLabel': 'https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/017812s036,018421s035,018558s030lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=17812'},\n",
       " '17823': {'ApplNo': '17823',\n",
       "  'Form': 'SOLUTION;TOPICAL',\n",
       "  'Drug': 'HALOG',\n",
       "  'ActiveIngredient': 'HALCINONIDE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'SUN PHARM INDS INC',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2004/17823s023lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=17823'},\n",
       " '17824': {'ApplNo': '17824',\n",
       "  'Form': 'OINTMENT;TOPICAL',\n",
       "  'Drug': 'HALOG',\n",
       "  'ActiveIngredient': 'HALCINONIDE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'SUN PHARM INDS INC',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2004/17824s024lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=17824'},\n",
       " '17830': {'ApplNo': '17830',\n",
       "  'Form': 'TABLET;ORAL',\n",
       "  'Drug': 'LODOSYN',\n",
       "  'ActiveIngredient': 'CARBIDOPA',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'ATON',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/017830s014s016s017s018s019s030lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=17830'},\n",
       " '17854': {'ApplNo': '17854',\n",
       "  'Form': 'TABLET;ORAL',\n",
       "  'Drug': 'REGLAN',\n",
       "  'ActiveIngredient': 'METOCLOPRAMIDE HYDROCHLORIDE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'ANI PHARMS',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2017/017854s062lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=17854'},\n",
       " '17858': {'ApplNo': '17858',\n",
       "  'Form': 'SOLUTION;INJECTION, ORAL',\n",
       "  'Drug': 'AN-SULFUR COLLOID',\n",
       "  'ActiveIngredient': 'TECHNETIUM TC-99M SULFUR COLLOID KIT',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'SUN PHARM INDS INC',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/017858s049lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=17858'},\n",
       " '17866': {'ApplNo': '17866',\n",
       "  'Form': 'LIQUID;IRRIGATION',\n",
       "  'Drug': 'STERILE WATER IN PLASTIC CONTAINER',\n",
       "  'ActiveIngredient': 'STERILE WATER FOR IRRIGATION',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'BAXTER HLTHCARE',\n",
       "  'LatestLabel': 'https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/017428s071_017866s052lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=17866'},\n",
       " '17874': {'ApplNo': '17874',\n",
       "  'Form': 'SYSTEM;TRANSDERMAL',\n",
       "  'Drug': 'TRANSDERM SCOP',\n",
       "  'ActiveIngredient': 'SCOPOLAMINE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'BAXTER HLTHCARE CORP',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/017874s043s044lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=17874'},\n",
       " '17881': {'ApplNo': '17881',\n",
       "  'Form': 'INJECTABLE;INJECTION',\n",
       "  'Drug': 'TECHNETIUM TC 99M ALBUMIN AGGREGATED KIT',\n",
       "  'ActiveIngredient': 'TECHNETIUM TC-99M ALBUMIN AGGREGATED KIT',\n",
       "  'ApplType': 'BLA',\n",
       "  'Sponsor': 'DRAXIMAGE',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2009/017881s010lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=17881'},\n",
       " '17892': {'ApplNo': '17892',\n",
       "  'Form': 'TABLET;ORAL',\n",
       "  'Drug': 'HALCION',\n",
       "  'ActiveIngredient': 'TRIAZOLAM',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'PFIZER',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2023/017892s057lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=17892'},\n",
       " '17948': {'ApplNo': '17948',\n",
       "  'Form': 'TABLET;ORAL',\n",
       "  'Drug': 'NORMINEST FE',\n",
       "  'ActiveIngredient': 'ETHINYL ESTRADIOL;NORETHINDRONE; FERROUS FUMARATE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'GD SEARLE LLC',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/017948s047lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=17948'},\n",
       " '17955': {'ApplNo': '17955',\n",
       "  'Form': 'GEL;TOPICAL',\n",
       "  'Drug': 'RETIN-A',\n",
       "  'ActiveIngredient': 'TRETINOIN',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'VALEANT INTL',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2002/16921s21s22s25lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=17955'},\n",
       " '17962': {'ApplNo': '17962',\n",
       "  'Form': 'TABLET;ORAL',\n",
       "  'Drug': 'PARLODEL',\n",
       "  'ActiveIngredient': 'BROMOCRIPTINE MESYLATE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'VALIDUS PHARMS',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/017962s083lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=17962'},\n",
       " '17963': {'ApplNo': '17963',\n",
       "  'Form': 'TABLET;ORAL',\n",
       "  'Drug': 'LOPRESSOR',\n",
       "  'ActiveIngredient': 'METOPROLOL TARTRATE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'VALIDUS PHARMS',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/017963s068lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=17963'},\n",
       " '17989': {'ApplNo': '17989',\n",
       "  'Form': 'INJECTABLE;INJECTION',\n",
       "  'Drug': 'HEMABATE',\n",
       "  'ActiveIngredient': 'CARBOPROST TROMETHAMINE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'PFIZER',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/017989s019lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=17989'},\n",
       " '18008': {'ApplNo': '18008',\n",
       "  'Form': 'INJECTABLE;INJECTION',\n",
       "  'Drug': 'POTASSIUM CHLORIDE 5MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER',\n",
       "  'ActiveIngredient': 'DEXTROSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'BAXTER HLTHCARE',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/18008s073,18037s073,18629s046,19308s030lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=18008'},\n",
       " '18013': {'ApplNo': '18013',\n",
       "  'Form': 'CAPSULE;ORAL',\n",
       "  'Drug': 'PAMELOR',\n",
       "  'ActiveIngredient': 'NORTRIPTYLINE HYDROCHLORIDE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'SPECGX LLC',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/018013s064lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=18013'},\n",
       " '18016': {'ApplNo': '18016',\n",
       "  'Form': 'INJECTABLE;INJECTION',\n",
       "  'Drug': 'SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER',\n",
       "  'ActiveIngredient': 'SODIUM CHLORIDE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'BAXTER HLTHCARE',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/016677s169,018016s067,020178s021lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=18016'},\n",
       " '18027': {'ApplNo': '18027',\n",
       "  'Form': 'TABLET, EXTENDED RELEASE;ORAL',\n",
       "  'Drug': 'LITHOBID',\n",
       "  'ActiveIngredient': 'LITHIUM CARBONATE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'ANI PHARMS',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/018027s069lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=18027'},\n",
       " '18035': {'ApplNo': '18035',\n",
       "  'Form': 'INJECTABLE;INJECTION',\n",
       "  'Drug': 'DRAXIMAGE MDP-25',\n",
       "  'ActiveIngredient': 'TECHNETIUM TC-99M MEDRONATE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'JUBILANT',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2011/018035s032lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=18035'},\n",
       " '18037': {'ApplNo': '18037',\n",
       "  'Form': 'INJECTABLE;INJECTION',\n",
       "  'Drug': 'DEXTROSE 5%, SODIUM CHLORIDE 0.2% AND POTASSIUM CHLORIDE 20MEQ (K)',\n",
       "  'ActiveIngredient': 'DEXTROSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'BAXTER HLTHCARE',\n",
       "  'LatestLabel': 'https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/18008s073,18037s073,18629s046,19308s030lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=18037'},\n",
       " '18045': {'ApplNo': '18045',\n",
       "  'Form': 'CAPSULE;ORAL',\n",
       "  'Drug': 'EMCYT',\n",
       "  'ActiveIngredient': 'ESTRAMUSTINE PHOSPHATE SODIUM',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'PHARMACIA AND UPJOHN',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2008/018045s023lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=18045'},\n",
       " '18057': {'ApplNo': '18057',\n",
       "  'Form': 'INJECTABLE;INJECTION',\n",
       "  'Drug': 'CISPLATIN',\n",
       "  'ActiveIngredient': 'CISPLATIN',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'HQ SPCLT PHARMA',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/018057s092lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=18057'},\n",
       " '18060': {'ApplNo': '18060',\n",
       "  'Form': 'SUPPOSITORY;RECTAL',\n",
       "  'Drug': 'ACEPHEN',\n",
       "  'ActiveIngredient': 'ACETAMINOPHEN',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'COSETTE',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/018060Orig1s066lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=18060'},\n",
       " '18063': {'ApplNo': '18063',\n",
       "  'Form': 'TABLET;ORAL',\n",
       "  'Drug': 'CORGARD',\n",
       "  'ActiveIngredient': 'NADOLOL',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'USWM',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/018063s063lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=18063'},\n",
       " '18066': {'ApplNo': '18066',\n",
       "  'Form': 'TABLET;ORAL',\n",
       "  'Drug': 'UNISOM',\n",
       "  'ActiveIngredient': 'DOXYLAMINE SUCCINATE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'CHATTEM',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/018066Orig1s021lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=18066'},\n",
       " '18074': {'ApplNo': '18074',\n",
       "  'Form': 'CAPSULE, EXTENDED RELEASE;ORAL',\n",
       "  'Drug': 'PHENDIMETRAZINE TARTRATE',\n",
       "  'ActiveIngredient': 'PHENDIMETRAZINE TARTRATE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'VIRTUS PHARMS',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/018074Orig1s037lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=18074'},\n",
       " '18086': {'ApplNo': '18086',\n",
       "  'Form': 'SOLUTION/DROPS;OPHTHALMIC',\n",
       "  'Drug': 'TIMOPTIC',\n",
       "  'ActiveIngredient': 'TIMOLOL MALEATE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'BAUSCH AND LOMB INC',\n",
       "  'LatestLabel': 'https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/018086Orig1s080lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=18086'},\n",
       " '18090': {'ApplNo': '18090',\n",
       "  'Form': 'INJECTABLE;INJECTION',\n",
       "  'Drug': 'SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER',\n",
       "  'ActiveIngredient': 'SODIUM CHLORIDE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'ICU MEDICAL INC',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2017/018090sS116lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=18090'},\n",
       " '18124': {'ApplNo': '18124',\n",
       "  'Form': 'INJECTABLE;INJECTION',\n",
       "  'Drug': 'CIS-MDP',\n",
       "  'ActiveIngredient': 'TECHNETIUM TC-99M MEDRONATE KIT',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'SUN PHARM INDS INC',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2005/018124s013lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=18124'},\n",
       " '18132': {'ApplNo': '18132',\n",
       "  'Form': 'INJECTABLE;INJECTION',\n",
       "  'Drug': 'DOPAMINE HYDROCHLORIDE',\n",
       "  'ActiveIngredient': 'DOPAMINE HYDROCHLORIDE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'HOSPIRA',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/018132s067,018826s045lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=18132'},\n",
       " '18140': {'ApplNo': '18140',\n",
       "  'Form': 'INJECTABLE;INJECTION',\n",
       "  'Drug': 'ATIVAN',\n",
       "  'ActiveIngredient': 'LORAZEPAM',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'HIKMA',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2023/018140s051lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=18140'},\n",
       " '18147': {'ApplNo': '18147',\n",
       "  'Form': 'CAPSULE;ORAL',\n",
       "  'Drug': 'FELDENE',\n",
       "  'ActiveIngredient': 'PIROXICAM',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'PFIZER',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/018147_S052LBL.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=18147'},\n",
       " '18150': {'ApplNo': '18150',\n",
       "  'Form': 'INJECTABLE;INJECTION',\n",
       "  'Drug': 'THALLOUS CHLORIDE TL 201',\n",
       "  'ActiveIngredient': 'THALLOUS CHLORIDE TL-201',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'CURIUM',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2016/018150s027lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=18150'},\n",
       " '18163': {'ApplNo': '18163',\n",
       "  'Form': 'CAPSULE;ORAL',\n",
       "  'Drug': 'RESTORIL',\n",
       "  'ActiveIngredient': 'TEMAZEPAM',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'SPECGX LLC',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2023/018163s071lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=18163'},\n",
       " '18164': {'ApplNo': '18164',\n",
       "  'Form': 'TABLET;ORAL',\n",
       "  'Drug': 'ANAPROX DS',\n",
       "  'ActiveIngredient': 'NAPROXEN SODIUM',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'ATNAHS PHARMA US',\n",
       "  'LatestLabel': 'https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/017581s115,018164s065,020067s024lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=18164'},\n",
       " '18200': {'ApplNo': '18200',\n",
       "  'Form': 'TABLET;ORAL',\n",
       "  'Drug': 'MIDAMOR',\n",
       "  'ActiveIngredient': 'AMILORIDE HYDROCHLORIDE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'PADAGIS US',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/nda/2002/18-200S024_Midamor_Prntlbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=18200'},\n",
       " '18206': {'ApplNo': '18206',\n",
       "  'Form': 'TABLET;ORAL',\n",
       "  'Drug': 'LO/OVRAL FE',\n",
       "  'ActiveIngredient': 'ETHINYL ESTRADIOL; LEVONORGESTREL; FERROUS FUMARATE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'CADENCE HEALTH',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/018206s022lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=18206'},\n",
       " '18225': {'ApplNo': '18225',\n",
       "  'Form': 'TABLET;ORAL',\n",
       "  'Drug': 'BUMEX',\n",
       "  'ActiveIngredient': 'BUMETANIDE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'VALIDUS PHARMS',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2018/018225s028lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=18225'},\n",
       " '18227': {'ApplNo': '18227',\n",
       "  'Form': 'INJECTABLE;INJECTION',\n",
       "  'Drug': 'AMIDATE',\n",
       "  'ActiveIngredient': 'ETOMIDATE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'HOSPIRA',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2017/018227s032lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=18227'},\n",
       " '18240': {'ApplNo': '18240',\n",
       "  'Form': 'TABLET;ORAL',\n",
       "  'Drug': 'TENORMIN',\n",
       "  'ActiveIngredient': 'ATENOLOL',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'ALMATICA',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/018240s032lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=18240'},\n",
       " '18248': {'ApplNo': '18248',\n",
       "  'Form': 'INJECTABLE;INJECTION',\n",
       "  'Drug': 'OXYTOCIN',\n",
       "  'ActiveIngredient': 'OXYTOCIN',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'FRESENIUS KABI USA',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/018248s049lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=18248'},\n",
       " '18261': {'ApplNo': '18261',\n",
       "  'Form': 'INJECTABLE;INJECTION',\n",
       "  'Drug': 'PITOCIN',\n",
       "  'ActiveIngredient': 'OXYTOCIN',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'PAR STERILE PRODUCTS',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/018261Orig1s041lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=18261'},\n",
       " '18264': {'ApplNo': '18264',\n",
       "  'Form': 'INJECTABLE;INJECTION',\n",
       "  'Drug': 'DANTRIUM',\n",
       "  'ActiveIngredient': 'DANTROLENE SODIUM',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'PAR STERILE PRODUCTS',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2008/018264s025lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=18264'},\n",
       " '18276': {'ApplNo': '18276',\n",
       "  'Form': 'TABLET;ORAL',\n",
       "  'Drug': 'XANAX',\n",
       "  'ActiveIngredient': 'ALPRAZOLAM',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'UPJOHN',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2023/018276s059lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=18276'},\n",
       " '18279': {'ApplNo': '18279',\n",
       "  'Form': 'TABLET, EXTENDED RELEASE;ORAL',\n",
       "  'Drug': 'K-TAB',\n",
       "  'ActiveIngredient': 'POTASSIUM CHLORIDE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'ABBVIE',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2018/018279Orig1s037lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=18279'},\n",
       " '18300': {'ApplNo': '18300',\n",
       "  'Form': 'SOLUTION;TOPICAL',\n",
       "  'Drug': 'HIBISTAT',\n",
       "  'ActiveIngredient': 'CHLORHEXIDINE GLUCONATE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'MOLNLYCKE HLTH',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2018/018300Orig1s019lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=18300'},\n",
       " '18303': {'ApplNo': '18303',\n",
       "  'Form': 'TABLET;ORAL',\n",
       "  'Drug': 'LOPRESSOR HCT',\n",
       "  'ActiveIngredient': 'HYDROCHLOROTHIAZIDE; METOPROLOL TARTRATE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'VALIDUS PHARMS',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/018303s040lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=18303'},\n",
       " '18304': {'ApplNo': '18304',\n",
       "  'Form': 'INJECTABLE;INJECTION',\n",
       "  'Drug': 'SENSORCAINE',\n",
       "  'ActiveIngredient': 'BUPIVACAINE HYDROCHLORIDE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'FRESENIUS KABI USA',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/018304s050lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=18304'},\n",
       " '18321': {'ApplNo': '18321',\n",
       "  'Form': 'INJECTABLE;INJECTION',\n",
       "  'Drug': 'TECHNESCAN',\n",
       "  'ActiveIngredient': 'TECHNETIUM TC-99M OXIDRONATE KIT',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'CURIUM',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2017/018321s022lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=18321'},\n",
       " '18327': {'ApplNo': '18327',\n",
       "  'Form': 'GAS;INHALATION',\n",
       "  'Drug': 'XENON XE 133',\n",
       "  'ActiveIngredient': 'XENON XE-133',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'CURIUM',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2016/018327s005lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=18327'},\n",
       " '18332': {'ApplNo': '18332',\n",
       "  'Form': 'SUSPENSION;ORAL',\n",
       "  'Drug': 'INDOCIN',\n",
       "  'ActiveIngredient': 'INDOMETHACIN',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'EGALET',\n",
       "  'LatestLabel': 'https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/018332s042lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=18332'},\n",
       " '18333': {'ApplNo': '18333',\n",
       "  'Form': 'TABLET;ORAL',\n",
       "  'Drug': 'CARAFATE',\n",
       "  'ActiveIngredient': 'SUCRALFATE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'ALLERGAN',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/018333s034,019183s016lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=18333'},\n",
       " '18337': {'ApplNo': '18337',\n",
       "  'Form': 'SUPPOSITORY;RECTAL',\n",
       "  'Drug': 'ACETAMINOPHEN',\n",
       "  'ActiveIngredient': 'ACETAMINOPHEN',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'TARO PHARM INDS LTD',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/018337Orig1s035lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=18337'},\n",
       " '18401': {'ApplNo': '18401',\n",
       "  'Form': 'INJECTABLE;INJECTION',\n",
       "  'Drug': 'BUPRENEX',\n",
       "  'ActiveIngredient': 'BUPRENORPHINE HYDROCHLORIDE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'INDIVIOR INC',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/018401s026lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=18401'},\n",
       " '18422': {'ApplNo': '18422',\n",
       "  'Form': 'TABLET;ORAL',\n",
       "  'Drug': 'LOPID',\n",
       "  'ActiveIngredient': 'GEMFIBROZIL',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'PFIZER PHARMS',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/018422s059lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=18422'},\n",
       " '18449': {'ApplNo': '18449',\n",
       "  'Form': 'INJECTABLE;INJECTION',\n",
       "  'Drug': 'INTRALIPID 20%',\n",
       "  'ActiveIngredient': 'SOYBEAN OIL',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'FRESENIUS',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/018449s049lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=18449'},\n",
       " '18461': {'ApplNo': '18461',\n",
       "  'Form': 'INJECTABLE;INJECTION',\n",
       "  'Drug': 'LIDOCAINE HYDROCHLORIDE 0.2% AND DEXTROSE 5% IN PLASTIC CONTAINER',\n",
       "  'ActiveIngredient': 'LIDOCAINE HYDROCHLORIDE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'BAXTER HLTHCARE',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2017/018461s058lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=18461'},\n",
       " '18469': {'ApplNo': '18469',\n",
       "  'Form': 'SOLUTION;IRRIGATION',\n",
       "  'Drug': 'BSS PLUS',\n",
       "  'ActiveIngredient': 'CALCIUM CHLORIDE; DEXTROSE; GLUTATHIONE DISULFIDE; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM BICARBONATE; SODIUM CHLORIDE; SODIUM PHOSPHATE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'ALCON',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2016/018469s056lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=18469'},\n",
       " '18482': {'ApplNo': '18482',\n",
       "  'Form': 'CAPSULE;ORAL',\n",
       "  'Drug': 'PROCARDIA',\n",
       "  'ActiveIngredient': 'NIFEDIPINE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'PFIZER',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/018482s052lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=18482'},\n",
       " '18484': {'ApplNo': '18484',\n",
       "  'Form': 'INJECTABLE;INJECTION',\n",
       "  'Drug': 'PROSTIN VR PEDIATRIC',\n",
       "  'ActiveIngredient': 'ALPROSTADIL',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'PFIZER',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/018484Orig1s028lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=18484'},\n",
       " '18487': {'ApplNo': '18487',\n",
       "  'Form': 'TABLET;ORAL',\n",
       "  'Drug': 'FUROSEMIDE',\n",
       "  'ActiveIngredient': 'FUROSEMIDE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'MYLAN',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2016/018487s043lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=18487'},\n",
       " '18511': {'ApplNo': '18511',\n",
       "  'Form': 'INJECTABLE;INJECTION',\n",
       "  'Drug': 'DRAXIMAGE DTPA',\n",
       "  'ActiveIngredient': 'TECHNETIUM TC-99M PENTETATE KIT',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'JUBILANT',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/018511Orig1s031lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=18511'},\n",
       " '18514': {'ApplNo': '18514',\n",
       "  'Form': 'CREAM;TOPICAL',\n",
       "  'Drug': 'LOCOID',\n",
       "  'ActiveIngredient': 'HYDROCORTISONE BUTYRATE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'BAUSCH',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/018514s013lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=18514'},\n",
       " '18553': {'ApplNo': '18553',\n",
       "  'Form': 'CAPSULE, EXTENDED RELEASE;ORAL',\n",
       "  'Drug': 'INDERAL LA',\n",
       "  'ActiveIngredient': 'PROPRANOLOL HYDROCHLORIDE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'ANI PHARMS',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2011/018553s037lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=18553'},\n",
       " '18558': {'ApplNo': '18558',\n",
       "  'Form': 'TABLET;ORAL',\n",
       "  'Drug': 'LITHIUM CARBONATE',\n",
       "  'ActiveIngredient': 'LITHIUM CARBONATE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'HIKMA',\n",
       "  'LatestLabel': 'https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/017812s036,018421s035,018558s030lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=18558'},\n",
       " '18561': {'ApplNo': '18561',\n",
       "  'Form': 'INJECTABLE;INJECTION',\n",
       "  'Drug': 'DEXTROSE 70% IN PLASTIC CONTAINER',\n",
       "  'ActiveIngredient': 'DEXTROSE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'ICU MEDICAL INC',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2018/018561s060,018562s059,018563s060,018564s062,019345s047lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=18561'},\n",
       " '18562': {'ApplNo': '18562',\n",
       "  'Form': 'INJECTABLE;INJECTION',\n",
       "  'Drug': 'DEXTROSE 40% IN PLASTIC CONTAINER',\n",
       "  'ActiveIngredient': 'DEXTROSE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'ICU MEDICAL INC',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2018/018561s060,018562s059,018563s060,018564s062,019345s047lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=18562'},\n",
       " '18563': {'ApplNo': '18563',\n",
       "  'Form': 'INJECTABLE;INJECTION',\n",
       "  'Drug': 'DEXTROSE 50% IN PLASTIC CONTAINER',\n",
       "  'ActiveIngredient': 'DEXTROSE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'ICU MEDICAL INC',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2018/018561s060,018562s059,018563s060,018564s062,019345s047lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=18563'},\n",
       " '18564': {'ApplNo': '18564',\n",
       "  'Form': 'INJECTABLE;INJECTION',\n",
       "  'Drug': 'DEXTROSE 20% IN PLASTIC CONTAINER',\n",
       "  'ActiveIngredient': 'DEXTROSE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'ICU MEDICAL INC',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2018/018561s060,018562s059,018563s060,018564s062,019345s047lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=18564'},\n",
       " '18565': {'ApplNo': '18565',\n",
       "  'Form': 'INJECTABLE;INJECTION',\n",
       "  'Drug': 'DURAMORPH PF',\n",
       "  'ActiveIngredient': 'MORPHINE SULFATE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'HIKMA',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/018565s024lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=18565'},\n",
       " '18569': {'ApplNo': '18569',\n",
       "  'Form': 'TABLET;ORAL',\n",
       "  'Drug': 'FUROSEMIDE',\n",
       "  'ActiveIngredient': 'FUROSEMIDE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'EPIC PHARMA LLC',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/018569s066lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=18569'},\n",
       " '18594': {'ApplNo': '18594',\n",
       "  'Form': 'OINTMENT;TOPICAL',\n",
       "  'Drug': 'TOPICORT',\n",
       "  'ActiveIngredient': 'DESOXIMETASONE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'TARO PHARM INDS LTD',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/018594Orig1s008lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=18594'},\n",
       " '18602': {'ApplNo': '18602',\n",
       "  'Form': 'TABLET;ORAL',\n",
       "  'Drug': 'CARDIZEM',\n",
       "  'ActiveIngredient': 'DILTIAZEM HYDROCHLORIDE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'BAUSCH',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/018602Orig1s069lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=18602'},\n",
       " '18604': {'ApplNo': '18604',\n",
       "  'Form': 'OINTMENT;TOPICAL',\n",
       "  'Drug': 'ZOVIRAX',\n",
       "  'ActiveIngredient': 'ACYCLOVIR',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'BAUSCH',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2001/018604s018lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=18604'},\n",
       " '18609': {'ApplNo': '18609',\n",
       "  'Form': 'INJECTABLE;INJECTION',\n",
       "  'Drug': 'HEPARIN SODIUM 1,000 UNITS AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER',\n",
       "  'ActiveIngredient': 'HEPARIN SODIUM',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'BAXTER HLTHCARE',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/018609s058lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=18609'},\n",
       " '18612': {'ApplNo': '18612',\n",
       "  'Form': 'GUM, CHEWING;BUCCAL',\n",
       "  'Drug': 'NICORETTE',\n",
       "  'ActiveIngredient': 'NICOTINE POLACRILEX',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'GLAXOSMITHKLINE',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/018612Orig1s083,020066Orig1s065lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=18612'},\n",
       " '18615': {'ApplNo': '18615',\n",
       "  'Form': 'SUSPENSION;ORAL',\n",
       "  'Drug': 'SULFATRIM PEDIATRIC',\n",
       "  'ActiveIngredient': 'SULFAMETHOXAZOLE; TRIMETHOPRIM',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'PHARM ASSOC',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/018615s080lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=18615'},\n",
       " '18629': {'ApplNo': '18629',\n",
       "  'Form': 'INJECTABLE;INJECTION',\n",
       "  'Drug': 'DEXTROSE 5%, SODIUM CHLORIDE 0.33% AND POTASSIUM CHLORIDE 5MEQ IN PLASTIC CONTAINER',\n",
       "  'ActiveIngredient': 'DEXTROSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'BAXTER HLTHCARE',\n",
       "  'LatestLabel': 'https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/18008s073,18037s073,18629s046,19308s030lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=18629'},\n",
       " '18632': {'ApplNo': '18632',\n",
       "  'Form': 'LIQUID;N/A',\n",
       "  'Drug': 'STERILE WATER FOR INJECTION IN PLASTIC CONTAINER',\n",
       "  'ActiveIngredient': 'STERILE WATER FOR INJECTION',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'BAXTER HLTHCARE',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2016/018632s051lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=18632'},\n",
       " '18651': {'ApplNo': '18651',\n",
       "  'Form': 'CAPSULE;ORAL',\n",
       "  'Drug': 'MARINOL',\n",
       "  'ActiveIngredient': 'DRONABINOL',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'ALKEM LABS LTD',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2023/018651s033lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=18651'},\n",
       " '18652': {'ApplNo': '18652',\n",
       "  'Form': 'OINTMENT;TOPICAL',\n",
       "  'Drug': 'LOCOID',\n",
       "  'ActiveIngredient': 'HYDROCORTISONE BUTYRATE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'PRECISION DERMAT',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/018652s010lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=18652'},\n",
       " '18657': {'ApplNo': '18657',\n",
       "  'Form': 'INJECTABLE;INJECTION',\n",
       "  'Drug': 'FLAGYL I.V. RTU IN PLASTIC CONTAINER',\n",
       "  'ActiveIngredient': 'METRONIDAZOLE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'BAXTER HLTHCARE',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/018657s039lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=18657'},\n",
       " '18658': {'ApplNo': '18658',\n",
       "  'Form': 'SUSPENSION, EXTENDED RELEASE;ORAL',\n",
       "  'Drug': 'DELSYM',\n",
       "  'ActiveIngredient': 'DEXTROMETHORPHAN POLISTIREX',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'RB HLTH',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/018658Orig1s030lbl_replacement.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=18658'},\n",
       " '18667': {'ApplNo': '18667',\n",
       "  'Form': 'INJECTABLE;INJECTION',\n",
       "  'Drug': 'FUROSEMIDE',\n",
       "  'ActiveIngredient': 'FUROSEMIDE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'HOSPIRA',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/018667s043lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=18667'},\n",
       " '18671': {'ApplNo': '18671',\n",
       "  'Form': 'CAPSULE;ORAL',\n",
       "  'Drug': 'SODIUM IODIDE I 123',\n",
       "  'ActiveIngredient': 'SODIUM IODIDE I-123',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'CARDINAL HEALTH 418',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2008/018671s016lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=18671'},\n",
       " '18677': {'ApplNo': '18677',\n",
       "  'Form': 'CAPSULE;ORAL',\n",
       "  'Drug': 'CESAMET',\n",
       "  'ActiveIngredient': 'NABILONE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'BAUSCH',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/018677Orig1s017lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=18677'},\n",
       " '18679': {'ApplNo': '18679',\n",
       "  'Form': 'TABLET;ORAL',\n",
       "  'Drug': 'TRIMETHOPRIM',\n",
       "  'ActiveIngredient': 'TRIMETHOPRIM',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'MAYNE PHARMA',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2016/018679s044lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=18679'},\n",
       " '18680': {'ApplNo': '18680',\n",
       "  'Form': 'INTRAUTERINE DEVICE;INTRAUTERINE',\n",
       "  'Drug': 'PARAGARD T 380A',\n",
       "  'ActiveIngredient': 'COPPER',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'COOPERSURGICAL',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/018680s069s070lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=18680'},\n",
       " '18681': {'ApplNo': '18681',\n",
       "  'Form': 'SOLUTION;IRRIGATION',\n",
       "  'Drug': \"LACTATED RINGER'S IN PLASTIC CONTAINER\",\n",
       "  'ActiveIngredient': 'CALCIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM CHLORIDE; SODIUM LACTATE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'B BRAUN',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/018681s027lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=18681'},\n",
       " '18692': {'ApplNo': '18692',\n",
       "  'Form': 'INJECTABLE;SPINAL',\n",
       "  'Drug': 'MARCAINE',\n",
       "  'ActiveIngredient': 'BUPIVACAINE HYDROCHLORIDE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'HOSPIRA',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/018692s024lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=18692'},\n",
       " '18701': {'ApplNo': '18701',\n",
       "  'Form': 'INJECTABLE;INJECTION',\n",
       "  'Drug': 'HALDOL',\n",
       "  'ActiveIngredient': 'HALOPERIDOL DECANOATE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'JANSSEN PHARMS',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/015923s093s098,018701s071s076lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=18701'},\n",
       " '18705': {'ApplNo': '18705',\n",
       "  'Form': 'SPRAY, METERED;SUBLINGUAL',\n",
       "  'Drug': 'NITROLINGUAL PUMPSPRAY',\n",
       "  'ActiveIngredient': 'NITROGLYCERIN',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'POHL BOSKAMP',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2018/018705s025lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=18705'},\n",
       " '18708': {'ApplNo': '18708',\n",
       "  'Form': 'TABLET;ORAL',\n",
       "  'Drug': 'DORAL',\n",
       "  'ActiveIngredient': 'QUAZEPAM',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'GALT PHARMS',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2023/018708s029lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=18708'},\n",
       " '18714': {'ApplNo': '18714',\n",
       "  'Form': 'TABLET;ORAL',\n",
       "  'Drug': 'BILTRICIDE',\n",
       "  'ActiveIngredient': 'PRAZIQUANTEL',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'BAYER HLTHCARE',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/018714s018lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=18714'},\n",
       " '18716': {'ApplNo': '18716',\n",
       "  'Form': 'TABLET;ORAL',\n",
       "  'Drug': 'TRANDATE',\n",
       "  'ActiveIngredient': 'LABETALOL HYDROCHLORIDE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'ALVOGEN',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2010/018716s026lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=18716'},\n",
       " '18723': {'ApplNo': '18723',\n",
       "  'Form': 'TABLET, DELAYED RELEASE;ORAL',\n",
       "  'Drug': 'DEPAKOTE',\n",
       "  'ActiveIngredient': 'DIVALPROEX SODIUM',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'ABBVIE',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/018723s065lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=18723'},\n",
       " '18735': {'ApplNo': '18735',\n",
       "  'Form': 'INJECTABLE;INJECTION',\n",
       "  'Drug': 'ISOVUE-M 200',\n",
       "  'ActiveIngredient': 'IOPAMIDOL',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'BRACCO',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/018735s067lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=18735'},\n",
       " '18737': {'ApplNo': '18737',\n",
       "  'Form': 'CREAM;TOPICAL',\n",
       "  'Drug': 'EXELDERM',\n",
       "  'ActiveIngredient': 'SULCONAZOLE NITRATE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'JOURNEY',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2003/18737slr003_exelderm_lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=18737'},\n",
       " '18738': {'ApplNo': '18738',\n",
       "  'Form': 'SOLUTION;TOPICAL',\n",
       "  'Drug': 'EXELDERM',\n",
       "  'ActiveIngredient': 'SULCONAZOLE NITRATE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'JOURNEY',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2009/018738s009lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=18738'},\n",
       " '18741': {'ApplNo': '18741',\n",
       "  'Form': 'OINTMENT, AUGMENTED;TOPICAL',\n",
       "  'Drug': 'DIPROLENE',\n",
       "  'ActiveIngredient': 'BETAMETHASONE DIPROPIONATE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'ORGANON',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/018741s040lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=18741'},\n",
       " '18748': {'ApplNo': '18748',\n",
       "  'Form': 'CREAM;TOPICAL',\n",
       "  'Drug': 'LOPROX',\n",
       "  'ActiveIngredient': 'CICLOPIROX',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'MEDIMETRIKS PHARMS',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/018748s024,019824s023,020519s016lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=18748'},\n",
       " '18760': {'ApplNo': '18760',\n",
       "  'Form': 'TABLET;ORAL',\n",
       "  'Drug': 'TENORETIC 100',\n",
       "  'ActiveIngredient': 'ATENOLOL; CHLORTHALIDONE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'ALMATICA',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/018760s029lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=18760'},\n",
       " '18771': {'ApplNo': '18771',\n",
       "  'Form': 'INSERT;OPHTHALMIC',\n",
       "  'Drug': 'LACRISERT',\n",
       "  'ActiveIngredient': 'HYDROXYPROPYL CELLULOSE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'VALEANT PHARMS INTL',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2008/018771s017lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=18771'},\n",
       " '18780': {'ApplNo': '18780',\n",
       "  'Form': 'INJECTABLE;INJECTION',\n",
       "  'Drug': 'HUMULIN R',\n",
       "  'ActiveIngredient': 'INSULIN RECOMBINANT HUMAN',\n",
       "  'ApplType': 'BLA',\n",
       "  'Sponsor': 'LILLY',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/018780s180lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=18780'},\n",
       " '18781': {'ApplNo': '18781',\n",
       "  'Form': 'INJECTABLE;INJECTION',\n",
       "  'Drug': 'HUMULIN N',\n",
       "  'ActiveIngredient': 'INSULIN SUSP ISOPHANE RECOMBINANT HUMAN',\n",
       "  'ApplType': 'BLA',\n",
       "  'Sponsor': 'LILLY',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/018781s193lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=18781'},\n",
       " '18823': {'ApplNo': '18823',\n",
       "  'Form': 'TABLET;ORAL',\n",
       "  'Drug': 'FUROSEMIDE',\n",
       "  'ActiveIngredient': 'FUROSEMIDE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'HIKMA',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2017/018823s044lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=18823'},\n",
       " '18826': {'ApplNo': '18826',\n",
       "  'Form': 'INJECTABLE;INJECTION',\n",
       "  'Drug': 'DOPAMINE HYDROCHLORIDE IN DEXTROSE 5% IN PLASTIC CONTAINER',\n",
       "  'ActiveIngredient': 'DOPAMINE HYDROCHLORIDE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'HOSPIRA',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/018826s047lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=18826'},\n",
       " '18827': {'ApplNo': '18827',\n",
       "  'Form': 'CREAM;TOPICAL',\n",
       "  'Drug': 'LOTRISONE',\n",
       "  'ActiveIngredient': 'BETAMETHASONE DIPROPIONATE; CLOTRIMAZOLE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'ORGANON',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/018827s050lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=18827'},\n",
       " '18841': {'ApplNo': '18841',\n",
       "  'Form': 'TABLET;ORAL',\n",
       "  'Drug': 'DAYPRO',\n",
       "  'ActiveIngredient': 'OXAPROZIN',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'PFIZER',\n",
       "  'LatestLabel': 'https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/018841s033lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=18841'},\n",
       " '18883': {'ApplNo': '18883',\n",
       "  'Form': 'SOLUTION;INTRAPERITONEAL',\n",
       "  'Drug': 'DELFLEX W/ DEXTROSE 1.5% IN PLASTIC CONTAINER',\n",
       "  'ActiveIngredient': 'CALCIUM CHLORIDE; DEXTROSE; MAGNESIUM CHLORIDE; SODIUM CHLORIDE; SODIUM LACTATE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'FRESENIUS MEDCL',\n",
       "  'LatestLabel': 'https://www.accessdata.fda.gov/drugsatfda_docs/label/2015/018883Orig1s057,020171Orig1s039lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=18883'},\n",
       " '18890': {'ApplNo': '18890',\n",
       "  'Form': 'INJECTABLE;INJECTION',\n",
       "  'Drug': 'METRONIDAZOLE IN PLASTIC CONTAINER',\n",
       "  'ActiveIngredient': 'METRONIDAZOLE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'HOSPIRA',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/018890s054lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=18890'},\n",
       " '18891': {'ApplNo': '18891',\n",
       "  'Form': 'SYSTEM;TRANSDERMAL',\n",
       "  'Drug': 'CATAPRES-TTS-1',\n",
       "  'ActiveIngredient': 'CLONIDINE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'LAVIPHARM',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/018891s028lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=18891'},\n",
       " '18893': {'ApplNo': '18893',\n",
       "  'Form': 'INJECTABLE;INJECTION',\n",
       "  'Drug': 'SODIUM ACETATE',\n",
       "  'ActiveIngredient': 'SODIUM ACETATE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'HOSPIRA',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/018893s025lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=18893'},\n",
       " '18897': {'ApplNo': '18897',\n",
       "  'Form': 'SOLUTION;INTRAVENOUS',\n",
       "  'Drug': 'SODIUM CHLORIDE 14.6%',\n",
       "  'ActiveIngredient': 'SODIUM CHLORIDE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'HOSPIRA',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/018897Orig1s024lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=18897'},\n",
       " '18900': {'ApplNo': '18900',\n",
       "  'Form': 'INJECTABLE;INJECTION',\n",
       "  'Drug': 'METRO I.V. IN PLASTIC CONTAINER',\n",
       "  'ActiveIngredient': 'METRONIDAZOLE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'B BRAUN',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/018900s041lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=18900'},\n",
       " '18902': {'ApplNo': '18902',\n",
       "  'Form': 'INJECTABLE;INJECTION',\n",
       "  'Drug': 'FUROSEMIDE',\n",
       "  'ActiveIngredient': 'FUROSEMIDE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'FRESENIUS KABI USA',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/018902Orig1s033lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=18902'},\n",
       " '18916': {'ApplNo': '18916',\n",
       "  'Form': 'INJECTABLE;INJECTION',\n",
       "  'Drug': 'HEPARIN SODIUM 12,500 UNITS IN SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER',\n",
       "  'ActiveIngredient': 'HEPARIN SODIUM',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'HOSPIRA',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/018916s071lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=18916'},\n",
       " '18921': {'ApplNo': '18921',\n",
       "  'Form': 'SOLUTION;IRRIGATION',\n",
       "  'Drug': \"LACTATED RINGER'S IN PLASTIC CONTAINER\",\n",
       "  'ActiveIngredient': 'CALCIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM CHLORIDE; SODIUM LACTATE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'BAXTER HLTHCARE',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/018921s031lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=18921'},\n",
       " '18925': {'ApplNo': '18925',\n",
       "  'Form': 'SOLUTION;INTRAVENOUS',\n",
       "  'Drug': 'VERAPAMIL HYDROCHLORIDE',\n",
       "  'ActiveIngredient': 'VERAPAMIL HYDROCHLORIDE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'EXELA PHARMA',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2016/018925s010lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=18925'},\n",
       " '18927': {'ApplNo': '18927',\n",
       "  'Form': 'SUSPENSION;ORAL',\n",
       "  'Drug': 'TEGRETOL',\n",
       "  'ActiveIngredient': 'CARBAMAZEPINE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'NOVARTIS',\n",
       "  'LatestLabel': 'https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/016608s115_018281_s058_018927s055_020234_s047.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=18927'},\n",
       " '18931': {'ApplNo': '18931',\n",
       "  'Form': 'INJECTABLE;INJECTION',\n",
       "  'Drug': 'TRAVASOL 5.5% IN PLASTIC CONTAINER',\n",
       "  'ActiveIngredient': 'AMINO ACIDS',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'BAXTER HLTHCARE',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/018931s055,020849s025lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=18931'},\n",
       " '18936': {'ApplNo': '18936',\n",
       "  'Form': 'CAPSULE;ORAL',\n",
       "  'Drug': 'PROZAC',\n",
       "  'ActiveIngredient': 'FLUOXETINE HYDROCHLORIDE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'ELI LILLY AND CO',\n",
       "  'LatestLabel': 'https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/018936s111lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=18936'},\n",
       " '18938': {'ApplNo': '18938',\n",
       "  'Form': 'INJECTABLE;INJECTION',\n",
       "  'Drug': 'DDAVP',\n",
       "  'ActiveIngredient': 'DESMOPRESSIN ACETATE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'FERRING PHARMS INC',\n",
       "  'LatestLabel': 'https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/018938Orig1s039lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=18938'},\n",
       " '18948': {'ApplNo': '18948',\n",
       "  'Form': 'TABLET;ORAL',\n",
       "  'Drug': 'CARNITOR',\n",
       "  'ActiveIngredient': 'LEVOCARNITINE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'LEADIANT BIOSCI INC',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2018/018948s028,019257s014lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=18948'},\n",
       " '18956': {'ApplNo': '18956',\n",
       "  'Form': 'SOLUTION;INJECTION, ORAL, RECTAL',\n",
       "  'Drug': 'OMNIPAQUE 180',\n",
       "  'ActiveIngredient': 'IOHEXOL',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'GE HEALTHCARE',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/018956s113,020608s045lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=18956'},\n",
       " '18961': {'ApplNo': '18961',\n",
       "  'Form': 'INJECTABLE;INJECTION',\n",
       "  'Drug': 'CHROMIC CHLORIDE IN PLASTIC CONTAINER',\n",
       "  'ActiveIngredient': 'CHROMIC CHLORIDE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'HOSPIRA',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2002/18961s12lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=18961'},\n",
       " '18962': {'ApplNo': '18962',\n",
       "  'Form': 'INJECTABLE;INJECTION',\n",
       "  'Drug': 'MANGANESE CHLORIDE IN PLASTIC CONTAINER',\n",
       "  'ActiveIngredient': 'MANGANESE CHLORIDE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'HOSPIRA',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2002/18962slr011lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=18962'},\n",
       " '18965': {'ApplNo': '18965',\n",
       "  'Form': 'SUSPENSION;ORAL',\n",
       "  'Drug': 'NAPROSYN',\n",
       "  'ActiveIngredient': 'NAPROXEN',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'ATNAHS PHARMA US',\n",
       "  'LatestLabel': 'https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/018965s027lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=18965'},\n",
       " '18977': {'ApplNo': '18977',\n",
       "  'Form': 'TABLET;ORAL-28',\n",
       "  'Drug': 'TRI-NORINYL 28-DAY',\n",
       "  'ActiveIngredient': 'ETHINYL ESTRADIOL; NORETHINDRONE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'MAYNE PHARMA',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/018977s043lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=18977'},\n",
       " '18983': {'ApplNo': '18983',\n",
       "  'Form': 'FOR SOLUTION;ORAL',\n",
       "  'Drug': 'COLYTE WITH FLAVOR PACKS',\n",
       "  'ActiveIngredient': 'POLYETHYLENE GLYCOL 3350; POTASSIUM CHLORIDE; SODIUM BICARBONATE; SODIUM CHLORIDE; SODIUM SULFATE ANHYDROUS',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'MYLAN SPECIALITY LP',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/018983s051lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=18983'},\n",
       " '18989': {'ApplNo': '18989',\n",
       "  'Form': 'TABLET;ORAL',\n",
       "  'Drug': 'ADVIL',\n",
       "  'ActiveIngredient': 'IBUPROFEN',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'GLAXOSMITHKLINE',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/018989Orig1s099lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=18989'},\n",
       " '18998': {'ApplNo': '18998',\n",
       "  'Form': 'TABLET;ORAL',\n",
       "  'Drug': 'VASOTEC',\n",
       "  'ActiveIngredient': 'ENALAPRIL MALEATE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'BAUSCH',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2018/018998s083lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=18998'},\n",
       " '19011': {'ApplNo': '19011',\n",
       "  'Form': 'FOR SOLUTION;ORAL',\n",
       "  'Drug': 'GOLYTELY',\n",
       "  'ActiveIngredient': 'POLYETHYLENE GLYCOL 3350; POTASSIUM CHLORIDE; SODIUM BICARBONATE; SODIUM CHLORIDE; SODIUM SULFATE ANHYDROUS',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'BRAINTREE',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/019011s033lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=19011'},\n",
       " '19012': {'ApplNo': '19012',\n",
       "  'Form': 'TABLET;ORAL',\n",
       "  'Drug': 'MOTRIN IB',\n",
       "  'ActiveIngredient': 'IBUPROFEN',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'J AND J CONSUMER INC',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/019012Orig1s059lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=19012'},\n",
       " '19018': {'ApplNo': '19018',\n",
       "  'Form': 'INJECTABLE;INJECTION',\n",
       "  'Drug': 'TROPHAMINE',\n",
       "  'ActiveIngredient': 'AMINO ACIDS',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'B BRAUN',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/019018Orig1s036lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=19018'},\n",
       " '19022': {'ApplNo': '19022',\n",
       "  'Form': 'INJECTABLE;INJECTION',\n",
       "  'Drug': 'SODIUM CHLORIDE 3% IN PLASTIC CONTAINER',\n",
       "  'ActiveIngredient': 'SODIUM CHLORIDE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'BAXTER HLTHCARE',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2018/019022s031lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=19022'},\n",
       " '19028': {'ApplNo': '19028',\n",
       "  'Form': 'SOLUTION;DENTAL',\n",
       "  'Drug': 'PERIDEX',\n",
       "  'ActiveIngredient': 'CHLORHEXIDINE GLUCONATE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': '3M',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/019028s020lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=19028'},\n",
       " '19034': {'ApplNo': '19034',\n",
       "  'Form': 'INJECTABLE;INJECTION',\n",
       "  'Drug': 'DILAUDID',\n",
       "  'ActiveIngredient': 'HYDROMORPHONE HYDROCHLORIDE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'FRESENIUS KABI USA',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/019034s035lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=19034'},\n",
       " '19044': {'ApplNo': '19044',\n",
       "  'Form': 'INJECTABLE;INJECTION',\n",
       "  'Drug': 'INDIUM IN 111 OXYQUINOLINE',\n",
       "  'ActiveIngredient': 'INDIUM IN-111 OXYQUINOLINE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'GE HEALTHCARE',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/019044Orig1s025lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=19044'},\n",
       " '19049': {'ApplNo': '19049',\n",
       "  'Form': 'CREAM;TOPICAL',\n",
       "  'Drug': 'RETIN-A',\n",
       "  'ActiveIngredient': 'TRETINOIN',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'BAUSCH',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2002/16921s21s22s25lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=19049'},\n",
       " '19050': {'ApplNo': '19050',\n",
       "  'Form': 'INJECTABLE;INJECTION',\n",
       "  'Drug': 'SUFENTA PRESERVATIVE FREE',\n",
       "  'ActiveIngredient': 'SUFENTANIL CITRATE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'AKORN',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/019050s037lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=19050'},\n",
       " '19071': {'ApplNo': '19071',\n",
       "  'Form': 'TABLET, EXTENDED RELEASE;ORAL',\n",
       "  'Drug': 'UROCIT-K',\n",
       "  'ActiveIngredient': 'POTASSIUM CITRATE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'MISSION PHARMA',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/019071s013lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=19071'},\n",
       " '19079': {'ApplNo': '19079',\n",
       "  'Form': 'SUSPENSION/DROPS;OPHTHALMIC',\n",
       "  'Drug': 'FLAREX',\n",
       "  'ActiveIngredient': 'FLUOROMETHOLONE ACETATE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'EYEVANCE',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/019079s033lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=19079'},\n",
       " '19090': {'ApplNo': '19090',\n",
       "  'Form': 'INJECTABLE;INJECTION',\n",
       "  'Drug': 'ZANTAC',\n",
       "  'ActiveIngredient': 'RANITIDINE HYDROCHLORIDE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'PAI HOLDINGS PHARM',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2009/019090s053,019593s042lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=19090'},\n",
       " '19101': {'ApplNo': '19101',\n",
       "  'Form': 'INJECTABLE;INJECTION',\n",
       "  'Drug': 'FENTANYL CITRATE PRESERVATIVE FREE',\n",
       "  'ActiveIngredient': 'FENTANYL CITRATE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'HIKMA',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/019101s051lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=19101'},\n",
       " '19115': {'ApplNo': '19115',\n",
       "  'Form': 'INJECTABLE;INJECTION',\n",
       "  'Drug': 'FENTANYL CITRATE',\n",
       "  'ActiveIngredient': 'FENTANYL CITRATE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'HOSPIRA',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/019115s033lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=19115'},\n",
       " '19116': {'ApplNo': '19116',\n",
       "  'Form': 'SOLUTION;TOPICAL',\n",
       "  'Drug': 'LOCOID',\n",
       "  'ActiveIngredient': 'HYDROCORTISONE BUTYRATE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'BAUSCH',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/019116s009lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=19116'},\n",
       " '19123': {'ApplNo': '19123',\n",
       "  'Form': 'TABLET, EXTENDED RELEASE;ORAL',\n",
       "  'Drug': 'KLOR-CON',\n",
       "  'ActiveIngredient': 'POTASSIUM CHLORIDE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'UPSHER SMITH LABS',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2018/019123s036lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=19123'},\n",
       " '19125': {'ApplNo': '19125',\n",
       "  'Form': 'SOLUTION;TOPICAL',\n",
       "  'Drug': 'EXIDINE',\n",
       "  'ActiveIngredient': 'CHLORHEXIDINE GLUCONATE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'XTTRIUM',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/019125Orig1s045lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=19125'},\n",
       " '19127': {'ApplNo': '19127',\n",
       "  'Form': 'AEROSOL, METERED;TOPICAL',\n",
       "  'Drug': 'EXIDINE',\n",
       "  'ActiveIngredient': 'CHLORHEXIDINE GLUCONATE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'XTTRIUM',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2017/019127Orig1s022lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=19127'},\n",
       " '19129': {'ApplNo': '19129',\n",
       "  'Form': 'TABLET;ORAL',\n",
       "  'Drug': 'MAXZIDE',\n",
       "  'ActiveIngredient': 'HYDROCHLOROTHIAZIDE; TRIAMTERENE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'AUROBINDO PHARMA USA',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/019129s056lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=19129'},\n",
       " '19152': {'ApplNo': '19152',\n",
       "  'Form': 'TABLET, EXTENDED RELEASE;ORAL',\n",
       "  'Drug': 'CALAN SR',\n",
       "  'ActiveIngredient': 'VERAPAMIL HYDROCHLORIDE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'PFIZER',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/019152Orig1s045lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=19152'},\n",
       " '19157': {'ApplNo': '19157',\n",
       "  'Form': 'SOLUTION;ORAL',\n",
       "  'Drug': 'PEDIAPRED',\n",
       "  'ActiveIngredient': 'PREDNISOLONE SODIUM PHOSPHATE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'SETON PHARM',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2018/019157s021lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=19157'},\n",
       " '19183': {'ApplNo': '19183',\n",
       "  'Form': 'SUSPENSION;ORAL',\n",
       "  'Drug': 'CARAFATE',\n",
       "  'ActiveIngredient': 'SUCRALFATE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'ALLERGAN',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2017/019183s019lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=19183'},\n",
       " '19193': {'ApplNo': '19193',\n",
       "  'Form': 'FOR SOLUTION;INHALATION',\n",
       "  'Drug': 'PROVOCHOLINE',\n",
       "  'ActiveIngredient': 'METHACHOLINE CHLORIDE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'METHAPHARM',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/019193s026lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=19193'},\n",
       " '19216': {'ApplNo': '19216',\n",
       "  'Form': 'SUSPENSION/DROPS;OPHTHALMIC',\n",
       "  'Drug': 'FML FORTE',\n",
       "  'ActiveIngredient': 'FLUOROMETHOLONE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'ALLERGAN',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/019216s025lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=19216'},\n",
       " '19219': {'ApplNo': '19219',\n",
       "  'Form': 'SOLUTION/DROPS;OPHTHALMIC',\n",
       "  'Drug': 'BETAGAN',\n",
       "  'ActiveIngredient': 'LEVOBUNOLOL HYDROCHLORIDE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'ALLERGAN',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2017/019219s029lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=19219'},\n",
       " '19221': {'ApplNo': '19221',\n",
       "  'Form': 'TABLET;ORAL',\n",
       "  'Drug': 'VASERETIC',\n",
       "  'ActiveIngredient': 'ENALAPRIL MALEATE; HYDROCHLOROTHIAZIDE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'BAUSCH',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/019221s050lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=19221'},\n",
       " '19257': {'ApplNo': '19257',\n",
       "  'Form': 'SOLUTION;ORAL',\n",
       "  'Drug': 'CARNITOR',\n",
       "  'ActiveIngredient': 'LEVOCARNITINE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'LEADIANT BIOSCI INC',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2018/018948s028,019257s014lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=19257'},\n",
       " '19258': {'ApplNo': '19258',\n",
       "  'Form': 'SOLUTION;TOPICAL',\n",
       "  'Drug': 'CIDA-STAT',\n",
       "  'ActiveIngredient': 'CHLORHEXIDINE GLUCONATE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'ECOLAB',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2018/019258Orig1s026lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=19258'},\n",
       " '19261': {'ApplNo': '19261',\n",
       "  'Form': 'SOLUTION/DROPS;OPHTHALMIC',\n",
       "  'Drug': 'PAREMYD',\n",
       "  'ActiveIngredient': 'HYDROXYAMPHETAMINE HYDROBROMIDE; TROPICAMIDE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'AKORN',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2001/19261s8lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=19261'},\n",
       " '19268': {'ApplNo': '19268',\n",
       "  'Form': 'TABLET;ORAL',\n",
       "  'Drug': 'CYTOTEC',\n",
       "  'ActiveIngredient': 'MISOPROSTOL',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'PFIZER',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2018/019268s051lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=19268'},\n",
       " '19270': {'ApplNo': '19270',\n",
       "  'Form': 'SOLUTION/DROPS;OPHTHALMIC',\n",
       "  'Drug': 'BETOPTIC',\n",
       "  'ActiveIngredient': 'BETAXOLOL HYDROCHLORIDE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'SANDOZ INC',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2006/19270s031lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=19270'},\n",
       " '19281': {'ApplNo': '19281',\n",
       "  'Form': 'INJECTABLE;INJECTION',\n",
       "  'Drug': 'CYKLOKAPRON',\n",
       "  'ActiveIngredient': 'TRANEXAMIC ACID',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'PFIZER',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/019281Orig1s047lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=19281'},\n",
       " '19308': {'ApplNo': '19308',\n",
       "  'Form': 'INJECTABLE;INJECTION',\n",
       "  'Drug': 'POTASSIUM CHLORIDE 5MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER',\n",
       "  'ActiveIngredient': 'DEXTROSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'BAXTER HLTHCARE',\n",
       "  'LatestLabel': 'https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/18008s073,18037s073,18629s046,19308s030lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=19308'},\n",
       " '19316': {'ApplNo': '19316',\n",
       "  'Form': 'SOLUTION;INTRAMUSCULAR, INTRAVENOUS',\n",
       "  'Drug': 'MAGNESIUM SULFATE',\n",
       "  'ActiveIngredient': 'MAGNESIUM SULFATE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'FRESENIUS KABI USA',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2018/019316s024lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=19316'},\n",
       " '19339': {'ApplNo': '19339',\n",
       "  'Form': 'INJECTABLE;INJECTION',\n",
       "  'Drug': 'HEPARIN SODIUM 12,500 UNITS IN DEXTROSE 5% IN PLASTIC CONTAINER',\n",
       "  'ActiveIngredient': 'HEPARIN SODIUM',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'HOSPIRA',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/018916s063,019339s052,019805s034lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=19339'},\n",
       " '19345': {'ApplNo': '19345',\n",
       "  'Form': 'INJECTABLE;INJECTION',\n",
       "  'Drug': 'DEXTROSE 30% IN PLASTIC CONTAINER',\n",
       "  'ActiveIngredient': 'DEXTROSE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'ICU MEDICAL INC',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2018/018561s060,018562s059,018563s060,018564s062,019345s047lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=19345'},\n",
       " '19353': {'ApplNo': '19353',\n",
       "  'Form': 'INJECTABLE;INJECTION',\n",
       "  'Drug': 'ALFENTA',\n",
       "  'ActiveIngredient': 'ALFENTANIL HYDROCHLORIDE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'AKORN',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/019353s023lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=19353'},\n",
       " '19356': {'ApplNo': '19356',\n",
       "  'Form': 'GEL;TOPICAL',\n",
       "  'Drug': 'NAFTIN',\n",
       "  'ActiveIngredient': 'NAFTIFINE HYDROCHLORIDE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'SEBELA IRELAND LTD',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2018/019356s008,019599s014,204286s003lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=19356'},\n",
       " '19367': {'ApplNo': '19367',\n",
       "  'Form': 'INJECTABLE;INJECTION',\n",
       "  'Drug': \"POTASSIUM CHLORIDE 5MEQ IN DEXTROSE 5% AND LACTATED RINGER'S IN PLASTIC CONTAINER\",\n",
       "  'ActiveIngredient': 'CALCIUM CHLORIDE; DEXTROSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE; SODIUM LACTATE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'BAXTER HLTHCARE',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/019367s036lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=19367'},\n",
       " '19386': {'ApplNo': '19386',\n",
       "  'Form': 'INJECTABLE;INJECTION',\n",
       "  'Drug': 'BREVIBLOC IN PLASTIC CONTAINER',\n",
       "  'ActiveIngredient': 'ESMOLOL HYDROCHLORIDE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'BAXTER HLTHCARE',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/019386s043lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=19386'},\n",
       " '19389': {'ApplNo': '19389',\n",
       "  'Form': 'SPRAY, METERED;NASAL',\n",
       "  'Drug': 'BECONASE AQ',\n",
       "  'ActiveIngredient': 'BECLOMETHASONE DIPROPIONATE MONOHYDRATE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'GLAXOSMITHKLINE',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/019389Orig1s034lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=19389'},\n",
       " '19414': {'ApplNo': '19414',\n",
       "  'Form': 'INJECTABLE;INJECTION',\n",
       "  'Drug': 'CARDIOGEN-82',\n",
       "  'ActiveIngredient': 'RUBIDIUM CHLORIDE RB-82',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'BRACCO',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/019414Orig1s021lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=19414'},\n",
       " '19422': {'ApplNo': '19422',\n",
       "  'Form': 'SOLUTION;TOPICAL',\n",
       "  'Drug': 'EXIDINE',\n",
       "  'ActiveIngredient': 'CHLORHEXIDINE GLUCONATE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'XTTRIUM',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/019422Orig1s049Lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=19422'},\n",
       " '19430': {'ApplNo': '19430',\n",
       "  'Form': 'INJECTABLE;INTRAMUSCULAR, SUBCUTANEOUS',\n",
       "  'Drug': 'EPIPEN',\n",
       "  'ActiveIngredient': 'EPINEPHRINE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'MYLAN SPECIALITY LP',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/019430Orig1s091lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=19430'},\n",
       " '19452': {'ApplNo': '19452',\n",
       "  'Form': 'OIL;TOPICAL',\n",
       "  'Drug': 'DERMA-SMOOTHE/FS',\n",
       "  'ActiveIngredient': 'FLUOCINOLONE ACETONIDE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'HILL DERMAC',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/019452Orig1s040lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=19452'},\n",
       " '19463': {'ApplNo': '19463',\n",
       "  'Form': 'SOLUTION/DROPS;OPHTHALMIC',\n",
       "  'Drug': 'TIMOPTIC IN OCUDOSE',\n",
       "  'ActiveIngredient': 'TIMOLOL MALEATE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'BAUSCH AND LOMB INC',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2017/019463s031lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=19463'},\n",
       " '19465': {'ApplNo': '19465',\n",
       "  'Form': 'INJECTABLE;INJECTION',\n",
       "  'Drug': 'SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER',\n",
       "  'ActiveIngredient': 'SODIUM CHLORIDE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'HOSPIRA',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2016/019465s055lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=19465'},\n",
       " '19480': {'ApplNo': '19480',\n",
       "  'Form': 'INJECTABLE;INJECTION',\n",
       "  'Drug': 'SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER',\n",
       "  'ActiveIngredient': 'SODIUM CHLORIDE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'HOSPIRA',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2016/019480s046lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=19480'},\n",
       " '19481': {'ApplNo': '19481',\n",
       "  'Form': 'SOLUTION;IRRIGATION',\n",
       "  'Drug': 'RENACIDIN',\n",
       "  'ActiveIngredient': 'CITRIC ACID; GLUCONOLACTONE; MAGNESIUM CARBONATE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'UNITED GUARDIAN',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/019481s013lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=19481'},\n",
       " '19487': {'ApplNo': '19487',\n",
       "  'Form': 'SOLUTION;ORAL',\n",
       "  'Drug': 'IMODIUM A-D',\n",
       "  'ActiveIngredient': 'LOPERAMIDE HYDROCHLORIDE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'J AND J CONSUMER INC',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/019487Orig1s034lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=19487'},\n",
       " '19501': {'ApplNo': '19501',\n",
       "  'Form': 'SOLUTION;TOPICAL',\n",
       "  'Drug': 'ROGAINE (FOR MEN)',\n",
       "  'ActiveIngredient': 'MINOXIDIL',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'JOHNSON AND JOHNSON',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/019501Orig1s029lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=19501'},\n",
       " '19516': {'ApplNo': '19516',\n",
       "  'Form': 'TABLET, EXTENDED RELEASE;ORAL',\n",
       "  'Drug': 'MS CONTIN',\n",
       "  'ActiveIngredient': 'MORPHINE SULFATE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'PURDUE PHARMA LP',\n",
       "  'LatestLabel': 'https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/019516s057lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=19516'},\n",
       " '19531': {'ApplNo': '19531',\n",
       "  'Form': 'INJECTABLE;INJECTION',\n",
       "  'Drug': 'NUTRILIPID 10%',\n",
       "  'ActiveIngredient': 'SOYBEAN OIL',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'B BRAUN',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/019531s010lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=19531'},\n",
       " '19537': {'ApplNo': '19537',\n",
       "  'Form': 'TABLET;ORAL',\n",
       "  'Drug': 'CIPRO',\n",
       "  'ActiveIngredient': 'CIPROFLOXACIN HYDROCHLORIDE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'BAYER HLTHCARE',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/019537s092lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=19537'},\n",
       " '19569': {'ApplNo': '19569',\n",
       "  'Form': 'TABLET;ORAL',\n",
       "  'Drug': 'THIOLA',\n",
       "  'ActiveIngredient': 'TIOPRONIN',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'MISSION PHARMA',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/019569s006lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=19569'},\n",
       " '19574': {'ApplNo': '19574',\n",
       "  'Form': 'TABLET;ORAL',\n",
       "  'Drug': 'THALITONE',\n",
       "  'ActiveIngredient': 'CHLORTHALIDONE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'CASPER PHARMA LLC',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/019574s017lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=19574'},\n",
       " '19594': {'ApplNo': '19594',\n",
       "  'Form': 'CAPSULE;ORAL',\n",
       "  'Drug': 'ACTIGALL',\n",
       "  'ActiveIngredient': 'URSODIOL',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'TEVA BRANDED PHARM',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2018/019594s21lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=19594'},\n",
       " '19599': {'ApplNo': '19599',\n",
       "  'Form': 'CREAM;TOPICAL',\n",
       "  'Drug': 'NAFTIN',\n",
       "  'ActiveIngredient': 'NAFTIFINE HYDROCHLORIDE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'SEBELA IRELAND LTD',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2018/019356s008,019599s014,204286s003lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=19599'},\n",
       " '19600': {'ApplNo': '19600',\n",
       "  'Form': 'CAPSULE;ORAL',\n",
       "  'Drug': 'OXSORALEN-ULTRA',\n",
       "  'ActiveIngredient': 'METHOXSALEN',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'BAUSCH',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2003/19600slr006,009_oxsoralen-ultra_lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=19600'},\n",
       " '19603': {'ApplNo': '19603',\n",
       "  'Form': 'INJECTABLE;INJECTION',\n",
       "  'Drug': 'MANNITOL 20% IN PLASTIC CONTAINER',\n",
       "  'ActiveIngredient': 'MANNITOL',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'ICU MEDICAL INC',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/019603s040lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=19603'},\n",
       " '19614': {'ApplNo': '19614',\n",
       "  'Form': 'CAPSULE, EXTENDED RELEASE;ORAL',\n",
       "  'Drug': 'VERELAN',\n",
       "  'ActiveIngredient': 'VERAPAMIL HYDROCHLORIDE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'SOCIETAL CDMO',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/019614s056lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=19614'},\n",
       " '19615': {'ApplNo': '19615',\n",
       "  'Form': 'INJECTABLE;INJECTION',\n",
       "  'Drug': 'DOPAMINE HYDROCHLORIDE IN DEXTROSE 5% IN PLASTIC CONTAINER',\n",
       "  'ActiveIngredient': 'DOPAMINE HYDROCHLORIDE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'BAXTER HLTHCARE',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2017/019615s024lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=19615'},\n",
       " '19617': {'ApplNo': '19617',\n",
       "  'Form': 'GEL;ENDOCERVICAL',\n",
       "  'Drug': 'PREPIDIL',\n",
       "  'ActiveIngredient': 'DINOPROSTONE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'PFIZER',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2017/019617s017lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=19617'},\n",
       " '19618': {'ApplNo': '19618',\n",
       "  'Form': 'ENEMA;RECTAL',\n",
       "  'Drug': 'ROWASA',\n",
       "  'ActiveIngredient': 'MESALAMINE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'MYLAN SPECIALITY LP',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/019618s030lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=19618'},\n",
       " '19626': {'ApplNo': '19626',\n",
       "  'Form': 'INJECTABLE;INJECTION',\n",
       "  'Drug': 'DEXTROSE 5% IN PLASTIC CONTAINER',\n",
       "  'ActiveIngredient': 'DEXTROSE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'B BRAUN',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/019626s030lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=19626'},\n",
       " '19627': {'ApplNo': '19627',\n",
       "  'Form': 'INJECTABLE;INJECTION',\n",
       "  'Drug': 'DIPRIVAN',\n",
       "  'ActiveIngredient': 'PROPOFOL',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'FRESENIUS KABI USA',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/019627s069lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=19627'},\n",
       " '19630': {'ApplNo': '19630',\n",
       "  'Form': 'INJECTABLE;INJECTION',\n",
       "  'Drug': 'POTASSIUM CHLORIDE 0.037% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.11% IN PLASTIC CONTAINER',\n",
       "  'ActiveIngredient': 'DEXTROSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'B BRAUN',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2004/19630s023lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=19630'},\n",
       " '19631': {'ApplNo': '19631',\n",
       "  'Form': 'INJECTABLE;INJECTION',\n",
       "  'Drug': 'DEXTROSE 2.5% AND SODIUM CHLORIDE 0.11% IN PLASTIC CONTAINER',\n",
       "  'ActiveIngredient': 'DEXTROSE; SODIUM CHLORIDE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'B BRAUN',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2004/19631s023lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=19631'},\n",
       " '19632': {'ApplNo': '19632',\n",
       "  'Form': 'INJECTABLE;INJECTION',\n",
       "  'Drug': \"LACTATED RINGER'S IN PLASTIC CONTAINER\",\n",
       "  'ActiveIngredient': 'CALCIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM CHLORIDE; SODIUM LACTATE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'B BRAUN',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/019632s050,019634s050,020002s032lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=19632'},\n",
       " '19634': {'ApplNo': '19634',\n",
       "  'Form': 'INJECTABLE;INJECTION',\n",
       "  'Drug': \"DEXTROSE 2.5% IN HALF-STRENGTH LACTATED RINGER'S IN PLASTIC CONTAINER\",\n",
       "  'ActiveIngredient': 'CALCIUM CHLORIDE; DEXTROSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE; SODIUM LACTATE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'B BRAUN',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/019632s050,019634s050,020002s032lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=19634'},\n",
       " '19635': {'ApplNo': '19635',\n",
       "  'Form': 'INJECTABLE;INJECTION',\n",
       "  'Drug': 'SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER',\n",
       "  'ActiveIngredient': 'SODIUM CHLORIDE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'B BRAUN',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/019635s035lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=19635'},\n",
       " '19640': {'ApplNo': '19640',\n",
       "  'Form': 'INJECTABLE;INJECTION',\n",
       "  'Drug': 'HUMATROPE',\n",
       "  'ActiveIngredient': 'SOMATROPIN',\n",
       "  'ApplType': 'BLA',\n",
       "  'Sponsor': 'LILLY',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2004/19640s040lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=19640'},\n",
       " '19649': {'ApplNo': '19649',\n",
       "  'Form': 'TABLET;ORAL',\n",
       "  'Drug': 'FLUMADINE',\n",
       "  'ActiveIngredient': 'RIMANTADINE HYDROCHLORIDE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'SUN PHARM INDS INC',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2010/019649s015lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=19649'},\n",
       " '19655': {'ApplNo': '19655',\n",
       "  'Form': 'CAPSULE;ORAL',\n",
       "  'Drug': 'RETROVIR',\n",
       "  'ActiveIngredient': 'ZIDOVUDINE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'VIIV HLTHCARE',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/019655Orig1s059,019910Orig1s046,019951Orig1s037lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=19655'},\n",
       " '19658': {'ApplNo': '19658',\n",
       "  'Form': 'TABLET;ORAL',\n",
       "  'Drug': 'CLARITIN',\n",
       "  'ActiveIngredient': 'LORATADINE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'BAYER HEALTHCARE LLC',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/019658Orig1s056lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=19658'},\n",
       " '19667': {'ApplNo': '19667',\n",
       "  'Form': 'INJECTABLE;INJECTION',\n",
       "  'Drug': 'SANDOSTATIN',\n",
       "  'ActiveIngredient': 'OCTREOTIDE ACETATE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'NOVARTIS',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/019667s073lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=19667'},\n",
       " '19668': {'ApplNo': '19668',\n",
       "  'Form': 'TABLET;ORAL',\n",
       "  'Drug': 'CARDURA',\n",
       "  'ActiveIngredient': 'DOXAZOSIN MESYLATE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'VIATRIS',\n",
       "  'LatestLabel': 'https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/019668Orig1s032lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=19668'},\n",
       " '19670': {'ApplNo': '19670',\n",
       "  'Form': 'TABLET, EXTENDED RELEASE;ORAL',\n",
       "  'Drug': 'CLARITIN-D',\n",
       "  'ActiveIngredient': 'LORATADINE; PSEUDOEPHEDRINE SULFATE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'BAYER HEALTHCARE LLC',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2018/019670Orig1s034,020470Orig1s047Lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=19670'},\n",
       " '19676': {'ApplNo': '19676',\n",
       "  'Form': 'Injectable; Injection',\n",
       "  'Drug': 'NUTROPIN',\n",
       "  'ActiveIngredient': 'SOMATROPIN [rDNA origin]',\n",
       "  'ApplType': 'BLA',\n",
       "  'Sponsor': 'GENENTECH',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2005/019676s020,021lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=19676'},\n",
       " '19680': {'ApplNo': '19680',\n",
       "  'Form': 'CAPSULE, DELAYED REL PELLETS;ORAL',\n",
       "  'Drug': 'DEPAKOTE',\n",
       "  'ActiveIngredient': 'DIVALPROEX SODIUM',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'ABBVIE',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/019680s052lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=19680'},\n",
       " '19684': {'ApplNo': '19684',\n",
       "  'Form': 'TABLET, EXTENDED RELEASE;ORAL',\n",
       "  'Drug': 'PROCARDIA XL',\n",
       "  'ActiveIngredient': 'NIFEDIPINE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'PFIZER',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/019684s033lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=19684'},\n",
       " '19699': {'ApplNo': '19699',\n",
       "  'Form': 'INJECTABLE;INJECTION',\n",
       "  'Drug': 'POTASSIUM CHLORIDE 0.15% IN DEXTROSE 5% IN PLASTIC CONTAINER',\n",
       "  'ActiveIngredient': 'DEXTROSE; POTASSIUM CHLORIDE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'B BRAUN',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/019699s033lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=19699'},\n",
       " '19700': {'ApplNo': '19700',\n",
       "  'Form': 'SOLUTION/DROPS;OPHTHALMIC',\n",
       "  'Drug': 'ACULAR',\n",
       "  'ActiveIngredient': 'KETOROLAC TROMETHAMINE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'ALLERGAN',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/019700s028lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=19700'},\n",
       " '19708': {'ApplNo': '19708',\n",
       "  'Form': 'INJECTABLE;INJECTION',\n",
       "  'Drug': 'POTASSIUM CHLORIDE 0.15% IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER',\n",
       "  'ActiveIngredient': 'POTASSIUM CHLORIDE; SODIUM CHLORIDE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'B BRAUN',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2004/19708s013lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=19708'},\n",
       " '19710': {'ApplNo': '19710',\n",
       "  'Form': 'INJECTABLE;INJECTION',\n",
       "  'Drug': 'OPTIRAY 320',\n",
       "  'ActiveIngredient': 'IOVERSOL',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'LIEBEL-FLARSHEIM',\n",
       "  'LatestLabel': 'https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/019710Orig1s064lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=19710'},\n",
       " '19715': {'ApplNo': '19715',\n",
       "  'Form': 'CAPSULE;ORAL',\n",
       "  'Drug': 'DIPENTUM',\n",
       "  'ActiveIngredient': 'OLSALAZINE SODIUM',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'MYLAN SPCLT VIATRIS',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/019715s032lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=19715'},\n",
       " '19717': {'ApplNo': '19717',\n",
       "  'Form': 'INJECTABLE;INJECTION',\n",
       "  'Drug': 'HUMULIN 70/30',\n",
       "  'ActiveIngredient': 'INSULIN RECOMBINANT HUMAN; INSULIN SUSP ISOPHANE RECOMBINANT HUMAN',\n",
       "  'ApplType': 'BLA',\n",
       "  'Sponsor': 'LILLY',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/019717s174lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=19717'},\n",
       " '19726': {'ApplNo': '19726',\n",
       "  'Form': 'IMPLANT;IMPLANTATION',\n",
       "  'Drug': 'ZOLADEX',\n",
       "  'ActiveIngredient': 'GOSERELIN ACETATE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'TERSERA',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/019726s059,020578s037lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=19726'},\n",
       " '19732': {'ApplNo': '19732',\n",
       "  'Form': 'INJECTABLE;INJECTION',\n",
       "  'Drug': 'LUPRON DEPOT',\n",
       "  'ActiveIngredient': 'LEUPROLIDE ACETATE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'ABBVIE ENDOCRINE INC',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/019732s045,020517s043lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=19732'},\n",
       " '19734': {'ApplNo': '19734',\n",
       "  'Form': 'INJECTABLE;INTRAVENOUS',\n",
       "  'Drug': 'CARDENE IN 4.8% DEXTROSE IN PLASTIC CONTAINER',\n",
       "  'ActiveIngredient': 'NICARDIPINE HYDROCHLORIDE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'CHIESI',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/019734Orig1s031lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=19734'},\n",
       " '19758': {'ApplNo': '19758',\n",
       "  'Form': 'TABLET;ORAL',\n",
       "  'Drug': 'CLOZARIL',\n",
       "  'ActiveIngredient': 'CLOZAPINE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'HERITAGE LIFE',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/019758s101lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=19758'},\n",
       " '19759': {'ApplNo': '19759',\n",
       "  'Form': 'INJECTABLE;INJECTION',\n",
       "  'Drug': 'SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER',\n",
       "  'ActiveIngredient': 'SODIUM CHLORIDE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'HOSPIRA',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2016/019759s047lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=19759'},\n",
       " '19763': {'ApplNo': '19763',\n",
       "  'Form': 'INJECTABLE;INJECTION',\n",
       "  'Drug': 'IFEX',\n",
       "  'ActiveIngredient': 'IFOSFAMIDE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'BAXTER HLTHCARE',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2018/019763s020lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=19763'},\n",
       " '19764': {'ApplNo': '19764',\n",
       "  'Form': 'INJECTABLE;INJECTION',\n",
       "  'Drug': 'SAIZEN',\n",
       "  'ActiveIngredient': 'SOMATROPIN',\n",
       "  'ApplType': 'BLA',\n",
       "  'Sponsor': 'EMD SERONO',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2004/19764s020lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=19764'},\n",
       " '19766': {'ApplNo': '19766',\n",
       "  'Form': 'TABLET;ORAL',\n",
       "  'Drug': 'ZOCOR',\n",
       "  'ActiveIngredient': 'SIMVASTATIN',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'ORGANON',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/019766s102lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=19766'},\n",
       " '19771': {'ApplNo': '19771',\n",
       "  'Form': 'TABLET;ORAL',\n",
       "  'Drug': 'ADVIL COLD AND SINUS',\n",
       "  'ActiveIngredient': 'IBUPROFEN; PSEUDOEPHEDRINE HYDROCHLORIDE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'GLAXOSMITHKLINE',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/019771orig1s045lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=19771'},\n",
       " '19774': {'ApplNo': '19774',\n",
       "  'Form': 'INJECTABLE;INJECTION',\n",
       "  'Drug': 'ZOMACTON',\n",
       "  'ActiveIngredient': 'SOMATROPIN',\n",
       "  'ApplType': 'BLA',\n",
       "  'Sponsor': 'FERRING',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2005/19774s009lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=19774'},\n",
       " '19777': {'ApplNo': '19777',\n",
       "  'Form': 'TABLET;ORAL',\n",
       "  'Drug': 'ZESTRIL',\n",
       "  'ActiveIngredient': 'LISINOPRIL',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'ALMATICA',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2017/019777s076lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=19777'},\n",
       " '19779': {'ApplNo': '19779',\n",
       "  'Form': 'SOLUTION/DROPS;OPHTHALMIC',\n",
       "  'Drug': 'IOPIDINE',\n",
       "  'ActiveIngredient': 'APRACLONIDINE HYDROCHLORIDE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'IMPRIMIS PHARMS USA',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2018/019779s025lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=19779'},\n",
       " '19781': {'ApplNo': '19781',\n",
       "  'Form': 'CAPSULE;ORAL',\n",
       "  'Drug': 'PROMETRIUM',\n",
       "  'ActiveIngredient': 'PROGESTERONE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'VIRTUS PHARMS',\n",
       "  'LatestLabel': 'https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/019781Orig1s022lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=19781'},\n",
       " '19785': {'ApplNo': '19785',\n",
       "  'Form': 'INJECTABLE;INJECTION',\n",
       "  'Drug': 'CARDIOLITE',\n",
       "  'ActiveIngredient': 'TECHNETIUM TC-99M SESTAMIBI KIT',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'LANTHEUS MEDCL',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/019785s022lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=19785'},\n",
       " '19787': {'ApplNo': '19787',\n",
       "  'Form': 'TABLET;ORAL',\n",
       "  'Drug': 'NORVASC',\n",
       "  'ActiveIngredient': 'AMLODIPINE BESYLATE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'VIATRIS',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2017/019787s062lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=19787'},\n",
       " '19796': {'ApplNo': '19796',\n",
       "  'Form': 'LOTION;TOPICAL',\n",
       "  'Drug': 'ELOCON',\n",
       "  'ActiveIngredient': 'MOMETASONE FUROATE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'ORGANON',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2018/019796s029lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=19796'},\n",
       " '19797': {'ApplNo': '19797',\n",
       "  'Form': 'FOR SOLUTION;ORAL',\n",
       "  'Drug': 'NULYTELY',\n",
       "  'ActiveIngredient': 'POLYETHYLENE GLYCOL 3350; POTASSIUM CHLORIDE; SODIUM BICARBONATE; SODIUM CHLORIDE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'BRAINTREE',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/019797s029lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=19797'},\n",
       " '19822': {'ApplNo': '19822',\n",
       "  'Form': 'SPONGE;TOPICAL',\n",
       "  'Drug': 'BIOSCRUB',\n",
       "  'ActiveIngredient': 'CHLORHEXIDINE GLUCONATE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'GRIFFEN',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2018/019822Orig1s008lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=19822'},\n",
       " '19824': {'ApplNo': '19824',\n",
       "  'Form': 'SUSPENSION;TOPICAL',\n",
       "  'Drug': 'LOPROX',\n",
       "  'ActiveIngredient': 'CICLOPIROX',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'MEDIMETRIKS PHARMS',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/018748s024,019824s023,020519s016lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=19824'},\n",
       " '19826': {'ApplNo': '19826',\n",
       "  'Form': 'INJECTABLE;INJECTION',\n",
       "  'Drug': 'THEOPHYLLINE 0.04% AND DEXTROSE 5% IN PLASTIC CONTAINER',\n",
       "  'ActiveIngredient': 'THEOPHYLLINE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'B BRAUN',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/019826s023lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=19826'},\n",
       " '19828': {'ApplNo': '19828',\n",
       "  'Form': 'CREAM;TOPICAL',\n",
       "  'Drug': 'OXISTAT',\n",
       "  'ActiveIngredient': 'OXICONAZOLE NITRATE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'FOUGERA PHARMS',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2004/19828slr009,20209slr005_oxistat_lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=19828'},\n",
       " '19829': {'ApplNo': '19829',\n",
       "  'Form': 'INJECTABLE;INJECTION',\n",
       "  'Drug': 'CERETEC',\n",
       "  'ActiveIngredient': 'TECHNETIUM TC-99M EXAMETAZIME KIT',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'GE HEALTHCARE',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2018/019829s034lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=19829'},\n",
       " '19830': {'ApplNo': '19830',\n",
       "  'Form': 'INJECTABLE;INJECTION',\n",
       "  'Drug': 'LIDOCAINE HYDROCHLORIDE 0.2% AND DEXTROSE 5% IN PLASTIC CONTAINER',\n",
       "  'ActiveIngredient': 'LIDOCAINE HYDROCHLORIDE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'B BRAUN',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/019830s027lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=19830'},\n",
       " '19835': {'ApplNo': '19835',\n",
       "  'Form': 'TABLET;ORAL',\n",
       "  'Drug': 'ZYRTEC ALLERGY',\n",
       "  'ActiveIngredient': 'CETIRIZINE HYDROCHLORIDE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'J AND J CONSUMER INC',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/019835Orig1s040lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=19835'},\n",
       " '19839': {'ApplNo': '19839',\n",
       "  'Form': 'TABLET;ORAL',\n",
       "  'Drug': 'ZOLOFT',\n",
       "  'ActiveIngredient': 'SERTRALINE HYDROCHLORIDE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'VIATRIS',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2023/019839s102,020990s059lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=19839'},\n",
       " '19841': {'ApplNo': '19841',\n",
       "  'Form': 'INJECTABLE;INJECTION',\n",
       "  'Drug': 'INDIUM IN 111 CHLORIDE',\n",
       "  'ActiveIngredient': 'INDIUM IN-111 CHLORIDE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'CURIUM',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2002/in111mal021902LB.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=19841'},\n",
       " '19845': {'ApplNo': '19845',\n",
       "  'Form': 'SUSPENSION/DROPS;OPHTHALMIC',\n",
       "  'Drug': 'BETOPTIC S',\n",
       "  'ActiveIngredient': 'BETAXOLOL HYDROCHLORIDE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'NOVARTIS',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/019845s030lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=19845'},\n",
       " '19851': {'ApplNo': '19851',\n",
       "  'Form': 'TABLET;ORAL',\n",
       "  'Drug': 'LOTENSIN',\n",
       "  'ActiveIngredient': 'BENAZEPRIL HYDROCHLORIDE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'VALIDUS PHARMS',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/019851s054lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=19851'},\n",
       " '19853': {'ApplNo': '19853',\n",
       "  'Form': 'CAPSULE;ORAL',\n",
       "  'Drug': 'CUPRIMINE',\n",
       "  'ActiveIngredient': 'PENICILLAMINE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'VALEANT PHARMS INTL',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2004/19853s012,014lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=19853'},\n",
       " '19860': {'ApplNo': '19860',\n",
       "  'Form': 'TABLET;ORAL',\n",
       "  'Drug': 'IMODIUM A-D',\n",
       "  'ActiveIngredient': 'LOPERAMIDE HYDROCHLORIDE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'J AND J CONSUMER INC',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/019860Orig1s033lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=19860'},\n",
       " '19865': {'ApplNo': '19865',\n",
       "  'Form': 'TABLET;ORAL',\n",
       "  'Drug': 'BETAPACE',\n",
       "  'ActiveIngredient': 'SOTALOL HYDROCHLORIDE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'LEGACY PHARMA',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/019865s022lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=19865'},\n",
       " '19872': {'ApplNo': '19872',\n",
       "  'Form': 'TABLET, EXTENDED RELEASE;ORAL',\n",
       "  'Drug': 'TYLENOL',\n",
       "  'ActiveIngredient': 'ACETAMINOPHEN',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'J AND J CONSUMER INC',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/019872Orig1s048lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=19872'},\n",
       " '19884': {'ApplNo': '19884',\n",
       "  'Form': 'INJECTABLE;INTRAVENOUS',\n",
       "  'Drug': 'MESNEX',\n",
       "  'ActiveIngredient': 'MESNA',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'BAXTER HLTHCARE',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2018/019884s016,020855s003lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=19884'},\n",
       " '19886': {'ApplNo': '19886',\n",
       "  'Form': 'SPRAY, METERED;NASAL',\n",
       "  'Drug': 'SYNAREL',\n",
       "  'ActiveIngredient': 'NAFARELIN ACETATE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'PFIZER',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/019886s038lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=19886'},\n",
       " '19887': {'ApplNo': '19887',\n",
       "  'Form': 'FOR SOLUTION;INHALATION',\n",
       "  'Drug': 'NEBUPENT',\n",
       "  'ActiveIngredient': 'PENTAMIDINE ISETHIONATE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'FRESENIUS KABI USA',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2011/019887s014lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=19887'},\n",
       " '19888': {'ApplNo': '19888',\n",
       "  'Form': 'TABLET;ORAL',\n",
       "  'Drug': 'ZESTORETIC',\n",
       "  'ActiveIngredient': 'HYDROCHLOROTHIAZIDE; LISINOPRIL',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'ALMATICA',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/019888s069lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=19888'},\n",
       " '19891': {'ApplNo': '19891',\n",
       "  'Form': 'SOLUTION;ORAL',\n",
       "  'Drug': 'DILAUDID',\n",
       "  'ActiveIngredient': 'HYDROMORPHONE HYDROCHLORIDE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'RHODES PHARMS',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/019891s029,019892s037lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=19891'},\n",
       " '19892': {'ApplNo': '19892',\n",
       "  'Form': 'TABLET;ORAL',\n",
       "  'Drug': 'DILAUDID',\n",
       "  'ActiveIngredient': 'HYDROMORPHONE HYDROCHLORIDE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'RHODES PHARMS',\n",
       "  'LatestLabel': 'https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/019891s029,019892s037lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=19892'},\n",
       " '19899': {'ApplNo': '19899',\n",
       "  'Form': 'TABLET;ORAL',\n",
       "  'Drug': 'SINE-AID IB',\n",
       "  'ActiveIngredient': 'IBUPROFEN; PSEUDOEPHEDRINE HYDROCHLORIDE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'J AND J CONSUMER INC',\n",
       "  'LatestLabel': 'https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/019899Orig1s020lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=19899'},\n",
       " '19901': {'ApplNo': '19901',\n",
       "  'Form': 'CAPSULE;ORAL',\n",
       "  'Drug': 'ALTACE',\n",
       "  'ActiveIngredient': 'RAMIPRIL',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'KING PHARMS LLC',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2017/019901s067lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=19901'},\n",
       " '19904': {'ApplNo': '19904',\n",
       "  'Form': 'INJECTABLE;INJECTION',\n",
       "  'Drug': 'POTASSIUM CHLORIDE 10MEQ IN PLASTIC CONTAINER',\n",
       "  'ActiveIngredient': 'POTASSIUM CHLORIDE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'BAXTER HLTHCARE',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/019904s021lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=19904'},\n",
       " '19906': {'ApplNo': '19906',\n",
       "  'Form': 'CAPSULE;ORAL',\n",
       "  'Drug': 'ANAFRANIL',\n",
       "  'ActiveIngredient': 'CLOMIPRAMINE HYDROCHLORIDE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'SPECGX LLC',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/019906s043lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=19906'},\n",
       " '19908': {'ApplNo': '19908',\n",
       "  'Form': 'TABLET;ORAL',\n",
       "  'Drug': 'AMBIEN',\n",
       "  'ActiveIngredient': 'ZOLPIDEM TARTRATE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'SANOFI AVENTIS US',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/019908s40s044s047lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=19908'},\n",
       " '19909': {'ApplNo': '19909',\n",
       "  'Form': 'SUSPENSION;ORAL',\n",
       "  'Drug': 'ZOVIRAX',\n",
       "  'ActiveIngredient': 'ACYCLOVIR',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'MYLAN',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2005/018828s030,020089s019,019909s020lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=19909'},\n",
       " '19910': {'ApplNo': '19910',\n",
       "  'Form': 'SOLUTION;ORAL',\n",
       "  'Drug': 'RETROVIR',\n",
       "  'ActiveIngredient': 'ZIDOVUDINE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'VIIV HLTHCARE',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/019655Orig1s059,019910Orig1s046,019951Orig1s037lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=19910'},\n",
       " '19921': {'ApplNo': '19921',\n",
       "  'Form': 'SOLUTION/DROPS;OPHTHALMIC',\n",
       "  'Drug': 'OCUFLOX',\n",
       "  'ActiveIngredient': 'OFLOXACIN',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'ALLERGAN',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2016/019921s021lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=19921'},\n",
       " '19922': {'ApplNo': '19922',\n",
       "  'Form': 'INJECTABLE;INJECTION',\n",
       "  'Drug': 'CORLOPAM',\n",
       "  'ActiveIngredient': 'FENOLDOPAM MESYLATE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'HOSPIRA',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/019922s019lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=19922'},\n",
       " '19931': {'ApplNo': '19931',\n",
       "  'Form': 'LOTION;TOPICAL',\n",
       "  'Drug': 'KLARON',\n",
       "  'ActiveIngredient': 'SULFACETAMIDE SODIUM',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'BAUSCH',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2010/019931s019lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=19931'},\n",
       " '19938': {'ApplNo': '19938',\n",
       "  'Form': 'INJECTABLE;INJECTION',\n",
       "  'Drug': 'NOVOLIN R',\n",
       "  'ActiveIngredient': 'INSULIN RECOMBINANT HUMAN',\n",
       "  'ApplType': 'BLA',\n",
       "  'Sponsor': 'NOVO NORDISK INC',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/019938s082lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=19938'},\n",
       " '19942': {'ApplNo': '19942',\n",
       "  'Form': 'INJECTABLE;INJECTION',\n",
       "  'Drug': 'INTRALIPID 30%',\n",
       "  'ActiveIngredient': 'SOYBEAN OIL',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'FRESENIUS',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/019942s020lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=19942'},\n",
       " '19943': {'ApplNo': '19943',\n",
       "  'Form': 'INJECTABLE; INJECTION',\n",
       "  'Drug': 'LUPRON DEPOT',\n",
       "  'ActiveIngredient': 'LEUPROLIDE ACETATE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'ABBVIE ENDOCRINE INC',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/020011s042,019943s035lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=19943'},\n",
       " '19949': {'ApplNo': '19949',\n",
       "  'Form': 'TABLET;ORAL',\n",
       "  'Drug': 'DIFLUCAN',\n",
       "  'ActiveIngredient': 'FLUCONAZOLE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'PFIZER',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2023/019949s073,020090s054lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=19949'},\n",
       " '19951': {'ApplNo': '19951',\n",
       "  'Form': 'INJECTABLE;INJECTION',\n",
       "  'Drug': 'RETROVIR',\n",
       "  'ActiveIngredient': 'ZIDOVUDINE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'VIIV HLTHCARE',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/019655Orig1s059,019910Orig1s046,019951Orig1s037lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=19951'},\n",
       " '19952': {'ApplNo': '19952',\n",
       "  'Form': 'INJECTABLE;INJECTION',\n",
       "  'Drug': 'HEPARIN SODIUM 20,000 UNITS IN DEXTROSE 5% IN PLASTIC CONTAINER',\n",
       "  'ActiveIngredient': 'HEPARIN SODIUM',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'B BRAUN',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2016/019952s033lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=19952'},\n",
       " '19953': {'ApplNo': '19953',\n",
       "  'Form': 'INJECTABLE;INJECTION',\n",
       "  'Drug': 'HEPARIN SODIUM 1,000 UNITS IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER',\n",
       "  'ActiveIngredient': 'HEPARIN SODIUM',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'B BRAUN',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2016/019953s032lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=19953'},\n",
       " '19955': {'ApplNo': '19955',\n",
       "  'Form': 'TABLET;ORAL',\n",
       "  'Drug': 'DDAVP',\n",
       "  'ActiveIngredient': 'DESMOPRESSIN ACETATE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'FERRING PHARMS INC',\n",
       "  'LatestLabel': 'https://www.accessdata.fda.gov/drugsatfda_docs/label/2007/017922s038,018938s027,019955s013lbl.pdf#page=33',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=19955'},\n",
       " '19959': {'ApplNo': '19959',\n",
       "  'Form': 'INJECTABLE;INJECTION',\n",
       "  'Drug': 'NOVOLIN N',\n",
       "  'ActiveIngredient': 'INSULIN SUSP ISOPHANE RECOMBINANT HUMAN',\n",
       "  'ApplType': 'BLA',\n",
       "  'Sponsor': 'NOVO NORDISK INC',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/019959s085lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=19959'},\n",
       " '19962': {'ApplNo': '19962',\n",
       "  'Form': 'TABLET, EXTENDED RELEASE;ORAL',\n",
       "  'Drug': 'TOPROL-XL',\n",
       "  'ActiveIngredient': 'METOPROLOL SUCCINATE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'TOPROL',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/019962s049lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=19962'},\n",
       " '19970': {'ApplNo': '19970',\n",
       "  'Form': 'INJECTABLE;INJECTION',\n",
       "  'Drug': 'NITROGLYCERIN IN DEXTROSE 5%',\n",
       "  'ActiveIngredient': 'NITROGLYCERIN',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'BAXTER HLTHCARE',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2016/019970s018lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=19970'},\n",
       " '19991': {'ApplNo': '19991',\n",
       "  'Form': 'INJECTABLE;INJECTION',\n",
       "  'Drug': 'NOVOLIN 70/30',\n",
       "  'ActiveIngredient': 'INSULIN RECOMBINANT HUMAN; INSULIN SUSP ISOPHANE RECOMBINANT HUMAN',\n",
       "  'ApplType': 'BLA',\n",
       "  'Sponsor': 'NOVO NORDISK INC',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/019991s085lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=19991'},\n",
       " '19992': {'ApplNo': '19992',\n",
       "  'Form': 'SOLUTION/DROPS;OPHTHALMIC',\n",
       "  'Drug': 'CILOXAN',\n",
       "  'ActiveIngredient': 'CIPROFLOXACIN HYDROCHLORIDE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'NOVARTIS',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2017/019992s026lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=19992'},\n",
       " '19998': {'ApplNo': '19998',\n",
       "  'Form': 'CAPSULE;ORAL',\n",
       "  'Drug': 'CHEMET',\n",
       "  'ActiveIngredient': 'SUCCIMER',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'RECORDATI RARE',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2018/019998s021lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=19998'},\n",
       " '20002': {'ApplNo': '20002',\n",
       "  'Form': 'INJECTABLE;INJECTION',\n",
       "  'Drug': \"RINGER'S IN PLASTIC CONTAINER\",\n",
       "  'ActiveIngredient': 'CALCIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM CHLORIDE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'B BRAUN',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/019632s050,019634s050,020002s032lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20002'},\n",
       " '20006': {'ApplNo': '20006',\n",
       "  'Form': 'INJECTABLE;INJECTION',\n",
       "  'Drug': 'MANNITOL 5% IN PLASTIC CONTAINER',\n",
       "  'ActiveIngredient': 'MANNITOL',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'B BRAUN',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/020006s028lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20006'},\n",
       " '200063': {'ApplNo': '200063',\n",
       "  'Form': 'TABLET, EXTENDED RELEASE;ORAL',\n",
       "  'Drug': 'CONTRAVE',\n",
       "  'ActiveIngredient': 'BUPROPION HYDROCHLORIDE; NALTREXONE HYDROCHLORIDE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'NALPROPION',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/200063s020lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=200063'},\n",
       " '20011': {'ApplNo': '20011',\n",
       "  'Form': 'INJECTABLE;INJECTION',\n",
       "  'Drug': 'LUPRON DEPOT',\n",
       "  'ActiveIngredient': 'LEUPROLIDE ACETATE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'ABBVIE ENDOCRINE INC',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/020011s042,019943s035lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20011'},\n",
       " '200175': {'ApplNo': '200175',\n",
       "  'Form': 'TABLET;ORAL',\n",
       "  'Drug': 'TRIBENZOR',\n",
       "  'ActiveIngredient': 'AMLODIPINE BESYLATE; HYDROCHLOROTHIAZIDE; OLMESARTAN MEDOXOMIL',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'COSETTE',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/200175s033lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=200175'},\n",
       " '20021': {'ApplNo': '20021',\n",
       "  'Form': 'TABLET, EXTENDED RELEASE;ORAL',\n",
       "  'Drug': 'SUDAFED 24 HOUR',\n",
       "  'ActiveIngredient': 'PSEUDOEPHEDRINE HYDROCHLORIDE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'J AND J CONSUMER INC',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2018/020021Orig1s012lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20021'},\n",
       " '200271': {'ApplNo': '200271',\n",
       "  'Form': 'SOLUTION;INTRAMUSCULAR',\n",
       "  'Drug': 'HYDROXYPROGESTERONE CAPROATE',\n",
       "  'ActiveIngredient': 'HYDROXYPROGESTERONE CAPROATE',\n",
       "  'ApplType': 'ANDA',\n",
       "  'Sponsor': 'ASPEN GLOBAL INC',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/200271lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=200271'},\n",
       " '20031': {'ApplNo': '20031',\n",
       "  'Form': 'TABLET;ORAL',\n",
       "  'Drug': 'PAXIL',\n",
       "  'ActiveIngredient': 'PAROXETINE HYDROCHLORIDE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'APOTEX',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/020031s012,020710s047lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20031'},\n",
       " '20032': {'ApplNo': '20032',\n",
       "  'Form': 'SUSPENSION;INTRATRACHEAL',\n",
       "  'Drug': 'SURVANTA',\n",
       "  'ActiveIngredient': 'BERACTANT',\n",
       "  'ApplType': 'BLA',\n",
       "  'Sponsor': 'ABBVIE',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/020032Orig1s047lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20032'},\n",
       " '200327': {'ApplNo': '200327',\n",
       "  'Form': 'POWDER;INTRAVENOUS',\n",
       "  'Drug': 'TEFLARO',\n",
       "  'ActiveIngredient': 'CEFTAROLINE FOSAMIL',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'ALLERGAN',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/200327Orig1s028lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=200327'},\n",
       " '20033': {'ApplNo': '20033',\n",
       "  'Form': 'TABLET;ORAL',\n",
       "  'Drug': 'LOTENSIN HCT',\n",
       "  'ActiveIngredient': 'BENAZEPRIL HYDROCHLORIDE; HYDROCHLOROTHIAZIDE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'VALIDUS PHARMS',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/020033s063lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20033'},\n",
       " '200403': {'ApplNo': '200403',\n",
       "  'Form': 'INJECTABLE;INJECTION',\n",
       "  'Drug': 'HYDROMORPHONE HYDROCHLORIDE',\n",
       "  'ActiveIngredient': 'HYDROMORPHONE HYDROCHLORIDE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'HOSPIRA INC',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/200403s018lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=200403'},\n",
       " '20047': {'ApplNo': '20047',\n",
       "  'Form': 'INJECTABLE;INJECTION',\n",
       "  'Drug': 'DEXTROSE 50% IN PLASTIC CONTAINER',\n",
       "  'ActiveIngredient': 'DEXTROSE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'BAXTER HLTHCARE',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/020047s021lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20047'},\n",
       " '20049': {'ApplNo': '20049',\n",
       "  'Form': 'CAPSULE, EXTENDED RELEASE;ORAL',\n",
       "  'Drug': 'PENTASA',\n",
       "  'ActiveIngredient': 'MESALAMINE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'TAKEDA PHARMS USA',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/020049s038lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20049'},\n",
       " '20051': {'ApplNo': '20051',\n",
       "  'Form': 'TABLET;ORAL',\n",
       "  'Drug': 'GLYNASE',\n",
       "  'ActiveIngredient': 'GLYBURIDE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'PFIZER',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2017/020051s022lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20051'},\n",
       " '200533': {'ApplNo': '200533',\n",
       "  'Form': 'TABLET, EXTENDED RELEASE;ORAL',\n",
       "  'Drug': 'NUCYNTA ER',\n",
       "  'ActiveIngredient': 'TAPENTADOL HYDROCHLORIDE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'COLLEGIUM PHARM INC',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/200533s023lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=200533'},\n",
       " '200534': {'ApplNo': '200534',\n",
       "  'Form': 'CAPSULE;ORAL',\n",
       "  'Drug': 'OXYCODONE HYDROCHLORIDE',\n",
       "  'ActiveIngredient': 'OXYCODONE HYDROCHLORIDE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'GENUS LIFESCIENCES',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/200534s010,200535s017lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=200534'},\n",
       " '200535': {'ApplNo': '200535',\n",
       "  'Form': 'SOLUTION;ORAL',\n",
       "  'Drug': 'OXYCODONE HYDROCHLORIDE',\n",
       "  'ActiveIngredient': 'OXYCODONE HYDROCHLORIDE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'GENUS LIFESCIENCES',\n",
       "  'LatestLabel': 'https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/200534s010,200535s017lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=200535'},\n",
       " '200582': {'ApplNo': '200582',\n",
       "  'Form': 'SOLUTION;INTRAVENOUS',\n",
       "  'Drug': 'TOPOTECAN HYDROCHLORIDE',\n",
       "  'ActiveIngredient': 'TOPOTECAN HYDROCHLORIDE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'HOSPIRA INC',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/200582s003lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=200582'},\n",
       " '200603': {'ApplNo': '200603',\n",
       "  'Form': 'TABLET;ORAL',\n",
       "  'Drug': 'LATUDA',\n",
       "  'ActiveIngredient': 'LURASIDONE HYDROCHLORIDE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'SUNOVION PHARMS INC',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/200603s035lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=200603'},\n",
       " '20062': {'ApplNo': '20062',\n",
       "  'Form': 'CAPSULE, EXTENDED RELEASE;ORAL',\n",
       "  'Drug': 'CARDIZEM CD',\n",
       "  'ActiveIngredient': 'DILTIAZEM HYDROCHLORIDE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'BAUSCH',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/020062s046lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20062'},\n",
       " '20064': {'ApplNo': '20064',\n",
       "  'Form': 'CAPSULE;ORAL',\n",
       "  'Drug': 'MACROBID',\n",
       "  'ActiveIngredient': 'NITROFURANTOIN; NITROFURANTOIN, MACROCRYSTALLINE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'ALMATICA',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/020064Orig1s029lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20064'},\n",
       " '20065': {'ApplNo': '20065',\n",
       "  'Form': 'SOLUTION/DROPS;OPHTHALMIC',\n",
       "  'Drug': 'OPCON-A',\n",
       "  'ActiveIngredient': 'NAPHAZOLINE HYDROCHLORIDE; PHENIRAMINE MALEATE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'BAUSCH AND LOMB',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/020065Orig1s033lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20065'},\n",
       " '200652': {'ApplNo': '200652',\n",
       "  'Form': 'TABLET;ORAL',\n",
       "  'Drug': 'ALOSETRON HYDROCHLORIDE',\n",
       "  'ActiveIngredient': 'ALOSETRON HYDROCHLORIDE',\n",
       "  'ApplType': 'ANDA',\n",
       "  'Sponsor': 'HIKMA',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/200652Orig1s000lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=200652'},\n",
       " '200655': {'ApplNo': '200655',\n",
       "  'Form': 'SOLUTION;INTRAVENOUS',\n",
       "  'Drug': 'FLUORODOPA F18',\n",
       "  'ActiveIngredient': 'FLUORODOPA F-18',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'FEINSTEIN',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/200655s000lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=200655'},\n",
       " '200656': {'ApplNo': '200656',\n",
       "  'Form': 'EMULSION;INTRAVENOUS',\n",
       "  'Drug': 'PERIKABIVEN IN PLASTIC CONTAINER',\n",
       "  'ActiveIngredient': 'AMINO ACIDS; CALCIUM CHLORIDE; DEXTROSE; MAGNESIUM SULFATE; POTASSIUM CHLORIDE; SODIUM ACETATE; SODIUM GLYCEROPHOSPHATE; SOYBEAN OIL',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'FRESENIUS KABI USA',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/200656s014lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=200656'},\n",
       " '20066': {'ApplNo': '20066',\n",
       "  'Form': 'GUM, CHEWING;BUCCAL',\n",
       "  'Drug': 'NICORETTE',\n",
       "  'ActiveIngredient': 'NICOTINE POLACRILEX',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'GLAXOSMITHKLINE',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/018612Orig1s083,020066Orig1s065lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20066'},\n",
       " '20067': {'ApplNo': '20067',\n",
       "  'Form': 'TABLET, DELAYED RELEASE;ORAL',\n",
       "  'Drug': 'EC-NAPROSYN',\n",
       "  'ActiveIngredient': 'NAPROXEN',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'ATNAHS PHARMA US',\n",
       "  'LatestLabel': 'https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/017581s115,018164s065,020067s024lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20067'},\n",
       " '200671': {'ApplNo': '200671',\n",
       "  'Form': 'CAPSULE, EXTENDED RELEASE;ORAL',\n",
       "  'Drug': 'DURLAZA',\n",
       "  'ActiveIngredient': 'ASPIRIN',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'ESPERO',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/200671s002lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=200671'},\n",
       " '200677': {'ApplNo': '200677',\n",
       "  'Form': 'SOLUTION;SUBCUTANEOUS',\n",
       "  'Drug': 'SIGNIFOR',\n",
       "  'ActiveIngredient': 'PASIREOTIDE DIASPARTATE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'RECORDATI RARE',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/200677s006lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=200677'},\n",
       " '200678': {'ApplNo': '200678',\n",
       "  'Form': 'TABLET, EXTENDED RELEASE;ORAL',\n",
       "  'Drug': 'KOMBIGLYZE XR',\n",
       "  'ActiveIngredient': 'METFORMIN HYDROCHLORIDE; SAXAGLIPTIN HYDROCHLORIDE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'ASTRAZENECA AB',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/200678s024lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=200678'},\n",
       " '20068': {'ApplNo': '20068',\n",
       "  'Form': 'INJECTABLE;INJECTION',\n",
       "  'Drug': 'FOSCAVIR',\n",
       "  'ActiveIngredient': 'FOSCARNET SODIUM',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'CLINIGEN HLTHCARE',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/020068Orig1s025lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20068'},\n",
       " '200738': {'ApplNo': '200738',\n",
       "  'Form': 'OINTMENT;OPHTHALMIC',\n",
       "  'Drug': 'LOTEMAX',\n",
       "  'ActiveIngredient': 'LOTEPREDNOL ETABONATE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'BAUSCH AND LOMB',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/200738s003lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=200738'},\n",
       " '200740': {'ApplNo': '200740',\n",
       "  'Form': 'SOLUTION/DROPS;OPHTHALMIC',\n",
       "  'Drug': 'CYSTARAN',\n",
       "  'ActiveIngredient': 'CYSTEAMINE HYDROCHLORIDE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'LEADIANT BIOSCI INC',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/200740s003lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=200740'},\n",
       " '20075': {'ApplNo': '20075',\n",
       "  'Form': 'INJECTABLE;INTRATHECAL',\n",
       "  'Drug': 'LIORESAL',\n",
       "  'ActiveIngredient': 'BACLOFEN',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'AMNEAL',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/020075Orig1s038lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20075'},\n",
       " '20076': {'ApplNo': '20076',\n",
       "  'Form': 'FILM, EXTENDED RELEASE;TRANSDERMAL',\n",
       "  'Drug': 'HABITROL',\n",
       "  'ActiveIngredient': 'NICOTINE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'DR REDDYS LABS SA',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/020076Orig1s051lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20076'},\n",
       " '200795': {'ApplNo': '200795',\n",
       "  'Form': 'INJECTABLE;INJECTION',\n",
       "  'Drug': 'GEMCITABINE HYDROCHLORIDE',\n",
       "  'ActiveIngredient': 'GEMCITABINE HYDROCHLORIDE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'HOSPIRA INC',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/200795Orig1s010lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=200795'},\n",
       " '200796': {'ApplNo': '200796',\n",
       "  'Form': 'TABLET;ORAL',\n",
       "  'Drug': 'EDARBI',\n",
       "  'ActiveIngredient': 'AZILSARTAN KAMEDOXOMIL',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'AZURITY',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/200796s012lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=200796'},\n",
       " '20080': {'ApplNo': '20080',\n",
       "  'Form': 'INJECTABLE;SUBCUTANEOUS',\n",
       "  'Drug': 'IMITREX',\n",
       "  'ActiveIngredient': 'SUMATRIPTAN SUCCINATE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'GLAXOSMITHKLINE',\n",
       "  'LatestLabel': 'https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/020080s054lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20080'},\n",
       " '20083': {'ApplNo': '20083',\n",
       "  'Form': 'CAPSULE;ORAL',\n",
       "  'Drug': 'SPORANOX',\n",
       "  'ActiveIngredient': 'ITRACONAZOLE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'JANSSEN PHARMS',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/020083s065lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20083'},\n",
       " '200890': {'ApplNo': '200890',\n",
       "  'Form': 'SOLUTION;OPHTHALMIC',\n",
       "  'Drug': 'ISOPTO CARPINE',\n",
       "  'ActiveIngredient': 'PILOCARPINE HYDROCHLORIDE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'NOVARTIS',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2010/200890s001lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=200890'},\n",
       " '20090': {'ApplNo': '20090',\n",
       "  'Form': 'FOR SUSPENSION;ORAL',\n",
       "  'Drug': 'DIFLUCAN',\n",
       "  'ActiveIngredient': 'FLUCONAZOLE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'PFIZER',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2023/019949s073,020090s054lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20090'},\n",
       " '200936': {'ApplNo': '200936',\n",
       "  'Form': 'GEL;TOPICAL',\n",
       "  'Drug': 'DICLOFENAC SODIUM ',\n",
       "  'ActiveIngredient': 'DICLOFENAC SODIUM',\n",
       "  'ApplType': 'ANDA',\n",
       "  'Sponsor': 'TOLMAR',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/200936Orig1s000lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=200936'},\n",
       " '201023': {'ApplNo': '201023',\n",
       "  'Form': 'SOLUTION;INTRAVENOUS',\n",
       "  'Drug': 'JEVTANA KIT',\n",
       "  'ActiveIngredient': 'CABAZITAXEL',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'SANOFI AVENTIS US',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/201023Orig1s025lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=201023'},\n",
       " '20105': {'ApplNo': '20105',\n",
       "  'Form': 'INJECTABLE;INJECTION',\n",
       "  'Drug': 'TRIOSTAT',\n",
       "  'ActiveIngredient': 'LIOTHYRONINE SODIUM',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'PAR STERILE PRODUCTS',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2002/20105s2lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20105'},\n",
       " '201107': {'ApplNo': '201107',\n",
       "  'Form': 'SOLUTION;ORAL',\n",
       "  'Drug': 'ABACAVIR SULFATE',\n",
       "  'ActiveIngredient': 'ABACAVIR SULFATE',\n",
       "  'ApplType': 'ANDA',\n",
       "  'Sponsor': 'HETERO LABS LTD III',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2016/201107Orig1s000lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=201107'},\n",
       " '20111': {'ApplNo': '20111',\n",
       "  'Form': 'SOLUTION;TOPICAL',\n",
       "  'Drug': 'CHLORHEXIDINE GLUCONATE',\n",
       "  'ActiveIngredient': 'CHLORHEXIDINE GLUCONATE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'BAJAJ',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/020111Orig1s013lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20111'},\n",
       " '201152': {'ApplNo': '201152',\n",
       "  'Form': 'TABLET, EXTENDED RELEASE;ORAL',\n",
       "  'Drug': 'VIRAMUNE XR',\n",
       "  'ActiveIngredient': 'NEVIRAPINE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'BOEHRINGER INGELHEIM',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/201152s014lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=201152'},\n",
       " '201153': {'ApplNo': '201153',\n",
       "  'Form': 'CREAM; TOPICAL',\n",
       "  'Drug': 'ZYCLARA',\n",
       "  'ActiveIngredient': 'IMIQUIMOD',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'GRACEWAY',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2011/201153s000,022483s001lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=201153'},\n",
       " '20118': {'ApplNo': '20118',\n",
       "  'Form': 'LIQUID;INHALATION',\n",
       "  'Drug': 'SUPRANE',\n",
       "  'ActiveIngredient': 'DESFLURANE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'BAXTER HLTHCARE',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/020118s026lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20118'},\n",
       " '201194': {'ApplNo': '201194',\n",
       "  'Form': 'SOLUTION;ORAL',\n",
       "  'Drug': 'OXYCODONE HYDROCHLORIDE',\n",
       "  'ActiveIngredient': 'OXYCODONE HYDROCHLORIDE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'VISTAPHARM',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/201194s009lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=201194'},\n",
       " '201195': {'ApplNo': '201195',\n",
       "  'Form': 'INJECTABLE;INJECTION',\n",
       "  'Drug': 'DOCETAXEL',\n",
       "  'ActiveIngredient': 'DOCETAXEL',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'ACCORD HLTHCARE',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/201195s015lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=201195'},\n",
       " '20122': {'ApplNo': '20122',\n",
       "  'Form': 'INJECTABLE;INJECTION',\n",
       "  'Drug': 'NIPENT',\n",
       "  'ActiveIngredient': 'PENTOSTATIN',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'HOSPIRA INC',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/020122s015lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20122'},\n",
       " '20123': {'ApplNo': '20123',\n",
       "  'Form': 'INJECTABLE;INJECTION',\n",
       "  'Drug': 'OMNISCAN',\n",
       "  'ActiveIngredient': 'GADODIAMIDE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'GE HEALTHCARE',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2018/020123s047,022066s009lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20123'},\n",
       " '20126': {'ApplNo': '20126',\n",
       "  'Form': 'CREAM;TOPICAL',\n",
       "  'Drug': 'ZONALON',\n",
       "  'ActiveIngredient': 'DOXEPIN HYDROCHLORIDE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'MYLAN',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2002/20126slr006_Zonalon_lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20126'},\n",
       " '201277': {'ApplNo': '201277',\n",
       "  'Form': 'SOLUTION;INTRAVENOUS',\n",
       "  'Drug': 'GADAVIST',\n",
       "  'ActiveIngredient': 'GADOBUTROL',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'BAYER HLTHCARE',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/201277s020lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=201277'},\n",
       " '201280': {'ApplNo': '201280',\n",
       "  'Form': 'TABLET;ORAL',\n",
       "  'Drug': 'TRADJENTA',\n",
       "  'ActiveIngredient': 'LINAGLIPTIN',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'BOEHRINGER INGELHEIM',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/201280s025lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=201280'},\n",
       " '201281': {'ApplNo': '201281',\n",
       "  'Form': 'TABLET;ORAL',\n",
       "  'Drug': 'JENTADUETO',\n",
       "  'ActiveIngredient': 'LINAGLIPTIN; METFORMIN HYDROCHLORIDE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'BOEHRINGER INGELHEIM',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/201281s031lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=201281'},\n",
       " '201292': {'ApplNo': '201292',\n",
       "  'Form': 'TABLET;ORAL',\n",
       "  'Drug': 'GILOTRIF',\n",
       "  'ActiveIngredient': 'AFATINIB DIMALEATE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'BOEHRINGER INGELHEIM',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/201292s017lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=201292'},\n",
       " '20131': {'ApplNo': '20131',\n",
       "  'Form': 'INJECTABLE;INJECTION',\n",
       "  'Drug': 'PROHANCE',\n",
       "  'ActiveIngredient': 'GADOTERIDOL',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'BRACCO',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/020131Orig1s037lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20131'},\n",
       " '20132': {'ApplNo': '20132',\n",
       "  'Form': 'TABLET;ORAL',\n",
       "  'Drug': 'IMITREX',\n",
       "  'ActiveIngredient': 'SUMATRIPTAN SUCCINATE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'GLAXOSMITHKLINE',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2017/020132s029lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20132'},\n",
       " '20134': {'ApplNo': '20134',\n",
       "  'Form': 'INJECTABLE;INJECTION',\n",
       "  'Drug': 'METASTRON',\n",
       "  'ActiveIngredient': 'STRONTIUM CHLORIDE SR-89',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'Q BIOMED',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/020134s012lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20134'},\n",
       " '201361': {'ApplNo': '201361',\n",
       "  'Form': 'CAPSULE;ORAL',\n",
       "  'Drug': 'OMEPRAZOLE AND SODIUM BICARBONATE',\n",
       "  'ActiveIngredient': 'OMEPRAZOLE; SODIUM BICARBONATE',\n",
       "  'ApplType': 'ANDA',\n",
       "  'Sponsor': 'PERRIGO R AND D',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2016/201361Orig1s000lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=201361'},\n",
       " '201367': {'ApplNo': '201367',\n",
       "  'Form': 'SUSPENSION;ORAL',\n",
       "  'Drug': 'BANZEL',\n",
       "  'ActiveIngredient': 'RUFINAMIDE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'EISAI INC',\n",
       "  'LatestLabel': 'https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/021911s017,201367s008lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=201367'},\n",
       " '201370': {'ApplNo': '201370',\n",
       "  'Form': 'INJECTABLE;INJECTION',\n",
       "  'Drug': 'HEPARIN SODIUM',\n",
       "  'ActiveIngredient': 'HEPARIN SODIUM',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'PFIZER',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/201370s013s014lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=201370'},\n",
       " '201373': {'ApplNo': '201373',\n",
       "  'Form': 'SUSPENSION;ORAL',\n",
       "  'Drug': \"CHILDREN'S ALLEGRA ALLERGY\",\n",
       "  'ActiveIngredient': 'FEXOFENADINE HYDROCHLORIDE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'CHATTEM SANOFI',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/201373Orig1s013lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=201373'},\n",
       " '20140': {'ApplNo': '20140',\n",
       "  'Form': 'POWDER;INTRAVENOUS',\n",
       "  'Drug': 'FUSILEV',\n",
       "  'ActiveIngredient': 'LEVOLEUCOVORIN CALCIUM',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'ACROTECH BIOPHARMA',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/020140s026lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20140'},\n",
       " '201444': {'ApplNo': '201444',\n",
       "  'Form': 'SOLUTION, SOLUTION;INTRAVENOUS, INTRAVENOUS',\n",
       "  'Drug': 'NITHIODOTE',\n",
       "  'ActiveIngredient': 'SODIUM NITRITE; SODIUM THIOSULFATE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'HOPE PHARMS',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/201444s026lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=201444'},\n",
       " '20145': {'ApplNo': '20145',\n",
       "  'Form': 'FILM, EXTENDED RELEASE;TRANSDERMAL',\n",
       "  'Drug': 'NITRO-DUR',\n",
       "  'ActiveIngredient': 'NITROGLYCERIN',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'USPHARMA',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/020145s027lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20145'},\n",
       " '20148': {'ApplNo': '20148',\n",
       "  'Form': 'SPRAY, METERED;NASAL',\n",
       "  'Drug': 'MIGRANAL',\n",
       "  'ActiveIngredient': 'DIHYDROERGOTAMINE MESYLATE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'BAUSCH',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/020148s026lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20148'},\n",
       " '201525': {'ApplNo': '201525',\n",
       "  'Form': 'INJECTABLE;INJECTION',\n",
       "  'Drug': 'DOCETAXEL',\n",
       "  'ActiveIngredient': 'DOCETAXEL',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'SANDOZ',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/201525s022lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=201525'},\n",
       " '201532': {'ApplNo': '201532',\n",
       "  'Form': 'SOLUTION;INTRAVENOUS',\n",
       "  'Drug': 'HALAVEN',\n",
       "  'ActiveIngredient': 'ERIBULIN MESYLATE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'EISAI INC',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/201532s023lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=201532'},\n",
       " '201573': {'ApplNo': '201573',\n",
       "  'Form': 'CAPSULE, DELAYED RELEASE;ORAL',\n",
       "  'Drug': 'FENOFIBRIC ACID',\n",
       "  'ActiveIngredient': 'CHOLINE FENOFIBRATE',\n",
       "  'ApplType': 'ANDA',\n",
       "  'Sponsor': 'ANCHEN PHARMS',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/201573Orig1s000lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=201573'},\n",
       " '20162': {'ApplNo': '20162',\n",
       "  'Form': 'INJECTABLE;INJECTION',\n",
       "  'Drug': 'ACTHREL',\n",
       "  'ActiveIngredient': 'CORTICORELIN OVINE TRIFLUTATE',\n",
       "  'ApplType': 'BLA',\n",
       "  'Sponsor': 'FERRING',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/020162s010lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20162'},\n",
       " '20163': {'ApplNo': '20163',\n",
       "  'Form': 'SOLUTION;INTRAPERITONEAL',\n",
       "  'Drug': 'DIANEAL PD-2 W/ DEXTROSE 1.5% IN PLASTIC CONTAINER',\n",
       "  'ActiveIngredient': 'CALCIUM CHLORIDE; DEXTROSE; MAGNESIUM CHLORIDE; SODIUM CHLORIDE; SODIUM LACTATE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'BAXTER HLTHCARE',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2016/017512s123,020163s028,020183s027lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20163'},\n",
       " '201635': {'ApplNo': '201635',\n",
       "  'Form': 'CAPSULE, EXTENDED RELEASE;ORAL',\n",
       "  'Drug': 'TROKENDI XR',\n",
       "  'ActiveIngredient': 'TOPIRAMATE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'SUPERNUS PHARMS',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/201635s030lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=201635'},\n",
       " '20164': {'ApplNo': '20164',\n",
       "  'Form': 'INJECTABLE;SUBCUTANEOUS',\n",
       "  'Drug': 'LOVENOX (PRESERVATIVE FREE)',\n",
       "  'ActiveIngredient': 'ENOXAPARIN SODIUM',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'SANOFI AVENTIS US',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/020164Orig1s131lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20164'},\n",
       " '20165': {'ApplNo': '20165',\n",
       "  'Form': 'FILM, EXTENDED RELEASE;TRANSDERMAL',\n",
       "  'Drug': 'NICODERM CQ',\n",
       "  'ActiveIngredient': 'NICOTINE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'CHATTEM SANOFI',\n",
       "  'LatestLabel': 'https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/020165Orig1s047lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20165'},\n",
       " '201657': {'ApplNo': '201657',\n",
       "  'Form': 'SOLUTION;INTRAVENOUS',\n",
       "  'Drug': 'PARICALCITOL',\n",
       "  'ActiveIngredient': 'PARICALCITOL',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'HOSPIRA',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/201657s006lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=201657'},\n",
       " '201688': {'ApplNo': '201688',\n",
       "  'Form': 'POWDER;INHALATION',\n",
       "  'Drug': 'TOBI PODHALER',\n",
       "  'ActiveIngredient': 'TOBRAMYCIN',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'MYLAN SPECIALITY LP',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/201688s010lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=201688'},\n",
       " '20169': {'ApplNo': '20169',\n",
       "  'Form': 'TABLET;ORAL',\n",
       "  'Drug': 'NILANDRON',\n",
       "  'ActiveIngredient': 'NILUTAMIDE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'CONCORDIA',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2017/020169s008lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20169'},\n",
       " '201691': {'ApplNo': '201691',\n",
       "  'Form': 'TABLET;ORAL',\n",
       "  'Drug': 'HYDROXYCHLOROQUINE SULFATE',\n",
       "  'ActiveIngredient': 'HYDROXYCHLOROQUINE SULFATE',\n",
       "  'ApplType': 'ANDA',\n",
       "  'Sponsor': 'ALKALOIDA ZRT',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2018/201691Orig1s000lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=201691'},\n",
       " '201699': {'ApplNo': '201699',\n",
       "  'Form': 'TABLET;ORAL',\n",
       "  'Drug': 'DIFICID',\n",
       "  'ActiveIngredient': 'FIDAXOMICIN',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'CUBIST PHARMS LLC',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/201699s013,213138s001lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=201699'},\n",
       " '20171': {'ApplNo': '20171',\n",
       "  'Form': 'SOLUTION;INTRAPERITONEAL',\n",
       "  'Drug': 'DELFLEX W/ DEXTROSE 1.5% LOW MAGNESIUM LOW CALCIUM IN PLASTIC CONTAINER',\n",
       "  'ActiveIngredient': 'CALCIUM CHLORIDE; DEXTROSE; MAGNESIUM CHLORIDE; SODIUM CHLORIDE; SODIUM LACTATE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'FRESENIUS MEDCL',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/018883Orig1s057,020171Orig1s039lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20171'},\n",
       " '201739': {'ApplNo': '201739',\n",
       "  'Form': 'SOLUTION;INTRAMUSCULAR, SUBCUTANEOUS',\n",
       "  'Drug': 'AUVI-Q',\n",
       "  'ActiveIngredient': 'EPINEPHRINE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'KALEO INC',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/201739s015lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=201739'},\n",
       " '20178': {'ApplNo': '20178',\n",
       "  'Form': 'INJECTABLE;INJECTION',\n",
       "  'Drug': 'SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER',\n",
       "  'ActiveIngredient': 'SODIUM CHLORIDE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'BAXTER HLTHCARE',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/016677s169,018016s067,020178s021lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20178'},\n",
       " '20179': {'ApplNo': '20179',\n",
       "  'Form': 'INJECTABLE;INJECTION',\n",
       "  'Drug': 'DEXTROSE 5% IN PLASTIC CONTAINER',\n",
       "  'ActiveIngredient': 'DEXTROSE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'BAXTER HLTHCARE',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/020179s056lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20179'},\n",
       " '20180': {'ApplNo': '20180',\n",
       "  'Form': 'TABLET;ORAL',\n",
       "  'Drug': 'PROSCAR',\n",
       "  'ActiveIngredient': 'FINASTERIDE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'ORGANON',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/020180s049lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20180'},\n",
       " '201803': {'ApplNo': '201803',\n",
       "  'Form': 'TABLET;ORAL',\n",
       "  'Drug': 'ADVIL',\n",
       "  'ActiveIngredient': 'IBUPROFEN SODIUM',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'GLAXOSMITHKLINE',\n",
       "  'LatestLabel': 'https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/201803Orig1s016lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=201803'},\n",
       " '201811': {'ApplNo': '201811',\n",
       "  'Form': 'INJECTABLE;INJECTION',\n",
       "  'Drug': 'ARGATROBAN',\n",
       "  'ActiveIngredient': 'ARGATROBAN',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'FRESENIUS KABI USA',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2018/201811s006lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=201811'},\n",
       " '20182': {'ApplNo': '20182',\n",
       "  'Form': 'INJECTABLE;INJECTION',\n",
       "  'Drug': 'CARNITOR',\n",
       "  'ActiveIngredient': 'LEVOCARNITINE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'LEADIANT BIOSCI INC',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2018/020182s015lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20182'},\n",
       " '201820': {'ApplNo': '201820',\n",
       "  'Form': 'SOLUTION;INHALATION',\n",
       "  'Drug': 'BETHKIS',\n",
       "  'ActiveIngredient': 'TOBRAMYCIN',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'CHIESI',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/201820s005lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=201820'},\n",
       " '20183': {'ApplNo': '20183',\n",
       "  'Form': 'SOLUTION;INTRAPERITONEAL',\n",
       "  'Drug': 'DIANEAL LOW CALCIUM W/ DEXTROSE 1.5% IN PLASTIC CONTAINER',\n",
       "  'ActiveIngredient': 'CALCIUM CHLORIDE; DEXTROSE; MAGNESIUM CHLORIDE; SODIUM CHLORIDE; SODIUM LACTATE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'BAXTER HLTHCARE',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2016/017512s123,020163s028,020183s027lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20183'},\n",
       " '201849': {'ApplNo': '201849',\n",
       "  'Form': 'POWDER;INTRAMUSCULAR, INTRAVENOUS',\n",
       "  'Drug': 'GLUCAGON',\n",
       "  'ActiveIngredient': 'GLUCAGON HYDROCHLORIDE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'FRESENIUS KABI USA',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/201849s013lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=201849'},\n",
       " '20186': {'ApplNo': '20186',\n",
       "  'Form': 'TABLET;ORAL',\n",
       "  'Drug': 'ZIAC',\n",
       "  'ActiveIngredient': 'BISOPROLOL FUMARATE; HYDROCHLOROTHIAZIDE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'TEVA BRANDED PHARM',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/020186s037lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20186'},\n",
       " '20189': {'ApplNo': '20189',\n",
       "  'Form': 'TABLET;ORAL',\n",
       "  'Drug': 'FELBATOL',\n",
       "  'ActiveIngredient': 'FELBAMATE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'MYLAN SPECIALITY LP',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/020189s027lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20189'},\n",
       " '20191': {'ApplNo': '20191',\n",
       "  'Form': 'SOLUTION/DROPS;OPHTHALMIC',\n",
       "  'Drug': 'ALOMIDE',\n",
       "  'ActiveIngredient': 'LODOXAMIDE TROMETHAMINE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'NOVARTIS',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2003/20191slr018_alomide_lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20191'},\n",
       " '201922': {'ApplNo': '201922',\n",
       "  'Form': 'CAPSULE, EXTENDED RELEASE;ORAL',\n",
       "  'Drug': 'XIMINO',\n",
       "  'ActiveIngredient': 'MINOCYCLINE HYDROCHLORIDE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'JOURNEY',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/201922s002lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=201922'},\n",
       " '201923': {'ApplNo': '201923',\n",
       "  'Form': 'IMPLANT;INTRAVITREAL',\n",
       "  'Drug': 'ILUVIEN',\n",
       "  'ActiveIngredient': 'FLUOCINOLONE ACETONIDE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'ALIMERA SCIENCES INC',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2017/201923s002lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=201923'},\n",
       " '20193': {'ApplNo': '20193',\n",
       "  'Form': 'CAPSULE;ORAL',\n",
       "  'Drug': 'ELMIRON',\n",
       "  'ActiveIngredient': 'PENTOSAN POLYSULFATE SODIUM',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'JANSSEN PHARMS',\n",
       "  'LatestLabel': 'https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/020193Orig1s015lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20193'},\n",
       " '201971': {'ApplNo': '201971',\n",
       "  'Form': 'TABLET;ORAL',\n",
       "  'Drug': 'RASAGILINE MESYLATE',\n",
       "  'ActiveIngredient': 'RASAGILINE MESYLATE',\n",
       "  'ApplType': 'ANDA',\n",
       "  'Sponsor': 'AUROBINDO PHARMA USA',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2017/201971Orig1s000lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=201971'},\n",
       " '202008': {'ApplNo': '202008',\n",
       "  'Form': 'SOLUTION;INTRAVENOUS',\n",
       "  'Drug': 'AMYVID',\n",
       "  'ActiveIngredient': 'FLORBETAPIR F-18',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'AVID RADIOPHARMS INC',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/202008s036lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=202008'},\n",
       " '20201': {'ApplNo': '20201',\n",
       "  'Form': 'INJECTABLE;INJECTION',\n",
       "  'Drug': 'DOBUTAMINE HYDROCHLORIDE IN DEXTROSE 5% IN PLASTIC CONTAINER',\n",
       "  'ActiveIngredient': 'DOBUTAMINE HYDROCHLORIDE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'HOSPIRA',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/021201s040lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20201'},\n",
       " '202020': {'ApplNo': '202020',\n",
       "  'Form': 'TABLET, DELAYED RELEASE;ORAL',\n",
       "  'Drug': 'RAYOS',\n",
       "  'ActiveIngredient': 'PREDNISONE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'HORIZON',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/202020s012lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=202020'},\n",
       " '202022': {'ApplNo': '202022',\n",
       "  'Form': 'TABLET;ORAL',\n",
       "  'Drug': 'EDURANT',\n",
       "  'ActiveIngredient': 'RILPIVIRINE HYDROCHLORIDE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'JANSSEN PRODS',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/202022s019lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=202022'},\n",
       " '20204': {'ApplNo': '20204',\n",
       "  'Form': 'TABLET;ORAL',\n",
       "  'Drug': 'ALEVE',\n",
       "  'ActiveIngredient': 'NAPROXEN SODIUM',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'BAYER',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/020204Orig1s083Lbledt.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20204'},\n",
       " '202049': {'ApplNo': '202049',\n",
       "  'Form': 'POWDER;INHALATION',\n",
       "  'Drug': 'BRONCHITOL',\n",
       "  'ActiveIngredient': 'MANNITOL',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'CHIESI',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/202049s000lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=202049'},\n",
       " '202051': {'ApplNo': '202051',\n",
       "  'Form': 'TABLET;ORAL',\n",
       "  'Drug': 'ADEFOVIR DIPIVOXIL',\n",
       "  'ActiveIngredient': 'ADEFOVIR DIPIVOXIL',\n",
       "  'ApplType': 'ANDA',\n",
       "  'Sponsor': 'SIGMAPHARM LABS LLC',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/202051Orig1s000lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=202051'},\n",
       " '202053': {'ApplNo': '202053',\n",
       "  'Form': 'SOLUTION/DROPS;OPHTHALMIC',\n",
       "  'Drug': 'DORZOLAMIDE HYDROCHLORIDE',\n",
       "  'ActiveIngredient': 'DORZOLAMIDE HYDROCHLORIDE',\n",
       "  'ApplType': 'ANDA',\n",
       "  'Sponsor': 'INDOCO',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/202053Orig1s000lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=202053'},\n",
       " '202057': {'ApplNo': '202057',\n",
       "  'Form': 'CAPSULE;ORAL',\n",
       "  'Drug': 'VASCEPA',\n",
       "  'ActiveIngredient': 'ICOSAPENT ETHYL',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'AMARIN PHARMS',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/202057s035lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=202057'},\n",
       " '202067': {'ApplNo': '202067',\n",
       "  'Form': 'TABLET;ORAL',\n",
       "  'Drug': 'ONFI',\n",
       "  'ActiveIngredient': 'CLOBAZAM',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'LUNDBECK PHARMS LLC',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2023/202067s007,203993s009lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=202067'},\n",
       " '202080': {'ApplNo': '202080',\n",
       "  'Form': 'TABLET;ORAL',\n",
       "  'Drug': 'OXAYDO',\n",
       "  'ActiveIngredient': 'OXYCODONE HYDROCHLORIDE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'ZYLA',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/202080s012lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=202080'},\n",
       " '20209': {'ApplNo': '20209',\n",
       "  'Form': 'LOTION;TOPICAL',\n",
       "  'Drug': 'OXISTAT',\n",
       "  'ActiveIngredient': 'OXICONAZOLE NITRATE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'ANI PHARMS',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/020209Orig1s014lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20209'},\n",
       " '202091': {'ApplNo': '202091',\n",
       "  'Form': 'FOR SUSPENSION;ORAL',\n",
       "  'Drug': 'SUPRAX',\n",
       "  'ActiveIngredient': 'CEFIXIME',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'LUPIN LTD',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/202091s009lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=202091'},\n",
       " '202100': {'ApplNo': '202100',\n",
       "  'Form': 'FOR SUSPENSION, EXTENDED RELEASE;ORAL',\n",
       "  'Drug': 'QUILLIVANT XR',\n",
       "  'ActiveIngredient': 'METHYLPHENIDATE HYDROCHLORIDE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'NEXTWAVE',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/202100s018lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=202100'},\n",
       " '202101': {'ApplNo': '202101',\n",
       "  'Form': 'TABLET;ORAL',\n",
       "  'Drug': 'ARIPIPRAZOLE',\n",
       "  'ActiveIngredient': 'ARIPIPRAZOLE',\n",
       "  'ApplType': 'ANDA',\n",
       "  'Sponsor': 'ALEMBIC PHARMS',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/202101s000lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=202101'},\n",
       " '202102': {'ApplNo': '202102',\n",
       "  'Form': 'TABLET, ORALLY DISINTEGRATING;ORAL',\n",
       "  'Drug': 'ARIPIPRAZOLE',\n",
       "  'ActiveIngredient': 'ARIPIPRAZOLE',\n",
       "  'ApplType': 'ANDA',\n",
       "  'Sponsor': 'ALEMBIC PHARMS',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/202102s000lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=202102'},\n",
       " '202106': {'ApplNo': '202106',\n",
       "  'Form': 'POWDER;INTRAVENOUS',\n",
       "  'Drug': 'MEROPENEM AND SODIUM CHLORIDE IN DUPLEX CONTAINER',\n",
       "  'ActiveIngredient': 'MEROPENEM',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'B BRAUN MEDICAL INC',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/202106s007lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=202106'},\n",
       " '202107': {'ApplNo': '202107',\n",
       "  'Form': 'TABLET;ORAL',\n",
       "  'Drug': 'KORLYM',\n",
       "  'ActiveIngredient': 'MIFEPRISTONE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'CORCEPT THERAP',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/202107s008lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=202107'},\n",
       " '202123': {'ApplNo': '202123',\n",
       "  'Form': 'TABLET;ORAL',\n",
       "  'Drug': 'COMPLERA',\n",
       "  'ActiveIngredient': 'EMTRICITABINE; RILPIVIRINE HYDROCHLORIDE; TENOFOVIR DISOPROXIL FUMARATE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'GILEAD SCIENCES INC',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/202123s031lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=202123'},\n",
       " '202129': {'ApplNo': '202129',\n",
       "  'Form': 'AEROSOL, METERED;NASAL',\n",
       "  'Drug': 'ZETONNA',\n",
       "  'ActiveIngredient': 'CICLESONIDE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'COVIS',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/202129s004s005s006lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=202129'},\n",
       " '20213': {'ApplNo': '20213',\n",
       "  'Form': 'FOR SOLUTION;OPHTHALMIC',\n",
       "  'Drug': 'MIOCHOL-E',\n",
       "  'ActiveIngredient': 'ACETYLCHOLINE CHLORIDE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'BAUSCH AND LOMB',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2006/020213s010lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20213'},\n",
       " '202133': {'ApplNo': '202133',\n",
       "  'Form': 'TABLET;ORAL',\n",
       "  'Drug': 'FLUOXETINE HYDROCHLORIDE',\n",
       "  'ActiveIngredient': 'FLUOXETINE HYDROCHLORIDE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'ALMATICA',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/202133s012lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=202133'},\n",
       " '202145': {'ApplNo': '202145',\n",
       "  'Form': 'CREAM;TOPICAL',\n",
       "  'Drug': 'HYDROCORTISONE BUTYRATE',\n",
       "  'ActiveIngredient': 'HYDROCORTISONE BUTYRATE',\n",
       "  'ApplType': 'ANDA',\n",
       "  'Sponsor': 'GLENMARK GENERICS',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/202145Orig1lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=202145'},\n",
       " '20215': {'ApplNo': '20215',\n",
       "  'Form': 'TABLET;ORAL',\n",
       "  'Drug': 'MONOKET',\n",
       "  'ActiveIngredient': 'ISOSORBIDE MONONITRATE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'ECI PHARMS LLC',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/020215s024lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20215'},\n",
       " '202153': {'ApplNo': '202153',\n",
       "  'Form': 'SOLUTION;INTRAVENOUS',\n",
       "  'Drug': 'RUBY-FILL',\n",
       "  'ActiveIngredient': 'RUBIDIUM CHLORIDE RB-82',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'JUBILANT',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/202153s012lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=202153'},\n",
       " '202155': {'ApplNo': '202155',\n",
       "  'Form': 'TABLET;ORAL',\n",
       "  'Drug': 'ELIQUIS',\n",
       "  'ActiveIngredient': 'APIXABAN',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'BRISTOL MYERS SQUIBB',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/202155s034lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=202155'},\n",
       " '202158': {'ApplNo': '202158',\n",
       "  'Form': 'SOLUTION;INTRAVENOUS, INTRAVESICULAR, OPHTHALMIC',\n",
       "  'Drug': 'RADIOGENIX SYSTEM',\n",
       "  'ActiveIngredient': 'TECHNETIUM TC-99M SODIUM PERTECHNETATE GENERATOR',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'NORTHSTAR MEDICAL',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/202158s017lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=202158'},\n",
       " '20216': {'ApplNo': '20216',\n",
       "  'Form': 'CREAM;TOPICAL, VAGINAL',\n",
       "  'Drug': 'PREMARIN',\n",
       "  'ActiveIngredient': 'ESTROGENS, CONJUGATED',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'WYETH PHARMS',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2017/020216s083lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20216'},\n",
       " '202192': {'ApplNo': '202192',\n",
       "  'Form': 'TABLET;ORAL',\n",
       "  'Drug': 'JAKAFI',\n",
       "  'ActiveIngredient': 'RUXOLITINIB PHOSPHATE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'INCYTE CORP',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/202192s027lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=202192'},\n",
       " '20220': {'ApplNo': '20220',\n",
       "  'Form': 'INJECTABLE;INJECTION',\n",
       "  'Drug': 'ULTRAVIST 370',\n",
       "  'ActiveIngredient': 'IOPROMIDE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'BAYER HLTHCARE',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/020220s052,021425s034lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20220'},\n",
       " '202207': {'ApplNo': '202207',\n",
       "  'Form': 'INJECTABLE;INJECTION',\n",
       "  'Drug': 'LYMPHOSEEK KIT',\n",
       "  'ActiveIngredient': 'TECHNETIUM TC-99M TILMANOCEPT',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'CARDINAL HEALTH 414',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/202207s012lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=202207'},\n",
       " '20221': {'ApplNo': '20221',\n",
       "  'Form': 'INJECTABLE;INJECTION',\n",
       "  'Drug': 'ETHYOL',\n",
       "  'ActiveIngredient': 'AMIFOSTINE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'CLINIGEN',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/020221s036lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20221'},\n",
       " '202211': {'ApplNo': '202211',\n",
       "  'Form': 'FILM, EXTENDED RELEASE;TRANSDERMAL',\n",
       "  'Drug': 'OXYTROL FOR WOMEN',\n",
       "  'ActiveIngredient': 'OXYBUTYNIN',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'ALLERGAN',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2016/202211Orig1s004lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=202211'},\n",
       " '20222': {'ApplNo': '20222',\n",
       "  'Form': 'TABLET;ORAL',\n",
       "  'Drug': 'COLESTID',\n",
       "  'ActiveIngredient': 'COLESTIPOL HYDROCHLORIDE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'PFIZER',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2017/020222Orig1s006lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20222'},\n",
       " '202231': {'ApplNo': '202231',\n",
       "  'Form': 'POWDER;INTRAVENOUS',\n",
       "  'Drug': 'LEVOTHYROXINE SODIUM',\n",
       "  'ActiveIngredient': 'LEVOTHYROXINE SODIUM',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'FRESENIUS KABI USA',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/202231s003lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=202231'},\n",
       " '202236': {'ApplNo': '202236',\n",
       "  'Form': 'SPRAY, METERED;NASAL',\n",
       "  'Drug': 'DYMISTA',\n",
       "  'ActiveIngredient': 'AZELASTINE HYDROCHLORIDE; FLUTICASONE PROPIONATE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'MYLAN SPECIALITY LP',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/202236s013lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=202236'},\n",
       " '202240': {'ApplNo': '202240',\n",
       "  'Form': 'CAPSULE;ORAL',\n",
       "  'Drug': 'CELECOXIB',\n",
       "  'ActiveIngredient': 'CELECOXIB',\n",
       "  'ApplType': 'ANDA',\n",
       "  'Sponsor': 'LUPIN LTD',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/202240Orig1s000lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=202240'},\n",
       " '20226': {'ApplNo': '20226',\n",
       "  'Form': 'SOLUTION/DROPS;OPHTHALMIC',\n",
       "  'Drug': 'NAPHCON-A',\n",
       "  'ActiveIngredient': 'NAPHAZOLINE HYDROCHLORIDE; PHENIRAMINE MALEATE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'ALCON',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/020226Orig1s035lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20226'},\n",
       " '202270': {'ApplNo': '202270',\n",
       "  'Form': 'TABLET, EXTENDED RELEASE;ORAL',\n",
       "  'Drug': 'JANUMET XR',\n",
       "  'ActiveIngredient': 'METFORMIN HYDROCHLORIDE; SITAGLIPTIN PHOSPHATE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'MERCK SHARP DOHME',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/202270s026lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=202270'},\n",
       " '202276': {'ApplNo': '202276',\n",
       "  'Form': 'TABLET;ORAL',\n",
       "  'Drug': 'STENDRA',\n",
       "  'ActiveIngredient': 'AVANAFIL',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'METUCHEN PHARMS',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/202276s020lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=202276'},\n",
       " '202292': {'ApplNo': '202292',\n",
       "  'Form': 'TABLET, DELAYED RELEASE;ORAL',\n",
       "  'Drug': 'MYTESI',\n",
       "  'ActiveIngredient': 'CROFELEMER',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'NAPO PHARMS INC',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/202292s007lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=202292'},\n",
       " '202293': {'ApplNo': '202293',\n",
       "  'Form': 'TABLET;ORAL',\n",
       "  'Drug': 'FARXIGA',\n",
       "  'ActiveIngredient': 'DAPAGLIFLOZIN',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'ASTRAZENECA AB',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/202293Orig1s027lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=202293'},\n",
       " '202294': {'ApplNo': '202294',\n",
       "  'Form': 'CAPSULE, DELAYED RELEASE;ORAL',\n",
       "  'Drug': 'DEXLANSOPRAZOLE',\n",
       "  'ActiveIngredient': 'DEXLANSOPRAZOLE',\n",
       "  'ApplType': 'ANDA',\n",
       "  'Sponsor': 'PAR PHARM INC',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2017/202294Orig1s000lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=202294'},\n",
       " '202317': {'ApplNo': '202317',\n",
       "  'Form': 'GEL;TOPICAL',\n",
       "  'Drug': 'VALCHLOR',\n",
       "  'ActiveIngredient': 'MECHLORETHAMINE HYDROCHLORIDE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'HELSINN',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/202317s010lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=202317'},\n",
       " '20232': {'ApplNo': '20232',\n",
       "  'Form': 'CAPSULE;ORAL',\n",
       "  'Drug': 'FIORICET W/ CODEINE',\n",
       "  'ActiveIngredient': 'ACETAMINOPHEN; BUTALBITAL; CAFFEINE; CODEINE PHOSPHATE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'ACTAVIS LABS UT INC',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/020232s045lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20232'},\n",
       " '202324': {'ApplNo': '202324',\n",
       "  'Form': 'TABLET;ORAL',\n",
       "  'Drug': 'INLYTA',\n",
       "  'ActiveIngredient': 'AXITINIB',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'PF PRISM CV',\n",
       "  'LatestLabel': 'https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/202324Orig1s014CorrectedLbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=202324'},\n",
       " '202331': {'ApplNo': '202331',\n",
       "  'Form': 'TABLET;ORAL',\n",
       "  'Drug': 'EDARBYCLOR',\n",
       "  'ActiveIngredient': 'AZILSARTAN KAMEDOXOMIL; CHLORTHALIDONE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'AZURITY',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/202331s016lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=202331'},\n",
       " '20234': {'ApplNo': '20234',\n",
       "  'Form': 'TABLET, EXTENDED RELEASE;ORAL',\n",
       "  'Drug': 'TEGRETOL-XR',\n",
       "  'ActiveIngredient': 'CARBAMAZEPINE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'NOVARTIS',\n",
       "  'LatestLabel': 'https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/016608s115_018281_s058_018927s055_020234_s047.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20234'},\n",
       " '202344': {'ApplNo': '202344',\n",
       "  'Form': 'TABLET, EFFERVESCENT;ORAL',\n",
       "  'Drug': 'BINOSTO',\n",
       "  'ActiveIngredient': 'ALENDRONATE SODIUM',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'ASCEND THERAPS US',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/202344s015lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=202344'},\n",
       " '20235': {'ApplNo': '20235',\n",
       "  'Form': 'CAPSULE;ORAL',\n",
       "  'Drug': 'NEURONTIN',\n",
       "  'ActiveIngredient': 'GABAPENTIN',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'VIATRIS',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/020235s069,020882s050,021129s050lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20235'},\n",
       " '20237': {'ApplNo': '20237',\n",
       "  'Form': 'TABLET;ORAL',\n",
       "  'Drug': 'SALAGEN',\n",
       "  'ActiveIngredient': 'PILOCARPINE HYDROCHLORIDE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'CONCORDIA',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2003/020237s012lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20237'},\n",
       " '202379': {'ApplNo': '202379',\n",
       "  'Form': 'TABLET;ORAL',\n",
       "  'Drug': 'ZYTIGA',\n",
       "  'ActiveIngredient': 'ABIRATERONE ACETATE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'JANSSEN BIOTECH',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/202379s035lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=202379'},\n",
       " '20238': {'ApplNo': '20238',\n",
       "  'Form': 'TABLET;ORAL',\n",
       "  'Drug': 'TAGAMET HB',\n",
       "  'ActiveIngredient': 'CIMETIDINE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'MEDTECH PRODUCTS',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/020238Orig1s026lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20238'},\n",
       " '202402': {'ApplNo': '202402',\n",
       "  'Form': 'INJECTABLE;INTRAVENOUS',\n",
       "  'Drug': 'IBUPROFEN LYSINE',\n",
       "  'ActiveIngredient': 'IBUPROFEN LYSINE',\n",
       "  'ApplType': 'ANDA',\n",
       "  'Sponsor': 'XGEN PHARMS',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2016/202402Orig1s000lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=202402'},\n",
       " '20241': {'ApplNo': '20241',\n",
       "  'Form': 'TABLET;ORAL',\n",
       "  'Drug': 'LAMICTAL',\n",
       "  'ActiveIngredient': 'LAMOTRIGINE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'GLAXOSMITHKLINE LLC',\n",
       "  'LatestLabel': 'https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/020241s064,020764s057,022251s028lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20241'},\n",
       " '202428': {'ApplNo': '202428',\n",
       "  'Form': 'AEROSOL, FOAM;TOPICAL',\n",
       "  'Drug': 'FABIOR',\n",
       "  'ActiveIngredient': 'TAZAROTENE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'MAYNE PHARMA',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/202428lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=202428'},\n",
       " '202429': {'ApplNo': '202429',\n",
       "  'Form': 'TABLET;ORAL',\n",
       "  'Drug': 'ZELBORAF',\n",
       "  'ActiveIngredient': 'VEMURAFENIB',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'HOFFMANN LA ROCHE',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/202429s019lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=202429'},\n",
       " '202439': {'ApplNo': '202439',\n",
       "  'Form': 'TABLET;ORAL',\n",
       "  'Drug': 'XARELTO',\n",
       "  'ActiveIngredient': 'RIVAROXABAN',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'JANSSEN PHARMS',\n",
       "  'LatestLabel': 'https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/022406Orig1s039,202439Orig1s038correctedlbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=202439'},\n",
       " '202450': {'ApplNo': '202450',\n",
       "  'Form': 'POWDER, METERED;INHALATION',\n",
       "  'Drug': 'TUDORZA PRESSAIR',\n",
       "  'ActiveIngredient': 'ACLIDINIUM BROMIDE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'COVIS',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/202450s012lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=202450'},\n",
       " '20246': {'ApplNo': '20246',\n",
       "  'Form': 'INJECTABLE;INJECTION',\n",
       "  'Drug': 'DEPO-PROVERA',\n",
       "  'ActiveIngredient': 'MEDROXYPROGESTERONE ACETATE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'PFIZER',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/020246s060s062lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20246'},\n",
       " '20248': {'ApplNo': '20248',\n",
       "  'Form': 'INJECTABLE;INJECTION',\n",
       "  'Drug': 'INTRALIPID 20%',\n",
       "  'ActiveIngredient': 'SOYBEAN OIL',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'FRESENIUS',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/020248s026lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20248'},\n",
       " '202489': {'ApplNo': '202489',\n",
       "  'Form': 'TABLET;ORAL',\n",
       "  'Drug': 'TINIDAZOLE',\n",
       "  'ActiveIngredient': 'TINIDAZOLE',\n",
       "  'ApplType': 'ANDA',\n",
       "  'Sponsor': 'UNIQUE',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/202489Orig1s000lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=202489'},\n",
       " '202511': {'ApplNo': '202511',\n",
       "  'Form': 'SOLUTION;ORAL',\n",
       "  'Drug': 'SODIUM SULFATE, POTASSIUM SULFATE AND MAGNESIUM SULFATE ',\n",
       "  'ActiveIngredient': 'MAGNESIUM SULFATE; POTASSIUM SULFATE; SODIUM SULFATE',\n",
       "  'ApplType': 'ANDA',\n",
       "  'Sponsor': 'NOVEL LABS INC',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2017/202511Orig1s000lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=202511'},\n",
       " '202514': {'ApplNo': '202514',\n",
       "  'Form': 'SOLUTION/DROPS;OPHTHALMIC',\n",
       "  'Drug': 'ZIOPTAN',\n",
       "  'ActiveIngredient': 'TAFLUPROST',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'THEA PHARMA',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/202514s003s004lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=202514'},\n",
       " '202515': {'ApplNo': '202515',\n",
       "  'Form': 'INJECTABLE;INJECTION',\n",
       "  'Drug': 'MORPHINE SULFATE',\n",
       "  'ActiveIngredient': 'MORPHINE SULFATE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'HOSPIRA INC',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/202515Orig1s033lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=202515'},\n",
       " '202543': {'ApplNo': '202543',\n",
       "  'Form': 'INJECTABLE;INTRAVENOUS',\n",
       "  'Drug': 'LEVETIRACETAM IN SODIUM CHLORIDE',\n",
       "  'ActiveIngredient': 'LEVETIRACETAM',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'HQ SPECIALITY PHARMA',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/202543s019lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=202543'},\n",
       " '20255': {'ApplNo': '20255',\n",
       "  'Form': 'INJECTABLE;INJECTION',\n",
       "  'Drug': 'DOBUTAMINE HYDROCHLORIDE IN DEXTROSE 5% IN PLASTIC CONTAINER',\n",
       "  'ActiveIngredient': 'DOBUTAMINE HYDROCHLORIDE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'BAXTER HLTHCARE',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/020255s020lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20255'},\n",
       " '202565': {'ApplNo': '202565',\n",
       "  'Form': 'SOLUTION/DROPS;OPHTHALMIC',\n",
       "  'Drug': 'BIMATOPROST',\n",
       "  'ActiveIngredient': 'BIMATOPROST',\n",
       "  'ApplType': 'ANDA',\n",
       "  'Sponsor': 'SANDOZ INC',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/202565Orig1s000lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=202565'},\n",
       " '202570': {'ApplNo': '202570',\n",
       "  'Form': 'CAPSULE;ORAL',\n",
       "  'Drug': 'XALKORI',\n",
       "  'ActiveIngredient': 'CRIZOTINIB',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'PF PRISM CV',\n",
       "  'LatestLabel': 'https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/202570s033lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=202570'},\n",
       " '202573': {'ApplNo': '202573',\n",
       "  'Form': 'TABLET;ORAL',\n",
       "  'Drug': 'RITONAVIR',\n",
       "  'ActiveIngredient': 'RITONAVIR',\n",
       "  'ApplType': 'ANDA',\n",
       "  'Sponsor': 'CIPLA',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/202573Orig1s000lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=202573'},\n",
       " '20258': {'ApplNo': '20258',\n",
       "  'Form': 'SOLUTION/DROPS;OPHTHALMIC',\n",
       "  'Drug': 'IOPIDINE',\n",
       "  'ActiveIngredient': 'APRACLONIDINE HYDROCHLORIDE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'IMPRIMIS PHARMS USA',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2018/020258s030lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20258'},\n",
       " '202595': {'ApplNo': '202595',\n",
       "  'Form': 'CAPSULE;ORAL',\n",
       "  'Drug': 'OSELTAMIVIR PHOSPHATE',\n",
       "  'ActiveIngredient': 'OSELTAMIVIR PHOSPHATE',\n",
       "  'ApplType': 'ANDA',\n",
       "  'Sponsor': 'NATCO',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2016/202595Orig1s000lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=202595'},\n",
       " '202611': {'ApplNo': '202611',\n",
       "  'Form': 'TABLET, EXTENDED RELEASE;ORAL',\n",
       "  'Drug': 'MYRBETRIQ',\n",
       "  'ActiveIngredient': 'MIRABEGRON',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'APGDI',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/202611Orig1s017lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=202611'},\n",
       " '20263': {'ApplNo': '20263',\n",
       "  'Form': 'POWDER;INTRAMUSCULAR',\n",
       "  'Drug': 'LUPRON DEPOT-PED KIT',\n",
       "  'ActiveIngredient': 'LEUPROLIDE ACETATE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'ABBVIE ENDOCRINE INC',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/020263s050lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20263'},\n",
       " '202662': {'ApplNo': '202662',\n",
       "  'Form': 'TABLET;ORAL',\n",
       "  'Drug': 'OXYCODONE HYDROCHLORIDE',\n",
       "  'ActiveIngredient': 'OXYCODONE HYDROCHLORIDE',\n",
       "  'ApplType': 'ANDA',\n",
       "  'Sponsor': 'EPIC PHARMA LLC',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/202662Orig1s000lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=202662'},\n",
       " '202667': {'ApplNo': '202667',\n",
       "  'Form': 'SOLUTION/DROPS;OPHTHALMIC',\n",
       "  'Drug': 'COSOPT PF',\n",
       "  'ActiveIngredient': 'DORZOLAMIDE HYDROCHLORIDE; TIMOLOL MALEATE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'THEA PHARMA',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/202667s000lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=202667'},\n",
       " '20267': {'ApplNo': '20267',\n",
       "  'Form': 'TABLET;ORAL',\n",
       "  'Drug': 'JUNIOR STRENGTH ADVIL',\n",
       "  'ActiveIngredient': 'IBUPROFEN',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'GLAXOSMITHKLINE',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2017/020267Orig1s015lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20267'},\n",
       " '202688': {'ApplNo': '202688',\n",
       "  'Form': 'CAPSULE, EXTENDED RELEASE;ORAL',\n",
       "  'Drug': 'PROPAFENONE HYDROCHLORIDE',\n",
       "  'ActiveIngredient': 'PROPAFENONE HYDROCHLORIDE',\n",
       "  'ApplType': 'ANDA',\n",
       "  'Sponsor': 'WATSON LABS INC',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/202688Orig1s000lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=202688'},\n",
       " '202714': {'ApplNo': '202714',\n",
       "  'Form': 'POWDER;INTRAVENOUS',\n",
       "  'Drug': 'KYPROLIS',\n",
       "  'ActiveIngredient': 'CARFILZOMIB',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'ONYX THERAP',\n",
       "  'LatestLabel': 'https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/202714s034lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=202714'},\n",
       " '20272': {'ApplNo': '20272',\n",
       "  'Form': 'TABLET;ORAL',\n",
       "  'Drug': 'RISPERDAL',\n",
       "  'ActiveIngredient': 'RISPERIDONE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'JANSSEN PHARMS',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/020272s087,021444s059lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20272'},\n",
       " '202723': {'ApplNo': '202723',\n",
       "  'Form': 'TABLET;ORAL',\n",
       "  'Drug': 'DONEPEZIL HYDROCHLORIDE',\n",
       "  'ActiveIngredient': 'DONEPEZIL HYDROCHLORIDE',\n",
       "  'ApplType': 'ANDA',\n",
       "  'Sponsor': 'DR REDDYS',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/202723Orig1s000lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=202723'},\n",
       " '20273': {'ApplNo': '20273',\n",
       "  'Form': 'OINTMENT;TOPICAL',\n",
       "  'Drug': 'DOVONEX',\n",
       "  'ActiveIngredient': 'CALCIPOTRIENE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'LEO PHARMA AS',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/020273s013,020554s012lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20273'},\n",
       " '202736': {'ApplNo': '202736',\n",
       "  'Form': 'LOTION;TOPICAL',\n",
       "  'Drug': 'SKLICE',\n",
       "  'ActiveIngredient': 'IVERMECTIN',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'ARBOR PHARMS LLC',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/202736Orig1s009lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=202736'},\n",
       " '202784': {'ApplNo': '202784',\n",
       "  'Form': 'CAPSULE, DELAYED REL PELLETS;ORAL',\n",
       "  'Drug': 'ESOMEPRAZOLE MAGNESIUM',\n",
       "  'ActiveIngredient': 'ESOMEPRAZOLE MAGNESIUM',\n",
       "  'ApplType': 'ANDA',\n",
       "  'Sponsor': 'HETERO LABS LTD III',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/202784Orig1s000lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=202784'},\n",
       " '20280': {'ApplNo': '20280',\n",
       "  'Form': 'INJECTABLE;INJECTION',\n",
       "  'Drug': 'GENOTROPIN PRESERVATIVE FREE',\n",
       "  'ActiveIngredient': 'SOMATROPIN',\n",
       "  'ApplType': 'BLA',\n",
       "  'Sponsor': 'PHARMACIA',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2000/20280S23LTR.PDF',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20280'},\n",
       " '202806': {'ApplNo': '202806',\n",
       "  'Form': 'CAPSULE;ORAL',\n",
       "  'Drug': 'TAFINLAR',\n",
       "  'ActiveIngredient': 'DABRAFENIB MESYLATE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'NOVARTIS',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/202806s022lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=202806'},\n",
       " '202810': {'ApplNo': '202810',\n",
       "  'Form': 'TABLET, EXTENDED RELEASE;ORAL',\n",
       "  'Drug': 'OXTELLAR XR',\n",
       "  'ActiveIngredient': 'OXCARBAZEPINE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'SUPERNUS PHARMS',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2018/202810s010lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=202810'},\n",
       " '202811': {'ApplNo': '202811',\n",
       "  'Form': 'CAPSULE;ORAL',\n",
       "  'Drug': 'LINZESS',\n",
       "  'ActiveIngredient': 'LINACLOTIDE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'ALLERGAN',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/202811s018lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=202811'},\n",
       " '202813': {'ApplNo': '202813',\n",
       "  'Form': 'AEROSOL, METERED;NASAL',\n",
       "  'Drug': 'QNASL',\n",
       "  'ActiveIngredient': 'BECLOMETHASONE DIPROPIONATE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'TEVA BRANDED PHARM',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2018/202813Orig1s012lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=202813'},\n",
       " '202832': {'ApplNo': '202832',\n",
       "  'Form': 'INJECTABLE;INJECTION',\n",
       "  'Drug': 'SODIUM CHLORIDE 0.9%',\n",
       "  'ActiveIngredient': 'SODIUM CHLORIDE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'MEDEFIL INC',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/202832Orig1s006lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=202832'},\n",
       " '202834': {'ApplNo': '202834',\n",
       "  'Form': 'TABLET;ORAL',\n",
       "  'Drug': 'FYCOMPA',\n",
       "  'ActiveIngredient': 'PERAMPANEL',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'EISAI INC',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/202834s016,208277s004lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=202834'},\n",
       " '202860': {'ApplNo': '202860',\n",
       "  'Form': 'GAS;INHALATION',\n",
       "  'Drug': 'GENOSYL',\n",
       "  'ActiveIngredient': 'NITRIC OXIDE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'VERO BIOTECH INC',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/202860s000lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=202860'},\n",
       " '20287': {'ApplNo': '20287',\n",
       "  'Form': 'INJECTABLE;SUBCUTANEOUS',\n",
       "  'Drug': 'FRAGMIN',\n",
       "  'ActiveIngredient': 'DALTEPARIN SODIUM',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'PFIZER',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/020287Orig1s076lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20287'},\n",
       " '202872': {'ApplNo': '202872',\n",
       "  'Form': 'GEL;OPHTHALMIC',\n",
       "  'Drug': 'LOTEMAX',\n",
       "  'ActiveIngredient': 'LOTEPREDNOL ETABONATE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'BAUSCH AND LOMB INC',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2018/202872s002lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=202872'},\n",
       " '202895': {'ApplNo': '202895',\n",
       "  'Form': 'SUSPENSION;ORAL',\n",
       "  'Drug': 'PREZISTA',\n",
       "  'ActiveIngredient': 'DARUNAVIR',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'JANSSEN PRODS',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/021976s067,202895s035lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=202895'},\n",
       " '202939': {'ApplNo': '202939',\n",
       "  'Form': 'TABLET, EXTENDED RELEASE;ORAL',\n",
       "  'Drug': 'QUETIAPINE FUMARATE',\n",
       "  'ActiveIngredient': 'QUETIAPINE FUMARATE',\n",
       "  'ApplType': 'ANDA',\n",
       "  'Sponsor': 'INTELLIPHARMACEUTICS',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2017/202939Orig1s000lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=202939'},\n",
       " '202941': {'ApplNo': '202941',\n",
       "  'Form': 'TABLET;ORAL',\n",
       "  'Drug': 'LAMIVUDINE',\n",
       "  'ActiveIngredient': 'LAMIVUDINE',\n",
       "  'ApplType': 'ANDA',\n",
       "  'Sponsor': 'APOTEX',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/202941Orig1s000_lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=202941'},\n",
       " '202958': {'ApplNo': '202958',\n",
       "  'Form': 'TABLET, EXTENDED RELEASE;ORAL',\n",
       "  'Drug': 'LEVETIRACETAM',\n",
       "  'ActiveIngredient': 'LEVETIRACETAM',\n",
       "  'ApplType': 'ANDA',\n",
       "  'Sponsor': 'APOTEX',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/202958Orig1s000lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=202958'},\n",
       " '202964': {'ApplNo': '202964',\n",
       "  'Form': 'FOR SOLUTION;ORAL',\n",
       "  'Drug': 'DICLOFENAC POTASSIUM',\n",
       "  'ActiveIngredient': 'DICLOFENAC POTASSIUM',\n",
       "  'ApplType': 'ANDA',\n",
       "  'Sponsor': 'PAR FORM',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2016/202964Orig1s000lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=202964'},\n",
       " '20297': {'ApplNo': '20297',\n",
       "  'Form': 'TABLET;ORAL',\n",
       "  'Drug': 'COREG',\n",
       "  'ActiveIngredient': 'CARVEDILOL',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'WOODWARD',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2017/020297s038lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20297'},\n",
       " '202971': {'ApplNo': '202971',\n",
       "  'Form': 'FOR SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR',\n",
       "  'Drug': 'ABILIFY MAINTENA KIT',\n",
       "  'ActiveIngredient': 'ARIPIPRAZOLE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'OTSUKA PHARM CO LTD',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/202971s013lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=202971'},\n",
       " '20298': {'ApplNo': '20298',\n",
       "  'Form': 'INJECTABLE;INJECTION',\n",
       "  'Drug': 'ALOPRIM',\n",
       "  'ActiveIngredient': 'ALLOPURINOL SODIUM',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'MYLAN',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/020298s012lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20298'},\n",
       " '202992': {'ApplNo': '202992',\n",
       "  'Form': 'TABLET;ORAL',\n",
       "  'Drug': 'AUBAGIO',\n",
       "  'ActiveIngredient': 'TERIFLUNOMIDE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'SANOFI AVENTIS US',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/202992s013s015lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=202992'},\n",
       " '203039': {'ApplNo': '203039',\n",
       "  'Form': 'TABLET, ORALLY DISINTEGRATING;ORAL',\n",
       "  'Drug': 'CLOZAPINE',\n",
       "  'ActiveIngredient': 'CLOZAPINE',\n",
       "  'ApplType': 'ANDA',\n",
       "  'Sponsor': 'TEVA PHARMS USA',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/203039Orig1s000lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=203039'},\n",
       " '203045': {'ApplNo': '203045',\n",
       "  'Form': 'TABLET, CHEWABLE;ORAL',\n",
       "  'Drug': 'ISENTRESS',\n",
       "  'ActiveIngredient': 'RALTEGRAVIR POTASSIUM',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'MSD SUB MERCK',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/022145s044,203045s017,205786s009lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=203045'},\n",
       " '203049': {'ApplNo': '203049',\n",
       "  'Form': 'INJECTABLE;INJECTION',\n",
       "  'Drug': 'ARGATROBAN',\n",
       "  'ActiveIngredient': 'ARGATROBAN',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'HIKMA PHARM CO LTD',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/203049s007lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=203049'},\n",
       " '203058': {'ApplNo': '203058',\n",
       "  'Form': 'SOLUTION/DROPS;OPHTHALMIC',\n",
       "  'Drug': 'DORZOLAMIDE HYDROCHLORIDE AND TIMOLOL MALEATE',\n",
       "  'ActiveIngredient': 'DORZOLAMIDE HYDROCHLORIDE; TIMOLOL MALEATE',\n",
       "  'ApplType': 'ANDA',\n",
       "  'Sponsor': 'AKORN',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/203058Orig1s000lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=203058'},\n",
       " '203085': {'ApplNo': '203085',\n",
       "  'Form': 'TABLET;ORAL',\n",
       "  'Drug': 'STIVARGA',\n",
       "  'ActiveIngredient': 'REGORAFENIB',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'BAYER HLTHCARE',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/203085Orig1s014lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=203085'},\n",
       " '20309': {'ApplNo': '20309',\n",
       "  'Form': 'INJECTABLE;INJECTION',\n",
       "  'Drug': 'MAGNESIUM SULFATE IN PLASTIC CONTAINER',\n",
       "  'ActiveIngredient': 'MAGNESIUM SULFATE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'HOSPIRA',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/020309Orig1s032lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20309'},\n",
       " '203094': {'ApplNo': '203094',\n",
       "  'Form': 'TABLET;ORAL',\n",
       "  'Drug': 'TYBOST',\n",
       "  'ActiveIngredient': 'COBICISTAT',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'GILEAD SCIENCES INC',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/203094s016lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=203094'},\n",
       " '20310': {'ApplNo': '20310',\n",
       "  'Form': 'SHAMPOO;TOPICAL',\n",
       "  'Drug': 'NIZORAL ANTI-DANDRUFF',\n",
       "  'ActiveIngredient': 'KETOCONAZOLE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'KRAMER',\n",
       "  'LatestLabel': 'https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/020310Orig1s029lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20310'},\n",
       " '203100': {'ApplNo': '203100',\n",
       "  'Form': 'TABLET;ORAL',\n",
       "  'Drug': 'STRIBILD',\n",
       "  'ActiveIngredient': 'COBICISTAT; ELVITEGRAVIR; EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'GILEAD SCIENCES INC',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/203100s036lblet.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=203100'},\n",
       " '203108': {'ApplNo': '203108',\n",
       "  'Form': 'SPRAY, METERED;INHALATION',\n",
       "  'Drug': 'STRIVERDI RESPIMAT',\n",
       "  'ActiveIngredient': 'OLODATEROL HYDROCHLORIDE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'BOEHRINGER INGELHEIM',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/203108s008lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=203108'},\n",
       " '203109': {'ApplNo': '203109',\n",
       "  'Form': 'FOR SUSPENSION;ORAL',\n",
       "  'Drug': 'REVATIO',\n",
       "  'ActiveIngredient': 'SILDENAFIL CITRATE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'VIATRIS',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/203109Orig1s015lblrpl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=203109'},\n",
       " '203137': {'ApplNo': '203137',\n",
       "  'Form': 'INJECTABLE;INTRAVENOUS',\n",
       "  'Drug': 'VIZAMYL',\n",
       "  'ActiveIngredient': 'FLUTEMETAMOL F-18',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'GE HEALTHCARE',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/203137s013lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=203137'},\n",
       " '20314': {'ApplNo': '20314',\n",
       "  'Form': 'INJECTABLE;INJECTION',\n",
       "  'Drug': 'OCTREOSCAN',\n",
       "  'ActiveIngredient': 'INDIUM IN-111 PENTETREOTIDE KIT',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'CURIUM',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/020314Orig1s012lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20314'},\n",
       " '203152': {'ApplNo': '203152',\n",
       "  'Form': 'SOLUTION/DROPS;OPHTHALMIC',\n",
       "  'Drug': 'OLOPATADINE HYDROCHLORIDE',\n",
       "  'ActiveIngredient': 'OLOPATADINE HYDROCHLORIDE',\n",
       "  'ApplType': 'ANDA',\n",
       "  'Sponsor': 'USV',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/203152Orig1s000lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=203152'},\n",
       " '203155': {'ApplNo': '203155',\n",
       "  'Form': 'INJECTABLE;INTRAVENOUS',\n",
       "  'Drug': 'CHOLINE C-11',\n",
       "  'ActiveIngredient': 'CHOLINE C-11',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'MCPRF',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/203155s000lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=203155'},\n",
       " '203159': {'ApplNo': '203159',\n",
       "  'Form': 'INTRAUTERINE DEVICE;INTRAUTERINE',\n",
       "  'Drug': 'SKYLA',\n",
       "  'ActiveIngredient': 'LEVONORGESTREL',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'BAYER HLTHCARE',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/203159s013lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=203159'},\n",
       " '203168': {'ApplNo': '203168',\n",
       "  'Form': 'SOLUTION/DROPS;OPHTHALMIC',\n",
       "  'Drug': 'PROLENSA',\n",
       "  'ActiveIngredient': 'BROMFENAC SODIUM',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'BAUSCH AND LOMB',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/203168s000lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=203168'},\n",
       " '203188': {'ApplNo': '203188',\n",
       "  'Form': 'TABLET;ORAL',\n",
       "  'Drug': 'KALYDECO',\n",
       "  'ActiveIngredient': 'IVACAFTOR',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'VERTEX PHARMS',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/203188s034,207925s013lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=203188'},\n",
       " '203195': {'ApplNo': '203195',\n",
       "  'Form': 'CAPSULE;ORAL',\n",
       "  'Drug': 'SUPRAX',\n",
       "  'ActiveIngredient': 'CEFIXIME',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'LUPIN LTD',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2018/202091S007_203195_S008lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=203195'},\n",
       " '203202': {'ApplNo': '203202',\n",
       "  'Form': 'CAPSULE;ORAL',\n",
       "  'Drug': 'NORTHERA',\n",
       "  'ActiveIngredient': 'DROXIDOPA',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'LUNDBECK NA LTD',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2017/203202s007lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=203202'},\n",
       " '203214': {'ApplNo': '203214',\n",
       "  'Form': 'TABLET;ORAL',\n",
       "  'Drug': 'XELJANZ',\n",
       "  'ActiveIngredient': 'TOFACITINIB CITRATE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'PF PRISM CV',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/203214s028,208246s013,213082s003lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=203214'},\n",
       " '203231': {'ApplNo': '203231',\n",
       "  'Form': 'INJECTABLE;INTRAVENOUS',\n",
       "  'Drug': 'ZOLEDRONIC ACID',\n",
       "  'ActiveIngredient': 'ZOLEDRONIC ACID',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'INFORLIFE',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/203231Orig1s019Lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=203231'},\n",
       " '20325': {'ApplNo': '20325',\n",
       "  'Form': 'TABLET;ORAL',\n",
       "  'Drug': 'PEPCID AC',\n",
       "  'ActiveIngredient': 'FAMOTIDINE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'J AND J CONSUMER INC',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/020325Orig1s041lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20325'},\n",
       " '203255': {'ApplNo': '203255',\n",
       "  'Form': 'FOR SUSPENSION;INTRAMUSCULAR',\n",
       "  'Drug': 'SIGNIFOR LAR KIT',\n",
       "  'ActiveIngredient': 'PASIREOTIDE PAMOATE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'RECORDATI RARE',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/203255s008lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=203255'},\n",
       " '203260': {'ApplNo': '203260',\n",
       "  'Form': 'TABLET;ORAL',\n",
       "  'Drug': 'LAMIVUDINE',\n",
       "  'ActiveIngredient': 'LAMIVUDINE',\n",
       "  'ApplType': 'ANDA',\n",
       "  'Sponsor': 'HETERO LABS LTD V',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/203260Orig1s000lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=203260'},\n",
       " '203263': {'ApplNo': '203263',\n",
       "  'Form': 'INJECTABLE, LIPOSOMAL;INJECTION',\n",
       "  'Drug': 'DOXORUBICIN HYDROCHLORIDE (LIPOSOMAL)',\n",
       "  'ActiveIngredient': 'DOXORUBICIN HYDROCHLORIDE',\n",
       "  'ApplType': 'ANDA',\n",
       "  'Sponsor': 'SUN PHARM',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/203263lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=203263'},\n",
       " '20327': {'ApplNo': '20327',\n",
       "  'Form': 'INJECTABLE;INJECTION',\n",
       "  'Drug': 'ISOVUE-250',\n",
       "  'ActiveIngredient': 'IOPAMIDOL',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'BRACCO',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/020327s023lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20327'},\n",
       " '203284': {'ApplNo': '203284',\n",
       "  'Form': 'LIQUID;ORAL',\n",
       "  'Drug': 'RAVICTI',\n",
       "  'ActiveIngredient': 'GLYCEROL PHENYLBUTYRATE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'HORIZON THERAP US',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/203284Orig1s012lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=203284'},\n",
       " '20329': {'ApplNo': '20329',\n",
       "  'Form': 'TABLET, EXTENDED RELEASE;ORAL',\n",
       "  'Drug': 'GLUCOTROL XL',\n",
       "  'ActiveIngredient': 'GLIPIZIDE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'PFIZER',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/020329Orig1s035lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20329'},\n",
       " '20330': {'ApplNo': '20330',\n",
       "  'Form': 'SOLUTION, GEL FORMING/DROPS;OPHTHALMIC',\n",
       "  'Drug': 'TIMOPTIC-XE',\n",
       "  'ActiveIngredient': 'TIMOLOL MALEATE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'BAUSCH AND LOMB INC',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2018/020330s032lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20330'},\n",
       " '203312': {'ApplNo': '203312',\n",
       "  'Form': 'CAPSULE, EXTENDED RELEASE;ORAL',\n",
       "  'Drug': 'RYTARY',\n",
       "  'ActiveIngredient': 'CARBIDOPA; LEVODOPA',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'IMPAX LABS INC',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/203312s011lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=203312'},\n",
       " '203314': {'ApplNo': '203314',\n",
       "  'Form': 'SOLUTION;SUBCUTANEOUS',\n",
       "  'Drug': 'TRESIBA',\n",
       "  'ActiveIngredient': 'INSULIN DEGLUDEC',\n",
       "  'ApplType': 'BLA',\n",
       "  'Sponsor': 'NOVO',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/203314s018s020lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=203314'},\n",
       " '203324': {'ApplNo': '203324',\n",
       "  'Form': 'SOLUTION/DROPS;OPHTHALMIC',\n",
       "  'Drug': 'PHOTREXA',\n",
       "  'ActiveIngredient': \"RIBOFLAVIN 5'-PHOSPHATE SODIUM\",\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'GLAUKOS',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/203324s006lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=203324'},\n",
       " '20333': {'ApplNo': '20333',\n",
       "  'Form': 'CAPSULE;ORAL',\n",
       "  'Drug': 'AGRYLIN',\n",
       "  'ActiveIngredient': 'ANAGRELIDE HYDROCHLORIDE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'TAKEDA PHARMS USA',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/020333s027lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20333'},\n",
       " '20334': {'ApplNo': '20334',\n",
       "  'Form': 'CAPSULE;ORAL',\n",
       "  'Drug': 'FLAGYL',\n",
       "  'ActiveIngredient': 'METRONIDAZOLE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'PFIZER',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/020334s012lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20334'},\n",
       " '203340': {'ApplNo': '203340',\n",
       "  'Form': 'SOLUTION;ORAL',\n",
       "  'Drug': 'NYMALIZE',\n",
       "  'ActiveIngredient': 'NIMODIPINE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'AZURITY',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/203340Orig1s013lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=203340'},\n",
       " '203341': {'ApplNo': '203341',\n",
       "  'Form': 'TABLET;ORAL',\n",
       "  'Drug': 'BOSULIF',\n",
       "  'ActiveIngredient': 'BOSUTINIB MONOHYDRATE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'PF PRISM CV',\n",
       "  'LatestLabel': 'https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/203341s020lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=203341'},\n",
       " '203388': {'ApplNo': '203388',\n",
       "  'Form': 'CAPSULE;ORAL',\n",
       "  'Drug': 'ERIVEDGE',\n",
       "  'ActiveIngredient': 'VISMODEGIB',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'GENENTECH',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/203388s016lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=203388'},\n",
       " '203389': {'ApplNo': '203389',\n",
       "  'Form': 'CAPSULE, DELAYED RELEASE;ORAL',\n",
       "  'Drug': 'PROCYSBI',\n",
       "  'ActiveIngredient': 'CYSTEAMINE BITARTRATE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'HORIZON',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/203389s027,213491s002lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=203389'},\n",
       " '203414': {'ApplNo': '203414',\n",
       "  'Form': 'TABLET;ORAL',\n",
       "  'Drug': 'KAZANO',\n",
       "  'ActiveIngredient': 'ALOGLIPTIN BENZOATE; METFORMIN HYDROCHLORIDE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'TAKEDA PHARMS USA',\n",
       "  'LatestLabel': 'https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/203414s013lbl.pdf#page=32',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=203414'},\n",
       " '203415': {'ApplNo': '203415',\n",
       "  'Form': 'CAPSULE;ORAL',\n",
       "  'Drug': 'XTANDI',\n",
       "  'ActiveIngredient': 'ENZALUTAMIDE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'ASTELLAS',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/203415s019,213674s006lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=203415'},\n",
       " '203441': {'ApplNo': '203441',\n",
       "  'Form': 'POWDER;SUBCUTANEOUS',\n",
       "  'Drug': 'GATTEX KIT',\n",
       "  'ActiveIngredient': 'TEDUGLUTIDE RECOMBINANT',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'TAKEDA PHARMS USA',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2023/203441Orig1s016lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=203441'},\n",
       " '203469': {'ApplNo': '203469',\n",
       "  'Form': 'TABLET;ORAL',\n",
       "  'Drug': 'ICLUSIG',\n",
       "  'ActiveIngredient': 'PONATINIB HYDROCHLORIDE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'TAKEDA PHARMS USA',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/203469s035lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=203469'},\n",
       " '203479': {'ApplNo': '203479',\n",
       "  'Form': 'SUSPENSION;ORAL',\n",
       "  'Drug': 'VERSACLOZ',\n",
       "  'ActiveIngredient': 'CLOZAPINE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'TASMAN PHARMA',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/203479s012lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=203479'},\n",
       " '203491': {'ApplNo': '203491',\n",
       "  'Form': 'SUSPENSION/DROPS;OPHTHALMIC',\n",
       "  'Drug': 'ILEVRO',\n",
       "  'ActiveIngredient': 'NEPAFENAC',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'NOVARTIS',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/203491s001lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=203491'},\n",
       " '203496': {'ApplNo': '203496',\n",
       "  'Form': 'TABLET, EXTENDED RELEASE;ORAL',\n",
       "  'Drug': 'ORENITRAM',\n",
       "  'ActiveIngredient': 'TREPROSTINIL DIOLAMINE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'UNITED THERAP',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/203496Orig1s013lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=203496'},\n",
       " '203505': {'ApplNo': '203505',\n",
       "  'Form': 'TABLET;ORAL',\n",
       "  'Drug': 'OSPHENA',\n",
       "  'ActiveIngredient': 'OSPEMIFENE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'DUCHESNAY',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/203505s015lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=203505'},\n",
       " '20351': {'ApplNo': '20351',\n",
       "  'Form': 'INJECTABLE;INJECTION',\n",
       "  'Drug': 'VISIPAQUE 270',\n",
       "  'ActiveIngredient': 'IODIXANOL',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'GE HEALTHCARE',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/020351s054,020808s032lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20351'},\n",
       " '203510': {'ApplNo': '203510',\n",
       "  'Form': 'SOLUTION/DROPS;OPHTHALMIC',\n",
       "  'Drug': 'PHENYLEPHRINE HYDROCHLORIDE',\n",
       "  'ActiveIngredient': 'PHENYLEPHRINE HYDROCHLORIDE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'PARAGON BIOTECK',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/203510s005lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=203510'},\n",
       " '20353': {'ApplNo': '20353',\n",
       "  'Form': 'TABLET, EXTENDED RELEASE;ORAL',\n",
       "  'Drug': 'NAPRELAN',\n",
       "  'ActiveIngredient': 'NAPROXEN SODIUM',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'ALMATICA',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/020353s038lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20353'},\n",
       " '203551': {'ApplNo': '203551',\n",
       "  'Form': 'INJECTABLE;INJECTION',\n",
       "  'Drug': 'DOCETAXEL',\n",
       "  'ActiveIngredient': 'DOCETAXEL',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'ACTAVIS LLC',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/203551s009lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=203551'},\n",
       " '20356': {'ApplNo': '20356',\n",
       "  'Form': 'TABLET, EXTENDED RELEASE;ORAL',\n",
       "  'Drug': 'SULAR',\n",
       "  'ActiveIngredient': 'NISOLDIPINE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'COVIS',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2017/020356s027lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20356'},\n",
       " '203560': {'ApplNo': '203560',\n",
       "  'Form': 'TABLET, FOR SUSPENSION;ORAL',\n",
       "  'Drug': 'DEFERASIROX',\n",
       "  'ActiveIngredient': 'DEFERASIROX',\n",
       "  'ApplType': 'ANDA',\n",
       "  'Sponsor': 'ACTAVIS ELIZABETH',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2016/203560Orig1s000lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=203560'},\n",
       " '203563': {'ApplNo': '203563',\n",
       "  'Form': 'SOLUTION;INTRAVENOUS',\n",
       "  'Drug': 'LEVOLEUCOVORIN CALCIUM',\n",
       "  'ActiveIngredient': 'LEVOLEUCOVORIN CALCIUM',\n",
       "  'ApplType': 'ANDA',\n",
       "  'Sponsor': 'SANDOZ INC',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/203563Orig1s000lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=203563'},\n",
       " '203565': {'ApplNo': '203565',\n",
       "  'Form': 'SOLUTION;INTRAVENOUS',\n",
       "  'Drug': 'INJECTAFER',\n",
       "  'ActiveIngredient': 'FERRIC CARBOXYMALTOSE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'AM REGENT',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/203565Orig1s019lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=203565'},\n",
       " '203567': {'ApplNo': '203567',\n",
       "  'Form': 'SOLUTION;TOPICAL',\n",
       "  'Drug': 'JUBLIA',\n",
       "  'ActiveIngredient': 'EFINACONAZOLE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'BAUSCH',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/203567s010lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=203567'},\n",
       " '20358': {'ApplNo': '20358',\n",
       "  'Form': 'TABLET, EXTENDED RELEASE;ORAL',\n",
       "  'Drug': 'WELLBUTRIN SR',\n",
       "  'ActiveIngredient': 'BUPROPION HYDROCHLORIDE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'GLAXOSMITHKLINE',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/020358s066lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20358'},\n",
       " '203585': {'ApplNo': '203585',\n",
       "  'Form': 'POWDER;SUBCUTANEOUS',\n",
       "  'Drug': 'SYNRIBO',\n",
       "  'ActiveIngredient': 'OMACETAXINE MEPESUCCINATE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'TEVA PHARMS INTL',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/203585Orig1s008lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=203585'},\n",
       " '203593': {'ApplNo': '203593',\n",
       "  'Form': 'TABLET;ORAL',\n",
       "  'Drug': 'DROSPIRENONE, ETHINYL ESTRADIOL AND LEVOMEFOLATE CALCIUM',\n",
       "  'ActiveIngredient': 'DROSPIRENONE; ETHINYL ESTRADIOL; LEVOMEFOLATE CALCIUM',\n",
       "  'ApplType': 'ANDA',\n",
       "  'Sponsor': 'WATSON LABS INC',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2016/203593Orig1s000lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=203593'},\n",
       " '203594': {'ApplNo': '203594',\n",
       "  'Form': 'TABLET;ORAL',\n",
       "  'Drug': 'DROSPIRENONE, ETHINYL ESTRADIOL AND LEVOMEFOLATE CALCIUM',\n",
       "  'ActiveIngredient': 'DROSPIRENONE; ETHINYL ESTRADIOL; LEVOMEFOLATE CALCIUM',\n",
       "  'ApplType': 'ANDA',\n",
       "  'Sponsor': 'WATSON LABS INC',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2016/203594Orig1s000lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=203594'},\n",
       " '203629': {'ApplNo': '203629',\n",
       "  'Form': 'SOLUTION;INTRAVENOUS',\n",
       "  'Drug': 'NEOSTIGMINE METHYLSULFATE',\n",
       "  'ActiveIngredient': 'NEOSTIGMINE METHYLSULFATE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'FRESENIUS KABI USA',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/203629s003lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=203629'},\n",
       " '203634': {'ApplNo': '203634',\n",
       "  'Form': 'TABLET, EXTENDED RELEASE;ORAL',\n",
       "  'Drug': 'UCERIS',\n",
       "  'ActiveIngredient': 'BUDESONIDE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'SALIX',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/203634s007lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=203634'},\n",
       " '20364': {'ApplNo': '20364',\n",
       "  'Form': 'CAPSULE;ORAL',\n",
       "  'Drug': 'LOTREL',\n",
       "  'ActiveIngredient': 'AMLODIPINE BESYLATE; BENAZEPRIL HYDROCHLORIDE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'NOVARTIS',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/020364Orig1s068lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20364'},\n",
       " '203649': {'ApplNo': '203649',\n",
       "  'Form': 'INJECTABLE;IV (INFUSION), SUBCUTANEOUS',\n",
       "  'Drug': 'TREPROSTINIL',\n",
       "  'ActiveIngredient': 'TREPROSTINIL',\n",
       "  'ApplType': 'ANDA',\n",
       "  'Sponsor': 'SANDOZ INC',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2017/203649Orig1s000lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=203649'},\n",
       " '203655': {'ApplNo': '203655',\n",
       "  'Form': 'INJECTABLE;INJECTION',\n",
       "  'Drug': 'MELPHALAN HYDROCHLORIDE',\n",
       "  'ActiveIngredient': 'MELPHALAN HYDROCHLORIDE',\n",
       "  'ApplType': 'ANDA',\n",
       "  'Sponsor': 'DR REDDYS',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2017/203655Orig1s000lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=203655'},\n",
       " '203667': {'ApplNo': '203667',\n",
       "  'Form': 'TABLET;ORAL',\n",
       "  'Drug': 'MINASTRIN 24 FE',\n",
       "  'ActiveIngredient': 'ETHINYL ESTRADIOL; NORETHINDRONE ACETATE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'APIL',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/203667s014lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=203667'},\n",
       " '20367': {'ApplNo': '20367',\n",
       "  'Form': 'INJECTABLE;INJECTION',\n",
       "  'Drug': 'CEREZYME',\n",
       "  'ActiveIngredient': 'IMIGLUCERASE',\n",
       "  'ApplType': 'BLA',\n",
       "  'Sponsor': 'GENZYME',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/020367_S119lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20367'},\n",
       " '203684': {'ApplNo': '203684',\n",
       "  'Form': 'FOR SUSPENSION;INTRAVENOUS',\n",
       "  'Drug': 'LUMASON',\n",
       "  'ActiveIngredient': 'SULFUR HEXAFLUORIDE LIPID-TYPE A MICROSPHERES',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'BRACCO',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/203684s009lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=203684'},\n",
       " '20369': {'ApplNo': '20369',\n",
       "  'Form': 'OINTMENT;OPHTHALMIC',\n",
       "  'Drug': 'CILOXAN',\n",
       "  'ActiveIngredient': 'CIPROFLOXACIN HYDROCHLORIDE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'NOVARTIS',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2017/020369s022lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20369'},\n",
       " '203697': {'ApplNo': '203697',\n",
       "  'Form': 'CAPSULE;ORAL',\n",
       "  'Drug': 'VAZALORE',\n",
       "  'ActiveIngredient': 'ASPIRIN',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'PLX PHARMA',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/203697Orig1s009lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=203697'},\n",
       " '203711': {'ApplNo': '203711',\n",
       "  'Form': 'INJECTABLE;INJECTION',\n",
       "  'Drug': 'ONDANSETRON HYDROCHLORIDE',\n",
       "  'ActiveIngredient': 'ONDANSETRON HYDROCHLORIDE',\n",
       "  'ApplType': 'ANDA',\n",
       "  'Sponsor': 'QILU PHARM HAINAN',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/203711Orig1s000lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=203711'},\n",
       " '20372': {'ApplNo': '20372',\n",
       "  'Form': 'INJECTABLE;INJECTION',\n",
       "  'Drug': 'MYOVIEW',\n",
       "  'ActiveIngredient': 'TECHNETIUM TC-99M TETROFOSMIN KIT',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'GE HEALTHCARE',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/020372Orig1s033lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20372'},\n",
       " '20375': {'ApplNo': '20375',\n",
       "  'Form': 'FILM, EXTENDED RELEASE;TRANSDERMAL',\n",
       "  'Drug': 'CLIMARA',\n",
       "  'ActiveIngredient': 'ESTRADIOL',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'BAYER HLTHCARE',\n",
       "  'LatestLabel': 'https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/020375Orig1s045,s046lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20375'},\n",
       " '203752': {'ApplNo': '203752',\n",
       "  'Form': 'FILM, EXTENDED RELEASE;TRANSDERMAL',\n",
       "  'Drug': 'MINIVELLE',\n",
       "  'ActiveIngredient': 'ESTRADIOL',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'NOVEN',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/203752Orig1s016lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=203752'},\n",
       " '203756': {'ApplNo': '203756',\n",
       "  'Form': 'CAPSULE;ORAL',\n",
       "  'Drug': 'COMETRIQ',\n",
       "  'ActiveIngredient': 'CABOZANTINIB S-MALATE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'EXELIXIS',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/203756s009lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=203756'},\n",
       " '20378': {'ApplNo': '20378',\n",
       "  'Form': 'INJECTABLE;SUBCUTANEOUS',\n",
       "  'Drug': 'GONAL-F',\n",
       "  'ActiveIngredient': 'FOLLITROPIN ALFA/BETA',\n",
       "  'ApplType': 'BLA',\n",
       "  'Sponsor': 'EMD SERONO',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/020378s045,s067,s075lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20378'},\n",
       " '20379': {'ApplNo': '20379',\n",
       "  'Form': 'INJECTABLE;INJECTION',\n",
       "  'Drug': 'CAVERJECT',\n",
       "  'ActiveIngredient': 'ALPROSTADIL',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'PFIZER',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/020379s038lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20379'},\n",
       " '203791': {'ApplNo': '203791',\n",
       "  'Form': 'TABLET;BUCCAL',\n",
       "  'Drug': 'SITAVIG',\n",
       "  'ActiveIngredient': 'ACYCLOVIR',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'EPI HLTH',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/203791s001lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=203791'},\n",
       " '20380': {'ApplNo': '20380',\n",
       "  'Form': 'GEL;TOPICAL',\n",
       "  'Drug': 'DIFFERIN',\n",
       "  'ActiveIngredient': 'ADAPALENE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'GALDERMA LABS LP',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2018/020380Orig1s013lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20380'},\n",
       " '203826': {'ApplNo': '203826',\n",
       "  'Form': 'SOLUTION;INTRAVENOUS',\n",
       "  'Drug': 'PHENYLEPHRINE HYDROCHLORIDE',\n",
       "  'ActiveIngredient': 'PHENYLEPHRINE HYDROCHLORIDE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'HIKMA',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/203826s009lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=203826'},\n",
       " '203849': {'ApplNo': '203849',\n",
       "  'Form': 'TABLET, EXTENDED RELEASE;ORAL',\n",
       "  'Drug': 'MORPHINE SULFATE',\n",
       "  'ActiveIngredient': 'MORPHINE SULFATE',\n",
       "  'ApplType': 'ANDA',\n",
       "  'Sponsor': 'ACTAVIS ELIZABETH',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/203849Orig1s000MG.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=203849'},\n",
       " '20385': {'ApplNo': '20385',\n",
       "  'Form': 'SPRAY, METERED;NASAL',\n",
       "  'Drug': 'NICOTROL',\n",
       "  'ActiveIngredient': 'NICOTINE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'PFIZER INC',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/020385s011lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20385'},\n",
       " '203856': {'ApplNo': '203856',\n",
       "  'Form': 'CAPSULE;ORAL',\n",
       "  'Drug': 'CYCLOPHOSPHAMIDE',\n",
       "  'ActiveIngredient': 'CYCLOPHOSPHAMIDE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'HIKMA',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/203856s003lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=203856'},\n",
       " '203858': {'ApplNo': '203858',\n",
       "  'Form': 'CAPSULE;ORAL',\n",
       "  'Drug': 'JUXTAPID',\n",
       "  'ActiveIngredient': 'LOMITAPIDE MESYLATE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'AMRYT',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/203858s019lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=203858'},\n",
       " '20386': {'ApplNo': '20386',\n",
       "  'Form': 'TABLET;ORAL',\n",
       "  'Drug': 'COZAAR',\n",
       "  'ActiveIngredient': 'LOSARTAN POTASSIUM',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'ORGANON',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/020386s064lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20386'},\n",
       " '20387': {'ApplNo': '20387',\n",
       "  'Form': 'TABLET;ORAL',\n",
       "  'Drug': 'HYZAAR',\n",
       "  'ActiveIngredient': 'HYDROCHLOROTHIAZIDE; LOSARTAN POTASSIUM',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'ORGANON',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/020387s067lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20387'},\n",
       " '20392': {'ApplNo': '20392',\n",
       "  'Form': 'CAPSULE;ORAL',\n",
       "  'Drug': 'CYSTAGON',\n",
       "  'ActiveIngredient': 'CYSTEAMINE BITARTRATE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'MYLAN',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2007/020392s010lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20392'},\n",
       " '203922': {'ApplNo': '203922',\n",
       "  'Form': 'SOLUTION;INTRAVENOUS',\n",
       "  'Drug': 'SODIUM NITRITE',\n",
       "  'ActiveIngredient': 'SODIUM NITRITE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'HOPE PHARMS',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/203922s003lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=203922'},\n",
       " '203923': {'ApplNo': '203923',\n",
       "  'Form': 'SOLUTION;INTRAVENOUS',\n",
       "  'Drug': 'SODIUM THIOSULFATE',\n",
       "  'ActiveIngredient': 'SODIUM THIOSULFATE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'HOPE PHARMS',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/203923s004lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=203923'},\n",
       " '203952': {'ApplNo': '203952',\n",
       "  'Form': 'SUSPENSION;ENTERAL',\n",
       "  'Drug': 'DUOPA',\n",
       "  'ActiveIngredient': 'CARBIDOPA; LEVODOPA',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'ABBVIE INC',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/203952s011lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=203952'},\n",
       " '20397': {'ApplNo': '20397',\n",
       "  'Form': 'TABLET;ORAL',\n",
       "  'Drug': 'ZANAFLEX',\n",
       "  'ActiveIngredient': 'TIZANIDINE HYDROCHLORIDE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'LEGACY PHARMA',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/021447s011_020397s026lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20397'},\n",
       " '203971': {'ApplNo': '203971',\n",
       "  'Form': 'SOLUTION;INTRAVENOUS',\n",
       "  'Drug': 'XOFIGO',\n",
       "  'ActiveIngredient': 'RADIUM RA-223 DICHLORIDE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'BAYER HLTHCARE',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/203971s016lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=203971'},\n",
       " '203975': {'ApplNo': '203975',\n",
       "  'Form': 'POWDER;INHALATION',\n",
       "  'Drug': 'ANORO ELLIPTA',\n",
       "  'ActiveIngredient': 'UMECLIDINIUM BROMIDE; VILANTEROL TRIFENATATE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'GLAXOSMITHKLINE',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/203975s013lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=203975'},\n",
       " '203985': {'ApplNo': '203985',\n",
       "  'Form': 'TABLET, FOR SUSPENSION;ORAL',\n",
       "  'Drug': 'AFINITOR DISPERZ',\n",
       "  'ActiveIngredient': 'EVEROLIMUS',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'NOVARTIS PHARM',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/203985s023,022334s051lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=203985'},\n",
       " '203993': {'ApplNo': '203993',\n",
       "  'Form': 'SUSPENSION;ORAL',\n",
       "  'Drug': 'ONFI',\n",
       "  'ActiveIngredient': 'CLOBAZAM',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'LUNDBECK PHARMS LLC',\n",
       "  'LatestLabel': 'https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/202067s007,203993s009lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=203993'},\n",
       " '20400': {'ApplNo': '20400',\n",
       "  'Form': 'GEL;TOPICAL',\n",
       "  'Drug': 'AVITA',\n",
       "  'ActiveIngredient': 'TRETINOIN',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'MYLAN',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2011/020400s005lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20400'},\n",
       " '20401': {'ApplNo': '20401',\n",
       "  'Form': 'CAPSULE, EXTENDED RELEASE;ORAL',\n",
       "  'Drug': 'TIAZAC',\n",
       "  'ActiveIngredient': 'DILTIAZEM HYDROCHLORIDE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'BAUSCH',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2016/020401s042lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20401'},\n",
       " '204016': {'ApplNo': '204016',\n",
       "  'Form': 'SOLUTION;INTRAVENOUS',\n",
       "  'Drug': 'ZOLEDRONIC ACID',\n",
       "  'ActiveIngredient': 'ZOLEDRONIC ACID',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'HOSPIRA',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2018/204016s003lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=204016'},\n",
       " '204017': {'ApplNo': '204017',\n",
       "  'Form': 'SYSTEM;TRANSDERMAL',\n",
       "  'Drug': 'TWIRLA',\n",
       "  'ActiveIngredient': 'ETHINYL ESTRADIOL; LEVONORGESTREL',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'AGILE',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/204017s004lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=204017'},\n",
       " '20402': {'ApplNo': '20402',\n",
       "  'Form': 'CAPSULE;ORAL',\n",
       "  'Drug': 'ADVIL LIQUI-GELS',\n",
       "  'ActiveIngredient': 'IBUPROFEN',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'GLAXOSMITHKLINE',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/020402Orig1s053lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20402'},\n",
       " '204026': {'ApplNo': '204026',\n",
       "  'Form': 'CAPSULE;ORAL',\n",
       "  'Drug': 'POMALYST',\n",
       "  'ActiveIngredient': 'POMALIDOMIDE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'BRISTOL',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/204026s028lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=204026'},\n",
       " '204029': {'ApplNo': '204029',\n",
       "  'Form': 'SOLUTION;INTRAVENOUS',\n",
       "  'Drug': 'CLOFARABINE',\n",
       "  'ActiveIngredient': 'CLOFARABINE',\n",
       "  'ApplType': 'ANDA',\n",
       "  'Sponsor': 'ABON PHARMS LLC',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2017/204029Orig1s000lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=204029'},\n",
       " '204042': {'ApplNo': '204042',\n",
       "  'Form': 'TABLET;ORAL',\n",
       "  'Drug': 'INVOKANA',\n",
       "  'ActiveIngredient': 'CANAGLIFLOZIN',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'JANSSEN PHARMS',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/204042s039lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=204042'},\n",
       " '20405': {'ApplNo': '20405',\n",
       "  'Form': 'TABLET;ORAL',\n",
       "  'Drug': 'LANOXIN',\n",
       "  'ActiveIngredient': 'DIGOXIN',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'CONCORDIA',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/020405s015lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20405'},\n",
       " '20406': {'ApplNo': '20406',\n",
       "  'Form': 'CAPSULE, DELAYED REL PELLETS;ORAL',\n",
       "  'Drug': 'PREVACID',\n",
       "  'ActiveIngredient': 'LANSOPRAZOLE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'TAKEDA PHARMS USA',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/020406s094,021428s041lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20406'},\n",
       " '204060': {'ApplNo': '204060',\n",
       "  'Form': 'TABLET;ORAL',\n",
       "  'Drug': 'FOSAMPRENAVIR CALCIUM',\n",
       "  'ActiveIngredient': 'FOSAMPRENAVIR CALCIUM',\n",
       "  'ApplType': 'ANDA',\n",
       "  'Sponsor': 'MYLAN',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2016/204060lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=204060'},\n",
       " '204061': {'ApplNo': '204061',\n",
       "  'Form': 'TABLET;ORAL',\n",
       "  'Drug': 'QUARTETTE',\n",
       "  'ActiveIngredient': 'ETHINYL ESTRADIOL; LEVONORGESTREL',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'TEVA BRANDED PHARM',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/204061s005s006lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=204061'},\n",
       " '204063': {'ApplNo': '204063',\n",
       "  'Form': 'CAPSULE, DELAYED RELEASE;ORAL',\n",
       "  'Drug': 'TECFIDERA',\n",
       "  'ActiveIngredient': 'DIMETHYL FUMARATE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'BIOGEN INC',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/204063s028s030lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=204063'},\n",
       " '204078': {'ApplNo': '204078',\n",
       "  'Form': 'SOLUTION;INTRAVENOUS',\n",
       "  'Drug': 'BLOXIVERZ',\n",
       "  'ActiveIngredient': 'NEOSTIGMINE METHYLSULFATE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'EXELA PHARMA',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/204078s010lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=204078'},\n",
       " '204096': {'ApplNo': '204096',\n",
       "  'Form': 'CAPSULE, EXTENDED RELEASE;ORAL',\n",
       "  'Drug': 'ASTAGRAF XL',\n",
       "  'ActiveIngredient': 'TACROLIMUS',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'ASTELLAS',\n",
       "  'LatestLabel': 'https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/050708s054,050709s047,204096s010lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=204096'},\n",
       " '20411': {'ApplNo': '20411',\n",
       "  'Form': 'INSERT, EXTENDED RELEASE;VAGINAL',\n",
       "  'Drug': 'CERVIDIL',\n",
       "  'ActiveIngredient': 'DINOPROSTONE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'FERRING PHARMS INC',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/020411Orig1s031lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20411'},\n",
       " '204114': {'ApplNo': '204114',\n",
       "  'Form': 'TABLET;ORAL',\n",
       "  'Drug': 'MEKINIST',\n",
       "  'ActiveIngredient': 'TRAMETINIB DIMETHYL SULFOXIDE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'NOVARTIS',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/204114s024lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=204114'},\n",
       " '204141': {'ApplNo': '204141',\n",
       "  'Form': 'SPRAY;TOPICAL',\n",
       "  'Drug': 'TOPICORT',\n",
       "  'ActiveIngredient': 'DESOXIMETASONE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'TARO PHARMS',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/204141s009lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=204141'},\n",
       " '20415': {'ApplNo': '20415',\n",
       "  'Form': 'TABLET;ORAL',\n",
       "  'Drug': 'REMERON',\n",
       "  'ActiveIngredient': 'MIRTAZAPINE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'ORGANON USA INC',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/020415s038,021208s028lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20415'},\n",
       " '204150': {'ApplNo': '204150',\n",
       "  'Form': 'TABLET, EXTENDED RELEASE;ORAL',\n",
       "  'Drug': 'DESVENLAFAXINE',\n",
       "  'ActiveIngredient': 'DESVENLAFAXINE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'ALEMBIC PHARMS LTD',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/204150s018lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=204150'},\n",
       " '204153': {'ApplNo': '204153',\n",
       "  'Form': 'CREAM;TOPICAL',\n",
       "  'Drug': 'LUZU',\n",
       "  'ActiveIngredient': 'LULICONAZOLE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'BAUSCH',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2018/204153s004s005lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=204153'},\n",
       " '204154': {'ApplNo': '204154',\n",
       "  'Form': 'TABLET;ORAL',\n",
       "  'Drug': 'IVERMECTIN',\n",
       "  'ActiveIngredient': 'IVERMECTIN',\n",
       "  'ApplType': 'ANDA',\n",
       "  'Sponsor': 'EDENBRIDGE PHARMS',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/204154Orig1s000lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=204154'},\n",
       " '204168': {'ApplNo': '204168',\n",
       "  'Form': 'CAPSULE, EXTENDED RELEASE;ORAL',\n",
       "  'Drug': 'FETZIMA',\n",
       "  'ActiveIngredient': 'LEVOMILNACIPRAN HYDROCHLORIDE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'ALLERGAN',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/204168s007lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=204168'},\n",
       " '204200': {'ApplNo': '204200',\n",
       "  'Form': 'SOLUTION;INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS',\n",
       "  'Drug': 'ADRENALIN',\n",
       "  'ActiveIngredient': 'EPINEPHRINE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'PAR STERILE PRODUCTS',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2023/204200Orig1s018lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=204200'},\n",
       " '204223': {'ApplNo': '204223',\n",
       "  'Form': 'SOLUTION;INTRAMUSCULAR, INTRAVENOUS',\n",
       "  'Drug': 'MORPHINE SULFATE',\n",
       "  'ActiveIngredient': 'MORPHINE SULFATE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'FRESENIUS KABI USA',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/204223s015lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=204223'},\n",
       " '204242': {'ApplNo': '204242',\n",
       "  'Form': 'TABLET;SUBLINGUAL',\n",
       "  'Drug': 'ZUBSOLV',\n",
       "  'ActiveIngredient': 'BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'OREXO US INC',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/204242s021s023lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=204242'},\n",
       " '204251': {'ApplNo': '204251',\n",
       "  'Form': 'SUSPENSION/DROPS;OPHTHALMIC',\n",
       "  'Drug': 'SIMBRINZA',\n",
       "  'ActiveIngredient': 'BRIMONIDINE TARTRATE; BRINZOLAMIDE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'ALCON LABS INC',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/204251s006lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=204251'},\n",
       " '204255': {'ApplNo': '204255',\n",
       "  'Form': 'SOLUTION, METERED;TRANSDERMAL',\n",
       "  'Drug': 'TESTOSTERONE',\n",
       "  'ActiveIngredient': 'TESTOSTERONE',\n",
       "  'ApplType': 'ANDA',\n",
       "  'Sponsor': 'PADAGIS ISRAEL',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2017/204255Orig1s000lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=204255'},\n",
       " '20427': {'ApplNo': '20427',\n",
       "  'Form': 'TABLET;ORAL',\n",
       "  'Drug': 'SABRIL',\n",
       "  'ActiveIngredient': 'VIGABATRIN',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'LUNDBECK PHARMS LLC',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/020427s025,022006s026lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20427'},\n",
       " '204275': {'ApplNo': '204275',\n",
       "  'Form': 'POWDER;INHALATION',\n",
       "  'Drug': 'BREO ELLIPTA',\n",
       "  'ActiveIngredient': 'FLUTICASONE FUROATE; VILANTEROL TRIFENATATE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'GLAXO GRP LTD',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/204275s017lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=204275'},\n",
       " '20428': {'ApplNo': '20428',\n",
       "  'Form': 'CREAM;TOPICAL',\n",
       "  'Drug': 'AZELEX',\n",
       "  'ActiveIngredient': 'AZELAIC ACID',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'ALMIRALL',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2003/20428slr016_azelex_lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20428'},\n",
       " '204286': {'ApplNo': '204286',\n",
       "  'Form': 'GEL;TOPICAL',\n",
       "  'Drug': 'NAFTIN',\n",
       "  'ActiveIngredient': 'NAFTIFINE HYDROCHLORIDE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'SEBELA IRELAND LTD',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/204286s004lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=204286'},\n",
       " '204300': {'ApplNo': '204300',\n",
       "  'Form': 'SOLUTION;INTRAVENOUS',\n",
       "  'Drug': 'VAZCULEP',\n",
       "  'ActiveIngredient': 'PHENYLEPHRINE HYDROCHLORIDE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'EXELA PHARMA',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/204300Orig1s011lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=204300'},\n",
       " '204312': {'ApplNo': '204312',\n",
       "  'Form': 'INJECTABLE;INTRAVENOUS',\n",
       "  'Drug': 'LEVETIRACETAM',\n",
       "  'ActiveIngredient': 'LEVETIRACETAM',\n",
       "  'ApplType': 'ANDA',\n",
       "  'Sponsor': 'EUGIA PHARMA',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2016/204312Origs000lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=204312'},\n",
       " '204326': {'ApplNo': '204326',\n",
       "  'Form': 'TABLET, ORALLY DISINTEGRATING, EXTENDED RELEASE;ORAL',\n",
       "  'Drug': 'ADZENYS XR-ODT',\n",
       "  'ActiveIngredient': 'AMPHETAMINE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'NEOS THERAPS',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/204326s008lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=204326'},\n",
       " '204353': {'ApplNo': '204353',\n",
       "  'Form': 'TABLET;ORAL',\n",
       "  'Drug': 'INVOKAMET',\n",
       "  'ActiveIngredient': 'CANAGLIFLOZIN; METFORMIN HYDROCHLORIDE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'JANSSEN PHARMS',\n",
       "  'LatestLabel': 'https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/204353s041,205879s018lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=204353'},\n",
       " '204354': {'ApplNo': '204354',\n",
       "  'Form': 'SUPPOSITORY;RECTAL',\n",
       "  'Drug': 'MESALAMINE',\n",
       "  'ActiveIngredient': 'MESALAMINE',\n",
       "  'ApplType': 'ANDA',\n",
       "  'Sponsor': 'MYLAN',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/204354Orig1s000lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=204354'},\n",
       " '204369': {'ApplNo': '204369',\n",
       "  'Form': 'TABLET; ORAL',\n",
       "  'Drug': 'STIVARGA',\n",
       "  'ActiveIngredient': 'REGORAFENIB',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'BAYER HEALTHCARE PHARMS',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/204369lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=204369'},\n",
       " '204370': {'ApplNo': '204370',\n",
       "  'Form': 'CAPSULE;ORAL',\n",
       "  'Drug': 'VRAYLAR',\n",
       "  'ActiveIngredient': 'CARIPRAZINE HYDROCHLORIDE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'ALLERGAN',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/204370s009lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=204370'},\n",
       " '204384': {'ApplNo': '204384',\n",
       "  'Form': 'TABLET;ORAL',\n",
       "  'Drug': 'SIRTURO',\n",
       "  'ActiveIngredient': 'BEDAQUILINE FUMARATE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'JANSSEN THERAP',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/204384s016lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=204384'},\n",
       " '20439': {'ApplNo': '20439',\n",
       "  'Form': 'SOLUTION/DROPS;OPHTHALMIC',\n",
       "  'Drug': 'BETIMOL',\n",
       "  'ActiveIngredient': 'TIMOLOL',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'THEA PHARMA',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2004/20439s011lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20439'},\n",
       " '204399': {'ApplNo': '204399',\n",
       "  'Form': 'GEL;TRANSDERMAL',\n",
       "  'Drug': 'VOGELXO',\n",
       "  'ActiveIngredient': 'TESTOSTERONE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'UPSHER SMITH LABS',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/204399s012lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=204399'},\n",
       " '204410': {'ApplNo': '204410',\n",
       "  'Form': 'TABLET;ORAL',\n",
       "  'Drug': 'OPSUMIT',\n",
       "  'ActiveIngredient': 'MACITENTAN',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'ACTELION',\n",
       "  'LatestLabel': 'https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/204410s022lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=204410'},\n",
       " '204412': {'ApplNo': '204412',\n",
       "  'Form': 'CAPSULE, DELAYED RELEASE;ORAL',\n",
       "  'Drug': 'DELZICOL',\n",
       "  'ActiveIngredient': 'MESALAMINE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'APIL',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/204412s016lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=204412'},\n",
       " '204417': {'ApplNo': '204417',\n",
       "  'Form': 'TABLET, EXTENDED RELEASE;ORAL',\n",
       "  'Drug': 'ELEPSIA XR',\n",
       "  'ActiveIngredient': 'LEVETIRACETAM',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'TRIPOINT',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/204417s004lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=204417'},\n",
       " '204426': {'ApplNo': '204426',\n",
       "  'Form': 'CAPSULE;ORAL',\n",
       "  'Drug': 'TAYTULLA',\n",
       "  'ActiveIngredient': 'ETHINYL ESTRADIOL; NORETHINDRONE ACETATE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'APIL',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/204426s010lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=204426'},\n",
       " '204427': {'ApplNo': '204427',\n",
       "  'Form': 'SOLUTION;TOPICAL',\n",
       "  'Drug': 'KERYDIN',\n",
       "  'ActiveIngredient': 'TAVABOROLE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'ANACOR PHARMS INC',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2018/204427s006lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=204427'},\n",
       " '204431': {'ApplNo': '204431',\n",
       "  'Form': 'TABLET;SUBLINGUAL',\n",
       "  'Drug': 'BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE',\n",
       "  'ActiveIngredient': 'BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE',\n",
       "  'ApplType': 'ANDA',\n",
       "  'Sponsor': 'ETHYPHARM USA CORP',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/204431Orig1s000lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=204431'},\n",
       " '20444': {'ApplNo': '20444',\n",
       "  'Form': 'INJECTABLE;INJECTION',\n",
       "  'Drug': 'FLOLAN',\n",
       "  'ActiveIngredient': 'EPOPROSTENOL SODIUM',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'GLAXOSMITHKLINE LLC',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/020444s025lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20444'},\n",
       " '204441': {'ApplNo': '204441',\n",
       "  'Form': 'TABLET;ORAL',\n",
       "  'Drug': 'JYNARQUE',\n",
       "  'ActiveIngredient': 'TOLVAPTAN',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'OTSUKA',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/204441s008lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=204441'},\n",
       " '204447': {'ApplNo': '204447',\n",
       "  'Form': 'TABLET;ORAL',\n",
       "  'Drug': 'TRINTELLIX',\n",
       "  'ActiveIngredient': 'VORTIOXETINE HYDROBROMIDE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'TAKEDA PHARMS USA',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/204447s024lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=204447'},\n",
       " '204475': {'ApplNo': '204475',\n",
       "  'Form': 'TABLET;ORAL',\n",
       "  'Drug': 'FENOFIBRATE',\n",
       "  'ActiveIngredient': 'FENOFIBRATE',\n",
       "  'ApplType': 'ANDA',\n",
       "  'Sponsor': 'MYLAN PHARMS INC',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2016/204475Orig1s000lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=204475'},\n",
       " '204485': {'ApplNo': '204485',\n",
       "  'Form': 'SOLUTION;INTRAVENOUS',\n",
       "  'Drug': 'VASOSTRICT',\n",
       "  'ActiveIngredient': 'VASOPRESSIN',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'PAR STERILE PRODUCTS',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/204485Orig1s027lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=204485'},\n",
       " '20449': {'ApplNo': '20449',\n",
       "  'Form': 'INJECTABLE;INJECTION',\n",
       "  'Drug': 'TAXOTERE',\n",
       "  'ActiveIngredient': 'DOCETAXEL',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'SANOFI AVENTIS US',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2023/020449s086lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20449'},\n",
       " '20450': {'ApplNo': '20450',\n",
       "  'Form': 'INJECTABLE;INJECTION',\n",
       "  'Drug': 'CEREBYX',\n",
       "  'ActiveIngredient': 'FOSPHENYTOIN SODIUM',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'PARKE DAVIS',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/020450s046lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20450'},\n",
       " '204508': {'ApplNo': '204508',\n",
       "  'Form': 'EMULSION;INTRAVENOUS',\n",
       "  'Drug': 'CLINOLIPID 20%',\n",
       "  'ActiveIngredient': 'OLIVE OIL; SOYBEAN OIL',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'BAXTER HLTHCARE CORP',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/204508s015lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=204508'},\n",
       " '20451': {'ApplNo': '20451',\n",
       "  'Form': 'INJECTABLE;INJECTION',\n",
       "  'Drug': 'PHOTOFRIN',\n",
       "  'ActiveIngredient': 'PORFIMER SODIUM',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'PINNACLE BIOLGS',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/020451s029,021525s005lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20451'},\n",
       " '204516': {'ApplNo': '204516',\n",
       "  'Form': 'CAPSULE;ORAL',\n",
       "  'Drug': 'BRISDELLE',\n",
       "  'ActiveIngredient': 'PAROXETINE MESYLATE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'SEBELA IRELAND LTD',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/204516s011lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=204516'},\n",
       " '20453': {'ApplNo': '20453',\n",
       "  'Form': 'CREAM;TOPICAL',\n",
       "  'Drug': 'PANDEL',\n",
       "  'ActiveIngredient': 'HYDROCORTISONE PROBUTATE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'ANI PHARMS',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2017/020453s007lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20453'},\n",
       " '204569': {'ApplNo': '204569',\n",
       "  'Form': 'TABLET;ORAL',\n",
       "  'Drug': 'BELSOMRA',\n",
       "  'ActiveIngredient': 'SUVOREXANT',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'MERCK SHARP DOHME',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/204569s008lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=204569'},\n",
       " '20457': {'ApplNo': '20457',\n",
       "  'Form': 'INJECTABLE;INJECTION',\n",
       "  'Drug': 'ETOPOPHOS PRESERVATIVE FREE',\n",
       "  'ActiveIngredient': 'ETOPOSIDE PHOSPHATE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'CHEPLAPHARM',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/020457s019lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20457'},\n",
       " '204623': {'ApplNo': '204623',\n",
       "  'Form': 'SOLUTION;TOPICAL',\n",
       "  'Drug': 'PENNSAID',\n",
       "  'ActiveIngredient': 'DICLOFENAC SODIUM',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'HORIZON',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/204623s009lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=204623'},\n",
       " '204629': {'ApplNo': '204629',\n",
       "  'Form': 'TABLET;ORAL',\n",
       "  'Drug': 'JARDIANCE',\n",
       "  'ActiveIngredient': 'EMPAGLIFLOZIN',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'BOEHRINGER INGELHEIM',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/204629s039lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=204629'},\n",
       " '204630': {'ApplNo': '204630',\n",
       "  'Form': 'SOLUTION;INTRAVENOUS',\n",
       "  'Drug': 'PROVAYBLUE',\n",
       "  'ActiveIngredient': 'METHYLENE BLUE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'PROVEPHARM SAS',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/204630Orig1s018lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=204630'},\n",
       " '204640': {'ApplNo': '204640',\n",
       "  'Form': 'SOLUTION;INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS',\n",
       "  'Drug': 'ADRENALIN',\n",
       "  'ActiveIngredient': 'EPINEPHRINE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'PAR STERILE PRODUCTS',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2023/204640Orig1s018lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=204640'},\n",
       " '20465': {'ApplNo': '20465',\n",
       "  'Form': 'TABLET; ORAL',\n",
       "  'Drug': 'AZULFIDINE',\n",
       "  'ActiveIngredient': 'SULFASALAZINE ',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'PHARMACIA AND UPJOHN',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/pre96/007073s133,020465s000,021243s000lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20465'},\n",
       " '204655': {'ApplNo': '204655',\n",
       "  'Form': 'CAPSULE, DELAYED RELEASE;ORAL',\n",
       "  'Drug': 'NEXIUM 24HR',\n",
       "  'ActiveIngredient': 'ESOMEPRAZOLE MAGNESIUM',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'ASTRAZENECA LP',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/204655Orig1s018lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=204655'},\n",
       " '204671': {'ApplNo': '204671',\n",
       "  'Form': 'TABLET;ORAL',\n",
       "  'Drug': 'SOVALDI',\n",
       "  'ActiveIngredient': 'SOFOSBUVIR',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'GILEAD SCIENCES INC',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/204671s017,212480s002lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=204671'},\n",
       " '204677': {'ApplNo': '204677',\n",
       "  'Form': 'SOLUTION;INTRAVENOUS',\n",
       "  'Drug': 'NEURACEQ',\n",
       "  'ActiveIngredient': 'FLORBETABEN F-18',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'LIFE MOLECULAR',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/204677Orig1s021lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=204677'},\n",
       " '20468': {'ApplNo': '20468',\n",
       "  'Form': 'SPRAY, METERED;NASAL',\n",
       "  'Drug': 'NASACORT ALLERGY 24 HOUR',\n",
       "  'ActiveIngredient': 'TRIAMCINOLONE ACETONIDE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'CHATTEM SANOFI',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2018/020468Orig1s046lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20468'},\n",
       " '204684': {'ApplNo': '204684',\n",
       "  'Form': 'CAPSULE;ORAL',\n",
       "  'Drug': 'IMPAVIDO',\n",
       "  'ActiveIngredient': 'MILTEFOSINE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'KNIGHT THERAPS',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/204684s006lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=204684'},\n",
       " '20470': {'ApplNo': '20470',\n",
       "  'Form': 'TABLET, EXTENDED RELEASE;ORAL',\n",
       "  'Drug': 'CLARITIN-D 24 HOUR',\n",
       "  'ActiveIngredient': 'LORATADINE; PSEUDOEPHEDRINE SULFATE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'BAYER HEALTHCARE LLC',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2018/019670Orig1s034,020470Orig1s047Lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20470'},\n",
       " '204708': {'ApplNo': '204708',\n",
       "  'Form': 'GEL;TOPICAL',\n",
       "  'Drug': 'MIRVASO',\n",
       "  'ActiveIngredient': 'BRIMONIDINE TARTRATE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'GALDERMA LABS LP',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2016/204708s005lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=204708'},\n",
       " '20471': {'ApplNo': '20471',\n",
       "  'Form': 'TABLET;ORAL',\n",
       "  'Drug': 'ZYFLO',\n",
       "  'ActiveIngredient': 'ZILEUTON',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'CHIESI',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/020471s017lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20471'},\n",
       " '20472': {'ApplNo': '20472',\n",
       "  'Form': 'INSERT, EXTENDED RELEASE;VAGINAL',\n",
       "  'Drug': 'ESTRING',\n",
       "  'ActiveIngredient': 'ESTRADIOL',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'PFIZER',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/020472Orig1s019Lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20472'},\n",
       " '204734': {'ApplNo': '204734',\n",
       "  'Form': 'POWDER;ORAL',\n",
       "  'Drug': 'FOSRENOL',\n",
       "  'ActiveIngredient': 'LANTHANUM CARBONATE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'TAKEDA PHARMS USA',\n",
       "  'LatestLabel': 'https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/021468s023,204734s005lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=204734'},\n",
       " '20475': {'ApplNo': '20475',\n",
       "  'Form': 'GEL;TOPICAL',\n",
       "  'Drug': 'RETIN-A MICRO',\n",
       "  'ActiveIngredient': 'TRETINOIN',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'VALEANT INTL',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/020475s021lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20475'},\n",
       " '204760': {'ApplNo': '204760',\n",
       "  'Form': 'TABLET;ORAL',\n",
       "  'Drug': 'MOVANTIK',\n",
       "  'ActiveIngredient': 'NALOXEGOL OXALATE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'REDHILL',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/204760s009lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=204760'},\n",
       " '204767': {'ApplNo': '204767',\n",
       "  'Form': 'SOLUTION;INTRAVENOUS',\n",
       "  'Drug': 'ACETAMINOPHEN',\n",
       "  'ActiveIngredient': 'ACETAMINOPHEN',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'FRESENIUS KABI USA',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/204767s007lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=204767'},\n",
       " '20478': {'ApplNo': '20478',\n",
       "  'Form': 'LIQUID;INHALATION',\n",
       "  'Drug': 'ULTANE',\n",
       "  'ActiveIngredient': 'SEVOFLURANE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'ABBVIE',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/020478s034lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20478'},\n",
       " '204781': {'ApplNo': '204781',\n",
       "  'Form': 'SOLUTION;INTRAVENOUS',\n",
       "  'Drug': 'DOTAREM',\n",
       "  'ActiveIngredient': 'GADOTERATE MEGLUMINE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'GUERBET',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/204781s012lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=204781'},\n",
       " '204785': {'ApplNo': '204785',\n",
       "  'Form': 'CAPSULE;ORAL',\n",
       "  'Drug': 'TREZIX',\n",
       "  'ActiveIngredient': 'ACETAMINOPHEN; CAFFEINE; DIHYDROCODEINE BITARTRATE',\n",
       "  'ApplType': 'ANDA',\n",
       "  'Sponsor': 'XSPIRE PHARMA',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/204785Orig1s000lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=204785'},\n",
       " '204790': {'ApplNo': '204790',\n",
       "  'Form': 'TABLET;ORAL',\n",
       "  'Drug': 'TIVICAY',\n",
       "  'ActiveIngredient': 'DOLUTEGRAVIR SODIUM',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'VIIV HLTHCARE',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/204790s030,213983s003lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=204790'},\n",
       " '204803': {'ApplNo': '204803',\n",
       "  'Form': 'SOLUTION, EXTENDED RELEASE;INFILTRATION',\n",
       "  'Drug': 'POSIMIR',\n",
       "  'ActiveIngredient': 'BUPIVACAINE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'INNOCOLL',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/204803Orig1s001lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=204803'},\n",
       " '204819': {'ApplNo': '204819',\n",
       "  'Form': 'TABLET;ORAL',\n",
       "  'Drug': 'ADEMPAS',\n",
       "  'ActiveIngredient': 'RIOCIGUAT',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'BAYER HLTHCARE',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/204819s015lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=204819'},\n",
       " '204820': {'ApplNo': '204820',\n",
       "  'Form': 'CAPSULE;ORAL',\n",
       "  'Drug': 'MITIGARE',\n",
       "  'ActiveIngredient': 'COLCHICINE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'HIKMA INTL PHARMS',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/204820s000lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=204820'},\n",
       " '204824': {'ApplNo': '204824',\n",
       "  'Form': 'SOLUTION;SUBCUTANEOUS',\n",
       "  'Drug': 'OTREXUP',\n",
       "  'ActiveIngredient': 'METHOTREXATE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'OTTER PHARMS',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/204824s010lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=204824'},\n",
       " '20485': {'ApplNo': '20485',\n",
       "  'Form': 'SOLUTION/DROPS;OPHTHALMIC',\n",
       "  'Drug': 'VISINE',\n",
       "  'ActiveIngredient': 'NAPHAZOLINE HYDROCHLORIDE; PHENIRAMINE MALEATE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'JOHNSON AND JOHNSON',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2018/020485Orig1s013lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20485'},\n",
       " '20487': {'ApplNo': '20487',\n",
       "  'Form': 'TABLET;ORAL',\n",
       "  'Drug': 'VALTREX',\n",
       "  'ActiveIngredient': 'VALACYCLOVIR HYDROCHLORIDE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'GLAXOSMITHKLINE',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/020487s022lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20487'},\n",
       " '20488': {'ApplNo': '20488',\n",
       "  'Form': 'INJECTABLE;INJECTION',\n",
       "  'Drug': 'MAGNESIUM SULFATE IN DEXTROSE 5% IN PLASTIC CONTAINER',\n",
       "  'ActiveIngredient': 'MAGNESIUM SULFATE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'HOSPIRA',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/020488Orig1s024lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20488'},\n",
       " '204886': {'ApplNo': '204886',\n",
       "  'Form': 'TABLET;ORAL',\n",
       "  'Drug': 'ZONTIVITY',\n",
       "  'ActiveIngredient': 'VORAPAXAR SULFATE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'XSPIRE PHARMA',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/204886s005lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=204886'},\n",
       " '20489': {'ApplNo': '20489',\n",
       "  'Form': 'FILM, EXTENDED RELEASE;TRANSDERMAL',\n",
       "  'Drug': 'ANDRODERM',\n",
       "  'ActiveIngredient': 'TESTOSTERONE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'ALLERGAN',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/020489s036lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20489'},\n",
       " '20491': {'ApplNo': '20491',\n",
       "  'Form': 'INJECTABLE;INJECTION',\n",
       "  'Drug': 'CORVERT',\n",
       "  'ActiveIngredient': 'IBUTILIDE FUMARATE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'PFIZER',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/nda/2001/20-491S003.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20491'},\n",
       " '204957': {'ApplNo': '204957',\n",
       "  'Form': 'SOLUTION;INTRAVENOUS',\n",
       "  'Drug': 'ACETAMINOPHEN',\n",
       "  'ActiveIngredient': 'ACETAMINOPHEN',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'B BRAUN MEDICAL INC',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/204957s000lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=204957'},\n",
       " '204958': {'ApplNo': '204958',\n",
       "  'Form': 'POWDER;INTRAVENOUS',\n",
       "  'Drug': 'KENGREAL',\n",
       "  'ActiveIngredient': 'CANGRELOR',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'CHIESI',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/204958s002lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=204958'},\n",
       " '20496': {'ApplNo': '20496',\n",
       "  'Form': 'TABLET;ORAL',\n",
       "  'Drug': 'AMARYL',\n",
       "  'ActiveIngredient': 'GLIMEPIRIDE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'SANOFI AVENTIS US',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2018/020496s029lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20496'},\n",
       " '20497': {'ApplNo': '20497',\n",
       "  'Form': 'TABLET;ORAL',\n",
       "  'Drug': 'FARESTON',\n",
       "  'ActiveIngredient': 'TOREMIFENE CITRATE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'KYOWA KIRIN',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2017/020497s009lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20497'},\n",
       " '20498': {'ApplNo': '20498',\n",
       "  'Form': 'TABLET;ORAL',\n",
       "  'Drug': 'CASODEX',\n",
       "  'ActiveIngredient': 'BICALUTAMIDE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'ANI PHARMS',\n",
       "  'LatestLabel': 'https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/020498s028lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20498'},\n",
       " '204988': {'ApplNo': '204988',\n",
       "  'Form': 'TABLET;ORAL',\n",
       "  'Drug': 'RUFINAMIDE',\n",
       "  'ActiveIngredient': 'RUFINAMIDE',\n",
       "  'ApplType': 'ANDA',\n",
       "  'Sponsor': 'HIKMA',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2016/204988Orig1s000lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=204988'},\n",
       " '20500': {'ApplNo': '20500',\n",
       "  'Form': 'SUSPENSION;ORAL',\n",
       "  'Drug': 'MEPRON',\n",
       "  'ActiveIngredient': 'ATOVAQUONE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'GLAXOSMITHKLINE LLC',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/020500s019lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20500'},\n",
       " '205003': {'ApplNo': '205003',\n",
       "  'Form': 'TABLET;ORAL',\n",
       "  'Drug': 'PRESTALIA',\n",
       "  'ActiveIngredient': 'AMLODIPINE BESYLATE; PERINDOPRIL ARGININE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'ADHERA',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2017/205003s003lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=205003'},\n",
       " '205004': {'ApplNo': '205004',\n",
       "  'Form': 'POWDER;INTRAVENOUS',\n",
       "  'Drug': 'BORTEZOMIB',\n",
       "  'ActiveIngredient': 'BORTEZOMIB',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'FRESENIUS KABI USA',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/205004s003lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=205004'},\n",
       " '205029': {'ApplNo': '205029',\n",
       "  'Form': 'SOLUTION;INTRAVENOUS, INTRAOCULAR, INTRAMUSCULAR, SUBCUTANEOUS',\n",
       "  'Drug': 'EPINEPHRINE',\n",
       "  'ActiveIngredient': 'EPINEPHRINE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'BPI LABS',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/205029s006lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=205029'},\n",
       " '20503': {'ApplNo': '20503',\n",
       "  'Form': 'AEROSOL, METERED;INHALATION',\n",
       "  'Drug': 'PROVENTIL-HFA',\n",
       "  'ActiveIngredient': 'ALBUTEROL SULFATE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'KINDEVA',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2017/020503s054lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20503'},\n",
       " '20504': {'ApplNo': '20504',\n",
       "  'Form': 'CAPSULE;ORAL',\n",
       "  'Drug': 'MICROZIDE',\n",
       "  'ActiveIngredient': 'HYDROCHLOROTHIAZIDE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'TEVA BRANDED PHARM',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/020504s026lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20504'},\n",
       " '20505': {'ApplNo': '20505',\n",
       "  'Form': 'TABLET;ORAL',\n",
       "  'Drug': 'TOPAMAX',\n",
       "  'ActiveIngredient': 'TOPIRAMATE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'JANSSEN PHARMS',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/020505s064,020844s054lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20505'},\n",
       " '205053': {'ApplNo': '205053',\n",
       "  'Form': 'TABLET, DELAYED RELEASE;ORAL',\n",
       "  'Drug': 'NOXAFIL',\n",
       "  'ActiveIngredient': 'POSACONAZOLE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'MERCK SHARP DOHME',\n",
       "  'LatestLabel': 'https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/205053Orig1s013lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=205053'},\n",
       " '205054': {'ApplNo': '205054',\n",
       "  'Form': 'FOR SUSPENSION;INTRAMUSCULAR',\n",
       "  'Drug': 'LUTRATE DEPOT KIT',\n",
       "  'ActiveIngredient': 'LEUPROLIDE ACETATE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'INVAGEN PHARMS',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2018/205054s000lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=205054'},\n",
       " '205065': {'ApplNo': '205065',\n",
       "  'Form': 'POWDER;ORAL',\n",
       "  'Drug': 'KUVAN',\n",
       "  'ActiveIngredient': 'SAPROPTERIN DIHYDROCHLORIDE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'BIOMARIN PHARM',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/022181s020,205065s006lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=205065'},\n",
       " '205075': {'ApplNo': '205075',\n",
       "  'Form': 'TABLET;ORAL',\n",
       "  'Drug': 'RUFINAMIDE',\n",
       "  'ActiveIngredient': 'RUFINAMIDE',\n",
       "  'ApplType': 'ANDA',\n",
       "  'Sponsor': 'GLENMARK PHARMS LTD',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2016/205075Orig1s000lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=205075'},\n",
       " '205076': {'ApplNo': '205076',\n",
       "  'Form': 'CREAM;TOPICAL',\n",
       "  'Drug': 'OXICONAZOLE NITRATE',\n",
       "  'ActiveIngredient': 'OXICONAZOLE NITRATE',\n",
       "  'ApplType': 'ANDA',\n",
       "  'Sponsor': 'TARO PHARMS',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2016/205076Orig1s000lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=205076'},\n",
       " '205095': {'ApplNo': '205095',\n",
       "  'Form': 'TABLET;ORAL',\n",
       "  'Drug': 'RUFINAMIDE',\n",
       "  'ActiveIngredient': 'RUFINAMIDE',\n",
       "  'ApplType': 'ANDA',\n",
       "  'Sponsor': 'MYLAN',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2016/205095Orig1s000lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=205095'},\n",
       " '205098': {'ApplNo': '205098',\n",
       "  'Form': 'SOLUTION;INTRAVENOUS',\n",
       "  'Drug': 'VARITHENA',\n",
       "  'ActiveIngredient': 'POLIDOCANOL',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'PROVENSIS',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/205098s031lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=205098'},\n",
       " '205108': {'ApplNo': '205108',\n",
       "  'Form': 'SOLUTION;ORAL',\n",
       "  'Drug': 'SOTYLIZE',\n",
       "  'ActiveIngredient': 'SOTALOL HYDROCHLORIDE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'AZURITY',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/205108s000lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=205108'},\n",
       " '205109': {'ApplNo': '205109',\n",
       "  'Form': 'TABLET, CHEWABLE;ORAL',\n",
       "  'Drug': 'VELPHORO',\n",
       "  'ActiveIngredient': 'FERRIC OXYHYDROXIDE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'VIFOR FRESENIUS',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/205109s008lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=205109'},\n",
       " '205122': {'ApplNo': '205122',\n",
       "  'Form': 'CAPSULE, EXTENDED RELEASE;ORAL',\n",
       "  'Drug': 'QUDEXY XR',\n",
       "  'ActiveIngredient': 'TOPIRAMATE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'UPSHER SMITH LABS',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/205122s014lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=205122'},\n",
       " '20516': {'ApplNo': '20516',\n",
       "  'Form': 'SUSPENSION;ORAL',\n",
       "  'Drug': \"CHILDREN'S MOTRIN\",\n",
       "  'ActiveIngredient': 'IBUPROFEN',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'J AND J CONSUMER INC',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/020516Orig1s038lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20516'},\n",
       " '20517': {'ApplNo': '20517',\n",
       "  'Form': 'INJECTABLE;INJECTION',\n",
       "  'Drug': 'LUPRON DEPOT',\n",
       "  'ActiveIngredient': 'LEUPROLIDE ACETATE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'ABBVIE ENDOCRINE INC',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/019732s045,020517s043lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20517'},\n",
       " '205175': {'ApplNo': '205175',\n",
       "  'Form': 'AEROSOL, FOAM;TOPICAL',\n",
       "  'Drug': 'ECOZA',\n",
       "  'ActiveIngredient': 'ECONAZOLE NITRATE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'RESILIA PHARMS',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/205175s003lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=205175'},\n",
       " '20521': {'ApplNo': '20521',\n",
       "  'Form': 'SUSPENSION;INTRATRACHEAL',\n",
       "  'Drug': 'INFASURF PRESERVATIVE FREE',\n",
       "  'ActiveIngredient': 'CALFACTANT',\n",
       "  'ApplType': 'BLA',\n",
       "  'Sponsor': 'ONY',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/1998/20521lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20521'},\n",
       " '20522': {'ApplNo': '20522',\n",
       "  'Form': 'INJECTABLE;INJECTION',\n",
       "  'Drug': 'NUTROPIN AQ NUSPIN',\n",
       "  'ActiveIngredient': 'SOMATROPIN',\n",
       "  'ApplType': 'BLA',\n",
       "  'Sponsor': 'GENENTECH',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/nda/2000/20-522S013_Somatropin_prntlbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20522'},\n",
       " '205223': {'ApplNo': '205223',\n",
       "  'Form': 'GEL;VAGINAL',\n",
       "  'Drug': 'NUVESSA',\n",
       "  'ActiveIngredient': 'METRONIDAZOLE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'CHEMO RESEARCH SL',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/205223s006lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=205223'},\n",
       " '20524': {'ApplNo': '20524',\n",
       "  'Form': 'CREAM;TOPICAL',\n",
       "  'Drug': 'MENTAX',\n",
       "  'ActiveIngredient': 'BUTENAFINE HYDROCHLORIDE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'MYLAN',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2001/20524s5lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20524'},\n",
       " '205266': {'ApplNo': '205266',\n",
       "  'Form': 'CAPSULE;ORAL',\n",
       "  'Drug': 'ODOMZO',\n",
       "  'ActiveIngredient': 'SONIDEGIB PHOSPHATE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'SUN PHARM',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/205266s006lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=205266'},\n",
       " '20527': {'ApplNo': '20527',\n",
       "  'Form': 'TABLET;ORAL-28',\n",
       "  'Drug': 'PREMPRO',\n",
       "  'ActiveIngredient': 'ESTROGENS, CONJUGATED; MEDROXYPROGESTERONE ACETATE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'WYETH PHARMS',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2017/020527s065lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20527'},\n",
       " '20529': {'ApplNo': '20529',\n",
       "  'Form': 'GEL;TOPICAL',\n",
       "  'Drug': 'CONDYLOX',\n",
       "  'ActiveIngredient': 'PODOFILOX',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'ALLERGAN',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/1997/020529s000lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20529'},\n",
       " '205327': {'ApplNo': '205327',\n",
       "  'Form': 'TABLET, EXTENDED RELEASE;ORAL',\n",
       "  'Drug': 'METHYLPHENIDATE HYDROCHLORIDE',\n",
       "  'ActiveIngredient': 'METHYLPHENIDATE HYDROCHLORIDE',\n",
       "  'ApplType': 'ANDA',\n",
       "  'Sponsor': 'OSMOTICA',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2017/205327Orig1s000lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=205327'},\n",
       " '20533': {'ApplNo': '20533',\n",
       "  'Form': 'SOLUTION;INJECTION',\n",
       "  'Drug': 'NAROPIN',\n",
       "  'ActiveIngredient': 'ROPIVACAINE HYDROCHLORIDE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'FRESENIUS KABI USA',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/020533Orig1s044lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20533'},\n",
       " '205352': {'ApplNo': '205352',\n",
       "  'Form': 'TABLET;ORAL',\n",
       "  'Drug': 'ALEVE PM',\n",
       "  'ActiveIngredient': 'DIPHENHYDRAMINE HYDROCHLORIDE; NAPROXEN SODIUM',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'BAYER HLTHCARE',\n",
       "  'LatestLabel': 'https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/205352Orig1s016lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=205352'},\n",
       " '205379': {'ApplNo': '205379',\n",
       "  'Form': 'INJECTABLE;INTRAVENOUS',\n",
       "  'Drug': 'ESOMEPRAZOLE SODIUM',\n",
       "  'ActiveIngredient': 'ESOMEPRAZOLE SODIUM',\n",
       "  'ApplType': 'ANDA',\n",
       "  'Sponsor': 'ACCORD HLTHCARE',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/205379Orig1s000lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=205379'},\n",
       " '20538': {'ApplNo': '20538',\n",
       "  'Form': 'SYSTEM;TRANSDERMAL',\n",
       "  'Drug': 'VIVELLE-DOT',\n",
       "  'ActiveIngredient': 'ESTRADIOL',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'NOVARTIS',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/020538Orig1s040lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20538'},\n",
       " '205382': {'ApplNo': '205382',\n",
       "  'Form': 'POWDER;INHALATION',\n",
       "  'Drug': 'INCRUSE ELLIPTA',\n",
       "  'ActiveIngredient': 'UMECLIDINIUM BROMIDE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'GLAXO GRP ENGLAND',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/205382s010lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=205382'},\n",
       " '205388': {'ApplNo': '205388',\n",
       "  'Form': 'SOLUTION;IRRIGATION',\n",
       "  'Drug': 'OMIDRIA',\n",
       "  'ActiveIngredient': 'KETOROLAC TROMETHAMINE; PHENYLEPHRINE HYDROCHLORIDE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'RAYNER SURGICAL',\n",
       "  'LatestLabel': 'https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/205388s006lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=205388'},\n",
       " '205395': {'ApplNo': '205395',\n",
       "  'Form': 'TABLET;ORAL',\n",
       "  'Drug': 'PREZCOBIX',\n",
       "  'ActiveIngredient': 'COBICISTAT; DARUNAVIR',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'JANSSEN PRODS',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/205395s024lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=205395'},\n",
       " '20541': {'ApplNo': '20541',\n",
       "  'Form': 'TABLET;ORAL',\n",
       "  'Drug': 'ARIMIDEX',\n",
       "  'ActiveIngredient': 'ANASTROZOLE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'ANI PHARMS',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2018/020541s031lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20541'},\n",
       " '205410': {'ApplNo': '205410',\n",
       "  'Form': 'SOLUTION;ORAL',\n",
       "  'Drug': 'HEMANGEOL',\n",
       "  'ActiveIngredient': 'PROPRANOLOL HYDROCHLORIDE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'PIERRE FABRE DERMA',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/205410s006lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=205410'},\n",
       " '205422': {'ApplNo': '205422',\n",
       "  'Form': 'TABLET;ORAL',\n",
       "  'Drug': 'REXULTI',\n",
       "  'ActiveIngredient': 'BREXPIPRAZOLE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'OTSUKA',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/205422Orig1s008lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=205422'},\n",
       " '205433': {'ApplNo': '205433',\n",
       "  'Form': 'SOLUTION;INHALATION',\n",
       "  'Drug': 'KITABIS PAK',\n",
       "  'ActiveIngredient': 'TOBRAMYCIN',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'PULMOFLOW INC',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/205433s005lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=205433'},\n",
       " '205434': {'ApplNo': '205434',\n",
       "  'Form': 'SPRAY, METERED;NASAL',\n",
       "  'Drug': 'FLONASE ALLERGY RELIEF',\n",
       "  'ActiveIngredient': 'FLUTICASONE PROPIONATE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'GLAXOSMITHKLINE CONS',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2017/205434Orig1s005lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=205434'},\n",
       " '205435': {'ApplNo': '205435',\n",
       "  'Form': 'TABLET;ORAL',\n",
       "  'Drug': 'SIVEXTRO',\n",
       "  'ActiveIngredient': 'TEDIZOLID PHOSPHATE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'CUBIST PHARMS LLC',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/205435s014,205435s009lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=205435'},\n",
       " '205436': {'ApplNo': '205436',\n",
       "  'Form': 'POWDER;INTRAVENOUS',\n",
       "  'Drug': 'SIVEXTRO',\n",
       "  'ActiveIngredient': 'TEDIZOLID PHOSPHATE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'CUBIST PHARMS LLC',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/205435s014,205435s009lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=205436'},\n",
       " '205437': {'ApplNo': '205437',\n",
       "  'Form': 'TABLET;ORAL',\n",
       "  'Drug': 'OTEZLA',\n",
       "  'ActiveIngredient': 'APREMILAST',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'AMGEN INC',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/205437s011lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=205437'},\n",
       " '20547': {'ApplNo': '20547',\n",
       "  'Form': 'TABLET;ORAL',\n",
       "  'Drug': 'ACCOLATE',\n",
       "  'ActiveIngredient': 'ZAFIRLUKAST',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'STRIDES PHARMA',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/020547s033lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20547'},\n",
       " '205476': {'ApplNo': '205476',\n",
       "  'Form': 'POWDER;IV (INFUSION)',\n",
       "  'Drug': 'BENDAMUSTINE HYDROCHLORIDE',\n",
       "  'ActiveIngredient': 'BENDAMUSTINE HYDROCHLORIDE',\n",
       "  'ApplType': 'ANDA',\n",
       "  'Sponsor': 'INNOPHARMA LICENSING',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2016/205476Orig1s000lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=205476'},\n",
       " '205488': {'ApplNo': '205488',\n",
       "  'Form': 'GEL, METERED;NASAL',\n",
       "  'Drug': 'NATESTO',\n",
       "  'ActiveIngredient': 'TESTOSTERONE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'ACERUS',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2016/205488s002lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=205488'},\n",
       " '205489': {'ApplNo': '205489',\n",
       "  'Form': 'TABLET, ORALLY DISINTEGRATING, EXTENDED RELEASE;ORAL',\n",
       "  'Drug': 'COTEMPLA XR-ODT',\n",
       "  'ActiveIngredient': 'METHYLPHENIDATE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'NEOS THERAPS INC',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/205489s007lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=205489'},\n",
       " '205490': {'ApplNo': '205490',\n",
       "  'Form': 'TABLET, ORALLY DISINTEGRATING;ORAL',\n",
       "  'Drug': 'CETIRIZINE HYDROCHLORIDE ALLERGY',\n",
       "  'ActiveIngredient': 'CETIRIZINE HYDROCHLORIDE',\n",
       "  'ApplType': 'ANDA',\n",
       "  'Sponsor': 'PERRIGO R AND D',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/205490Orig1s000lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=205490'},\n",
       " '205494': {'ApplNo': '205494',\n",
       "  'Form': 'CAPSULE;ORAL',\n",
       "  'Drug': 'CERDELGA',\n",
       "  'ActiveIngredient': 'ELIGLUSTAT TARTRATE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'GENZYME CORP',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2018/205494s003lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=205494'},\n",
       " '20550': {'ApplNo': '20550',\n",
       "  'Form': 'Tablet; Oral',\n",
       "  'Drug': 'VALTREX',\n",
       "  'ActiveIngredient': 'VALACYCLOVIR HYDROCHLORIDE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'GLAXOSMITHKLINE',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2003/020550s019lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20550'},\n",
       " '20551': {'ApplNo': '20551',\n",
       "  'Form': 'INJECTABLE;INJECTION',\n",
       "  'Drug': 'NIMBEX',\n",
       "  'ActiveIngredient': 'CISATRACURIUM BESYLATE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'ABBVIE',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/020551s028lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20551'},\n",
       " '205525': {'ApplNo': '205525',\n",
       "  'Form': 'SOLUTION;ORAL',\n",
       "  'Drug': 'SYNDROS',\n",
       "  'ActiveIngredient': 'DRONABINOL',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'BENUVIA OPERATIONS',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/205525s011lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=205525'},\n",
       " '20554': {'ApplNo': '20554',\n",
       "  'Form': 'CREAM;TOPICAL',\n",
       "  'Drug': 'DOVONEX',\n",
       "  'ActiveIngredient': 'CALCIPOTRIENE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'LEO PHARMA AS',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/020273s013,020554s012lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20554'},\n",
       " '20555': {'ApplNo': '20555',\n",
       "  'Form': 'TABLET;ORAL',\n",
       "  'Drug': 'AXID AR',\n",
       "  'ActiveIngredient': 'NIZATIDINE',\n",
       "  'ApplType': 'NDA',\n",
       "  'Sponsor': 'GLAXOSMITHKLINE',\n",
       "  'LatestLabel': 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/020555Orig1s010lbl.pdf',\n",
       "  'LinkToFDA': 'https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20555'},\n",
       " ...}"
      ]
     },
     "execution_count": 23,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "applno_fda_dict"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 24,
   "id": "43b6d2cd",
   "metadata": {},
   "outputs": [],
   "source": [
    "with open(os.path.join(working_directory, 'drug_fda_dict.json'), 'w') as f:\n",
    "    json.dump(drug_fda_dict, f)\n",
    "    \n",
    "with open(os.path.join(working_directory, 'applno_fda_dict.json'), 'w') as f:\n",
    "    json.dump(applno_fda_dict, f)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 15,
   "id": "24154353",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "{'COZAAR',\n",
       " 'CLINOLIPID 20%',\n",
       " 'QVAR REDIHALER',\n",
       " 'DORAL',\n",
       " 'OXISTAT',\n",
       " 'PRIMAQUINE',\n",
       " 'HYDROCORTISONE VALERATE',\n",
       " 'SENSIPAR',\n",
       " 'BICILLIN L-A',\n",
       " 'CORTENEMA',\n",
       " 'SABRIL',\n",
       " 'UROCIT-K',\n",
       " 'ADCIRCA',\n",
       " 'SAIZEN',\n",
       " 'PLEGRIDY',\n",
       " 'XIPERE',\n",
       " 'BETAPACE',\n",
       " 'ZOMETA',\n",
       " 'INVELTYS',\n",
       " 'CEFAZOLIN AND DEXTROSE',\n",
       " 'MUCINEX',\n",
       " 'NYVEPRIA',\n",
       " 'NIPRIDE RTU IN SODIUM CHLORIDE 0.9%',\n",
       " 'PANRETIN',\n",
       " 'OXBRYTA',\n",
       " 'MONJUVI',\n",
       " 'PERJETA',\n",
       " 'SPY AGENT GREEN KIT',\n",
       " 'FOCALIN',\n",
       " 'ACETAMINOPHEN',\n",
       " 'GRANISETRON HYDROCHLORIDE',\n",
       " 'MINOCIN',\n",
       " 'NPLATE',\n",
       " 'FLUOXETINE HYDROCHLORIDE',\n",
       " 'NALFON',\n",
       " 'ACTIVELLA',\n",
       " 'VFEND',\n",
       " 'NAFTIN',\n",
       " 'BACTOCILL IN PLASTIC CONTAINER',\n",
       " 'MORPHINE SULFATE',\n",
       " 'XATMEP',\n",
       " 'ZERBAXA',\n",
       " 'EMGALITY',\n",
       " 'MOTRIN IB',\n",
       " 'RHOPRESSA',\n",
       " 'TYLENOL',\n",
       " 'RITONAVIR',\n",
       " 'LOTEMAX',\n",
       " 'DEXLANSOPRAZOLE',\n",
       " 'PEXEVA',\n",
       " 'SERTRALINE HYDROCHLORIDE',\n",
       " 'ONPATTRO',\n",
       " 'ADVIL',\n",
       " 'LEVOTHYROXINE SODIUM',\n",
       " 'CEFTRIAXONE AND DEXTROSE IN DUPLEX CONTAINER',\n",
       " 'DEXTROSE 5% IN SODIUM CHLORIDE 0.2% IN PLASTIC CONTAINER',\n",
       " 'TERLIVAZ',\n",
       " 'CEFIXIME',\n",
       " 'ZONALON',\n",
       " 'HUMIRA',\n",
       " 'ENTRESTO',\n",
       " 'PEGINTRON',\n",
       " 'EPANED',\n",
       " 'IGALMI',\n",
       " 'PRIFTIN',\n",
       " 'LOTEMAX SM',\n",
       " 'TRANSDERM SCOP',\n",
       " 'XYZAL ALLERGY 24HR',\n",
       " 'MIDAZOLAM HYDROCHLORIDE',\n",
       " 'TRINTELLIX',\n",
       " 'EXPAREL',\n",
       " 'NATACYN',\n",
       " 'RYALTRIS',\n",
       " 'LANSOPRAZOLE',\n",
       " 'ARANESP',\n",
       " 'CETRAXAL',\n",
       " 'DEXTROSE 70% IN PLASTIC CONTAINER',\n",
       " 'PRIMATENE MIST',\n",
       " 'GRALISE',\n",
       " 'DANYELZA',\n",
       " 'AROMASIN',\n",
       " 'KINERET',\n",
       " 'PERCOCET',\n",
       " 'LASIX',\n",
       " 'ADCETRIS',\n",
       " 'TACLONEX',\n",
       " 'MULTIHANCE MULTIPACK',\n",
       " 'VELCADE',\n",
       " 'CLOLAR',\n",
       " 'RELEXXII',\n",
       " 'INLYTA',\n",
       " 'CLENPIQ',\n",
       " 'XYLOCAINE',\n",
       " 'WELLBUTRIN XL',\n",
       " 'IFEX',\n",
       " 'SODIUM NITRITE',\n",
       " 'TIMOPTIC-XE',\n",
       " 'UREX',\n",
       " 'ORAPRED ODT',\n",
       " 'DOPRAM',\n",
       " 'ELELYSO',\n",
       " 'MAXITROL',\n",
       " 'FIASP',\n",
       " 'PRAXBIND',\n",
       " 'TISSUEBLUE',\n",
       " 'TRIZIVIR',\n",
       " 'ANAFRANIL',\n",
       " 'VORAXAZE',\n",
       " 'PRASUGREL',\n",
       " 'COMBIGAN',\n",
       " 'RINVOQ',\n",
       " 'ARAVA',\n",
       " 'DRAX EXAMETAZIME',\n",
       " 'ATIVAN',\n",
       " 'NOREPINEPHRINE BITARTRATE IN 0.9% SODIUM CHLORIDE',\n",
       " 'DIVIGEL',\n",
       " 'LYRICA CR',\n",
       " 'THYQUIDITY',\n",
       " 'TREANDA',\n",
       " 'TENOFOVIR DISOPROXIL FUMARATE',\n",
       " 'ROCKLATAN',\n",
       " 'CLARITIN-D',\n",
       " 'VIBERZI',\n",
       " 'ALOMIDE',\n",
       " 'ALTOPREV',\n",
       " 'SERNIVO',\n",
       " 'SOLOSEC',\n",
       " 'SPIRIVA RESPIMAT',\n",
       " 'CHLORAPREP ONE-STEP',\n",
       " 'DOVONEX',\n",
       " 'RAYOS',\n",
       " 'GOPRELTO',\n",
       " 'HORIZANT',\n",
       " 'CARBAGLU',\n",
       " 'AVIANE-28',\n",
       " 'DYANAVEL XR',\n",
       " 'ROBINUL',\n",
       " 'FLUDARABINE PHOSPHATE',\n",
       " 'CEFPODOXIME PROXETIL',\n",
       " 'TEPMETKO',\n",
       " 'LOMOTIL',\n",
       " 'CEFAZOLIN SODIUM',\n",
       " 'BIKTARVY',\n",
       " 'CILOXAN',\n",
       " 'SOMATULINE DEPOT',\n",
       " 'AKLIEF',\n",
       " 'EYLEA',\n",
       " 'HARVONI',\n",
       " 'FOSRENOL',\n",
       " 'RETIN-A MICRO',\n",
       " 'RIABNI',\n",
       " 'DURYSTA',\n",
       " 'EXKIVITY',\n",
       " 'TRODELVY',\n",
       " 'XIMINO',\n",
       " 'PLAQUENIL',\n",
       " 'QINLOCK',\n",
       " 'TIKOSYN',\n",
       " 'ROBAXIN',\n",
       " 'SYMPROIC',\n",
       " 'BICALUTAMIDE',\n",
       " 'CEFTRIAXONE',\n",
       " 'EMCYT',\n",
       " 'MEKTOVI',\n",
       " 'SYNERCID',\n",
       " 'PROCHLORPERAZINE EDISYLATE',\n",
       " 'VIGAMOX',\n",
       " 'SOLIQUA 100/33',\n",
       " 'GONAL-F RFF REDI-JECT',\n",
       " 'TRAMADOL HYDROCHLORIDE',\n",
       " 'EXFORGE',\n",
       " 'CIBINQO',\n",
       " 'MAVYRET',\n",
       " 'HYCAMTIN',\n",
       " 'QNASL',\n",
       " 'SKYLA',\n",
       " 'ALLEGRA-D 24 HOUR ALLERGY AND CONGESTION',\n",
       " 'BETAMETHASONE DIPROPIONATE',\n",
       " 'STIVARGA',\n",
       " 'REYATAZ',\n",
       " 'METHYLPHENIDATE HYDROCHLORIDE',\n",
       " 'ODOMZO',\n",
       " 'TIMOLOL MALEATE',\n",
       " \"CHILDREN'S ADVIL ALLERGY SINUS\",\n",
       " 'STRENSIQ',\n",
       " 'ZOMACTON',\n",
       " \"CHILDREN'S ZYRTEC HIVES RELIEF\",\n",
       " 'VIRACEPT',\n",
       " 'VENOFER',\n",
       " 'GENTAMICIN SULFATE',\n",
       " 'CEREBYX',\n",
       " 'ZYPITAMAG',\n",
       " 'CALCIUM DISODIUM VERSENATE',\n",
       " 'FORTAZ',\n",
       " 'CYTOMEL',\n",
       " 'SYNAGIS',\n",
       " 'INDOMETHACIN',\n",
       " 'ZOLOFT',\n",
       " 'DEPAKOTE',\n",
       " 'VALCHLOR',\n",
       " 'APLENZIN',\n",
       " \"CHILDREN'S ADVIL\",\n",
       " 'CLOROTEKAL',\n",
       " 'MOMETASONE FUROATE',\n",
       " 'CORDRAN',\n",
       " 'ENVARSUS XR',\n",
       " 'VIBRAMYCIN',\n",
       " 'KIMMTRAK',\n",
       " 'MULTAQ',\n",
       " 'EXJADE',\n",
       " 'EVOTAZ',\n",
       " 'NUCYNTA ER',\n",
       " 'STELARA',\n",
       " 'OLUX E',\n",
       " 'MIDAMOR',\n",
       " 'REGRANEX',\n",
       " 'ABILIFY MAINTENA KIT',\n",
       " 'COLYTE WITH FLAVOR PACKS',\n",
       " 'LIDEX',\n",
       " 'ACTEMRA',\n",
       " 'CLEOCIN T',\n",
       " 'BUPROPION HYDROCHLORIDE',\n",
       " 'DELFLEX W/ DEXTROSE 1.5% LOW MAGNESIUM LOW CALCIUM IN PLASTIC CONTAINER',\n",
       " 'PREVANTICS SWAB',\n",
       " 'THAM',\n",
       " 'NOXAFIL',\n",
       " 'MAGNESIUM SULFATE IN PLASTIC CONTAINER',\n",
       " 'BESIVANCE',\n",
       " 'IMPAVIDO',\n",
       " 'MYCAMINE',\n",
       " 'NEXTSTELLIS',\n",
       " 'TRILEPTAL',\n",
       " 'DESOXYN',\n",
       " 'PARAGARD T 380A',\n",
       " 'ARTESUNATE',\n",
       " 'ELITEK',\n",
       " 'SANDIMMUNE',\n",
       " 'DEXTROAMPHETAMINE SULFATE',\n",
       " 'TASMAR',\n",
       " 'PAMIDRONATE DISODIUM',\n",
       " 'REGONOL',\n",
       " 'TZIELD',\n",
       " 'GONAL-F RFF',\n",
       " 'RUFINAMIDE',\n",
       " 'OXCARBAZEPINE',\n",
       " 'CIPRO',\n",
       " 'ECONAZOLE NITRATE',\n",
       " 'TOFRANIL',\n",
       " 'KANUMA',\n",
       " 'SOLU-CORTEF',\n",
       " 'METHADOSE',\n",
       " 'CLINDAGEL',\n",
       " 'ALAVERT',\n",
       " 'GELNIQUE',\n",
       " 'VICTOZA',\n",
       " 'PERFOROMIST',\n",
       " 'CHLORHEXIDINE GLUCONATE',\n",
       " 'DIASTAT',\n",
       " 'BYSTOLIC',\n",
       " 'VIDAZA',\n",
       " 'TEZSPIRE',\n",
       " 'NUTROPIN',\n",
       " 'PREMPRO/PREMPHASE',\n",
       " 'EGRIFTA',\n",
       " 'CONCERTA',\n",
       " 'MS CONTIN',\n",
       " 'OCUFLOX',\n",
       " 'AZOPT',\n",
       " 'AURYXIA',\n",
       " 'FOSAMAX PLUS D',\n",
       " 'VECTICAL',\n",
       " 'PROCARDIA',\n",
       " 'CELESTONE SOLUSPAN',\n",
       " 'NORVASC',\n",
       " 'ACHROMYCIN V',\n",
       " 'EPIVIR',\n",
       " 'NUBEQA',\n",
       " 'ONUREG',\n",
       " 'ACTONEL',\n",
       " 'ZYLOPRIM',\n",
       " 'DULERA',\n",
       " 'VERDESO',\n",
       " 'KEPPRA XR',\n",
       " 'FLOLAN',\n",
       " 'STERITALC',\n",
       " 'CHORIONIC GONADOTROPIN',\n",
       " 'TOBRADEX ST',\n",
       " 'VTAMA',\n",
       " 'AXUMIN',\n",
       " 'LOTRIMIN AF',\n",
       " 'LEVOPHED',\n",
       " 'ARMONAIR DIGIHALER',\n",
       " 'PROHANCE MULTIPACK',\n",
       " 'LAMICTAL ODT',\n",
       " 'CIPRO XR',\n",
       " 'PROGESTERONE',\n",
       " 'CORPHEDRA',\n",
       " 'TEGRETOL-XR',\n",
       " 'TOLSURA',\n",
       " 'ZERVIATE',\n",
       " 'PROPARACAINE HYDROCHLORIDE',\n",
       " 'OGIVRI',\n",
       " 'EXELDERM',\n",
       " 'NOVOLOG',\n",
       " 'CAFCIT',\n",
       " 'ZEPATIER',\n",
       " 'ACTIGALL',\n",
       " 'PROCYSBI',\n",
       " 'LEVOCARNITINE',\n",
       " 'NUCALA',\n",
       " 'XOPENEX HFA',\n",
       " 'ADVIL ALLERGY AND CONGESTION RELIEF',\n",
       " 'OXYCONTIN',\n",
       " 'DOBUTAMINE HYDROCHLORIDE IN DEXTROSE 5% IN PLASTIC CONTAINER',\n",
       " 'TETRACAINE HYDROCHLORIDE',\n",
       " 'ZYCLARA',\n",
       " 'LOCAMETZ',\n",
       " 'GLIADEL',\n",
       " 'LICART',\n",
       " 'DEFITELIO',\n",
       " 'TRANEXAMIC ACID',\n",
       " 'ENTADFI',\n",
       " 'SIGNIFOR',\n",
       " 'XOPENEX',\n",
       " 'CONJUPRI',\n",
       " 'RESTASIS',\n",
       " 'ENALAPRIL MALEATE AND HYDROCHLOROTHIAZIDE',\n",
       " 'COREG',\n",
       " 'OLUMIANT',\n",
       " 'MYAMBUTOL',\n",
       " 'SODIUM SULFATE, POTASSIUM SULFATE AND MAGNESIUM SULFATE ',\n",
       " 'VIZIMPRO',\n",
       " 'PREMARIN',\n",
       " 'QDOLO',\n",
       " 'JELMYTO',\n",
       " 'POTASSIUM PHOSPHATES',\n",
       " 'VISINE',\n",
       " 'ANECTINE',\n",
       " 'BIORPHEN',\n",
       " 'IHEEZO',\n",
       " 'ZEJULA',\n",
       " 'SELZENTRY',\n",
       " 'SARCLISA',\n",
       " 'ACULAR LS',\n",
       " 'CARAFATE',\n",
       " 'MARCAINE',\n",
       " 'VIMOVO',\n",
       " 'YUSIMRY',\n",
       " 'ASMANEX TWISTHALER',\n",
       " 'METHYLPREDNISOLONE',\n",
       " 'ZEGALOGUE',\n",
       " 'GAZYVA',\n",
       " 'RELYVRIO',\n",
       " 'OMLONTI',\n",
       " 'SANDOSTATIN',\n",
       " 'PACERONE',\n",
       " 'PROMACTA',\n",
       " 'AYVAKIT',\n",
       " 'ROZEREM',\n",
       " 'OMEPRAZOLE AND SODIUM BICARBONATE',\n",
       " 'MITIGARE',\n",
       " 'FRAGMIN',\n",
       " 'FOTIVDA',\n",
       " 'LESCOL XL',\n",
       " 'MARPLAN',\n",
       " 'PHOTREXA',\n",
       " 'CETROTIDE',\n",
       " 'BEYAZ',\n",
       " 'SUBLIMAZE PRESERVATIVE FREE',\n",
       " 'CYTALUX',\n",
       " 'DEPO-MEDROL',\n",
       " 'ERYTHROCIN STEARATE',\n",
       " 'HYFTOR',\n",
       " 'ZORTRESS',\n",
       " 'LEUCOVORIN CALCIUM PRESERVATIVE FREE',\n",
       " 'RANEXA',\n",
       " 'PROTONIX IV',\n",
       " 'HUMULIN R',\n",
       " 'DIOVAN HCT',\n",
       " 'FIRDAPSE',\n",
       " 'EMPAVELI',\n",
       " 'SOGROYA',\n",
       " 'SYLVANT',\n",
       " 'SYMJEPI',\n",
       " 'TRANDATE',\n",
       " 'ABRAXANE',\n",
       " 'NULOJIX',\n",
       " 'CERDELGA',\n",
       " 'APRISO',\n",
       " 'GLUCAGEN',\n",
       " 'GOCOVRI',\n",
       " 'DETROL',\n",
       " 'FENOGLIDE',\n",
       " 'PEMETREXED DISODIUM',\n",
       " 'DEXTROSE 5% AND ELECTROLYTE NO. 48 IN PLASTIC CONTAINER',\n",
       " 'BSS',\n",
       " 'GLYCINE 1.5% IN PLASTIC CONTAINER',\n",
       " 'TRAZIMERA',\n",
       " 'MIOCHOL-E',\n",
       " 'COMBIPATCH',\n",
       " 'ONDANSETRON HYDROCHLORIDE',\n",
       " 'ZYVOX',\n",
       " 'ALTACE',\n",
       " 'COMPLERA',\n",
       " 'DSUVIA',\n",
       " 'INCRELEX',\n",
       " 'VALCYTE',\n",
       " 'CAPECITABINE',\n",
       " 'CLINIMIX E 2.75/5 SULFITE FREE W/ ELECT IN DEXTROSE 5% W/ CALCIUM IN PLASTIC CONTAINER',\n",
       " 'MIACALCIN',\n",
       " 'LAMISIL',\n",
       " 'MACROBID',\n",
       " 'TOPICORT',\n",
       " 'TELMISARTAN',\n",
       " 'OSELTAMIVIR PHOSPHATE',\n",
       " 'REZLIDHIA',\n",
       " 'EXSERVAN',\n",
       " 'JAKAFI',\n",
       " 'Xeomin',\n",
       " 'ULTRAVIST (PHARMACY BULK)',\n",
       " 'ENSPRYNG',\n",
       " 'CLOFARABINE',\n",
       " 'KUVAN',\n",
       " 'DESOGESTREL AND ETHINYL ESTRADIOL',\n",
       " 'CEFUROXIME AND DEXTROSE IN DUPLEX CONTAINER',\n",
       " 'INVOKANA',\n",
       " 'MEPHYTON',\n",
       " 'METHADONE HYDROCHLORIDE',\n",
       " 'MYTESI',\n",
       " 'FENOFIBRATE (MICRONIZED)',\n",
       " 'TWIRLA',\n",
       " 'DUETACT',\n",
       " 'AIRDUO RESPICLICK',\n",
       " 'E.E.S. 400',\n",
       " 'TAMIFLU',\n",
       " 'HUMALOG MIX 50/50',\n",
       " 'LINCOCIN',\n",
       " 'ORAQIX',\n",
       " 'PAXIL',\n",
       " 'DARTISLA ODT',\n",
       " 'TIVICAY',\n",
       " 'ZOMIG-ZMT',\n",
       " 'XYOSTED (AUTOINJECTOR)',\n",
       " 'JULUCA',\n",
       " 'MESNA',\n",
       " 'PALYNZIQ',\n",
       " 'BUTRANS',\n",
       " 'SEGLUROMET',\n",
       " 'COMETRIQ',\n",
       " 'VIVELLE-DOT',\n",
       " 'ZOMIG',\n",
       " 'MYLOTARG',\n",
       " 'PRIMAXIN',\n",
       " 'ANTIVERT',\n",
       " 'AUVI-Q',\n",
       " 'STRIBILD',\n",
       " 'RYTHMOL SR',\n",
       " 'PREVYMIS',\n",
       " 'NEPHROSCAN',\n",
       " 'SPRITAM',\n",
       " 'TEPADINA',\n",
       " 'GIMOTI',\n",
       " 'SENSORCAINE',\n",
       " 'SYMBICORT',\n",
       " 'TIGLUTIK KIT',\n",
       " 'LUCEMYRA',\n",
       " 'BYOOVIZ',\n",
       " 'TECHNETIUM TC-99M MERTIATIDE KIT',\n",
       " 'WELCHOL',\n",
       " 'JANUVIA',\n",
       " 'OMNIPAQUE 300',\n",
       " 'OXSORALEN-ULTRA',\n",
       " 'FABIOR',\n",
       " 'LEQEMBI',\n",
       " 'REMERON SOLTAB',\n",
       " 'EMTRIVA',\n",
       " 'VIMIZIM',\n",
       " 'HETLIOZ',\n",
       " 'VAGIFEM',\n",
       " 'DIGOXIN',\n",
       " 'LABETALOL HYDROCHLORIDE',\n",
       " 'REOPRO',\n",
       " 'FERRIPROX',\n",
       " 'ERYTHROMYCIN ETHYLSUCCINATE',\n",
       " 'TIMOPTIC IN OCUDOSE',\n",
       " 'EMEND',\n",
       " 'ZIAGEN',\n",
       " 'FENTANYL CITRATE',\n",
       " 'REZUROCK',\n",
       " 'TAVNEOS',\n",
       " 'SYNJARDY XR',\n",
       " 'TROKENDI XR',\n",
       " 'IBANDRONATE SODIUM',\n",
       " 'MULTIHANCE',\n",
       " \"CHILDREN'S ZYRTEC ALLERGY\",\n",
       " 'ADVAIR DISKUS 100/50',\n",
       " 'EMSAM',\n",
       " 'ESTROGEL',\n",
       " 'TRELEGY ELLIPTA',\n",
       " 'LEVONORGESTREL AND ETHINYL ESTRADIOL',\n",
       " 'VITRASE',\n",
       " 'QUVIVIQ',\n",
       " 'SIMPONI ARIA',\n",
       " 'BRUKINSA',\n",
       " 'ELIDEL',\n",
       " 'PORTRAZZA',\n",
       " 'ONFI',\n",
       " 'JATENZO',\n",
       " 'ATRIPLA',\n",
       " 'EPRONTIA',\n",
       " 'TARPEYO',\n",
       " 'SUSTIVA',\n",
       " 'TYMLOS',\n",
       " 'RISPERDAL CONSTA',\n",
       " 'ASTEPRO ALLERGY',\n",
       " 'SUMATRIPTAN SUCCINATE',\n",
       " 'METOPIRONE',\n",
       " 'ENTYVIO',\n",
       " 'SEPTRA',\n",
       " 'ZYRTEC-D 12 HOUR',\n",
       " 'ERYTHROCIN',\n",
       " 'CARDIOLITE',\n",
       " 'OSPHENA',\n",
       " 'PROLEUKIN',\n",
       " 'ACTHREL',\n",
       " 'CERIANNA',\n",
       " 'RIFADIN',\n",
       " 'PITAVASTATIN CALCIUM',\n",
       " 'RADICAVA',\n",
       " 'SPRYCEL',\n",
       " 'ZENPEP',\n",
       " 'ADASUVE',\n",
       " 'CHOLINE C-11',\n",
       " 'MANNITOL 5% IN PLASTIC CONTAINER',\n",
       " 'ZEGERID',\n",
       " 'ALTRENO',\n",
       " 'CLARINEX',\n",
       " 'TRI-NORINYL 28-DAY',\n",
       " 'EGATEN',\n",
       " 'ORAVIG',\n",
       " 'LIDOCAINE HYDROCHLORIDE 0.2% AND DEXTROSE 5% IN PLASTIC CONTAINER',\n",
       " 'DURACLON',\n",
       " 'SYNDROS',\n",
       " 'SEVELAMER CARBONATE',\n",
       " 'TRAVATAN Z',\n",
       " 'NEULASTA',\n",
       " 'ZARXIO',\n",
       " 'EPIVIR-HBV',\n",
       " 'NAPROSYN',\n",
       " 'FORFIVO XL',\n",
       " 'CONTRAVE',\n",
       " 'ZEMPLAR',\n",
       " 'CELONTIN',\n",
       " 'DICLOFENAC POTASSIUM',\n",
       " 'RYDAPT',\n",
       " 'LUMOXITI',\n",
       " 'CUVRIOR',\n",
       " 'RECORLEV',\n",
       " 'SEMGLEE',\n",
       " 'AIMOVIG',\n",
       " 'DEXTENZA',\n",
       " 'EFFEXOR XR',\n",
       " 'POTASSIUM CHLORIDE 0.15% IN SODIUM CHLORIDE 0.9%',\n",
       " 'CLEOCIN',\n",
       " 'SYMBYAX',\n",
       " 'CISPLATIN',\n",
       " 'AKYNZEO',\n",
       " 'HEPARIN SODIUM',\n",
       " 'LEXISCAN',\n",
       " 'BLENREP',\n",
       " 'SEGLENTIS',\n",
       " 'POLYETHYLENE GLYCOL 3350',\n",
       " 'LAMIVUDINE',\n",
       " 'EVAMIST',\n",
       " 'IDHIFA',\n",
       " 'INTRAROSA',\n",
       " 'TOVIAZ',\n",
       " 'ELAHERE',\n",
       " 'TRAVASOL 5.5% IN PLASTIC CONTAINER',\n",
       " 'LATISSE',\n",
       " 'LOPID',\n",
       " 'SAXENDA',\n",
       " 'NASONEX 24HR ALLERGY',\n",
       " 'MYXREDLIN',\n",
       " 'NITROGLYCERIN',\n",
       " 'AXID AR',\n",
       " 'BETHKIS',\n",
       " 'SULFAMETHOXAZOLE AND TRIMETHOPRIM',\n",
       " 'LEVETIRACETAM IN SODIUM CHLORIDE',\n",
       " 'VERAPAMIL HYDROCHLORIDE',\n",
       " 'ZIANA',\n",
       " 'POMALYST',\n",
       " 'DULOXETINE HYDROCHLORIDE',\n",
       " 'GONAL-F',\n",
       " 'DETROL LA',\n",
       " 'FELBATOL',\n",
       " 'READI-CAT 2',\n",
       " 'DUODOTE',\n",
       " 'FASLODEX',\n",
       " 'BUSULFEX',\n",
       " 'FIORICET W/ CODEINE',\n",
       " 'GEMCITABINE HYDROCHLORIDE',\n",
       " 'BACLOFEN',\n",
       " 'MENTAX',\n",
       " 'TRETINOIN',\n",
       " 'FOSPHENYTOIN SODIUM',\n",
       " 'NEXPLANON',\n",
       " 'CEFAZOLIN IN PLASTIC CONTAINER',\n",
       " 'MINIPRESS',\n",
       " 'NIACOR',\n",
       " 'ALPHAGAN P',\n",
       " 'VERQUVO',\n",
       " 'AKOVAZ',\n",
       " 'DIPROLENE',\n",
       " 'NOVOLOG MIX 70/30',\n",
       " 'VYLEESI (AUTOINJECTOR)',\n",
       " 'TASCENSO ODT',\n",
       " 'CORTEF',\n",
       " 'HALCION',\n",
       " 'FLUORESCEIN SODIUM AND BENOXINATE HYDROCHLORIDE',\n",
       " 'THIOTEPA',\n",
       " 'ADDYI',\n",
       " 'RELISTOR',\n",
       " \"POTASSIUM CHLORIDE 5MEQ IN DEXTROSE 5% AND LACTATED RINGER'S IN PLASTIC CONTAINER\",\n",
       " 'TRIUMEQ PD',\n",
       " 'XTANDI',\n",
       " 'TIROSINT-SOL',\n",
       " 'TREMFYA',\n",
       " 'ZINPLAVA',\n",
       " 'TARGRETIN',\n",
       " 'ABLYSINOL',\n",
       " 'GADAVIST',\n",
       " 'GLYXAMBI',\n",
       " 'KALETRA',\n",
       " 'PARNATE',\n",
       " 'ALECENSA',\n",
       " 'DEPO-TESTOSTERONE',\n",
       " 'ORTIKOS',\n",
       " 'ROXICODONE',\n",
       " 'LEVEMIR',\n",
       " 'MEMANTINE HYDROCHLORIDE',\n",
       " 'FORADIL',\n",
       " 'GEMTESA',\n",
       " 'XADAGO',\n",
       " 'BICNU',\n",
       " 'LEUCOVORIN CALCIUM',\n",
       " 'BAQSIMI',\n",
       " 'CARBATROL',\n",
       " 'EPZICOM',\n",
       " 'LOTRISONE',\n",
       " 'QBRELIS',\n",
       " \"CHILDREN'S CETIRIZINE HYDROCHLORIDE ALLERGY\",\n",
       " 'SPRIX',\n",
       " 'SODIUM IODIDE I 123',\n",
       " 'SYNJARDY',\n",
       " 'PENICILLIN V POTASSIUM',\n",
       " 'VALSARTAN',\n",
       " 'AMPHADASE',\n",
       " 'EMERPHED',\n",
       " 'KITABIS PAK',\n",
       " 'NARCAN',\n",
       " 'CYCLOSPORINE',\n",
       " 'ZOVIRAX',\n",
       " 'COMTAN',\n",
       " 'AZOR',\n",
       " 'JETREA',\n",
       " 'E-Z-HD',\n",
       " 'PROPRANOLOL HYDROCHLORIDE',\n",
       " 'DEFERASIROX',\n",
       " 'LABETALOL HYDROCHLORIDE IN DEXTROSE',\n",
       " 'TYVASO',\n",
       " 'DORZOLAMIDE HYDROCHLORIDE AND TIMOLOL MALEATE',\n",
       " 'OXYTOCIN',\n",
       " 'BARACLUDE',\n",
       " 'GRANISETRON HYDROCHLORIDE PRESERVATIVE FREE',\n",
       " 'LANTUS',\n",
       " 'ODEFSEY',\n",
       " 'XALATAN',\n",
       " 'SKYTROFA',\n",
       " 'AVEED',\n",
       " 'APTENSIO XR',\n",
       " 'VALTOCO',\n",
       " 'LUZU',\n",
       " 'H.P. ACTHAR GEL',\n",
       " 'XELSTRYM',\n",
       " 'REBIF',\n",
       " 'BREO ELLIPTA',\n",
       " 'EVOMELA',\n",
       " 'ALYMSYS',\n",
       " 'SORILUX',\n",
       " 'AMELUZ',\n",
       " 'LONSURF',\n",
       " 'WEGOVY',\n",
       " 'AVAPRO',\n",
       " 'KORLYM',\n",
       " 'TRAZODONE HYDROCHLORIDE',\n",
       " 'GALANTAMINE HYDROBROMIDE',\n",
       " 'ROZLYTREK',\n",
       " 'FORTESTA',\n",
       " 'TECHNELITE',\n",
       " 'PREGNYL',\n",
       " 'ISUPREL',\n",
       " 'HEMABATE',\n",
       " 'CYANOCOBALAMIN',\n",
       " 'METASTRON',\n",
       " 'ORFADIN',\n",
       " 'RYBELSUS',\n",
       " \"CHILDREN'S ADVIL COLD\",\n",
       " 'IBUPROFEN',\n",
       " 'ORSERDU',\n",
       " 'VAZALORE',\n",
       " 'NORLIQVA',\n",
       " 'VRAYLAR',\n",
       " 'RESTORIL',\n",
       " 'ADAKVEO',\n",
       " 'BRENZAVVY',\n",
       " 'KEVEYIS',\n",
       " 'PLUVICTO',\n",
       " 'ISTALOL',\n",
       " 'NIPENT',\n",
       " 'DOXORUBICIN HYDROCHLORIDE',\n",
       " 'ALUNBRIG',\n",
       " 'AGRYLIN',\n",
       " 'AMBIEN CR',\n",
       " 'FYLNETRA',\n",
       " 'DEXMEDETOMIDINE HYDROCHLORIDE',\n",
       " 'LACRISERT',\n",
       " 'RELEUKO',\n",
       " 'TECFIDERA',\n",
       " 'XIAFLEX',\n",
       " 'BENICAR HCT',\n",
       " 'PROHANCE',\n",
       " 'LIORESAL',\n",
       " 'METRONIDAZOLE IN PLASTIC CONTAINER',\n",
       " 'AEMCOLO',\n",
       " 'NOREPINEPHRINE BITARTRATE IN 5% DEXTROSE',\n",
       " 'BAVENCIO',\n",
       " 'LUVOX',\n",
       " 'RAZADYNE ER',\n",
       " 'HYSINGLA ER',\n",
       " 'IRESSA',\n",
       " 'VIVIMUSTA',\n",
       " 'OLPRUVA',\n",
       " 'LINEZOLID IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER',\n",
       " 'TOPAMAX',\n",
       " 'HYLENEX RECOMBINANT',\n",
       " 'LAMICTAL CD',\n",
       " 'RITALIN',\n",
       " 'RENAGEL',\n",
       " 'STERILE WATER FOR INJECTION IN PLASTIC CONTAINER',\n",
       " 'LUMIGAN',\n",
       " 'MYCAPSSA',\n",
       " 'TLANDO',\n",
       " 'MUCINEX DM',\n",
       " 'RELPAX',\n",
       " 'SULAR',\n",
       " 'ALOPRIM',\n",
       " 'INMAZEB',\n",
       " 'NORETHINDRONE ACETATE',\n",
       " 'ADMELOG',\n",
       " 'ESMOLOL HYDROCHLORIDE IN PLASTIC CONTAINER',\n",
       " 'COSMEGEN',\n",
       " 'NESACAINE',\n",
       " 'LIPIODOL',\n",
       " 'FOSCAVIR',\n",
       " 'CIMDUO',\n",
       " 'RISPERDAL',\n",
       " 'EXTINA',\n",
       " 'METHYLERGONOVINE MALEATE',\n",
       " 'FLUORODOPA F18',\n",
       " 'STEGLUJAN',\n",
       " 'DECITABINE',\n",
       " 'TRIPTODUR KIT',\n",
       " 'NORETHINDRONE AND ETHINYL ESTRADIOL AND FERROUS FUMARATE',\n",
       " 'BONSITY',\n",
       " 'VERKAZIA',\n",
       " 'ANGELIQ',\n",
       " 'CLARITIN-D 24 HOUR',\n",
       " 'LYRICA',\n",
       " 'PREZISTA',\n",
       " 'AVAGARD',\n",
       " 'EXTENDED PHENYTOIN SODIUM',\n",
       " 'SANCUSO',\n",
       " 'COMBIVENT RESPIMAT',\n",
       " 'DIPHENHYDRAMINE HYDROCHLORIDE PRESERVATIVE FREE',\n",
       " 'FLUPHENAZINE DECANOATE',\n",
       " 'SPEVIGO',\n",
       " 'SOLU-MEDROL',\n",
       " 'MESTINON',\n",
       " 'TALC',\n",
       " 'CAMPTOSAR',\n",
       " 'KLOR-CON M20',\n",
       " 'VASOSTRICT',\n",
       " 'PRADAXA',\n",
       " 'HEPARIN SODIUM 12,500 UNITS IN DEXTROSE 5% IN PLASTIC CONTAINER',\n",
       " 'TENORETIC 100',\n",
       " 'ANCOBON',\n",
       " 'PHOSPHOLINE IODIDE',\n",
       " 'ATOMOXETINE HYDROCHLORIDE',\n",
       " 'BASAGLAR',\n",
       " 'BREXAFEMME',\n",
       " 'SODIUM CHLORIDE 0.9%',\n",
       " 'AFREZZA',\n",
       " 'PROVENTIL-HFA',\n",
       " 'ORENCIA',\n",
       " 'ZYNLONTA',\n",
       " 'AN-SULFUR COLLOID',\n",
       " 'GAVRETO',\n",
       " 'TAGRISSO',\n",
       " 'TRISENOX',\n",
       " 'CLOZAPINE',\n",
       " 'ONGLYZA',\n",
       " 'GATTEX KIT',\n",
       " 'GOLYTELY',\n",
       " 'ONZETRA XSAIL',\n",
       " 'ABSORICA',\n",
       " 'INDOCIN',\n",
       " \"CHILDREN'S MOTRIN COLD\",\n",
       " 'OZURDEX',\n",
       " 'CHLORDIAZEPOXIDE AND AMITRIPTYLINE HYDROCHLORIDE',\n",
       " 'PIZENSY',\n",
       " 'MINOCYCLINE HYDROCHLORIDE',\n",
       " 'TECHNESCAN PYP KIT',\n",
       " 'MANGANESE CHLORIDE IN PLASTIC CONTAINER',\n",
       " 'ULTOMIRIS',\n",
       " 'KERYDIN',\n",
       " 'AJOVY',\n",
       " 'DALIRESP',\n",
       " 'ERYTHROMYCIN',\n",
       " 'ULTRACET',\n",
       " 'SUNLENCA',\n",
       " 'ZYKADIA',\n",
       " 'QWO',\n",
       " 'DIFLUCAN',\n",
       " 'FETZIMA',\n",
       " 'HUMATROPE',\n",
       " 'XENLETA',\n",
       " 'XTAMPZA ER',\n",
       " 'CORLANOR',\n",
       " 'TOLAK',\n",
       " 'PREVACID 24 HR',\n",
       " 'NORTHERA',\n",
       " 'CARBIDOPA AND LEVODOPA',\n",
       " 'MAXIDEX',\n",
       " 'ENTEREG',\n",
       " 'ANDROGEL',\n",
       " \"CHILDREN'S IBUPROFEN\",\n",
       " 'CAMPATH',\n",
       " 'PROGRAF',\n",
       " 'JEMPERLI',\n",
       " 'CENTANY',\n",
       " 'IMJUDO',\n",
       " 'ADUHELM',\n",
       " 'DIPRIVAN',\n",
       " 'SODIUM CHLORIDE 14.6%',\n",
       " 'OMNISCAN',\n",
       " 'TYBLUME',\n",
       " 'STENDRA',\n",
       " 'LAMPIT',\n",
       " 'ACTICLATE',\n",
       " 'MONOKET',\n",
       " 'BENZACLIN',\n",
       " 'OLOPATADINE HYDROCHLORIDE',\n",
       " 'ALDACTONE',\n",
       " 'BENICAR',\n",
       " 'DRAXIMAGE DTPA',\n",
       " 'LEVOLET',\n",
       " 'MICONAZOLE NITRATE COMBINATION PACK',\n",
       " 'ZITHROMAX',\n",
       " 'NEOSTIGMINE METHYLSULFATE',\n",
       " 'OMNIPAQUE 180',\n",
       " 'KYBELLA',\n",
       " 'GABITRIL',\n",
       " 'VITRAKVI',\n",
       " 'GLUCAGON',\n",
       " 'JALYN',\n",
       " 'SUTAB',\n",
       " 'ZULRESSO',\n",
       " 'RISPERIDONE',\n",
       " 'KRINTAFEL',\n",
       " 'LOSEASONIQUE',\n",
       " 'ZOCOR',\n",
       " 'DESVENLAFAXINE',\n",
       " 'FLAREX',\n",
       " 'CEREZYME',\n",
       " 'RITUXAN HYCELA',\n",
       " 'TOBI PODHALER',\n",
       " 'NEXOBRID',\n",
       " 'ANTARA (MICRONIZED)',\n",
       " 'DURAMORPH PF',\n",
       " 'BUPIVACAINE HYDROCHLORIDE',\n",
       " 'TRIJARDY XR',\n",
       " 'AMARYL',\n",
       " 'RYBREVANT',\n",
       " 'SOTYLIZE',\n",
       " 'OXERVATE',\n",
       " 'LUCENTIS',\n",
       " 'GEODON',\n",
       " 'DYMISTA',\n",
       " 'MACRODANTIN',\n",
       " 'DHIVY',\n",
       " 'MYFORTIC',\n",
       " 'VIAGRA',\n",
       " 'ELZONRIS',\n",
       " 'NATAZIA',\n",
       " 'ASPRUZYO SPRINKLE',\n",
       " 'TRELSTAR',\n",
       " 'TECHNESCAN',\n",
       " 'SAPHRIS',\n",
       " 'VESICARE',\n",
       " 'HUMALOG',\n",
       " 'HADLIMA',\n",
       " 'KLOR-CON',\n",
       " 'LOPINAVIR AND RITONAVIR',\n",
       " 'IXIFI',\n",
       " 'NUVESSA',\n",
       " 'YONSA',\n",
       " 'OMIDRIA',\n",
       " 'MAXALT-MLT',\n",
       " 'COLAZAL',\n",
       " 'TAYTULLA',\n",
       " 'ZANTAC',\n",
       " 'ZEGERID OTC',\n",
       " 'LOCOID LIPOCREAM',\n",
       " 'CAMZYOS',\n",
       " 'ADVAIR HFA',\n",
       " 'RETEVMO',\n",
       " 'LUPKYNIS',\n",
       " 'EDECRIN',\n",
       " 'CALDOLOR',\n",
       " 'TYRVAYA',\n",
       " 'TUKYSA',\n",
       " 'OFEV',\n",
       " 'ORACEA',\n",
       " 'GIVLAARI',\n",
       " 'INDIUM IN 111 OXYQUINOLINE',\n",
       " 'BECONASE AQ',\n",
       " 'DARZALEX FASPRO',\n",
       " 'OMEGAVEN',\n",
       " 'VUITY',\n",
       " 'RITUXAN',\n",
       " 'ATACAND',\n",
       " 'APOKYN',\n",
       " 'CHROMIC CHLORIDE IN PLASTIC CONTAINER',\n",
       " 'CYSVIEW KIT',\n",
       " 'ORTHO TRI-CYCLEN 21',\n",
       " 'MAXALT',\n",
       " 'TINIDAZOLE',\n",
       " 'ALLEGRA-D 12 HOUR ALLERGY AND CONGESTION',\n",
       " 'HETLIOZ LQ',\n",
       " 'SCEMBLIX',\n",
       " 'EOVIST',\n",
       " 'SILENOR',\n",
       " 'LUMIFY',\n",
       " 'OPSUMIT',\n",
       " 'PIFELTRO',\n",
       " 'SUTENT',\n",
       " 'TIGAN',\n",
       " 'ATELVIA',\n",
       " 'DAPTOMYCIN',\n",
       " 'ALEVE',\n",
       " 'PHESGO',\n",
       " 'KARBINAL ER',\n",
       " 'POSIMIR',\n",
       " 'AMITIZA',\n",
       " 'HYDROXYCHLOROQUINE SULFATE',\n",
       " 'SKLICE',\n",
       " 'ERYC',\n",
       " 'HIBICLENS',\n",
       " 'QUDEXY XR',\n",
       " 'FOSAPREPITANT DIMEGLUMINE',\n",
       " 'BETIMOL',\n",
       " 'BRINEURA',\n",
       " 'CERETEC',\n",
       " 'PENTASA',\n",
       " 'KONVOMEP',\n",
       " 'FARESTON',\n",
       " 'INTUNIV',\n",
       " 'ACEPHEN',\n",
       " 'PROPYLTHIOURACIL',\n",
       " 'OXYCODONE HYDROCHLORIDE',\n",
       " 'PROMETRIUM',\n",
       " 'DERMA-SMOOTHE/FS',\n",
       " 'NASACORT ALLERGY 24 HOUR',\n",
       " 'CALQUENCE',\n",
       " 'ADDERALL XR 10',\n",
       " \"CHILDREN'S CLARITIN\",\n",
       " 'XERESE',\n",
       " 'CIPRODEX',\n",
       " 'IMITREX',\n",
       " 'DONEPEZIL HYDROCHLORIDE',\n",
       " 'METROLOTION',\n",
       " 'MOUNJARO',\n",
       " 'PROTOPIC',\n",
       " 'VISTOGARD',\n",
       " 'COREG CR',\n",
       " 'CABLIVI',\n",
       " 'DIACOMIT',\n",
       " 'BONJESTA',\n",
       " 'LUMASON',\n",
       " ...}"
      ]
     },
     "execution_count": 15,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "set(drug_fda_dict.keys())"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "9c3fd467",
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "392fa846",
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "4f0f25fa",
   "metadata": {},
   "outputs": [],
   "source": []
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "Python 3 (ipykernel)",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.11.1"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 5
}
